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Abstract 
 
Due to their abundance in both natural products and synthetic pharmaceuticals, and their 
diverse and interesting biological properties, nitrogen containing compounds are of great 
importance to organic chemists. As such, synthetic methodology for the incorporation of 
nitrogen into organic compounds via the construction of C-N bonds is highly sought after. 
The research described in this thesis concerns the development of three methodologies 
for the synthesis of small nitrogen containing compounds via the amination of carbon sp2 
centres: 
 
1) Synthesis of N-Boc-aziridines  
Building upon recent reported methodology utilising O-(diphenylphosphinyl) hydroxylamine 
(DppONH2) as a nitrogen source for NH-aziridinations, studies were undertaken into the 
use of N-Boc-O-(diphenylphosphinyl) hydroxylamine (DppONHBoc) in the synthesis of N-
Boc-aziridines. Described herein are studies into the use of DppONHBoc as a nucleophilic 
nitrogen transfer agent (NNTA) for the aziridination of enones and vinyl sulfones under 
mildly basic conditions.  
 
2) Amination of aromatic C-H centres 
The use of a N-methyl morpholine (NMM)-derived aminimine as an aminating agent in the 
vicarious nucleophilic amination (VNA) of electron-deficient (hetero)arenes is also 
reported. Initial studies which used iodide hydrazinium salts as aminimines precursors in 
the amination of a range of electron-deficient substrates are described. An alternative 
reaction system utilising the in situ formation of NMM/DppONH2 hydrazinium salts, in-place 
of preformed hydrazinium salts, in the vicarious nucleophilic amination reaction was then 
developed. 
 
3) Synthesis of enantioenriched allylic amines 
Finally, the NCS-meditated amination/[2,3]-sigmatropic rearrangement of enantioenriched 
allylic selenides, utilising a range of amino acid derived and aryl amine nucleophiles, is 
used to access a wide range of novel vinyl glycine derived unnatural peptides and 
peptidomimetic products.  
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1 General Introduction 
 
The formation of C-N bonds is of great importance to organic chemists due to the 
abundance of nitrogen in both biologically active natural products and synthetic 
pharmaceuticals. As such, continued development of methodology for the incorporation of 
nitrogen into molecules is central to modern organic chemistry. The importance of nitrogen 
in both naturally occurring and synthetic compounds can be attributed a number of its 
fundamental properties,1 i.e. the basic character of the nitrogen lone pair, the hydrogen 
bond donating of the N-H bond, the capacity of nitrogen to carry a positive charge and, 
from the perspective of a medicinal chemist, the powerful effect that nitrogen modulation 
can have on the biological activity, for example the N-demethylation of analgesic 
morphine, affording normorphine with a corresponding four fold decrease in activity.2 
 
With this in mind, we set out to develop methodology for the synthesis of small nitrogen-
containing compounds via the incorporation of C-N bonds into organic molecules. To this 
end this thesis will describe the work investigating three reactions for amination of sp2 
carbon centres, accessing synthetically useful-nitrogen containing building blocks. Each 
chapter will provide a summary of the relevant literature associated with the project before 
going on to discuss in detail the work carried out for this thesis. 
 
N-Boc-aziridines are versatile building blocks offering opportunities for further manipulation 
via exploitation of the strained ring system. Chapter 2 will discuss work on the 
development of N-Boc-O-(diphenylphosphinyl)hydroxylamine as a nucleophilic nitrogen 
transfer agent for the synthesis of N-Boc-aziridines from both enones and vinyl sulfones. 
 
The direct amination of aromatic systems at C-H positions is a widely sought after and 
highly useful chemical transformation, circumventing the need for pre-functionalised 
aromatic systems, i.e. the use of aryl halides, or equivalents, in C-N cross coupling 
reactions. Whilst recently the development of transition metal catalysed direct C-H 
amination has been described, this field of chemistry is still relatively young and transition 
metal-free alternatives are still desirable. To this end vicarious nucleophilic amination of 
electron-deficient (hetero)arenes provides a simple route to amino-substituted aromatic 
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ring systems, without the need for pre-activation of the C-H centre or transition metal 
catalysts. Chapter 3 discusses the work into the use of aminimines as VNA aminating 
agents for the pseudo-C-H amination of electron-deficient (hetero)arenes. Initial work 
focused on the use of NMM derived hydrazinium iodide salts as aminating agents in VNA. 
Subsequent work then focused on the application of a DppONH2/NMM protocol for in situ 
hydrazinium formation to the VNA reactions, removing the need to handle stoichiometric 
amounts of hydrazinium salts. 
 
Finally, unnatural peptides and peptidomimetics have emerged as powerful tools in the 
development of novel drug compounds.3 Here, small molecules designed to mimic the 
natural peptide structure, but with key changes to the chemical structure, are used to 
improve drug like properties. Often increased metabolic stability is sought via replacement 
of a hydrolysable peptide bond with a more stable analogue or by the incorporation of 
unnatural amino acid side chains into peptides thereby increasing metabolic and 
conformational stability.4 Building upon previous work from the Armstrong group, Chapter 
4 focuses on the use of complex nitrogen sources in the synthesis of enantioenriched vinyl 
glycine derivatives via the amination/[2,3]-sigmatropic rearrangement of enantioenriched 
allylic selenides. The use of a range of amino acid amides, amino acid esters and N-aryl 
amines allows the synthesis of a wide range of vinyl glycine-derived unnatural peptides 
and peptidomimetics. This methodology was then tested in the synthesis of Perindopril, a 
marketed pharmaceutical containing a N,N-dicarboxymethlamine peptidomimetic motif.  
  
 14 
2 Use of O-(Diphenylphosphinyl) Hydroxylamines in the 
Aziridination of Enones and Phenyl Vinyl Sulfones 
 
In this chapter studies into the use of N-Boc-O-(diphenylphosphinyl) hydroxylamines 
(Figure 1) as nucleophilic nitrogen transfer agents (NNTA) in the synthesis of N-Boc 
aziridines will be discussed. 
 
 
Figure 1 General structure of O-(diphenylphosphinyl) hydroxylamines 
 
Numerous approaches for the synthesis of aziridines have been described in the literature 
and are covered in depth in the numerous reviews available on the subject.5–15 Typically 
methodologies for the synthesis of aziridines can be grouped into three general categories 
(Scheme 1); the transfer of a nitrogen source to olefins (route a), the transfer of a carbon 
source to imines (b) and the intramolecular cyclisation of amine derivatives (c).  
 
 
Scheme 1 General methodologies for the synthesis of aziridines 
 
Section 2.1 will focus on introducing literature examples of olefin aziridination (route a, 
Scheme 1) and in particular will focus on the use of metal nitrenoids and organocatalysts. 
Readers seeking an overview of other reported aziridination methodologies are directed to 
the reviews referenced above. 
 
Sections 2.2 and 2.3 will then go on to discuss our work into the use of DppONHBoc as a 
NNTA for the synthesis of N-Boc aziridines from both enones and vinyl sulfones. 
Ar P O
O
Ar
NHR
N
R"N-R" C
"         "
N R
NH XR
a b
c -HX
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2.1 Introduction 
2.1.1 Aziridination via Nitrene Additions to Alkenes 
 
The direct addition of a nitrene, or a nitrene equivalent, to an unsaturated hydrocarbon 
component is well documented as a method of aziridine synthesis. However, the use of 
free nitrene reagents, often generated by the thermal or photochemical decomposition of 
azides, is hampered by a number of limitations. These limitations include; the often-harsh 
reaction conditions required, competitive C-H insertion and poor cis/trans-stereocontrol. 
The poor observed cis/trans-selectivity results from the generation of both singlet and 
triplet nitrene intermediates. While singlet nitrenes insert in a concerted stereocontrolled 
manner (Scheme 2, Eq.1), the generally more stable triplet nitrene inserts in a stepwise 
manner (Eq. 2) via a transient diradical species that can undergo bond rotation. Facile 
conversion between singlet and triplet nitrenes, alongside the higher stability of the triplet 
nitrene, leads to mixtures of cis and trans-products.  
 
 
Scheme 2 Singlet vs. triplet nitrenes in the aziridination of alkenes 
 
The poor stereocontrol afforded by free nitrenes, and the harsh conditions needed to 
generate them, have led to the development of metal-stabilised nitrenes, which allow for 
use of milder reaction conditions and afford increased levels of stereocontrol. Furthermore, 
when combined with the use of chiral ligands, the use of metal-stabilised nitrenes allows 
the direct enantioselective preparation of aziridines from achiral alkenes. 
 
Eq. 1)
R1
R2
NR3
N
R1
R2
R3
Via:
R1 R2
NR3
Eq. 2)
R1
R2
NR3
N
R1
R2
R3
Via:
R1 R2
NR3
R1 R2
N
R3
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Copper-catalysed processes are the most widely employed metal-nitrenoid systems 
utilised in the aziridination of alkenes. The seminal work of Evans in 1993 described the 
use of bisoxazoline ligands in the CuOTf catalysed aziridination of cinnamate esters 
(where R1 = Me, tBu and Ph) with N-tosyliminobenzyliodinate (PhI=NTs) in excellent ee 
(94-97%) and good yields (60-76%) (Scheme 3).16 However, the methodology proved less 
reliable when applied to simple olefinic substrates such as styrene and trans-β-
methylstyrene (63% and 70% ee respectively). 
 
 
Scheme 3 Evans’ asymmetric aziridination of cinnamate esters using Cu-bisoxazoline-nitrenoids 
 
Simultaneously, Jacobsen developed a Cu-catalysed system utilising Schiff base ligands 
for the aziridination of a range of aromatic olefins (Scheme 4).17 Use of Schiff base ligand 
1 was found to afford the best results with good yields of the aziridine products (50-79%), 
though in general only moderate levels of enantioselectivity were observed (30-87% ee). 
However, with one example using a chromene derivative, a high yield (75%) and excellent 
ee (>98%) were observed. 
 
 
Scheme 4 Jacobsen’s asymmetric aziridination of aromatic olefins using Cu-Schiff base-nitrenoids 
 
More recently, Scott has utilised C2-symmetric biaryl Schiff bases in the Cu-catalysed 
aziridination of cinnamate esters with poor-to-good yields (32-89%) and high levels of 
enantioselectivity (88-99% ee).18 As with the examples from Evans and Jacobsen, Scott’s 
work suffered from poorer enantioselectivity for examples with simple olefin substrates, 
with the aziridination of styrene only proceeding with a 66% ee. Furthermore, the olefin 
PhI=NTs (2 eq.)
CuOTf (5 mol%), L* (6 mol%)
Ar
O
OR1 Ar
O
OR1
N
Ts
up to 97% ee
O
N N
O
R R
L* =
R = Ph, tBu, CMe2Ph
MeCN or toluene, rt, 24 h
PhI=NTs (1.5 eq.)
CuOTf (5-10 mol%), L* (6-12 mol%)
Ar R
1
R2 Ar
R1
R2
N
Ts N N
Cl
Cl
Cl
Cl
HH
L*=
1
CH2Cl2, - 40 °C, 15 min
up to >98% ee
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substrates were often required in excess (1-5 eq.) along with low reaction temperatures (-
40 °C) in order to obtain the optimal results. 
 
Kim has also reported the use of diimine ligands in the Cu-catalysed aziridination of simple 
olefins.19 Here, bisferrocenyldiamines are used as ligands in the CuOTf, PhI=NTs 
aziridination system affording moderate-to-good yields (65-88%) and generally good 
enantioselective (up to 98% ee). However, Kim’s methodology is let down by the 
requirement of a 10-fold excess of the olefin, relatively high catalyst loadings and yields 
that lag behind those observed using Scott’s reaction system. 
 
Xu has developed two additional bisoxazoline ligands, AnBoc20 and cHBox,21 for the Cu 
catalysed aziridination of chalcones. The cHBox ligand 2 proved to be the more effective of 
the two ligands, affording moderate-to-good yields (50-80%) and excellent 
enantioselectivities (80->99%) for the aziridination of both electron-rich and electron-
deficient chalcones (Scheme 5). However, the system suffers from two main drawbacks. 
Firstly, the requirement of a slight excess of the olefin (1.5 eq.) and secondly, the ligands 
were, again, not applicable to reactions with styrenes, affording very poor ee (6-15%). 
Both sets of ligands have been tested in the aziridination of 1,3-dienes, affording vinyl 
aziridines with modest yields and enantioselectivities and often poor diastereoselectivity.22 
 
 
Scheme 5 Xu’s Cu-cHBOX catalyst in the asymmetric aziridination of chalcones 
 
Ding reports the asymmetric aziridination of cinnamate esters using a C2-symmetric Cu-
diimine ligand system, synthesised from D-mannitol, with good-to-excellent 
enantioselectivities (80->99% ee). The presence of the co-ordinating group (C=O) in the 
cinnamate ester was found to be vital for the high levels of stereocontrol observed and, as 
such, the aziridination of simple olefins (e.g. styrenes) proceeded with poor 
stereocontrol.23 
PhI=NTs (2 eq.)
CuOTf (5 mol%), L* (6 mol%)
Ar
O
Ar Ar
O
Ar
N
Ts
up to >99% ee
O
N N
O
Ph Ph
S-cHBOX
2
L*=
CH2Cl2, rt, 6 h
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Hutchings reports the use of a Cu-exchange zeolite, along with Evans’ bisoxazoline 
ligands, in the aziridination of simple olefins without co-ordinating groups (e.g. styrenes), 
substrates often found to be troublesome in the Cu-nitrenoid systems described above.24 
The use of Cu-exchange zeolite allowed the aziridination of a range of styrenes with 
moderate-to-good enantioselectivities (64-95% ee). More recently, Li has used CuII 
complexes incorporating weakly co-ordinating anions for the racemic aziridination of 
styrene, with good yields and high levels of cis/trans selectivity.25 Trost and Dong also 
report a single example of the use of a N-heterocyclic carbene complex in the Cu-
catalysed aziridination of an electron-deficient cyclopentene during the total synthesis of 
(+)-agelastatin A.26 
 
One issue with the use of N-tosyliminobenzyliodinate, as a nitrogen source for 
aziridinations, are the often-problematic de-protections of the N-tosyl aziridines products. 
Dauban has overcome this by developing a 2-(trimethylsilyl)ethanesulfonyl protected 
iminobenzyliodinate for use in Cu-catalysed aziridination and has shown the subsequent 
deprotection of the N-Ses aziridines can be achieved in good yields using 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF).27,28 Dauban has also 
developed methodology for the in situ synthesis of iminobenzyliodinate via the reaction of 
iodosylbenzene (PhI=O) with sulfonamides and applied this to the synthesis of a range of 
simple and electron-deficient olefins, with yields comparable to examples using the 
preformed iminobenzyliodinates.29 However, when combined with the use of Evans’ chiral 
bisoxazoline ligand, this in situ methodology was found to be less enantioselective than 
the reaction system reported by Evans, with the aziridination of styrene proceeding with 
only a 59% ee. 
 
While Cu-nitrenoid systems are by far the most commonly applied to the aziridination of 
olefins other metal-nitrenoid systems (including Mn, Ru, Rh, Co, Fe and Ag) have been 
developed. These systems are often complimentary to the Cu systems due to their 
increased tolerance of substrates often incompatible with Cu-catalysed aziridination, such 
as use of simple styrene derivatives. 
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An early example by Katsuki utilised Mn-salen complexes for the aziridination of styrene 
with PhI=NTs, with good yields (76%) and high enantioselectivity (94%).30 However, lower 
yields and enantioselectivity were afforded with the use of substituted styrenes. Komatsu 
has also utilised Mn-salen-nitrodo complexes, in conjunction with a silver salt additive, in 
the aziridination of trans-substituted styrenes with moderate yields (50-70%) and high 
enantioselectivities (83-93% ee).31 However, this system suffers from the lower selectivity 
with the use of styrene and cis-substituted styrene derivatives, and the requirement of a 
large excess (10 eq.) of the olefin. 
 
Katsuki has achieved greater success with the use of Ru-salen complex 3 and a range of 
N-protected azides for the aziridination of a wide range of substrates, including styrenes, 
an enoate, an enamide, an ene-yne, indene as well as an unfunctionalised 1-octene, with 
generally moderate-to-good yields (28-99%) and excellent levels of enantioselectivity (92 
to >99% ee) (Scheme 6).32,33 
 
 
Scheme 6 Katsuki’s Ru-salen catalysts for the asymmetric aziridination of terminal olefins 
 
Du Bois provided examples of the use of Rh-catalysis in the racemic aziridination of both 
aromatic and aliphatic alkenes, including terminal alkyl examples, using sulfamate esters 
or phosphoramides as nitrogen sources with generally good yields (57-95%) (Scheme 7).34 
The use of Rh2(tfacam)4 (tfacam = CF3CONH) allowed for high selectivity for π-
functionalisation over the competitive σ-CH functionalisation, often observed with the use 
of similar Rh catalysts. Later, Du Bois applied this methodology for the diastereoselective 
intramolecular aziridination of chiral sulfamate esters.35 
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Scheme 7 Du Bois’ RhII-catalysed aziridination of alkenes 
 
Lebel provides further examples of the use of Rh-catalysis in the aziridination of styrene 
derivatives using chiral N-tosyloxycarbamates with moderate-to-good yields (51-85%) and 
poor-to-good diastereoselectivities (70:30 to 98:2 d.r.).36 
 
Recently, Zhang developed a CoII-porphyrin catalysed aziridination of styrenes with 
trichloroethoxysulfonyl azide (Tces-N3) with moderate-to-good yields (43-93%) and 
excellent enantioselectivities (80-99% ee).37 Notably this methodology could be applied to 
the use of α-methyl styrene and terminal alkyl olefins, albeit with a slight reduction in 
yields.  
 
Bolm has developed an Fe-catalysed racemic aziridination of a range of olefin substrates 
generally affording generally good yields (24-90%), although lower yields were observed 
with cis- and 1,1-dimethyl examples.38 Use of Evans’ bisoxazoline ligand in the reaction 
system allowed the asymmetric aziridination of styrene, with a 72% yield and a 40% ee.  
 
Finally, Perez has developed a reaction system using silver complexes bearing 
trispyrazolylborate ligands (Tp*,BrAg) for the racemic aziridination of 2,4-diene-1-ols by 
PhI=NHTs with good regioselectivity for the allylic alkene and proceeded in a 
stereocontrolled manner, i.e. E-alkenes afforded trans-aziridines and Z-alkenes afforded 
cis-aziridines.39,40 Perez proposes that co-ordination of the hydroxy group to the oxygen of 
the N-tosyl protecting group is responsible for directing the aziridination and the high 
selectivities observed. This hypothesis is further support by poorer results obtained with 
the use of protected 2,4-diene-1-ols. 
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2.1.2 Organocatalytic Methods for the Aziridination of Alkenes 
 
In this section, three general types of organocatalysis used in the aziridination of electron-
deficient alkenes will be covered, all linked by their use of nucleophilic nitrogen-transfer 
agents (NNTA). The topics covered will be; the use of chiral quaternary ammonium salts, 
the use of aminocatalysed processes and finally amine-promoted aziridination with 
aminimines (N-N ylides).  
 
With the use of NNTA typically the nucleophilic reagent possesses a nitrogen centre with 
an attached leaving group and reacts via initial conjugate addition to the electron-deficient 
alkene. This is followed by ring closure/displacement of the leaving group affording the 
aziridine product (Scheme 8). Variation of the substituents on the nitrogen source allows 
the synthesis of a range of N-protected aziridines, as well as N-H aziridines not readily 
accessed via the metal-nitrenoid methodologies discussed above. 
 
 
Scheme 8 Aziridination of enones with nucleophilic nitrogen transfer agents 
 
2.1.2.1 Use of Chiral Quaternary Ammonium Salts 
 
An early example of the use of organocatalysis in the aziridination of electron-deficient 
alkenes was reported in 1996 by Prabhakar.41,42 Prabhakar’s use of quaternary salts of 
cinchona alkaloids as phase transfer catalysts (PTC), with N-hydroxy-N-pivaloylanilines, 
allowed the aziridination of a range of acyclic electron-deficient alkenes to afford N-aryl 
aziridines with moderate yields and enantioselectivity (up to 61% ee). Murugan further 
developed this methodology through the use of PTC 4 with a range of N-aryl-hydroxamic 
acid and low concentrations of NaOH affording the corresponding N-aryl aziridines in 
moderate-to-good yields (53-92%) and higher ee (up to 98% ee) than achieved using the 
Prabhakar methodology (Scheme 9). Furthermore, the use of the pseudo-enantiomer of 
PTC 4 allows access to the opposite enantiomers with similar yields and enantioselectivity. 
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Scheme 9 Murugan’s PTC-mediated asymmetric aziridination of electron-deficient olefins 
 
The aziridination of electron-deficient alkenes with hydroxamic acids is proposed to 
proceed by an initial deprotonation of the hydroxamic acid 5, followed by rearrangement 
via oxaziridine 6 to afford the reactive NNTA N-acyloxyaniline anion 7 (Scheme 10).43 
 
 
Scheme 10 Base-mediated, in-situ formation of N-acyloxyaniline anion 7 
 
Tardella and co-workers have applied this PTC methodology to the aziridination of 2-
phenylsulfanyl-substituted cyclic enones, of varying ring size, with N-
nosylhydroxycarbamate and cinchona alkaloid salt 8, affording the corresponding 
aziridines with up to 75% ee (Scheme 11).44 
 
 
Scheme 11 PTC-catalysed asymmetric aziridination of 2-phenylsulfanyl-substituted cyclic enones 
 
Minakata has reported the aziridination of α,β-unsaturated amides with up to 87% ee using 
N-chloro-N-sodiocarbamates with a range of cinchona alkaloid derived PTC, although for 
optimum enantioselectivity a reaction temperature of -20 °C, along with the use of 2 eq. of 
alkene, was required (Scheme 12).45 Further reaction with catalytic DMAP in methanol 
allowed removal of the auxiliary amide group. Minakata subsequently combined this 
methodology with the use of chiral auxiliaries for the diastereoselective aziridination of α,β-
unsaturated amides with excellent stereocontrol (up to >99:1 d.r.).46 
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Scheme 12 Minakata’s PTC-catalysed asymmetric aziridination of α,β-unsaturated amides 
 
2.1.2.2 Use of Aminocatalysis 
 
Despite the successes with the use of chiral PTC catalysts in the enantioselective 
aziridination of electron-deficient alkenes, in many cases the reactions were found to be 
variable in both the yields obtained and the degree of stereocontrol observed. The use of 
chiral primary and secondary amine catalysts has been found to afford more robust 
reaction systems with, in general, higher levels of enantioselectivity. Typically, in these 
processes, the aminocatalyst facilitates the reaction by activation of the enal, or enone, 
substrate via initial formation of an electrophilic iminium species, followed by conjugate 
addition of the NNTA reagent, typically a hydroxamic ester, and then ring closure to afford 
the aziridine product. 
 
Córdova in 2007 reported the use of secondary amine diphenylprolinol catalyst 9 in 
asymmetric aziridination of a range of enals, using acylated hydroxycarbamates, with 
moderate-to-good yields (54-78%) and excellent enantiocontrol (84-99% ee), although only 
moderate diastereoselectivity was observed (4:1 to 19:1 d.r.) (Scheme 13).47 Córdova has 
since expanded the scope of this reaction to include α-substituted terminal enals48 and a 
range of α,β-disubstituted-α,β-unsaturated aldehydes.49 Greck also reported the 
asymmetric aziridination of α-branched enals in good yields and high enantioselectivities 
under similar conditions using the bis-(3,5-(CF)3-C6H3 prolinol catalyst 10.50 
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Scheme 13 Prolinol catalysed asymmetric aziridination of α,β-unsaturated aldehydes 
 
Hamada further developed this methodology with the use of sulfonylhydroxycarbamates 
along with TES-protected prolinol catalyst 11 improving upon diastereoselectivity observed 
under the Córdova conditions.51 In particular Hamada applied these conditions to the 
aziridination of aromatic enals with good yields and excellent levels of enantio- and 
diastereoselectivity (94-99% ee and >99:1 d.r.). However, the reaction only tolerated the 
use of electron-deficient aromatics and required a lower reaction temperature of -20 °C. 
 
Jørgensen has applied similar methodology to the aziridination of cyclic 2,4-dienals with 
TMS-protected prolinol catalyst ent-10, with aziridination occurring regioselectively at the 
endocyclic double bond, affording aziridines in up to 95% ee (Scheme 14).52 
 
 
Scheme 14 Jørgensen’s prolinol catalysed asymmetric aziridination of cyclic 2,4-dienals 
 
Melchiorre has applied a similar approach to the asymmetric aziridination of enones with 
sulfonylhydroxycarbamates, employing primary amine catalyst 12, to afford trans-aziridine 
products with good yields and, generally, excellent enantioselectivity (73-99% ee), though 
long reaction times were required (up to 72 h) (Scheme 15).53 Substitution at the β-olefin 
position was well tolerated with a range of alkyl, ester and aromatic examples, while only 
simple alkyl substitution was reported at the ketone (R2 = Me and Et). 
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Scheme 16 Melchiorre’s primary amine catalysed asymmetric aziridination of enones 
 
Melchiorre has subsequently expanded the scope to the asymmetric aziridination of cyclic 
enones.54 The use of 5, 6 and 7-membered rings were all well tolerated and underwent 
aziridination with generally good yields (33-93%) and good levels of stereocontrol (85-99% 
ee). While β-substitution was well tolerated, α-substitution was not and the cyclic enones 
were required in slight excess (1.2 eq.). The use of the pseudo-enantiomer of 12 allowed 
the aziridine of the opposite enantiomer to be accessed in similar yields and 
enantioselectivity. 
 
Hamada has reported the use of chiral diamine catalyst 13 for the asymmetric aziridination 
of cyclic enones with sulfonylhydroxycarbamates, with good yields (75-91%) and high 
enantioselectivity (88-97%), though the scope was limited to unsubstituted examples 
(Scheme 16). 
 
 
Scheme 16 Hamada’s diamine catalysed asymmetric aziridination of cyclic enones 
 
2.1.2.3 Use of Aminimines 
 
Finally, recent studies have highlighted the efficacy of N-N ylides (also referred to in the 
literature as aminimines and aminimides) as NNTA for the aziridination of electron-
deficient alkenes. The first reported example of the in situ formation of an aminimine and 
its use in the aziridination of chalcones comes from Ikeda in 1980.55 Under the Ikeda 
protocol the aminimine 14 is formed via the ring opening of propene oxide with 1,1-
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dimethylhydrazine, which, upon addition of the chalcone substrate, provided the aziridine 
product in moderate-to-good yields (67-89%) (Scheme 17). 
 
 
Scheme 17 Ikeda’s aziridination of chalcones with aminimine 14 
 
Xu has utilised hydrazinium salts as aminimine precursors in the aziridination of α,β-
unsaturated ketones.56 Xu employed DABCO derived bishydrazinium salt 15 for the 
aziridination of a range of chalcones and a single β-alkyl-substituted enone example in 
generally good yields (15-99%) (Scheme 18). Lower yields were observed with the use of 
nitro-substituted chalcones and the use of aliphatic enones, enolates and enamides were 
not tolerated.  
 
 
Scheme 18 Xu’s aziridination of α,β-unsaturated ketones using bishydrazinium salt 15 
 
More recently, Armstrong and co-workers utilised NMM derived hydrazinium salts 16 for 
the aziridination of chalcones, in generally moderate-to-good yields (17-95%) (Scheme 
19).57 Two sets of reaction conditions were developed with differing reactivity; use of the 
iodide salt 16a with KOtBu in DMSO displayed greater reactivity with electron-rich enones, 
while the use of nitrate salt 16b with NaOH in MeCN afforded better yields with the use of 
electron-deficient substrates. However, as with the work of Xu, neither set of conditions 
tolerated the use of alkyl-substituted enones. 
 
 
Scheme 19 Armstrong’s aziridination of chalcone using hydrazinium salt 16 
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Subsequent work by both Shi and Armstrong further developed this methodology through 
the use of tertiary amines and an appropriate electrophilic nitrogen source, allowing for the 
in situ formation of the hydrazinium salts via amination of the tertiary amine mediator. In 
2006 Shi reported the use of NMM with aminating agent O-(mesitylenesulfonyl) 
hydroxylamine 17 (MSH) and KOH for the in situ formation of aminimine 18.58 Application 
of this system to the aziridination of a wide range of chalcones, with a broad range of 
aromatic substitution, proceeded with moderate-to-good yields (49-85%) (Scheme 20). Shi 
also reported that the use of catalytic loadings of the tertiary amine (down to 10 mol%) 
were tolerated. Finally, Shi utilised a chiral tertiary amine, Trögers base 19, for the 
asymmetric aziridination of chalcone with moderate enantioselectivity (67% ee). 
 
Scheme 20 Shi’s aziridination of chalcone with in situ aminimine formation 
 
Armstrong showed that aminimine 18 could be generated in quantitative yields through the 
reaction of NMM, under basic conditions, with electrophilic aminating agent O-
(diphenylphosphinyl) hydroxyamine 20 (DppONH2) (Scheme 21).59  
 
 
Scheme 21 Armstrong’s enone aziridination with in situ formation of NMM-derived aminimine 18 
 
This methodology was then applied to the aziridination of a range of aromatic enone 
substrates, β-aromatic and β-alkyl, as well as a few α,β-unsaturated esters with generally 
good yields (32-97%) and complete trans-selectivity (Scheme 22). Further studies have 
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expanded the substrate scope of this reaction to both the aziridination of α,β,γ,δ-
unsubstituted ketones, with high selectivity for the α,β-olefin, providing access to a range 
of vinyl aziridines,60 and the aziridination of tert-butyl cinnamates.61 An asymmetric variant 
using chiral tertiary amines derivatives, of which quinine afforded the highest 
enantioselectivity, allowed the aziridination of chalcones and heteroaromatic-substituted 
enones with up to 77% ee.62 
 
 
Scheme 22 Armstrong’s aziridination of α,β-unsaturated ketones and esters 
 
Page has also utilised electrophilic aminating agent DppONH2 with bisnaphthalene-based 
chiral amines in the aziridination of chalcone, affording up to 43% ee.63 However, poor 
conversion was observed even after extended reaction times, with only 10% conversion 
after 48 hours at room temperature. 
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2.2 Project Aims 
 
The aziridination protocols, using O-(diphenylphosphinyl) hydroxylamine (DppONH2), 
previously developed in the Armstrong group reaction conditions required strong hydroxide 
or alkoxide bases (pKaH ca. 15.5-17),57,62,61 the use of which can lead to unwanted side 
reactions with base sensitive substrates. It was proposed that use of a N-substituted 
aminating reagent, such as N-Boc-O-(diphenylphosphinyl) hydroxylamine (DppONHBoc) 
with the increased acidity of its hydrazinium proton, would allow for the use of weaker 
bases, such as metal carbonates (pKaH ca. 10.3), in place of the hydroxide/alkoxide bases 
required for the NMM/DppONH2 reaction system. The use of the weaker carbamate base 
should afford an increased functional group tolerance and yields in the aziridination of 
base sensitive substrates, such as enones possessing enolizable and/or allylic protons.  
 
Initial test reactions, performed within the Armstrong group, had shown promising results 
for the use DppONHBoc in place of DppONH2 in the aziridination of enones.64 A summary 
of this work is described below in Table 1 and the text following it. 
 
The aim of the work described in this chapter was to continue on from this work and further 
develop the use of DppONHBoc as an alternative to DppONH2 in the aziridination of 
electron-deficient alkenes, allowing access to a range of N-Boc aziridines products, 
including substrates inaccessible via the DppONH2/NMM protocols. 
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2.3 Results and Discussion 
2.3.1 Use of DppONHBoc in Enone Aziridination 
 
Initially DppONHBoc 21 was tested in the aziridination reaction, as an alternative to 
DppONH2, using an enolizable enone prone to side reactions with the use of stronger 
hydroxide bases.  
 
DppONHBoc itself is easily accessed in near-quantitative yields from N-Boc-
hydroxylamine and diphenylphosphinic chloride (DppCl) (Scheme 23).65  
 
 
Scheme 23 Preparation of DppONHBoc 
 
Previous work in the Armstrong group used dialkyl substituted enone 22 as a test 
substrate for the DppONHBoc mediated aziridination.64 Enone 22 was chosen as it 
contained enolizable protons at both the ketone α-position and the allylic position. Only a 
limited scope of aliphatic enones containing allylic protons have been successfully utilised 
in the DppONH2/NMM mediated NH-aziridination59 and the successful aziridination of an 
enone with an enolizable proton at the ketone α-position has yet to be reported. 
 
Enone 22 was synthesised in one step via a Wittig reaction of the corresponding 
commercially available phosphorane and aldehyde. The initial studies then tested the 
DppONHBoc-mediated aziridination of enone 22 with a range of carbonate and hydrogen 
carbonate bases (Table 1).  
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Entry Base  Reaction Conc. (M) t (h) Conversion (%) a Yield (%) a  
 1 ii NaHCO3 0.044 16 <5 -  
2 i K2CO3 0.044 16 40 trace  
3 i Cs2CO3 0.044 16 63 63  
4 i Cs2CO3 0.044 40 85 85 (74) b  
5 i,c Cs2CO3 0.044 40 76 76  
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard.  
b Isolated yields, following column chromatography, in parentheses. c Reaction performed without NMM.  
Table 1 N-Boc aziridination of alkyl enone 22 with DppONHBoc i 
 
Initial attempts using NaHCO3 and K2CO3 (Entries 1&2) gave poor conversion of the 
starting enone and either no observable yield (NaHCO3, Entry 1), or only trace yield 
(K2CO3, Entry 2) of the desired N-Boc aziridine 23. The use of Cs2CO3 gave a 
considerable improvement in both the conversion of the starting enone and the yield of the 
product, possibly due to the increased solubility of Cs2CO3 in organic solvents relative to 
the sodium and potassium analogues, affording a 63% yield after 16 hours with no other 
significant product being formed (Entry 3). An increase in the reaction time to 40 hours 
(Entry 4) afforded an 85% conversion of the starting enone, although the poor stability of 
the product, during SiO2 column chromatography, resulted in a reduced 74% isolated yield 
following purification. Importantly, no side reactions were observed with good mass 
recovery and a crude reaction mixture made up solely of the enone, the aziridine product 
and DppONHBoc and its by products. 
 
Finally, a test reaction performed in the absence of NMM (Entry 5) only resulted in a slight 
decrease in conversion to the desired aziridine product and again with no other side 
reactions observed. This result seems to suggest a minimal role for the tertiary amine in 
the reaction and that the DppONHBoc was itself acting as the nucleophilic nitrogen 
transfer agent, without prior activation as the aminimine.  
 
                                            
i Reactions performed by Dr R.D.C. Pullin. 
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Considering these preliminary results, our work initially focused on further optimising the 
reaction. Here we proposed that simply increasing the concentration of the reaction would 
allow for an increased conversion without the need to increase the already lengthy reaction 
time. Further, we wished to ascertain if any aminimine was being formed when the 
DppONHBoc was used in place of the DppONH2 and, as such, if the DppONHBoc was 
itself acting as the NNTA for the aziridination of enone 22. Once this work was complete, 
the scope of the DppONHBoc-mediated N-Boc aziridination was then investigated. 
 
A further reaction carried out at double the concentration (0.088 M), and in the absence of 
NMM, afforded a 92% conversion of the starting enone 22 with a corresponding 92% NMR 
yield of aziridine 23. Again, loss of product was observed during purification affording an 
84% isolated yield of aziridine 23. The reaction was completely diastereoselective for the 
trans-aziridines, as determined by the 3J2H-3H coupling of the aziridine ring (2.6 Hz, 
generally cis-aziridine = ca. 7-9 Hz and trans-aziridine = ca. 2-4 Hz).53,59 
 
One possible reason for the lack of NMM promotion is that the electrophilic amination of 
NMM was not possible with DppONHBoc and the corresponding salt was not forming. 
While after 30 minutes a 1:1 solution of the unprotected DppONH2 and NMM (in CH2Cl2) 
affords a quantitative yield of ammonium diphenylphosphinate salt 24, attempts at an 
analogous reaction with DppONHBoc showed, by 1H NMR, no conversion of either starting 
material after 30 minutes (Scheme 24). 
 
 
Scheme 24 Ammonium diphenylphosphinate salt formation with O-(diphenylphosphinyl) hydroxylamines 
 
The results above support the hypothesis that no hydrazinium salt is formed during the 
aziridination reactions utilising DppONHBoc and suggests that NMM has no role in 
promoting the aziridination reaction through aminimine formation. This lack of salt 
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formation means that DppONHBoc is likely acting as a nucleophilic nitrogen transfer 
agent, with diphenyl phosphinic acid acting as the leaving group in the ring closure step 
(Scheme 25), rather than an electrophilic nitrogen source, as is the case in the NMM 
mediated aziridination with DppONH2. 
 
 
Scheme 25 DppONHBoc acting as a NNTA in the N-Boc Aziridination of enones 
 
With the aziridination of enone 22 affording high yields of the N-Boc aziridine product 23, 
the scope of DppONHBoc as a NNTA in the aziridination of electron-deficient enones was 
then studied (Table 2). A range of alkyl and aryl substituted enones were tested in the 
reaction, including examples with enolizable protons at the ketone α-position and/or allylic 
position, as well as examples with sterically bulky ketone substituents. The enone 
substrates, when not commercially available, were accessed via Wittig reactions of the 
corresponding aldehydes and phosphoranes (see Experimental Section 5.2.1). All 
examples were completely diastereoselective for the trans-aziridines according to 1H NMR 
analysis, as determined by the 3J2H-3H coupling of the aziridine ring (typically ca. 2.6 Hz). 
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Entry Enone Product Conversion (%) a Yield (%) a,b 
1 
 
23 92 92 (84) 
2 
 
33 95 72 (54) 
3 
 
34 55 25 (24) 
4 
 
35 65 29 (24) 
5 
 
36 100 94 (89) 
6 
 
- 0 - 
7 
 
- 0 - 
8 
 
- 0 - 
9 
 
37 56 16 (11) 
a  Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. b Isolated 
yields, following column chromatography, in parentheses. 
Table 2 Substrate scope of DppONHBoc mediated N-Boc aziridination of enones 
 
Initially more hindered enones were considered, testing whether this methodology could be 
complementary to the prolinol catalysed aziridinations described earlier in this chapter (see 
Section 2.1.2.2), where the aziridination of enones with bulky ketone substituents has 
proven difficult due to the sterically bulky ketone substituents slowing/preventing 
condensation of the prolinol catalyst with the enone. The reaction of ethyl substituted 
enone 25 (Table 2, Entry 2) showed high conversion (95%); however, unlike the methyl 
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 35 
substituted example discussed previously (Entry 1), the aziridine 33 was not the only 
product of the reaction, with a number of other small side product peaks observed in the 
crude NMR spectrum. Despite this and, again, the poor stability of the product during 
purification (SiO2 column), the aziridine product 33 was still isolated in a moderate 54% 
yield. The use of tert-butyl enone 26 (Entry 3) gave a much lower conversion (55%) and 
only a 24% isolated yield of aziridine 34. Despite the poor isolated yield, this result was 
particularly noteworthy as alternative aziridination methodologies utilising prolinol catalysis 
have not been reported to be compatible with tert-butyl enones and the use of the 
DppONHBoc aminating agent has allowed the first reported synthesis of aziridine 34.  
 
The aziridination of dialkyl enones is problematic under a number of conditions discussed 
in the introduction and these substrates often afford lower yields than aryl substituted 
examples. A number of reasons have been proposed for the increasing discrepancies 
between the high enone conversion and poorer yields of aziridine product obtained with 
the use of enone substrates with increasingly bulky ketone substituents. The first is the 
stability of the N-Boc aziridine products, which were found to decompose (< 1 week) 
despite being stored at low temperature (-20 °C). Though the bulky tert-butyl ketone 
substituted aziridine 34 did show the highest stability on silica, with only a 1% loss of 
product during column chromatography, perhaps due to the bulky substituent preventing 
loss of product by slowing the rate of nucleophilic attack at the ketone in the product 
aziridine. A second possible reason would be a decrease in the rate of the ring-closing 
step, perhaps due to increased steric hindrance associated with the use of increasing 
bulky ketone substituents, slowing the rate of product formation. 
 
Again, the use of dialkyl enone 27 (Entry 4) afforded a high conversion, 65%, but only a 
modest (24%) isolated yield of corresponding aziridine 35. The aziridination of enone 
substrate 28 (Entry 5), with no enolizable protons at the ketone α-position, preceded 
smoothly giving a 100% conversion, and a pleasing 89% isolated yield of the aziridine 
product.  
 
The use of enone substrates with extended conjugation of the enone into an aromatic ring 
failed to afford any conversion of the starting materials (Entries 6-8). While the exact 
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reason for this observed reactivity is not currently known, it is thought the lower reactivity 
observed with enones 29, 30 and 31 arises due to the 1,4-addition of DppONHBoc 
breaking the direct conjugation that exists between the aromatic ring and the α,β-
unsaturated ketone, with the corresponding loss of the aromatic resonance stabilisation. 
Additionally, in the case of tri-substituted enone 31 addition of DppONHBoc is further 
hindered by the increased steric bulk around the α,β-unsaturated carbons. 
 
In prolinol catalysed epoxidations66–68 comparable enone substrates have been tested and 
a similar trend in reactivity is observed (as with aziridination of enones using 
DppONHBoc). Where enones with aryl substituents at the allylic position (such as enone 
29) typically afford lower yields than the corresponding alkyl-substituted analogues (when 
the ketone substituent is an alkyl group). However, none of these examples show a 
complete cut-off in reactivity as observed with the use of aryl enones in the DppONHBoc-
mediated aziridination. 
 
Finally, use of cyclic enone 32 allowed access to aziridine 37 in a poor 11% isolated yield, 
despite a moderate conversion (56%) of the starting material. 
 
While this methodology does have some promise as an alternative to the more standard 
prolinol catalysed synthesis of N-Boc aziridines, it is hampered by both the limited 
substrate scope and the variable yields achieved. In order to try to improve the usefulness 
of this methodology, work was undertaken to expand the scope of this aziridination to 
other electron-deficient alkenes.  
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2.3.2 Use of DppONHBoc in Aziridination of Vinyl Sulfones 
 
Two substrates that had proven incompatible with the DppONH2/NMM methodology were 
chosen, namely phenyl vinyl sulfone and acrylonitrile (Table 3).  
 
 
Entry Substrate Product t (h) Conversion (%)a Yield (%)a,b 
1  - 40 50 <5 
2  38 2 85 54 (52) 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using  
Bn2O as an internal standard. b Isolated yields, following column chromatography, in parentheses. 
Table 3 Attempted N-Boc aziridination of electron-deficient alkenes 
 
Whilst attempts with the vinyl cyanide gave a moderate conversion, only minimal yields of 
the aziridine product were afforded. However, use of the phenyl vinyl sulfone afforded a 
promising 52% isolated yield of the sulfone-substituted aziridine 38. The remainder of the 
mass balance was shown to be the non-ring closed (NRC) product 39 (Figure 2) present in 
a 33% NMR yield. The NRC product 39 was not stable on SiO2; however, the use of 
preparative HPLC allowed isolation of NRC product 39, though still with significant loss of 
the product during purification (18% isolated yield). 
 
 
Figure 2 Non-ring-closed (NRC) product 
 
No further reaction of the NRC product 39 was observed upon re-submission to the 
reaction conditions, suggesting that the Cs2CO3 is not a strong enough base to 
deprotonate at the α-position of the sulfone (pKa ~30). Attempts at ring closure with a 
stronger base, NaOH, resulted in nucleophilic attack at the phosphorus in preference to 
deprotonation, giving rise to hydroxylamine product 40 (Scheme 26). No further bases 
were tested for the ring closing of the NRC product and instead a range of alternative 
bases were later tested in the aziridination with phenyl vinyl sulfone, see below. 
R
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Scheme 26 Attempts at NaOH mediated ring closure of NRC product 39 
 
Two reasons were proposed for the presence of the NRC product in the crude reaction 
mixture. Firstly, the aziridination of phenyl vinyl sulfone using DppONHBoc proceeds via a 
fast addition step followed by a slower rate determining ring-closing step and the reaction 
was time was not sufficient to allowed to go to completion. Secondly, the preferred 
explanation, that the addition product was being quenched/protonated under the reaction 
conditions, preventing ring closure, and that under the weakly basic conditions de-
protonation of the resulting NRC intermediate was not possible. 
 
To test these two hypotheses for the presence of the NRC product, initial studies looked at 
yields of desired N-Boc aziridine product 38 versus the undesired NRC product 39 at 
various time points over the course of the reaction. Due to the heterogeneous nature of the 
reaction mixture, reaction monitoring via sampling of a single reaction was not deemed a 
suitable method of reaction monitoring. As such, multiple reactions were run with the 
reactions quenched and worked up after a set time period. The 1H NMR yields of the 
starting material (SM), aziridine 38 and NRC product 39 in the crude reaction mixture were 
then calculated, relative to Bn2O as an internal standard (Figure 3). 
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Figure 3 Formation of N-Boc aziridine 38 and NRC product 39 with varying reaction time 
 
The results from the reaction monitoring show an initial rapid decrease in the concentration 
of the starting material along with a spike in the concentration of the NRC-product 39, 
which gradually decreases over the course of the reaction. (It should be noted that these 
results are after the quenching of the reaction with NH4Cl (sat. aq.). As such the yield of 
NRC product 39, at each time point, represents the combined concentration in the reaction 
mixture of the anionic addition intermediate and any protonated NRC product 39.) 
 
The rate of product formation is constant for the first two hours (up to 50% yield) after 
which rate of product formation dramatically decreases with only an additional 4% yield in 
the subsequent 2 hours. When left for a longer time period there is limited further 
conversion of the NRC intermediate to the aziridine product, up to a yield of 59% after 8 
hours. After 8 hours no significant further conversion was seen (<1%, data not shown in 
Figure 3). The lack of significant conversion of the NRC intermediate to the desired 
aziridine with increased reaction time (> 4 hours) indicates that the more likely reason for 
presence of the NRC product in the crude reaction mixture is the quenching of the 
intermediate anion affording the NRC product 39 (which as shown above cannot be 
deprotonated under the reaction conditions), rather than the reaction simply not being 
allowed to run to completion. 
SO2Ph
DppONHBoc (2.0 eq.), Cs2CO3 (3.0 eq.)
CH2Cl2, rt SO2Ph
BocN
N SO2Ph
Boc
DppO
39
+
38
0!10!
20!30!
40!50!
60!70!
80!90!
100!
0! 60! 120! 180! 240! 300! 360! 420! 480! 540!
NMR$Yield$
(%)$
Time$/$min$
SM$
38$
39$
 40 
The reaction monitoring seems to suggest that the reaction is proceeding via a faster 
addition step, giving rise to the initial spike in the yields of the NRC product, with a slower 
subsequent ring-closing step (Scheme 27). There also appears to an irreversible formation 
of NRC product 39 over the course of the reaction, likely due to the quenching of an 
anionic intermediate, preventing full conversion of the phenyl vinyl sulfone to the aziridine 
product.  
 
 
Scheme 27 Proposed mechanism for the DppONHBoc-mediated aziridination of phenyl vinyl sulfone 
 
With this in mind, studies were undertaken to determine if a change in the base used could 
affect the rate of the ring-closing step versus any protonation of the addition intermediate 
and increase the conversion of both the starting material and the intermediate anion. 
 
Initially, a number of inorganic and organic bases were screened. However, no bases were 
found that afforded any improvement over the use of Cs2CO3. These results are discussed 
in more detail below (Table 4). 
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Entry Base 
Conversion 
(%)a 
Yield 38 
(%)a 
Yield 39 
(%)a 
Yield 40 
(%)a 
1 K2CO3 13 0 0 0 
2 NaOH 100 4 19 70 
3 KOtBu 100 15 22 21 
4 NaH 100 20 52 0 
5 DBU 100 trace 26 0 
6 DIPEA 0 - - - 
7 NEt3 0 - - - 
8 2,6-lutidene 0 - - - 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. 
Table 4 Base screen for the N-Boc aziridination of phenyl vinyl sulfone 
 
Firstly, a range of alternative inorganic bases was tested in the aziridination of phenyl vinyl 
sulfone. K2CO3 (Entry 1), shown to be a poor base of the DppONHBoc mediated enone 
aziridination, again only gave a poor conversion of the starting material and afforded none 
of the aziridine or the NRC product. The use of sodium hydroxide (Entry 2) gave 
hydroxylamine 40 as a major product, suggesting that nucleophilic attack of the hydroxide 
anion at the phosphorus centre occurs more readily than the deprotonation/ring-closure. 
With the use of a more hindered alkoxide base, potassium tert-butoxide (Entry 3), 
hydroxylamine product 40 was still formed, though in a lower yield and with a three fold 
increase in the yield of aziridine 38, compared to the use of sodium hydroxide. However, 
the use of potassium tert-butoxide resulted in a less clean reaction, with multiple other, 
unidentified, side products in the crude NMR. The use of a non-nucleophilic base (sodium 
hydride, Entry 4) gave none of the hydroxylamine 40, but only a 20% yield of the aziridine 
38 with the NRC product 39 as the major product (52%).  
 
Secondly, a range of organic bases was then tested. The use of DBU (Entry 7) gave 
complete conversion of the starting material but only trace amounts of the aziridine 
product, while the use of DIPEA, triethylamine and 2,6-lutidene failed to afford any 
conversion of the starting material (Entries 8&9). 
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Finally, a range of organolithium bases was also tested in the aziridination reaction 
(dropwise base additions were carried out at -78 °C and the reaction slowly allowed to 
warm to room temperature with reaction monitoring by TLC). Of these only LiHMDS 
afforded any of the aziridine product 38, with a maximum yield of 15% afforded when 2 
equivalents of LiHMDS was used. Also tested were nBuLi, sBuLi, tBuLi and LDA; however, 
all caused decomposition of the DppONHBoc and only trace yields of the desired aziridine 
product. 
 
With the base screen failing to improve upon the yield obtained with the use of Cs2CO3, a 
solvent screen was carried out to determine if the reactivity could be tuned through the 
choice of solvent (Table 5). 
 
 
Entry Solvent 
Conversion 
 (%)a 
Yield 38 
 (%)a,b 
Yield 39  
(%)a 
1 CH2Cl2 96 54 (52) 33 
2 THF 99 66 (64) 27 
3 MeCN 100 23 77 
4 Et2O 60 24 25 
5 toluene 60 9 43 
6 nhexane 20 2 1 
7 EtOH 100 0 0 
8 1,4-dioxane 100 50 31 
9 DMSO 100 55 17 
10 DMF 100 52 0 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an  
internal standard. b Isolated yields, following column chromatography, in parentheses. 
Table 5 Solvent screen for the N-Boc aziridination of phenyl vinyl sulfone 
 
The results from the solvent screen showed THF to be the best solvent for the aziridination 
reaction (Table 5, Entry 2), affording a 66% yield of aziridine 38 and 27% of the NRC 
product 39, with only 6% of the starting material lost to other side reactions. The use of 
MeCN (Entry 3) afforded a clean reaction with complete conversion of the starting material 
SO2Ph
DppONHBoc (2.0 eq.)
Cs2CO3 (3.0 eq.)
solvent, rt, 4 h SO2Ph
BocN
N SO2Ph
Boc
DppO
3938
+
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and no loss of mass balance to side reactions. However, it was a poor solvent for the ring-
closing step, only affording a 23% yield of aziridine 38. The use of less polar aprotic 
solvents (Et2O, toluene and nhexane) failed to give complete conversion of the phenyl vinyl 
sulfone and only afforded low-to-fair yields of the desired aziridine (Entries 4-6). The use of 
a protic solvent was not compatible with the reaction, with the use of EtOH affording 100% 
conversion of the starting material but none of the desired aziridine product 38 or the NRC 
product 39. Instead a complex mixture of products was observed in the 1H NMR spectra of 
the crude reaction mixture, with peaks suggesting a number of CH2 environments similar 
to those in the NRC product 39, likely due to decomposition of either the intermediate 
anion or the NRC product 39. Use of co-ordinating solvents proved effective with 1,4-
dioxane, DMSO and DMF (Entries 8-10) all affording a high yield of the desired aziridine 
product with 100% conversion of the starting material. However, despite the decrease in 
the yields of the NRC product the reactions with these solvents showed more loss of 
material to side reactions than the reactions in THF and CH2Cl2. 
 
Whilst the use of Cs2CO3 in THF afforded the highest yield of the sulfonyl aziridine 38 
(64%), there was still a significant loss of material as the NRC product 39 (approximately 
2:1 ratio of the aziridine to NRC product). Finally, an optimisation of the reaction conditions 
was attempted to see if an improvement in this ratio could be achieved (Table 6). 
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Entry 
Change from  
Standard Conditionsa 
Conversion 
(%)b 
Yield 38 
(%)b 
Yield 39 
(%)b 
Yield 40 
(%)b 
1 none 99 66 27 0 
2 DppONHBoc (1.1 eq.) 75 51 23 0 
3 phenyl vinyl sulfone (2.0 eq.)c  91 62 16 0 
4 Cs2CO3 (2.0 eq.) 98 34 55 0 
5 Cs2CO3 (4.0 eq.) 100 64 24 0 
6 no base 0 - - 0 
7 40 °C 100 46 23 15 
8 60 °C 100 55 18 13 
a Standard conditions: To a mixture of vinyl sulfone (1.0 eq.) and DppONHBoc (2.0 eq.) in THF (0.1 M) is 
added Cs2CO2 (3.0 eq.) and the reaction stirred for 4 hours at room temperature, then quenched with 
NH4.Cl (sat. aq.). b Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an 
internal standard. c 1 eq. of DppONHBoc used. 
Table 6 Optimisation of the N-Boc aziridination of phenyl vinyl sulfone 
 
In the THF/Cs2CO3 reaction (Table 6, Entry 1) where the DppONHBoc was used in a two-
fold excess, there was an approximately 45% return of DppONHBoc (i.e. just over 1 
equivalent was reacted). To test whether the DppONHBoc could be used in lower excess a 
reaction was carried out using 1.1 equivalents of the DppONHBoc (Entry 2); however, only 
75% conversion of the phenyl vinyl sulfone was observed with a 51% yield of the aziridine 
38. The use of the DppONHBoc as the limiting reagent failed to offer any improvement in 
the yield of the reaction, with use of the phenyl vinyl sulfone in two-fold excess affording a 
slight decrease in yield (62% Entry 3) when compared to the use of DppONHBoc in 
excess (Entry 1). Changes in the base concentration offered no improvement in yield, with 
a decrease to two equivalents affording a reduced yield (Entry 4) and an increase to four 
equivalents (Entry 5) not affording any improvement in the yield, likely due to the reaction 
already being saturated in Cs2CO3 at three equivalents. A test reaction with no base 
resulted in no conversion of phenyl vinyl sulfone (Entry 6). Finally, reactions at higher 
reaction temperatures afforded decreased yields of the desired aziridine product 38 likely 
due to the increased rate of hydrolysis of NRC intermediates to hydroxylamine 40 and the 
observed slow decomposition of DppONHBoc at elevated temperatures.  
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2.3.3 Use of Alternative O-(Diphenylphosphinyl) hydroxylamine Aminating Agents 
 
With the optimisation of the reaction conditions failing to afford complete conversion of the 
NRC product to the desired aziridine product, it was decided to look at changing the 
electronics of the aminating agent. It was proposed that having more electron-deficient 
substituents on the phosphorus would make a better leaving group, and as such aid the 
ring-closing step. Novel O-(bis(3,5-bis(trifluoromethyl)phenyl)phosphinyl) hydroxylamine 
41 was initially chosen as there is a literature route to the diphenylphosphinic chloride 42 
precursor from commercially available bis(3,5-bis(trifluoromethyl)phenyl)chlorophosphine 
43.69 It was proposed that phosphinyl hydroxylamine 41 could be accessed via the 
reaction of phosphinyl chloride 42 with N-Boc hydroxylamine (Scheme 28). The phosphinyl 
chloride 42 was not isolated due to fear of hydrolysis to the phosphinic acid. However, the 
31P NMR spectrum of the crude reaction mixture showed complete conversion of 
chlorophosphine 43 and a new 31P shift, at 34.32 ppm (in the expected chemical shift 
range for a phosphinic chloride) and suggested the desired phosphinyl chloride was 
formed with approximately 85% purity. However, subsequent attempts at forming the N-
Boc-hydroxylamine gave none of the desired product, instead giving ammonium 
phosphonate salt 44 (Figure 4). Formation of this salt suggests that hydrolysis of either the 
phosphinic chloride or the product occurred under either the reaction conditions or during 
work up.  
 
 
Scheme 28 Attempted synthesis of bis(3,5-bis(trifluoromethyl)phenyl)phosphinyl hydroxylamine  
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Figure 4 Salt 44 formed during attempted synthesis of diphenylphosphinyl hydroxylamine 41 
 
Given the ease of hydrolysis of the bis(3,5-bis(trifluoromethyl) analogue 41 attempts to 
synthesise the less electron-poor bis-(4-chlorophenyl) analogue 45 were made. Bis-(4-
chlorophenyl) analogue 45 was chosen as while it is a novel compound, there are 
literature conditions reported for the synthesis of the corresponding phosphinic acid 46 
precursor from diethyl phosphite, in two steps, via phosphinic oxide 47 (Scheme 29).70 
 
 
Scheme 29 Synthesis of bis-(4-chlorophenyl)phosphinic acid 46 
 
Reaction of the phosphinic acid 46 with thionyl chloride allowed access to the phosphinyl 
chloride, further reaction with N-Boc-hydroxylamine afforded the desired O-(bis-(4-
chlorophenyl)phosphinyl) hydroxylamine 45 as a white crystalline solid in 41% yield, 
following partial recrystallisation from CH2Cl2 (Scheme 30). 
 
 
Scheme 30 Synthesis of O-(bis-(4-chlorophenyl)phosphinyl)hydroxylamine 45 
 
Also synthesised was the more electron-rich 4-methoxy analog 48, to allow comparison to 
the electron-poorer and electron-neutral analogs. It was expected that the more electron-
rich methoxy analog would afford a lower yield of the aziridine product and a 
corresponding higher yield of the NRC product, as the less nucleofugal phosphinyl motif 
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would slow the rate of the ring-closing step. The 4-methoxy analog 48 was synthesised in 
two steps, in a 61% overall yield following literature conditions from the phosphinic acid 49 
(Scheme 31).71 
 
 
Scheme 31 Synthesis of O-(bis-(4-methoxyphenyl)phosphinyl)hydroxylamine 48 
 
The two diphenylphosphinyl hydroxylamines where then tested in the aziridination of 
phenyl vinyl sulfone (Table 7). The use of the 4-chloro analog 45 (Table 7, Entry 2) gave a 
decreased yield of the NRC product as expected; however, a decreased 40% yield of the 
aziridine product was also obtained, compared to 66% obtained with DppONHBoc (Entry 
1). Also isolated was 35% of hydroxylamine 40, suggesting that the more labile leaving 
group of 4-chloro analog 45 resulted in increased hydrolysis of the NRC product, 
preventing ring-closure to the desired aziridine product. Use of the more electron-rich 4-
methoxy analog 48, Entry 3, afforded a decreased yield of the aziridine (13%), compared 
to the use of DppONHBoc, with a corresponding increased yield of the NRC product, 82%, 
as expected. 
 
 
Entry X Conversion (%)a Yield 38 (%)a Yield 39 (%)a Yield 40 (%)a  
1 H 99 66 27 0  
2 Cl 91 40 12 35  
3 OMe 100 13 82 0  
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. 
Table 7 N-Boc aziridination with O-(diphenylphosphinyl) hydroxylamine analogs 
 
The results of this study on the electronic properties of the phosphinyl functionality found 
that, as expected, a more electron-rich aryl moiety did decrease the yield of the aziridine, 
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presumably due to the bis-(4-methoxyphenyl)phosphinic acid being a poorer leaving 
group. However, with the use of the more electron-poor analog the increased rate of 
hydrolysis of phosphinyl hydroxylamine competes with the ring-closing step and as such 
no increase in yield of aziridine was observed.  
 
Although other O-(diphenylphosphinyl) hydroxylamines were not tested, if this study was 
continued a phosphinic acid leaving group with electronic properties which lie in between 
those of the 4-Cl and 4-H substituted diphenylphosphonic acids should be considered. As 
such the aim of further studies would be to attempt to find a leaving group that is suitably 
nucleofugal to increase the rate of ring-closing, while not so nucleofugal as to significantly 
increase the rate of the hydrolysis of the NRC intermediate and thus maximising the yield 
of the desired aziridine product.  
 
To evaluate possible O-(diarylphosphinyl) hydroxylamines it is proposed that the pKa of the 
corresponding phosphinic acids could be used to predict a suitable alternative, i.e. find 
phosphinic acids with pKa values between that of the bis-(4-chlorophenyl) and 
(diphenyl)phosphinic acid (pKa values of 1.62 and 2.32 respectively). However, a lack of 
reported pKa data for alternative phosphinic acids meant that an alternative series of 
compounds would have to be used and, as such, the pKa values of corresponding benzoic 
acids were considered (Figure 5). 
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Figure 5 pKa values for diphenylphosphinic acids and benzoic acids72,73 
 
Using the pKa of analogous benzoic acids as a reference for the leaving group ability/ 
electron-withdrawing properties of the substituents suggests that a benzoic acid with a pKa 
value within the range of 3.99 (4-Cl) and 4.20 (4-H) would be required. Possible, simple, 
benzoic acids that fit this criterion include replacing the 4-chloro substituent with a 4-fluoro 
(pKa of 4-iodobenzoic acid is 4.14) or alternatively either 3-hydroxy or 3-methoxy 
substituted benzoic acids, both of which have pKa values (4.08 and 4.09 respectively) 
which lie approximately half way between that of benzoic and 4-chlorobenzoic acids. The 
use of the corresponding O-(diphenylphosphinyl) hydroxylamines would offer a good 
starting point for further studies into the effect of ring electronics on the ratio of the desired 
aziridine product and the, unwanted, hydrolysed and non-hydrolysed NRC products. The 
O-(bis(-4-fluorophenyl)phosphinyl) hydroxylamine and corresponding 3-methoxy analogue 
would be in particular promising starting points as the commercial available Grignards 
would allow synthesis of the hydroxylamines via the same pathway used to accesses the 
4-chloro analogue (see Scheme 29 & 30 above). 
 
Finally, the tosyl analog, DppONHTs 50, was synthesised to examine whether this 
methodology could be used to access N-tosyl aziridines. Attempts at synthesising 
DppONHTs in one step from DppONH2 and tosyl chloride (with pyridine as a base) were 
unsuccessful, only affording diphenyl phosphinic acid and returned starting material. An 
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alternative approach, via N-tosyl hydroxylamine 51 and diphenylphosphinic chloride, 
proved successful, Scheme 32.  
 
 
Scheme 32 Synthesis of DppONHTs 
 
However, use of DppONHTs in the aziridination reaction failed to afford any of the desired 
N-tosyl sulfonyl aziridine (100% return of starting material), with increased reaction 
temperatures, up to reflux in THF, still failing to give any conversion. 
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2.3.4 Vinyl Sulfone Substrate Scope 
 
With work into the optimisation of the reaction complete, our focus then turned to the 
substrate scope of the reaction. Vinyl sulfones can be accessed via a number of different 
methodologies, these include; olefination of phosphonate vinyl sulfones74 with the 
corresponding aldehydes,75 protodesilylation of allylic silanes,76 elimination reactions77,78 
and oxidation of vinyl sulfides. All four approaches were used in the synthesis of a range of 
vinyl sulfones to be tested in the aziridination reaction (Scheme 33). 
 
 
Scheme 33 Synthesis of vinyl sulfones 
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The vinyl sulfones were then tested in the aziridination reaction, the results of which are 
discussed below (Table 8). 
 
 
Entry Vinyl Sulfone Conversion (%)a Product 
Aziridine 
Yield (%)a,b 
NRC Product 
Yield (%)a 
1 
 
0 - - - 
2 
 
0 - - - 
3 
 
0 - - - 
4  99 61 17(
c) 53 
5 
 
94 62 25 (24) 37 
6 
 
96 63 51 (49) 22 
7 
 
100 64 52 (46) 30 
8 
 
0 - - - 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. b Isolated 
yields, following column chromatography, in parentheses. c Product unstable on silica and could not be isolated. 
Table 8 Substrate scope of the DppONHBoc mediated N-Boc aziridination of vinyl sulfones 
 
The use of 1,2-disubstituted vinyl sulfones (Table 8, Entry 1-3) under the optimised 
DppONHBoc mediated aziridination conditions failed to afford any conversion of the 
starting materials, with no scrambling of double bond geometry observed in any of the 
vinyl sulfone starting materials (in particular with the use of vinyl sulfone 55 (Entry 2) 
reacted at a mixture of the E and Z-isomers). Entries 1 and 3 were both repeated at 
elevated temperatures (40 °C and 60 °C), though still no conversion of the vinyl sulfones 
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was observed. Changes in the substituent on the sulfone were tolerated, with both alkyl 
and phenyl substituents tolerated. Aziridination of methyl vinyl sulfone provided a 17% 
NMR yield of the desired aziridine (Entry 4) and the NRC product observed as the major 
product (53%); however, the methylsulfone-substituted aziridine was not stable on silica 
and could not be isolated. The use of ethyl analog 60 (Entry 5) afforded a 24% isolated 
yield with the NRC product observed as the major product (37% yield). The increased 
yields of the NRC products afforded by both the alkyl examples suggests either an 
increase in the rate of proton-transfer/quenching of the anionic intermediates or a 
decrease in the rate of ring closing compared to phenyl vinyl sulfone. 
 
Changes in the electronics of the phenyl ring were also tolerated, though both a more 
electron-rich tolyl substituted vinyl sulfone 58 (Entry 6) and a more electron-poor 4-fluoro 
substituted example 59 (Entry 7) afforded only moderate yields of the N-Boc aziridine 
products, 49% and 46% respectively. Finally, attempts with a phenyl vinyl sulfoxide proved 
unsuccessful with complete return of the starting materials (Entry 8). 
 
As with the enone examples (see Section 2.3.1), the aziridination reaction seems very 
sensitive to the electronics of the alkene, most notably with the use of 1,2-disubstituted 
vinyl sulfones completely shutting down the reaction. 
 
2.3.5 Aziridination of Ethenesulfonyl Fluoride (ESF) 
 
Despite first being synthesised at the beginning of the 20th century, the chemistry of ESF 
(65) remained little studied until an in-depth study was published by Hyatt in 1979.79 Hyatt 
highlighted in particular its properties as a highly reactive and selective Michael acceptor, 
particularly with nitrogen nucleophiles, and the stability of the sulfonyl fluoride functionality 
to a range of reaction conditions under which use of other sulfonyl halides would not be 
compatible. More recently Sharpless has further explored the chemistry of the sulfonyl 
fluorides and highlighted the further reactions of sulfonyl fluorides, and their application in 
affinity labelling and drug discovery.80 With this is mind, and in the absence of any 
methodology allowing access to sulfonyl fluoride-substituted aziridines, it was decided to 
test ESF as a substrate in the DppONHBoc mediated aziridination reaction. 
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ESF itself is easily accessed via fluorination of 2-chloroethan-1-sulfonyl chloride affording 
2-chloroethan-1-sulfonyl fluoride 66 followed by MgO mediated elimination (Scheme 34).80 
 
 
Scheme 34 Synthesis of ethenesulfonyl fluoride 
 
Initial attempts at the DppONHBoc-mediated aziridination, under the conditions optimised 
for the aziridination of vinyl sulfones, proved unsuccessful with none of the desired 
aziridine 67 being formed, despite 100% conversion of the ESF. The only product to be 
isolated in any significant yield was diphenylphosphinic fluoride (DppF) 68 (Scheme 35).  
 
 
Scheme 35 Initial attempt at ESF aziridination 
 
Likely mechanisms for the formation of the DppF 68 is fluoride attack on either the starting 
material or a NRC intermediate. However, as none of the NRC hydroxylamine product was 
observed in the crude reaction mixture, the reaction of a NRC product (formed after 
addition of the DppONHBoc) with fluoride was not occurring. A test reaction stirring 
DppONHBoc with CsF in CH2Cl2, after 1 hour afforded a mixture of starting material and 
DppF 68, suggesting that fluoride anions present in the reaction mixture were reacting with 
DppONHBoc. A further test reaction with ESF and Cs2CO3 showed slow decomposition of 
the ESF after 3 hours, with complete decomposition after 22 hours. This could perhaps be 
the source of the fluoride, though another possibility is displacement of the fluoride upon 
conjugate addition of the DppONHBoc (Scheme 36). 
 
 
Scheme 36 Possible source of fluoride during the attempted N-Boc aziridination of ESF 
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A solvent switch to DMF, the solvent most commonly employed in literature reactions with 
ESF, afforded a trace yield of products (Table 9, Entry 1). Test reactions stirring NaH with 
ESF showed no conversion of the ESF after 4 hours and looked like a promising 
alternative to the incompatible Cs2CO3. The use of NaH in the aziridination reaction did 
afford the desired aziridine product, albeit only in a 3% yield of aziridine 67 (with complete 
conversion of the starting material, Entry 2). Tertiary amine bases have been shown to be 
compatible with the use of ESF and as such triethylamine was tested and, although it 
failed to afford any of the aziridine, provided a 98% yield of the NRC product 69 (Entry 3). 
 
 
Entry Base (Eq.) 
Conversion 
(%)a 
Yield 67 
(%) 
Yield 68 
(%) 
Yield 69 
(%) 
1 Cs2CO3 (3.0) 100 trace - - 
2 NaH (1.1) 100 3 - - 
3 NEt3 (2.0) 100 - - 98 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. 
Table 9 Effect of base on the N-Boc aziridination of ESF 
 
The discovery of this efficient route to the NRC product 68 (Table 9, Entry 3) allowed 
optimisation of the ring-closing step of the reaction to be carried out (Table 10) offering the 
possibility of a two-step synthesis of the desired N-Boc aziridine. 
 
 
Entry Solvent 
Conversion 
(%)a 
Yield 67 
(%) 
Yield 68 
(%) 
Yield 70 
(%) 
Yield 65 
(%) 
1 CH2Cl2 93 1 - - - 
2 DMF 60 11 - - - 
3b DMF 50 19 4 3 4 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard.  b Reaction 
carried out at 0 °C. 
Table 10 Attempted ring closing of NRC sulfonyl fluoride 69 
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Sodium hydride was chosen as a non-nucleophilic base for initial studies; reaction in 
CH2Cl2 only afforded trace quantities of the desired aziridine product, with a complex 
mixture of by-products (Table 10, Entry 1). Again, a solvent switch to DMF afforded better 
results with an 11% yield of the aziridine 67, with a 60% conversion of the ESF (Entry 2). A 
decrease in reaction temperature gave reduced conversion of the starting material, but 
gave a cleaner reaction that alongside an increase in the yield of the desired aziridine 
product, allowed the characterisation of several other side products. Isolated from a 
reaction run at lower temperature (0 °C, Entry 3) was 19% of the desired aziridine 67, a 
4% yield of ESF (presumably formed via an E1cb mechanism), a 4% yield of DppF and a 
3% yield of cyclic sulfonyl hydroxylamine 70. A proposed mechanism for the formation of 
this cyclic sulfonyl product is via the initial hydrolysis of NRC product 69, followed by 
cyclisation with displacement of the fluoride. 
 
It was proposed that changing the counterion associated with the base used in the initial 
deprotonation might influence selectivity in favour of ring closure and away from the 
elimination of HF and decomposition of the deprotonated intermediate. To test this a small 
base screen was carried out (Table 11). With previous studies into reactions showing the 
NRC intermediates to be susceptible to nucleophilic attack at the phosphorus, only non-
nucleophilic bases were tested.  
 
 
Entry Base Solvent Conversion 
(%)a 
Yield 67 
(%) 
Yield 68 
(%) 
Yield 70 
(%) 
Yield 65 
(%) 
1b NaH DMF 96 4 1 1 - 
2 KH DMF 100 5 31 27 - 
3 LiHMDS THF 100 - - - 25 
4 Phosphazene base P1-tBu THF 100 - 60 56 - 
a Determined by 1H NMR spectroscopy of the crude reaction mixture using Bn2O as an internal standard. 
b Reaction with 15-crown-5 (1.1 eq.) 
Table 11 Base screen for the ring-closing of NRC product 69 
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+
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While changing the base was found to have a significant effect on the ratio of the products 
obtained, unfortunately none of the bases tested caused an increase in the yield of desired 
aziridine product 67 compared to that afforded with by NaH. The use of 15-crown-5 (Table 
11, Entry 1), to increase the solubility of the sodium hydride, had a negative effect on the 
yield of the aziridine 67 (4%). The use of KH (Entry 2) again afforded a decreased yield of 
the desired aziridine product 67 (5%), with DppF (31%) and cyclic sulfonyl hydroxylamine 
70 (27%) isolated as the major products. The use of LiHMDS (Entry 3) afforded the ESF 
as the major product with only trace amounts of the aziridine product observed, along with 
several unidentified side products. Finally, the use of phosphazene base P1-tBu gave none 
of the desired aziridine (Entry 4), but did give a 60% yield of DppF with a corresponding 
56% yield of cyclic sulfonyl hydroxylamine 70. 
 
Due to time constraints no further work was carried out into the aziridination of 
ethenesulfonyl fluoride. Whilst the DppONHBoc aziridination of ESF only afforded poor 
yields of the desired product, a high-yielding route to the non-ring-closed product was 
found. Initial screening of ring-closing conditions showed some promise, with a maximum 
19% yield of the aziridine being achieved. However, multiple other reaction pathways also 
exist and a more thorough optimisation is needed to increase the selectivity for the desired 
ring closing reaction over the competitive elimination/retro-Michael pathways. 
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2.4 Conclusions and Future Work 
 
To summarise, DppONHBoc was successfully utilised as the nitrogen source for the 
aziridination of a number of electron-deficient alkenes. Attempts at the formation of the 
hydrazinium salt upon reaction with tertiary amine NMM was unsuccessful suggesting that, 
unlike DppONH2, DppONHBoc is able to react directly as a nucleophilic nitrogen transfer 
agent. However, the substrate scope was found to be limited due to the sensitivity of 
aziridinations with DppONHBoc to changes in the substitution pattern/electronics of the 
electrophilic substrates. 
 
Attempts at the application of DppONHBoc to the aziridination of enones saw limited 
success. Whilst some high isolated yields (up to 89%) were achieved, on the whole, yields 
were variable and the substrate scope poor. Both aryl and alkyl functionality were well 
tolerated at the C-1 positions (R2), as was alkyl substitution at the C-3 position (R1); while 
further conjugation of the alkene (R1 = Ph, PhCH=CH) was not tolerated (Scheme 37). 
 
 
Scheme 37 Use of DppONHBoc as a NNTA in the aziridination of enones  
 
The reaction was also expanded to the aziridination of vinyl sulfones; however, the scope 
was limited to terminal vinyl sulfones and only moderate yields were observed due to a 
slow ring-closing step (Scheme 38). Finally, work into the aziridination of ESF was met 
with limited success, with studies providing evidence of multiple competing reaction paths. 
 
 
Scheme 38 Use of DppONHBoc as a NNTA in the aziridination of vinyl sulfones 
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Building upon the results described above, future work (as discussed in Section 2.3.3 
above) should focus on increasing the scope of the N-substituted (O-(diphenyl)phosphinyl) 
hydroxylamines, as this would enable firstly, the electronics of the NNTA to be fine tuned, 
and the effect of this on the ring-closing step to be further studied and secondly, through 
altering the N-substituent allow access to a wider range of N-protected aziridines. 
However, the multi-step synthesis and the poor stability of the electron-poor N-substituted-
diphenylphosphinyl hydroxylamines would detract from some of the simplicity of the 
DppONHBoc aziridination protocol. 
 
Also to be considered would be the use of in silico calculations to try to better rationalise 
the observed reactivity of DppONHBoc with enone and vinyl sulfone substrates, as well as 
further work to test DppONHBoc as a NNTA in other aziridination protocols, such as in the 
PTC or amino-catalysed methodologies discussed above (Section 2.1.2) 
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3 O-(Diphenylphosphinyl) Hydroxylamine (DppONH2) as a 
Nitrogen Source in the Vicarious Nucleophilic  Amination 
(VNA) of Electron-Deficient Aromatics 
 
Chapter 2 (Section 2.1.2.3) introduced the O-(diphenylphosphinyl) hydroxylamines/NMM 
protocol for the in situ formation of a NMM-derived aminimine 18 (Figure 6) and its use as 
an efficient nucleophilic nitrogen transfer agent (NNTA) for the aziridination of electron-
deficient alkenes. This chapter will discuss studies utilising the same in situ tertiary amine-
promoted formation of aminimine 18 in the vicarious nucleophilic amination (VNA) of 
electron-deficient arenes and heteroarenes. VNA allows direct access to primary 
(hetero)aryl amines which are important building blocks in a number of chemical 
industries, including the manufacture of agrochemicals, pharmaceuticals, dyes, pigments 
and rubber.81,82 
 
 
Figure 6 NMM derived aminimine 18 
 
Section 3.1 will provide a concise introduction into the nucleophilic substitution of hydrogen 
in electron-deficient aromatics and heteroaromatics. This introduction will provide an 
overview of the formation and subsequent reactions of σH-adducts (Meisenheimer 
complexes). It will then continue to discuss in more detail vicarious nucleophilic 
substitution of hydrogen (VNS), providing an overview of the initial development of the 
methodology as an alkylation strategy, mechanistic studies and its application to the 
amination and hydroxylation of electron-deficient arenes. For a more comprehensive 
overview of the field, readers are directed to the following reviews.83–86 
 
Sections 3.2 and 3.3 go on to discuss our work looking at the application of NMM-derived 
aminimine 18 to the vicarious nucleophilic amination (VNA) of electron-deficient arenes 
and heteroarenes. Initial studies focus on the use of pre-formed NMM hydrazinium salts 
N
O
NH
18
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and later studies on the application of the in situ protocol for hydrazinium salt formation in 
the VNA of electron-deficient arenes. 
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3.1 Introduction 
 
Aromatic nucleophilic substitution (SNAr)86,87 is a much utilised methodology for the further 
derivatisation of electron-deficient arenes. Typically SNAr reactions occur when a strongly 
electron-withdrawing substituent, often a nitro group, on an aromatic substrate directs 
nucleophilic attack to the ortho and para-positions. When the addition of the nucleophile 
occurs at a position where a nucleofugal leaving group is present a σX-adduct 71 (also 
referred to as a Meisenheimer complex,88 a 1:1 adduct formed between an electron-
deficient arene and a nucleophile) is formed. Generally the σX-adduct formed is unstable 
and its formation is followed by spontaneous departure of the leaving group restoring the 
aromaticity of the arene and affording the substitution product (Scheme 39). As such, 
formation of the σX-adduct 71, with most nucleophiles, can generally be considered 
irreversible and is typically the rate-determining step in SNAr reactions. 
 
 
Scheme 39 Formation of σH- vs. σX-adducts of electron-deficient arenes 
 
While SNAr undoubtedly proceeds though the formation of the σX-adduct 71, studies have 
shown that the formation of σH-adducts 72, via reversible nucleophilic attack at 
unsubstituted positions, is a faster process.88–90 However, since hydride displacement from 
the initially formed σH-adduct 72 is energetically unfavourable, a subsequent displacement-
addition equilibration leads to the formation of σX-adduct 71 and the SNAr products 
(Scheme 39).  
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While generally direct hydride displacement from σH-adducts cannot occur, formal 
nucleophilic substitution of hydrogen in electron-deficient (hetero)arenes can occur via 
alternative reaction pathways. (N.B. one example of a reaction that is proposed to proceed 
via the direct hydride displacement is the Chichibabin amination reaction.91) Early 
examples of reactions that are likely to occur via initial formation of a σH-adduct include, 
the Von Richter reaction92 (Scheme 40) and methodology for the formation of 
benzisoxazoles via the condensation of aromatic nitro compounds with arylacetonitriles93 
both of which likely proceed via a cyclisation reaction between a ortho-σH-adduct and the 
nitro group. 
 
 
Scheme 40 Mechanism of the Von Richter reaction 
 
As highlighted by the Von Richter reaction above, providing that reaction 
reagents/conditions are present for the efficient conversion of σH-adducts, nucleophilic 
substitution of hydrogen in electron-deficient arenes can occur even in the presence of 
nucleofugal substituents.  
 
Since then a number of general methodologies have been described for the transformation 
of σH-adducts, allowing the functionalisation of aromatic ring systems without the need for 
a leaving group.84–86 These include; oxidative nucleophilic substitution of hydrogen 
(ONSH),94 cine- and tele-substitutions,95 addition of nucleophile/ring-opening/ring-closure 
reactions (ANRORC),96 the conversion of σH-adducts to nitrosoarenes (the Von Richter 
reaction would be included within this general field)93,97 and, finally the most widely 
applicable and utilised of the methodologies, vicarious nucleophilic substitution (VNS). 
 
3.1.1 Vicarious Nucleophilic Substitution (VNS) 
 
Mąkosza first coined the term vicarious nucleophilic substitution in 1978 to describe the 
nucleophilic substitution of hydrogen in electron-deficient arenes where a nucleofugal 
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substituent present on the nucleophile acts as a vicarious leaving group in place of the 
hydride.98 In this first report, Mąkosza described the use of α-chlorophenyl sulfones in the 
base-mediated alkylation of substituted nitrobenzenes with moderate-to-good yields (48-
90%) (Scheme 41).  
 
 
Scheme 41 VNS of nitrobenzene with α-chlorophenyl sulfones 
 
The following, generally accepted, mechanism has been proposed for the VNS of nitro-
aromatics; an initial reversible formation of σH-adduct 73 is followed by β-elimination and 
then, during acidic work-up, re-aromatisation of the ring system (Scheme 42). A more 
detailed discussion of the mechanism and the mechanistic studies completed is included 
in Section 3.1.3 below. 
 
 
Scheme 42 VNS reaction pathways 
 
Despite Mąkosza being the first to coin the term vicarious nucleophilic substitution, earlier 
examples of the methylation of aromatic nitro compounds using dimethyloxosulfonium 
methylide99–101 and trichloromethyllithium102 are likely to proceed via a VNS mechanism. 
Also reported, simultaneously to Mąkosza’s first publication, was the first example of the 
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alkylation of nitrofuran with N-ethoxycarbonylmethylpyridinium ylide, again likely to 
proceed via a VNS reaction mechanism.103 
 
Since 1978 Mąkosza and others have expanded the scope of the VNS alkylation reactions 
both in terms of the electron-deficient electrophiles and nucleophiles tolerated.104–108 While 
any carbanion with a leaving group able to be eliminated as HX should undergo VNS with 
a sufficiently electron-deficient nitroarene, typically the carbanions utilised have a structure 
analogous to that of chloromethyl phenyl sulfone (still typically employed as the model 
carbanion for studies into electrophile scope) where Y is a nucleofugal leaving group and Z 
is an electron-withdrawing group capable of stabilising the carbanion (Figure 7). Studies 
have shown that a range of alkyl, aryl, halide and thiophenyl substituents are well tolerated 
in the α-position so long as the acidity of the α-proton is not significantly decreased. 
 
 
Figure 7 Carbanion precursors utilised in the VNS of electron-deficient arenes 
 
While any combination of the above substituents should create an efficient nucleophile for 
the VNS with any nitroarene, limitations can occur when unfavourable addition equilibria 
arise due to insufficient electron-deficiency or steric hindrance in the nitroarene. A good 
example of this is the observed reactivity of the carbanion of diethyl chloromalonate, which 
does not react with nitrobenzene but can react with the more electron-deficient 
nitrothiazoles.109 Further limitations can arise if the carbanion is too reactive and self 
condensation can occur, or if the stabilising EWG can also act as a leaving group in the β-
elimination step, such as with the use of phenyl sulfoxide.110 
 
The carbanions shown in Figure 7 have been utilised in the alkylation of a wide range of 
electron-deficient aromatics85,111–114 and heteroaromatics,115–117 with a general trend for 
increased reactivity with the use of more electron-deficient electrophilic substrates 
observed. The electrophiles utilised in VNS reactions fall into two categories. The first 
category includes aromatic rings activated with nitro groups; examples include 
Y
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nitrobenzenes, nitronaphthalenes, nitrophenols, nitrofurans, nitrothiophenes, N-substituted 
nitropyrroles and nitropyridines. The second category includes inherently electron-poor 
heteroarenes; examples include benzothiazole, acridine, 1,2,4-triazines and quinoline.  
 
Generally a good functional group tolerance has been observed for the VNS reaction with 
both electron-rich and poor substituents well tolerated, so long as overall the (hetero)arene 
is sufficiently electrophilic enough for a favourable addition equilibrium to exist. However, 
electrophilic substituents that allowed competitive nucleophile additions can present 
problems, for example with the use of 3-nitrobenzophenone where alongside the desired 
alkylation products 74, a second unwanted condensation side product 75 was also formed 
(Scheme 43).118  
 
 
Scheme 43 Competitive Darzens Reaction in the VNS alkylation of m-phenylketone nitrobenzene  
 
The formation of the condensation side product 75 is proposed to occur via an initial 
Darzens reaction to give an epoxide 76 followed by a rearrangement to aldehyde 77 and 
decarbonylation to give the condensation product 75 (Scheme 44). While no mechanism 
for the rearrangement of epoxide 76 to aldehyde 77 is discussed, a similar rearrangement 
has been observed in α-epoxy sulfoxides and sulfones, and is proposed to occur via ring 
opening of the epoxide with intramolecular migration of the p-tolylsulfonyl (or p-tolylsulfinyl) 
group, though in these examples Lewis acidic conditions or heating (ca. 50°C) was 
required.119,120 
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Scheme 44 Proposed mechanism for the formation of Darzens product 75 
 
Negatively-charged arenes are tolerated provided the negative charge is not conjugated 
with the aromatic π-system; for example with the use of nitrobenzoic acids, deprotonated 
under the basic VNS conditions.121 Examples with direct conjugation of negative charge 
into the aromatic ring such as the use of ortho/para-nitrophenols, which under the basic 
reaction conditions exist as nitrophenolates, failed to afford any of the desired VNS 
products.122 One possible reason for this decreased reactivity is simply that the 
nitrophenols are too electron-rich; however, both nitroanisoles123 and N,N-(dimethyl)-
nitroanilines124 are known to react well in VNS reaction. As such, the lack of reactivity with 
nitrophenols seems to lie in the direct conjugation of the negative charge of the 
nitrophenolates formed under the basic conditions, thus hindering the nucleophilic addition 
of the carbanion. 
 
The para-formylation of nitrobenzene via an initial VNS alkylation followed by hydrolysis 
has been reported by Katritzky using carbanions of tris-(benzotriazol-1-yl)methane.125 
Carbanions of benzotriazolyl-substituted diarylmethane 78, formed from the corresponding 
diarylmethanol, have also been utilised as nucleophiles in the synthesis of p-
(nitroaryl)diarylmethanes with a range of aryl motifs and generally with good yields 
(Scheme 45).108 
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Scheme 45 Katritzky’s synthesis of p-(nitroaryl)diarylmethanes 
 
Also reported are ring-opening and ring-closing variants of VNS alkylation reactions. 
Mąkosza reported the ring-opening VNS cyanomethylation of 1-nitronaphthalene with 
phenylcyano-oxiranes126 and Cava has reported an intramolecular tandem-Michael-VNS 
ring closure in the synthesis of alkavinone precursor 79, a key intermediate in the 
synthesis of anthracycline antibiotics (Scheme 46).127 
 
 
Scheme 46 Tandem-Michael-VNS ring closure step in the synthesis of alkavinone precursor 79 
 
3.1.2 Regio- and Chemo-Selectivity of VNS Alkylation Reactions 
 
The regioselectivity of the VNS reaction is largely determined by three factors; the 
structure of the electrophile, the structure of the carbanion and the reaction conditions 
(solvent, base, etc.).128,129 With the use of inherently electron-deficient 
polyazaheterocycles, such as 1,2,4-trazines and benzothiazole, the position of the 
electronegative heteroatoms define the site(s) of substitution and VNS reactions proceed 
with complete selectivity at those sites. With substrates activated by electron-withdrawing 
groups (i.e. nitro groups) the situation is more complicated, though in all cases nucleophilic 
addition is directed to either the para or ortho-positions. The use of unsymmetrical 
substrates, with the nitro-group in specific positions, can give rise to high levels of 
selectivity, for example 1-nitronaphthalene shows high levels of selectivity for substitution 
in the 2-positions, whilst 3-nitrofurans and 3-nitrothiophenes will only react in the 2-
positions. However, generally there is not sufficient difference in the electron densities at 
the ortho and para-positions for selectivity to be imparted by the structure of the 
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electrophile alone and other factors such as the structure of the carbanion or the reaction 
conditions also influence regioselectivity. 
 
The influence on regioselectivity exerted by the carbanion is largely a steric effect, though 
to a lesser extent the nature of the substituents and leaving group can play a role. An 
increase in the size or number of substituents at the α-position of the carbanion results in 
an increased preference for para-substitution, in cases where both the ortho and para-
positions are freely available. It is thought that the increased steric bulk hinders not only 
the initial formation of the ortho σH-adducts but also the second elimination step from the 
ortho σH-adducts. It is proposed that the increased steric bulk hinders the anti-periplanar 
orientation needed for the β-elimination step.111 The use of tertiary carbanions with 
multiple possible leaving groups, such as carbanions of trihalomethanes, can overcome 
this steric hindrance in the formation of the ortho-product by statistically favouring the β-
elimination and as such increasing selectivity for the ortho-product.130  
 
Finally, reaction conditions also play a role in the regioselectivity of VNS reactions. 
Typically in weak-base conditions (KOH/DMSO), high levels of para-selectivity are 
observed with the reaction of nitrobenzene with chloromethyl phenyl sulfones, often with 
no observed reaction at the ortho-positions when the para-position is unsubstituted. With 
the use of strong-base conditions (KOtBu/DMSO) and/or lower reaction temperatures the 
ortho-product can be observed, though as a minor product.131 A more detailed discussion 
of the effect of reaction conditions on the observed regioselectivity of the VNS alkylation of 
nitrobenzene can be found in Section 3.1.3. 
 
The regioselectivity of the VNS reaction is strongly affected by the state (level of solvation) 
of the carbanion in the reaction mixture. A study by Mąkosza found that use of KOtBu/THF 
base-solvent system in place of KOtBu/DMSO resulted in an exclusively ortho-selective 
alkylation of nitrobenzene with o-nitrobenzyl phenylsulfone.124 Mąkosza proposes that the 
tightly bound K+ carbanion present in THF, as opposed to the loosely bound solvated K+ 
carbanion in DMSO, co-ordinates the nitro groups and directs the carbanion addition to the 
ortho-position. This hypothesis is further supported by studies with HMPT and 18-crown-6 
additives. The addition of either of these additives to the reaction mixture, thereby 
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increasing the solvation of the potassium cation, resulted in decreased selectivity for the 
ortho-position. 
 
Nilsson took this approach a step further with the use of catalytic copper in the VNS 
synthesis of 2-(2,6-dinitrophenyl)-malonates, acetates and acetonitrile with high selectivity 
for the sterically hindered ortho-position (Scheme 47).106 Here the use of substoichiometric 
quantities of copper(I) chloride is thought to aid both formation and β-elimination of the σH-
adduct 80. The use of pyridine as a ligand for the copper was found to be vital for high 
yields and selectivity, it being proposed that the pyridine both enhances the reactivity of 
the copper alkoxide and solvates the copper salt formed in the elimination step. 
 
 
Scheme 47 Cu-catalysed VNS alkylation of 1,3-dinitrobenzenes 
 
The chemoselectivity for a VNS reaction pathway in preference to a SNAr pathway, when 
an appropriate leaving group is present, has been shown in numerous examples.132 Here 
chemoselectivity is dependent on the rate of reversible σH-adduct formation and 
subsequent β-elimination versus the, slower, generally, irreversible formation of the σX-
adduct. Complete selectivity for the VNS pathway is observed with 4-chloro/4-
bromonitrobenzene, while the use of 4-fluoro-substituted nitrobenzene results in SNAr 
substitution as a minor side-reaction. Even examples using Sanger’s reagent, (2,4-
dinitrofluorobenzene) known to be a highly reactive electrophile in SNAr reactions, can still 
afford predominantly the VNS products under the appropriate reaction conditions.133  
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3.1.3 Mechanistic Studies of Vicarious Nucleophilic Substitution 
 
The general VNS mechanism first proposed by Mąkosza, via initial formation of a σH-
adduct and then elimination of the vicarious leaving group, has been generally accepted, 
and is supported by the report of the first direct observation, by UV/Vis and NMR, of a VNS 
σH-adduct 81 (Scheme 48).134 
 
 
Scheme 48 First direct observation of a VNS σH-adduct 
 
Further studies have provided additional evidence for this mechanism and have answered 
some of the questions that surrounded the mechanism (Scheme 49). These questions 
were as follows;  
 
• Does the original addition occur via a direct addition or a SET pathway?  
• What does the dependency of regioselectivity on the reaction conditions (in particular 
base concentration and temperature) tell us about the formation of the σH-adduct? 
• Does the conversion of σH-adduct 82 to intermediate 83 occur via a hydride shift, as 
originally proposed by Mąkosza,105 or via a β-elimination? 
 
 
Scheme 49 Proposed general-mechanism for VNS of electron-poor arenes 
 
One of the first studies into the mechanism of the VNS reaction looked at the relative rates 
of VNS and SNAr reaction of 4-fluoronitrobenzene with the carbanion of α-chloromethyl 
phenylsulfone135 and it was observed that base concentrations were found to have a 
significant effect on the yields of VNS vs. SNAr substitution (Table 12). 
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X Yield 84 (%) Yield 85 (%) 
1.0 14 12 
2.0 66 8 
4.0 58 Trace 
2.0a 11 49 
a Portionwise base addition. 
Table 12 VNS vs. SNAr substitution of 4-fluoronitrobenzene with α-chloromethyl phenylsulfone 
 
The base dependency on the ratio of VNS vs. SNAr shown in these competition 
experiments provides strong evidence for the VNS reaction proceeding via a β-elimination 
pathway. Assuming that the formation of intermediate 83 was the rate-determining step, if 
a hydride shift was responsible for the formation of intermediate 83 then the rate of 
reaction would be independent of base concentration, whereas a base-induced β-
elimination would be dependent on base concentration. Given that the rate of SNAr 
reactions are known to be independent of base concentration then the rate of SNAr versus 
VNS should only vary with base concentration if a base-dependent rate-determining step 
was occurring in the VNS pathway. The observed trend for the increased selectivity for the 
VNS product 84 with increased base concentration, supports both the hypothesis that the 
reaction proceeds via a base-induced β-elimination and that the elimination step is the 
RDS. 
 
The rate dependency of the β-elimination on base concentration can also explain the 
observed increase in ortho-selectivity with increased base concentration/strength.111 It is 
proposed that initially nucleophilic attack occurs at the ortho-position, followed by 
subsequent equilibration with time to the thermodynamically preferred para-σH-adduct via 
a dissociation-addition mechanism. At higher base concentrations the rate of β-elimination 
increases and the reaction can be thought to be under kinetic control increasing selectivity 
for the ortho-position. At lower base concentrations the rate of β-elimination is slower and 
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the subsequent increased time for equilibration results in an increased selectivity for the 
thermodynamically preferred para-products. A decrease in reaction temperature has been 
shown to have a similar effect, trapping the kinetic product by slowing the rate of 
equilibration between the ortho and para-σH-adducts and increasing selectivity for 
substitution at the ortho-positions. 
 
KIE studies have lent further support to the base dependency of the β-elimination step. 
Reactions with 4-bromo-6-deuterio-2-fluoronitrobenzene revealed a large primary KIE (4.2) 
at lower base concentration (typical of those utilised in VNS reactions), while an increase 
in base concentration resulted in a secondary KIE (0.8) being observed (Scheme 50).132 
These results highlight the base-dependency on the rate of the β-elimination step and that 
at lower base concentrations the β-elimination step is the RDS, while at higher base 
concentrations the formation of the σH-adducts becomes the RDS. 
 
 
Scheme 50 VNS KIE experiments with varying base concentration  
 
The question of the mechanism of the initial nucleophilic addition is a more contentious 
one, with the two proposed mechanisms; a direct nucleophilic addition, (path a, Scheme 
51), and a step-wise SET transfer (path b) proposed by different researchers, based on 
differing evidence. 
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Scheme 51 Direct addition vs. SET pathways in VNS reactions 
 
Early ESR evidence for the existence of anion radicals upon the treatment of nitrobenzene 
with carbanions led to the suggestion of the initial nucleophilic attack occurring via a SET 
mechanism.136,137 However, Mąkosza proposes a direct nucleophilic attack, due to the lack 
of observed inhibition with the use of radical probes (incorporated into the carbanions) in 
VNS reactions, and argues that the highly sensitive nature of ESR can lead to erroneous 
results.138 Mąkosza also cites a lack of observable paramagnetic broadening in the NMR 
analysis of the formation of VNS σH-adduct intermediate 81 (see above, Scheme 48) as 
further evidence for the direct nucleophilic addition in the first step. With a lack of sufficient 
evidence supporting either mechanism, at this point further studies are required to answer 
the question of what is the mechanism of the initial nucleophilic addition in VNS. 
 
3.1.4 Vicarious Nucleophilic Aminations of Electron-Deficient Arenes 
 
Early examples from Meisenheimer reported the amination of dinitrobenzene with 
hydroxylamine under basic conditions; however yields were not reported and amination of 
mono-substituted nitro-arenes was not discussed (Scheme 52).139–143 The original report 
proposes that the reaction proceeds via an internal oxidation-reduction process following a 
double addition of hydroxylamine, rather than a VNA mechanism, but no mechanism has 
been proposed for this process.  
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Scheme 52 Meisenheimer’s amination of electron-deficient arenes 
 
The substrate scope of the hydroxyamine amination has since been extended to include 
nitronaphthalenes,144 5-nitropyridines145 and 4-nitroisoquinolines.145 Seko has further 
developed this methodology with the use of O-(methyl) hydroxylamine as an aminating 
agent in the copper-catalysed VNA of nitroarenes.146 The copper is proposed to activate 
the O-(methyl) hydroxylamine to the copper amidate 86 that acts as the active nitrogen 
source for the VNA of nitroarenes (Scheme 53). More recently Seko has again utilised O-
(methyl) hydroxylamine in a similar zinc-catalysed process for the ortho-selective 
amination of nitropyridines.147  
 
 
Scheme 53 Proposed mechanism for the Cu-mediated VNA amination of nitrobenzene 
 
A number of additional nucleophilic nitrogen transfer agents (NNTA) have since been 
utilised in the VNA of electron-deficient (hetero)arenes with, generally, similar trends in 
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regioselectivity and chemoselectivity to those observed in the VNS reactions with 
carbanions. Katritzky has reported the use of 4-amino-1,2,4-triazole 87 as a nitrogen 
source for the amination of a range of nitrobenzene derivatives with complete para-
selectivity in fair-to-good yields (22-91%) (Scheme 54).148 Similar trends in reactivity, to 
that of the VNS alkylation of nitrobenzene discussed above (Section 3.1.2), were 
observed, with higher yields afforded with the use of more electron-deficient electrophiles. 
 
 
Scheme 54 Katritzky’s amino-triazole mediated VNA of nitrobenzene 
 
Katritzky further expanded the scope of the VNA reactions with amino-triazole 87 to the 
amination of 1-nitronaphthalene (62%), 2-nitrofuran (13%) as well as notably the use of 
substituted amino-triazoles in the synthesis of N-substituted nitroanilines in fair-to-good 
yields.149 More recently Suwinski et al. reported the use of aminotriazole 87 in the 
amination of 1-aryl-4-nitroimidazoles in fair-to-moderate yields (30-72%), though electron-
poor aryl substituents at the 1-position were not tolerated,150 and in the amination of 
3,5,6,7 and 8-nitroquinolines with fair-to-good yields.151 
 
Mąkosza has reported the use of a wide range of sulfenamides as VNA aminating agents, 
of which sulfenamides 88-90 (Figure 8) proved to be the most promising for the amination 
of nitrobenzenes, with good regioselectivity for amination at the 4-position, and 
nitronaphthalene.152 More recently Mąkosza has expanded the electrophile scope to 
include 6-nitroquinoline, nitropyridines, nitrothiophenes, N-methylnitropyrroles and N-
methyl-5-nitroindole as well as the use of N-disubstituted sulfenamides in the synthesis of 
N-alkyl and N-arylnitroanilines.153 
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Figure 8 Aminating agents used in the VNA of electron-deficient arenes 
 
Pagoria has utilised 1,1,1-trimethylhydrazinium iodide 91 (Figure 8) in the amination of a 
range of meta-substituted nitrobenzenes (Scheme 55) with selectivity for amination at the 
ortho-position of nitrobenzene (85%, 61:39 o:p nitroaniline) even under strongly basic 
(KOtBu/DMSO) reaction conditions.154 
 
 
Scheme 55 Pagoria’s VNA of 3-substituted nitrobenzene with 1,1,1-trimethylhydrazinium iodide 
 
1,1,1-Trimethylhydrazinium iodide 91 has also been reported in the amination of 1,3-
dinitrobenzene (with generally good yields and good levels of ortho-selectivity),155 in the 
amination of nitroquinolines with moderate-to-good yields156 and in the amination of 3,5-
dinitro-1H-pyrazole.157 Recently ESR studies and ab intio calculation have lent some 
support to the involvement of a SET mechanism in the VNA with 1,1,1-
trimethylhydrazinium iodide,158 though further studies are required to provide more 
evidence for this hypothesis. 
 
3.1.5 Other Examples of VNS Reactions: Hydroxylation of Nitroarenes and the 
Alkylation of Electron-Deficient Alkenes 
 
The use of both alkyl and aryl hydrogen peroxides as nucleophiles in the VNS synthesis of 
nitrophenols have been reported with moderate-to-good yields (Scheme 56).159–161 As with 
the alkylation and amination examples, the substrate scope of this reaction has been 
extended to a range of nitro-substituted (hetero)arenes including: nitronaphthalenes, 
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nitropyridines, nitroquinolines and nitrothiophene,162 and has been utilised in the 
regioselective and cost effective synthesis of 4,6-diaminoresorcinol, a precursor for high-
strength liquid crystal polymers.163 
 
 
Scheme 56 Hydroxylation of nitroarenes via VNS of hydrogen  
 
The nucleophilic substitution of hydrogen in esters of fumaric and maleic acids has also 
been reported (Scheme 57).164 However, due to the lack of a driving force, such as the re-
aromatisation of the σH-adducts in the reactions with nitroarenes, the β-elimination step is 
often sluggish and the scope is limited. Furthermore, currently no mechanistic studies 
have been carried out and a competing cyclisation/ring-opening mechanism, in place of 
the VNS mechanism, cannot be ruled out.165 
 
 
Scheme 57 Nucleophilic substitution of hydrogen in electrophilic alkenes 
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3.2 Project Aims 
 
As introduced in Section 2.1.2.3, the Armstrong group has developed a transition metal-
free reaction system for nucleophilic nitrogen transfer through the use of aminimines 
produced in situ from DppONH2 and a tertiary amine, typically NMM. The resultant 
aminimine 18 has the appropriate characteristics needed to act as a nucleophilic nitrogen 
transfer agent in VNA reactions. 
 
The aim of this project was to evaluate the use of the aminimine 18 as a nucleophilic 
nitrogen transfer agent in the VNA of electron-deficient arenes and apply the developed 
methodology to the synthesis of a wide range of aminated arenes and heteroarenes. Initial 
studies focused on the use of pre-prepared salts, in an approach analogous to that 
describe by Pagoria.154 With the initial reactions using pre-formed salt proving successful, 
the use of the in situ salt formation protocol was then tested (Scheme 58). Development of 
an in situ reaction should offer a number of advantages over the use pre-prepared salts; 
firstly avoiding the need to prepare and handle, potentially hazardous, stoichiometric 
hydrazinium salts and secondly the possibility of altering reactivity and selectivity through 
the use of alternative tertiary amines.  
 
 
Scheme 58 Proposed amination of electron-deficient aromatics using DppONH2/NMM reaction system 
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Finally, the potential use of sub-stoichiometric amounts of the NMM promoter was studied 
with an aim of developing a catalytic variant of the NMM mediated VNA of electron-
deficient arenes. 
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3.3 Results and Discussion 
3.3.1 Initial Studies Using 4-Aminomorpholinium Salts 
 
Initial studies utilised NMM-derived hydrazinium iodide salt 16a to test the viability of the 
proposed VNA system and, in particular, the ability of NMM to act as an efficient leaving 
group in the VNA reaction. The iodide salt 16a was synthesised as a white crystalline solid 
from 4-aminomorpholine and methyl iodide (70%, Scheme 59). 
 
 
Scheme 59 Synthesis of 4-amino-4-methyl-mopholinium iodide 
 
The use of the iodide salt 16a was then tested in the amination of nitrobenzene and for this 
the protocol from Pagoria’s work, using trimethylhydrazinium iodide, was followed.154 
Under these conditions nitrobenzene was aminated using the iodide salt in slight excess in 
the presence of at least 2 equivalents of a strong alkoxide base, typically potassium tert-
butoxide, and a strongly co-ordinating solvent; here DMSO is used. The requirement of a 
co-ordinating solvent is common throughout the VNA methodology and is proposed to 
have the duel role of stabilising the σH-adduct (Meisenheimer complex) intermediate and 
solvating of the base. 
 
Use of the iodide salt 16a for the amination of nitrobenzene under these conditions 
afforded complete conversion of the nitrobenzene with the desired amino product 92 
afforded in a pleasing yield of 73% (Table 13, Entry 1), although only a slight 
regioselectivity for the para-position (1:1.2 ortho:para) was observed. 
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Entry Base Solvent 
Conversion of  
Nitrobenzene (%)a 
Yield o-92(%)b Yield p-92(%)b 
1 KOtBu DMSO 100 33 40 
2 NaOH DMSO 100 19 54 
3 NaOH DMF 100 5 26 
4 NaOH THF 55 - - 
5 NaOH CH2Cl2 <1 - - 
6 NaOH MeCN 85 - trace 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as  
the internal standard. b Isolated yields following column chromatography. 
Table 13 Use of morpholinium iodide salt 16a in the VNA of nitrobenzene 
 
The use of sodium hydroxide (Entry 2), the preferred base of the DppONH2/NMM 
aziridination methodology, in place of tert-butoxide afforded the same yield with an 
increased selectivity for para-92. This increased selectivity is likely explained by a 
decreased rate of the β-elimination step with the weaker hydroxide base, as discussed in 
Section 3.1.3 above. 
 
A small solvent screen was then carried out to test both solvents known to be effective for 
VNA reactions (Entries 3&4) and those solvents known to be compatible with the in situ 
formation of aminimine 18 (Entries 5&6). The use of DMF (Entry 3), often used as an 
alternative to DMSO in VNS reactions, resulted in a lower yield of nitroaniline (31%), 
though with almost twice the selectivity for the para-product, when compared to the DMSO 
reaction. Again this is proposed to be due to the decreased rate of β-elimination. While the 
use of THF (Entry 4) has been shown to be compatible with some VNS reaction 
systems,124 its use in the hydrazinium iodide system was not tolerated affording a 55% 
conversion of the nitrobenzene with none of the desired product obtained. The use of 
solvents known to be compatible with the in situ formation of aminimine 18 did not show 
any compatibility with the VNA reaction. The use of CH2Cl2 only gave return of the starting 
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materials (Entry 5), while the use of MeCN (Entry 6) saw almost complete conversion of 
the nitrobenzene, but only trace amounts of the desired amination product. 
 
With the efficacy of the NMM as a leaving group in VNA of nitrobenzene demonstrated a 
small study of substrate scope was then performed, looking at a range of nitro-aromatic 
and electron-deficient heteroaromatic compounds (Table 14). 
 
 
Entry Substrate Conversion of ArNO2 (%)a Product Yield (%)b 
1 
 
100 
 
54% (para) 
19% (ortho) 
2 
 
100 
 
79 
3 
 
100 
 
88 
4 
 
100 
 
41 
5 
 
0 - - 
6 
 
92 
 
20 
7 
 
100 
 
31 
8 
 
22 - - 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as  
the internal standard. b Isolated yields following column chromatography. 
Table 14 Substrate scope for the VNA using morpholinium iodide salt 16a 
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The use of more electron-deficient nitrobenzene-derived substrates saw an increase in 
yields, with 1,3-dinitrobenzene (Table 14, Entry 2) affording a 79% yield of the amination 
product 93, with substitution exclusively at the 6-position of the 1,3-dinitrobenzene. The 
amination of 1-nitronaphthalene proceeded with a high yield of 88% (Entry 3) with 
effectively complete selectivity for the 2-position (a small amount (~1%) of the 4-
aminoproduct was observed in the NMR spectrum of crude reaction mixture) in agreement 
with the selectivity previously reported (See Section 3.1.2 above). One reason for the 
observed increased reactivity with the use of 1-nitronaphthalene, compared to 
nitrobenzene, likely lies in the increased resonance stabilisation of nitronaphthalene (61 
kcal/mol) when compared to benzene (36 kcal/mol). This increased resonance stabilisation 
would lower the energy of the intermediate Meisenheimer complex helping drive the 
addition equilibrium towards the σH-adduct and thus increasing product formation. 
 
The use of electron-deficient heteroaromatics was also tolerated with amination of 
benzoxazole (Entry 4) affording the 2-amino product 95 in a 41% yield, providing the first 
example of the VNA of benzoxazole without activation by electron-withdrawing 
substituents. Attempts at the amination of oxazole (Entry 5) gave no conversion of the 
starting material, possibly due to either the oxazole being too electron-rich and/or the lack 
of resonance stabilisation afforded by the benzene ring present in benzoxazole, resulting 
in the addition equilibrium being shifted too far towards the starting materials. Use of the 
sulfur analogue benzothiazole (Entry 6) gave a lower yield of 20% and, as with the 
nitrobenzene examples, the use of a more electron-poor substrate 6-nitrobenzothiazole 
(Entry 7) afforded an increase in the yield to 31%. With the use of 1-methylbenzimidazole 
a 22% conversion of the starting material was observed, but none of the desired amination 
product was recovered. 
 
While the benzazole examples (Entries 4,6 & 7) only afforded at best moderate yields, the 
use of the DppONH2/NMM VNA protocol to access these N-unsubstituted aminobenzazole 
products offers a simple, complementary approach to the metal-catalysed direct amination 
methodologies, which typically only allow access to N-substituted aminobenzazole 
products.166 
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One final test reaction that was carried out, prior to attempts at the tertiary 
amine/DppONH2 in situ reaction, was the use of diphenylphosphinate salt 24 in place of 
the iodide salt. These test reactions with the diphenylphosphinate salt 24 allow a direct 
comparison to the NMM/DppONH2 in situ reaction, and will show the effect, if any, that the 
change in counter ion has on the reactivity/selectivity of the VNA reaction. DppONH2 itself 
can be accessed in one step from diphenylphosphinic chloride and hydroxylamine 
hydrochloride (Scheme 60). 
 
 
Scheme 60 Synthesis of DppONH2 
 
For the test reaction the diphenylphosphinate salt 24 was prepared via the reaction of a 
1:1 mixture of NMM and DppONH2 in CH2Cl2. Previous studies have shown that complete 
conversion of the starting material into diphenylphosphinate salt 24 occurs within 30 
minutes at room temperature.59 After stirring for 30 minutes the reaction mixture was 
concentrated under reduced pressure and used immediately in the VNA reactions (Table 
15.) 
 
 
Entry Base 
Conversion of 
Nitrobenzene   
(%)a 
Yield o-92(%)b Yield p-92(%)b 
1 KOtBu 100 7 34 
2 NaOH 100 4 34 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the 
internal standard. b Isolated yields following column chromatography. 
Table 15 VNA of nitrobenzene with diphenylphosphinate salt 24 
 
O
P Cl
HO-NH2•HCl (2.0 eq.)
NaOH (3.7 eq.)
H2O:Et2O 1:3.25
-15 °C → rt, 25 min
O
P OPhPh
NH2
2060%
NO2 N
O
NH2 24 (1.1 eq.)
O P
O
Ph
Ph
base (2.4 eq.), DMSO, 18 h
NO2
NH2
92
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Use of the diphenylphosphinic salt 24 reduced the overall yields in comparison with the 
iodide salt 16a, both with the use of potassium tert-butoxide (41%, Table 15, Entry 1) and 
sodium hydroxide (38%, Entry 2). However, similar trends in reactivity are observed with 
sodium hydroxide affording greater selectivity for para-92. Despite the lower yields these 
results validate the use of the diphenylphosphinate salt in the VNA reaction and provide 
precedent for the use of the in situ salt formation. The one question that remained to be 
answered was whether the in situ salt formation would be compatible with the solvents 
required for the VNA reactions. 
 
3.3.2 Initial Attempts at the Amination of Nitrobenzene with In Situ Formation of 4-
Amino-4-methylmorpholinium Salts 
 
Literature examples of the in situ formation of the morpholinium salt 24 and its application 
to the aziridination of electron-deficient alkenes showed CH2Cl2 and MeCN to be the 
preferred solvents.59,60 However, test reactions with pre-formed salts (Section 3.3.1) have 
shown these to be poor solvents for the VNA reaction, likely due to the lack of stabilisation 
of the σH-adduct intermediates and the poor solubility/lack of solvation of the 
alkoxide/hydroxide bases required. As such the initial study focused on finding the optimal 
solvent system required for the amination of nitrobenzene with in situ formation of 
diphenylphosphinate salt 24. A range of solvents were tested, both those shown to be 
compatible with the VNS reactions85 and those used in Armstrong’s aziridination 
methodology57 (Table 16). 
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Entry Solvent Base 
Conversion of 
Nitrobenzene (%)a 
Yield o-92 
(%)b 
Yield p-92 
(%)b 
1 DMSO NaOH 100 1 17 
2 DMF NaOH 57 trace 4 
3 THF NaOH 100 - - 
4 MeCN NaOH 71 trace 4 
5 CH2Cl2 NaOH 5 - - 
6 1,4-dioxane NaOH 100 - trace 
7 DME NaOH 100 - - 
8 DMSO KOtBu 97 9 17 
9 DMSO NaH/IPA 100 - - 
10 DMSO KOH 10 - trace 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as  
the internal standard.  b Isolated yields following column chromatography. 
Table 16 Solvent screen for the in situ salt formation in the VNA of nitrobenzene 
 
Initial attempts with DMSO and NaOH (Table 16, Entry 1) gave complete conversion of the 
starting materials but with a reduced yield (18%) when compared to the analogous 
examples with the pre-prepared salts (Table 15, Entry 2), though much higher 
regioselectivity was observed (1:17 o:p). One possible reason for this increased selectivity 
is in the physical properties of the reaction mixture. The use of pre-formed salt in DMSO 
gave a homogenous reaction mixture, while the protocol with in situ salt formation resulted 
in a thick heterogeneous reaction mixture. The thick heterogeneous reaction mixture might 
have resulted in a lower base concentration and corresponding decreased rate of β-
elimination. Test reactions at half the concentration and twice the reaction time still gave a 
thick heterogeneous reaction mixture and afforded no significant increase in yield or 
regioselectivity. Reactions run at lower concentrations still failed to give a homogeneous 
reaction mixture and were deemed too slow to be useful. 
 
The same trends in reactivity as with the use of pre-formed salt were observed with 
alternative solvents. The use of DMF resulted in a lower conversion of nitrobenzene and 
yield of nitroaniline (4%, Entry 2), whilst use of THF afforded complete conversion of the 
NO2
NH2
92
i) NMM (1.1 eq.), solvent, rt, 30 min
ii) base (2.4 eq.), nitrobenzene (1.0 eq.), 18 h
iii) [H+], 30 min
Ph P O
O
Ph
NH2
20
(1.1 eq)
Ph P OH
O
Ph
+
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starting material but none of the desired nitroaniline product was observed (Entry 3). In the 
in situ reaction the use of MeCN (Entry 4), which had given 0% yield with the pre-formed 
salt, afforded a low yield of 4% of the desired amination product. The use of CH2Cl2 again 
showed only minimal conversion of the starting materials (Entry 5). Reactions with 
alternative co-ordinating solvents 1,4-dioxane and DME (Entries 6&7) also failed to give 
any significant yield of the desired products.  
 
A small screen of alternative hydroxide and alkoxide bases showed that the use of KOtBu 
(Entry 8) gave an increased yield of 26%, when compared to the use of NaOH, though with 
the expected decreased regioselectivity. Reactions using either NaH/IPA, an alternative 
base system used in the Armstrong aziridination methodology, or KOH afforded none of 
the desired amination products. 
 
One possible reason for the lower yields afforded with the in situ salt formation in DMSO, 
when compared to the pre-formed salts, is that DMSO is hampering salt formation. This 
proposed poor compatibility of DMSO was highlighted by NMR studies of the salt formation 
in d6-DMSO. Unlike the quantitative formation of the diphenylphosphinate salt 24 observed 
in CH2Cl2/MeCN after 30 minutes, reactions in d6-DMSO afforded a complex mixture of 
products that included a low yield of the desired diphenylphosphinate salt 24. Furthermore, 
the poor yields compared to the high conversion achieved with the use of DMSO as a 
reaction solvent suggest that these side-products go on to react with the nitroarenes. 
 
With DMSO shown to be a poor solvent for the in situ VNA reaction, work was then 
focused on developing a reaction system using CH2Cl2, known to be compatible with the 
required salt formation. 
 
Two main reasons have been proposed for the poor conversion of nitrobenzene with the 
use of CH2Cl2; poor solubility/solvation of the base and the corresponding less basic 
nature of anions in non-coordinating solvent, and the instability of the intermediate 
Meisenheimer complex. Attempts were made to use additives to overcome the proposed 
incompatibilities with the use of CH2Cl2 in the VNA reaction (Table 17). Sodium hydroxide 
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was chosen as the base for these test reactions due to its well-demonstrated compatibility 
with the NMM/DppONH2 aminating system. 
 
 
Entry Additive 
Conversion of 
Nitrobenzene (%)a 
Yield o-92 
(%)b 
Yield p-92 
(%)b 
1 nBu4N.Cl (10 mol%) 97 - - 
2 nBu4N.Cl (100 mol%) 95 - - 
3 nBu4N.OH (10 mol%) 93 - - 
4 nBu4N.OH (2.4 eq.)c 59 - - 
5 15-crown-ether (2.4 eq.) 73 - - 
6 DMPU (10 mol%) 22 - trace 
7 DMPU (10 vol%) 43 - trace 
8 DMSO (10 mol%) 73 - 1 
9 DMSO (10 vol%) 68 trace 4 
10 
 
20 - 2 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. 
 b Isolated yields following column chromatography. c Reaction run without sodium hydroxide. 
Table 17 Use of additives in VNA of nitrobenzene 
 
Initial attempts used phase transfer catalysts in an attempt to improve the solubility of the 
sodium hydroxide base in CH2Cl2. Attempts with tetrabutylammonium chloride in both 10 
mol% (Table 17, Entry 1) and 100 mol% (Entry 2) failed to give any of the desired product, 
however almost complete conversion of the nitrobenzene was observed. This complete 
conversion is in contrast to the reaction without the additive which showed only 5% 
conversion of the starting material. The use of the analogous ammonium hydroxide salt, 
both in 10 mol% (Entry 3) and in 2.4 equivalent in place of the sodium hydroxide (Entry 4) 
also gave high conversion but with none of the desired aminated product. The use of 15-
crown-ether (Entry 5) in a 1:1 equivalent with the sodium hydroxide also gave none of the 
desired aminated product, though with lower conversion compared to the use of tetrabutyl 
ammonium salts. 
 
NO2
NH2
92
i) NMM (1.1 eq.), CH2Cl2, rt, 30 min
ii) NaOH (2.4 eq.), nitrobenzene (1.0 eq.), additive, 18 h
iii) [H+], 30 min
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O
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20
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Ph P OH
O
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+
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With the phase transfer catalysts failing to give any of the desired products, a range of 
additives, chosen to simulate the co-ordinating/solvating effect afforded with the use of 
DMSO, were tested. The use of co-ordinating solvent DMPU in 10 mol% (Entry 6) gave 
only 22% conversion of nitrobenzene, though for the first time traces of the desired product 
was observed. Increasing the amount of DMPU to 10 vol% gave an increased conversion 
of the nitrobenzene (43%), but still only traces of the desired products. The use of DMSO 
in similar quantities (Entries 8&9) gave a slight increase in conversion, but still very poor 
yields of the desired product were afforded. Finally 1,2-bis(phenylsulfinyl)ethene 98 (Entry 
10), used by White167 as sulfoxide promoter in Pd-catalysed C-H oxidations was tested, 
here it was hoped that the sulfoxide promoter would mimic the co-ordinating effect of 
DMSO both solvating the base and stabilising the Meisenheimer complex; however, only a 
2% yield of the desired product was observed. 
 
Test reactions with iodide salt 16a (Table 14) had shown improved reactivity over those 
using the diphenyl phosphinate salt 24 (Table 15). Could the use of iodide additives have a 
similar effect in increasing the yield of the in situ reaction in DMSO? For these reactions 
the solvent swap protocol described above (Table 15), with the salt formation in CH2Cl2 
and the VNA reaction in DMSO, was used to ensure that a full 1.5 eq. of the 
diphenylphosphinate salt 24 was present (Table 18). 
 
 
Entry Additive 
Conversion of 
Nitrobenzene   
(%)a 
Yield o-92 
(%)b 
Yield p-92 
(%)b 
1 NaI (1.1 eq.) 100 - trace 
2 Bu4N.I (1.1 eq.) 100 trace 10% 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the 
internal standard. b Isolated yields following column chromatography. 
Table 18 Use of iodide additives in VNA of nitrobenzene 
 
NO2
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92
Ph P OH
O
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+
i) NMM (1.1 eq.),
   CH2Cl2, rt, 30 min
ii) concentrated in vacuo
ii) NaOH (2.4 eq.), additive
    nitrobenzene, DMSO, 18 h
iii) [H+], 30 min
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20
(1.1 eq)
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Unfortunately, the use of NaI as an additive afforded none of the desired product (Table 
18, Entry 1), while the use of more soluble tetrabutylammonium iodide afforded a 10% 
yield of the para-product; however, this was still a decrease when compared to the 
additive-free reaction. 
 
3.3.3 Use of More Electron-Deficient Aromatic Electrophiles 
 
With additives and co-solvents failing to afford any increase in the yields of the VNA of 
nitrobenzene, either in CH2Cl2 or DMSO, it was decided to test both reaction systems with 
more electron-deficient substrates. The use of both 1,3-dinitrobenzene and 1-
nitronaphthalene in VNA reactions with pre-formed iodide salt 16a had shown significantly 
increased yields when compared to the use of nitrobenzene and were chosen as test 
substrates (Tables 19 & 20). 
 
 
Entry Solvent 
Conversion of 
Dinitrobenzene   
(%)a 
Yield 93 (%)b 
1 DMSO 93 21 
2 CH2Cl2 86 0 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the  
internal standard. b Isolated yields following column chromatography. 
Table 19 VNA of 1,3-dinitrobenzene with in situ salt formation 
 
As with the results using pre-formed salts, the use of the more electron-deficient aromatic 
dinitrobenzene, afforded an increased 21% yield of the aminated product (Table 19, Entry 
1), although again no aminated product was afforded with the use of DCM (Entry 2), 
despite high conversion of the dinitrobenzene. 
 
 
i) NMM (1.1 eq.), solvent, rt, 30 min
ii) NaOH (2.4 eq.), dinitrobenzene (1.0 eq.), 18 h
iii) [H+], 30 min
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Entry Base Solvent 
Conversion of 
Nitronaphthalene  
(%)a 
Yield 2-Amino 94 (%)b Yield 4-Amino 94 (%)b 
1 NaOH DMSO 70 20 6 
2 NaOH CH2Cl2 72 60 1 
3 KOtBu CH2Cl2 55 40 1 
4 NaH/IPA CH2Cl2 15 8 trace 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard.  
b Isolated yields following column chromatography. 
Table 20 VNA of 1-nitronaphthalene with in situ salt formation 
 
Initial attempts at the use of 1-nitronaphthalene (Table 20, Entry 1) in DMSO gave an 
increased yield of 26%, as expected with the observed trend of increased reactivity with 
increased electron deficiency of the aromatic substrates used, c.f. nitrobenzene (18%, 
Table 16) and dinitrobenzene (21%, Table 19). Pleasingly, unlike with other substrates 
tested, the use of CH2Cl2 (Table 20, Entry 2) gave similar conversion to the reaction in 
DMSO, but a significantly higher yield of the aminated products (61%) and a high 
selectivity for amination at the 2-position. This increased reactivity of 1-nitronaphthalene in 
CH2Cl2 is proposed to arise due to the increased stability of the intermediate 
Meisenheimer complex in CH2Cl2, when compared to those formed with the nitrobenzene 
substrates, alongside a complete formation of the required diphenyl phosphinate salt. This 
increased stability is likely due to the increased delocalisation of the negative charge into 
the second phenyl ring, i.e. the increased resonance stabilisation of nitronaphthalene (61 
kcal/mol) when compared to benzene (36 kcal/mol). Interestingly, the use of the stronger 
alkoxide base (KOtBu, entry 3) gave a decreased yield of 41%, suggesting some 
incompatibility between the salt/aminimine and strongly basic reaction conditions.  
 
The high selectivity for amination at the 2-position, over the 4-position, of 1-
nitronaphthalene is in agreement with reported literature with other nucleophiles, where 
selectivity of 1-nitronaphthalenene has been found to be less dependent of the steric bulk 
of the incoming nucleophile when compared to nitrobenzene substrates.149,168 This is 
i) NMM (1.1 eq.), solvent, rt, 30 min
ii) base (2.4 eq.), 1-nitronaphthalene (1.0 eq.), 18 h
iii) [H+], 30 min
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supported by molecular orbital calculations169–171 which have shown that the π-electron 
density is significantly lower at the 2-positon when compared to the 4-position, while in 
nitrobenzene the π-electron density is comparable at both the 2- and 4-positions. 
 
Also tested was the alternative base protocol from Armstrong’s aziridination methodology 
using a weaker alkoxide base (NaH/IPA) but this again provided poor conversion and only 
an 8% yield of the aminated products (Entry 4). 
 
With these results showing that with 1-nitronaphthatlene the use of non-coordinating 
solvents can be tolerated in VNS reaction, a further solvent screen was carried out (Table 
21). 
 
 
Entry Solvent 
Conversion of 
Nitronaphthalene   
(%)a 
Yield 2-Amino 94 (%)b Yield 4-Amino 94 (%)b 
1 DMF 85 38 10 
2 THF 69 60 2 
3 MeCN 63 39 5 
4 CHCl3 9 2 - 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard.  
b Isolated yields following column chromatography. 
Table 21 Solvent screen for the VNA of 1-nitronaphthalene with in situ salt formation 
 
The use of DMF gave an increased yield of 48% (Table 11, Entry 1) over the use of 
DMSO, likely due to increased compatibility with the salt formation, but still afforded a 
lower yield and selectivity than the use of CH2Cl2. The use of THF gave similar yields 
(62%) and selectivity to the use of CH2Cl2 (Entry 2), while MeCN gave decreased yield 
(44%) and selectivity (Entry 3). Finally, the use of chloroform gave poor conversion and 
yields (2%, Entry 4). For the further studies discussed below, CH2Cl2 was chosen in 
preference to THF as, while both showed similar reactivity, quantitative salt formation is 
i) NMM (1.1 eq.), solvent, rt, 30 min
ii) NaOH (2.4 eq.), 1-nitronaphthalene (1.0 eq.), 18 h
iii) [H+], 30 min
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known to occur within 30 minutes with CH2Cl2 and similar studies have not been carried 
out with THF. 
 
With CH2Cl2 shown to be the solvent of choice, next the optimisation of the reaction 
conditions/protocol was investigated (Table 22). 
 
 
Entry X 
NaOH 
(eq.) 
Conc. 
(M) 
t1 
(h) 
Conversion of 
Nitronaphthalene (%)a 
Yield 2-Amino 
94 (%)b 
Yield 4-Amino 
94 (%)b 
1 1.5 2.4 0.18 18 64 56 4 
2c 1.1 2.4 0.18 18 82 50 6 
3 1.1 3.0 0.18 18 69 59 4 
4 1.1 5.0 0.18 18 78 60 2 
5 1.1 2.4 0.18 24 73 62 6 
6 1.1 2.4 0.18 72 70 60 4 
7d 1.1 2.4 0.18 48 64 64 1 
8 1.1 2.4 0.06 18 64 46 1 
9 1.1 2.4 0.24 18 61 59 1 
10 1.1 2.4 0.40 18 79 59 6 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. 
b Isolated yields following column chromatography. c 1.5 eq. of DppONH2 added. d At 24 hours an extra 0.5 eq. of 
performed diphenylphosphinate salt 24 was added. 
Table 22 Optimisation of the VNA of 1-nitronaphthalene with in situ salt formation 
 
An increase in the equivalents of the nucleophile to 1.5 equivalents (Table 22, Entry 1) had 
no significant effect on either the yield or the selectivity of the reaction. The use of 
DppONH2 in excess resulted in an increased conversion but a decreased yield of the 
aminated products (Entry 2). Test reactions showed that DppONH2 can react with the 1-
nitronaphthalene in the absence of the tertiary amine; however, this did not afford the 
desired aminated product.  
 
Increasing the equivalents of the base to 3 or 5 equivalents (Entries 3&4) had no 
significant effect on the reactivity/selectivity, and only a slight increase in the conversion of 
i) NMM (X eq.), CH2Cl2, rt, 30 min
ii) NaOH, 1-nitronaphthalene (1.0 eq.), t1
iii) [H+], 30 min
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the starting material was observed, likely due to the reaction mixture already being 
saturated with 2.4 equivalents of sodium hydroxide.. An increase in reaction time to 24 
hours saw only a slight increase in the conversion and a corresponding increase in yield to 
68% (Entry 5). However, further increase in reaction time to 72 hours saw in no further 
increase in the conversion or yield (Entry 6). 
 
Several possibilities for the reaction stalling were considered, the first being the instability 
of the aminimine under extended reaction conditions. This was tested by the addition of an 
extra 0.5 equivalents of the pre-formed diphenylphosphinate salt 24 after 24 hours (Entry 
7). The reaction was then allowed to run for an additional 24 hours, but no increase in 
yields was observed. This lack of increased yields with the addition of the extra 
equivalents of diphenylphosphinate salt 24 suggests that aminimine stability was not a 
problem under the reaction conditions. 
 
It was observed that after addition of the base and 1-nitronaphthalene the reaction mixture 
was observed to instantly change from a clear pale yellow solution to a bright red/brown 
heterogeneous slurry, which continued to thicken over the course of the reaction. To test if 
the heterogeneous reaction mixture was causing the reaction to stall due to lowering the 
concentration of the reactants, reagents or base, the effect of reaction concentration was 
studied. A reaction run at lower concentration (0.06 M) (Entry 8) afforded a decreased 
yield though similar conversion of the nitrobenzene was observed. Increased 
concentrations (Entries 9&10) gave no significant change in yields, though at 0.4 M (Entry 
10) an increased conversion was observed. These results suggest that the poor solubility 
of reagents/reactants in the reaction mixture was not the cause of the reaction stalling. 
 
With optimised reaction conditions (Table 22, Entry 5) providing a yield of 68% of the 
aminated product, a screen of tertiary amines was used to test if the reactivity of the 
aminimine could be tuned through choice of the amine promoter (Table 23). Previous work 
within the Armstrong Group has shown that both secondary amines and aromatic amines 
(e.g. pyridine and DMAP) failed to promote the analogous aziridination reaction and as 
such were not included in the amine screen. 
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Entry NR3 
Conversion of  
Nitronaphthalene (%)a 
Yield 2-Amino 
94 (%)b 
Yield 4-Amino 
94 (%)b 
1 
 
63 59 3 
2 
 
55 49 4 
3 
 
63 51 3 
4 
 
76 40 2 
5 
 
70 52 2 
6 
 
66 62 2 
7 NEt3 60 32 trace 
8 NBu3 50 29 3 
9 quinine 31 19 1 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. 
b Isolated yields following column chromatography.  
Table 23 Tertiary amine screen for the VNA of 1-nitronaphthalene with in situ salt formation 
 
The tertiary amine screen started with N-methylpiperidine and N-methylpyrrolidine (Table 
23, Entries 1&2), both shown to be effective tertiary amine promoters in the analogous 
aziridination reaction.57 The use of N-methylpiperidine gave a slightly reduced yield of 61% 
(Entry 1) compared to the use of N-methylmorpholine (68% yield, Table 22) though with a 
slightly decreased regioselectivity. The use of a smaller ring size, N-methylpyrrolidine, 
afforded a lower conversion and a corresponding lower 53% yield with only a slightly 
reduced selectivity (Table 23, Entry 2). Increasing the bulk of the N-substituent (N-
ethylmorpholine) afforded similar conversion but a decrease in yield (54%, Entry 3) and no 
significant change in regioselectivity. Changes to the heteroatom at the 1-positon, 1,4-
dimethylpiperazine, gave a slight increase in conversion but a significantly lower yield 
i) NR3 (1.1 eq.), CH2Cl2, rt, 30 min
ii) NaOH (2.4 eq.), 1-nitronaphthalene (1.0 eq.), 24 h
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Ph P O
O
Ph
NH2
20
(1.1 eq)
Ph P OH
O
Ph
+
94
NO2
NH2
N
N
N
O
N
N
N
N
N
 97 
(42%, Entry 4), again with no significant change to the regioselectivity. Use of bicyclic 
tertiary amines gave mixed results with quinuclidine affording a decreased yield (54%, 
Entry 5) while DABCO (64%, Entry 6) gave a similar yield and conversion to the use of N-
methylmorpholine.  Use of non-cyclic tertiary amines was not well tolerated with both 
triethylamine and tributylamine affording significantly lower yields of the aminated product 
(Entries 7&8). Finally the use of quinine, used in the asymmetric aziridination of electron-
deficient alkenes,62 afforded only moderate conversion and poor yields (20%, Entry 9) of 
the aminated products. 
 
With the amine screen failing to find a tertiary amine that could give any increased 
reactivity or significantly altered regioselectivity, the substrate scope of the reaction was 
then studied. 
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3.3.4 Substrate Scope for the VNA of Electron-Deficient Aromatics with In Situ 
Formation of the Hydrazine Salt 
 
A range of electron-deficient heteroaromatics, both those activated by a nitro substituent 
and those inherently electron-deficient, were tested with the in situ reaction (Table 24). 
 
 
Entry Substrate Conversion of ArNO2 (%)a Product Yield (%)b 
1 
 
100 
 
14c 
2 
 
20 - - 
3 
 
21 
 
17 
4 
 
30 - - 
5d 
 
100 
 
31 
6 
 
0 - - 
7 
 
2 - - 
8 
 
28 - - 
9 
 
66 
 
5 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard.  
b Isolated yields following column chromatography. c Also isolated was 35% of dimerized product 
101. d 3.0 eq. of NaOH added. 
Table 24 Substrate scope for the VNA of electron-deficient heteroarenes with in situ salt formation 
i) NMM (1.1 eq.), CH2Cl2, rt, 30 min
ii) NaOH (2.4 eq.), substrate (1.0 eq.), 18 h
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3-Nitropyridine is known to be a highly reactive electrophile in VNS reactions, with a krel of 
7.8 x104 observed in competition studies with nitrobenzene in VNS reactions with the 
anion of chloromethyl phenyl sulfone.128 The use of 3-nitropyridine in the VNA amination 
reaction afforded complete conversion of the nitropyridine starting material (Table 24, 
Entry 1). However, despite the high conversion only a 14% yield of the desired 2-amino 
product 99 was isolated, as the substrate proved to be too reactive with the major product 
being a dimerised product 101 (Figure 9) isolated in 35% yield. 
 
 
Figure 9 Major product from the VNA of 3-nitropyridine 
 
A proposed mechanism (Scheme 61) for the formation of the dimer product is via an initial 
VNS reaction to afford intermediate I followed by an addition into a second nitropyridine 
affording Meisenheimer complex II. This is followed by either subsequent oxidation to 
afford the dimer product, in a similar mechanism to ONSH reactions85,94 or hydride 
displacement, as proposed in the mechanism of the Chichibabin reaction.91,172  
 
 
Scheme 61 Possible mechanism for the formation of dimer product 101 
 
Both nitrofuran and nitrothiophene have been shown to be efficient electrophiles in VNA 
reactions. However, the use of these substrates in the VNA reaction with NMM-derived 
aminimines showed poor reactivity, with nitrofuran failing to afford any of the desired 
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amination products (Entry 2). The use of 2-nitrothiophene saw slightly increased reactivity 
but still only minimal conversion (21%) and a corresponding low 17% yield of the 3-
aminoproduct 100 was observed (Entry 3). With longer reaction times the reaction was 
seen to stall in the same way as the reactions with 1-nitronaphthalene and as such failed 
to afford any significant increase in either conversion or yields. The difference in reactivity 
between the 2-nitrothiophene and 2-nitrofuran can again be related to the resonance 
stabilisation energies of the heteroaromatic rings, with the more reactive thiophene having 
a greater resonance stabilisation energy (29 kcal/mol versus 11 kcal/mol of furan). 
 
Again the use of oxazole (Entry 4) failed to afford any conversion; however, pleasingly the 
amination of benzoxazole was achieved albeit with only poor yields (31%, Entry 5). The 
use of both 1-methylimidazole and 1-methylbenzimidazole failed presumably because they 
were too electron-rich for the VNA reaction to occur (Entries 6&7). The use of the in situ 
protocol for salt formation was unable to aminate benzothiazole (Entry 8) and only afforded 
a poor yield with the more electron-deficient 6-ntirosubstrate (5%, Entry 9).  
 
Overall the substrate scope highlights the lower reactivity observed with the use of the in 
situ salt formation protocol (c.f. reactions with pre-formed iodide salts, Table 14 above). 
Again, increased reactivity can be achieved with the use of more electron-poor substrates 
and those substrates better able to stabilise the σH-adducts through increased 
delocalisation of the negative charge formed (i.e. a higher resonance stabilisation energy), 
e.g. bicyclic arenes/heteroarenes. 
 
3.3.5 Vicarious Nucleophilic Amination of 1-Nitronaphthalene with Sub-
Stoichiometric Loadings of Tertiary Amine 
 
In the mechanism of the VNA reaction with in situ formation of aminimine 18, alongside the 
aminated electron-deficient arene, NMM is returned as a co-product. With the NMM 
regenerated during the reaction, a catalytic reaction should be possible utilising sub-
stoichiometric quantities of NMM. Similar sub-stoichiometric reactions have been reported 
in the analogous catalytic aziridination mechanism.59 The use of sub-stoichiometric 
loadings of NMM was tested in the VNA of 1-nitronaphthelane (Table 25). 
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Entry X mol% 
Conversion of 
 Nitronaphthalene (%)a 
Yield 2-amino 
94 (%)b 
Yield 4-amino 
94 (%)b 
1 110 73 60 1 
2 75 69 60 2 
3 50 29 26 2 
4 25 23 15 trace 
a Determined by 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard.  
b Isolated yields following column chromatography. 
Table 25 Attempts at the VNA of 1-nitronaphthalene with catalytic loadings of tertiary amine 
 
The use of 75 mol% of NMM afforded a similar yield (62%) to the use of stoichiometric 
amounts (Table 25, Entry 2). However, as the conversion of the starting material was only 
69% (less than the mol% loadings of NMM) and suggests that no catalytic turnover of the 
tertiary amine was occurring. Use of lower loadings of NMM, 50 mol% and 25 mol%, 
(Entries 3&4) gave much lower conversion and yields of the aminated products. Again, in 
both cases the conversions were lower than the mol% loading of NMM and as such 
suggest that no catalytic turnover was occurring. 
 
Test reactions had shown the degradation of the DppONH2 upon prolonged stirring (24 h) 
with NaOH at room temperature. To test if degradation of the DppONH2 was preventing 
turnover, a reaction was run using a 50 mol% loading of NMM where the DppONH2 was 
added in two 0.55 equivalent portions (the second 0.55 eq. was added at 6 hours). 
However, this portionwise addition of the DppONH2 only gave a 14% yield of the 2-amino 
94 with an 84% RSM and as such DppONH2 stability was ruled out as a reason for the 
lack of turnover.  
 
With DppONH2 stability not a problem, it seems that formation of additional 
diphenylphosphinic salt 24 is not possible once 1-nitronaphthalene and base have been 
added to the reaction mixture. As such work into the catalytic reaction was stopped, as 
i) NMM (X mol%.), CH2Cl2, rt, 30 min
ii) NaOH (2.4 eq.), 1-nitronaphthalene (1.0 eq.), 24 h
iii) [H+], 30 min
Ph P O
O
Ph
NH2
20
(1.1 eq)
Ph P OH
O
Ph
+
94
NO2
NH2
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catalytic turnover of the NMM does not seem possible under the current reaction 
conditions. 
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3.4 Conclusions and Future Work 
 
Pre-formed hydrazinium iodide salt 16a was shown to be a useful nitrogen source for VNA 
of electron-deficient arenes (Scheme 62). Good yields were observed for the amination of 
nitro-substituted aromatic compounds, while the use of unactivated heterocycles (i.e. 
without additional electron-withdrawing substituents) proceeded with lower yields. One 
pleasing feature of the developed reaction with NNM iodide 16a was the tolerance for the 
use of a weaker hydroxide base in place of the stronger alkoxide bases utilised in all other 
reported VNA reactions.  
 
 
Scheme 62 Scope of the VNA of electron-deficient aromatics with iodide salt 16a 
 
Despite the use of NMM-derived aminimine proving to be well tolerated as a nitrogen 
source for VNA reactions, development of a protocol with in situ salt formation proved 
problematic. Solvent compatibility was a major issue with DMSO, the optimal solvent for 
the VNA reaction using pre-formed iodide salt 16a, not being compatible with the in situ 
salt formation. Conversely, CH2Cl2 and MeCN, solvents known to be compatible with the in 
situ salt formation proved ineffective solvents for the VNA reaction.  
 
Solvent screens found that DMSO was the optimal solvent for use with substrates whose 
σH-adducts were not sufficiently stabilised in CH2Cl2, this lack of stability is proposed to be 
due to lack of stabilisation of the negative charge of the σH-adduct. Whilst CH2Cl2 proved 
N
O
NH2
I
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NO2 NO2
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97 (R=NO2, X=S) 31%
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to be the optimal solvent in reactions were the (hetero)arene electrophile was either highly 
reactive or better able to stabilise the negative charge of the σH-adducts. In both reaction 
systems a trend for increased reaction yields with the use of more electron-poor 
electrophiles was observed (Scheme 63). 
 
 
Scheme 63 Substrate scope for the VNA of electron-deficient aromatics with in situ salt formation 
 
Finally, attempts at the use of sub-stoichiometric quantities of the tertiary amine, NMM, 
were unsuccessful with no evidence for catalyst turnover observed and the use of lower 
catalyst loading (<75 mol%) resulting in significantly reduced yields. 
 
If further work were to be carried out into the NMM/DppONH2 reaction system, a possible 
area of study would be the development of a system for the synthesis of N-substituted 
nitroanilines. However, as shown in Section 2.3.3 synthesis of N-substituted O-
(diphenylphosphinyl) hydroxylamines can be problematic and as such access to N-
substituted aminimines through the use of pre-formed hydrazinium iodide salt would be a 
good starting point. A second area that could be explored would be the use of chiral 
tertiary amines for the synthesis of C-2 symmetric biaryls through an enantioselective VNA 
desymmetrization. Thirdly, due to the lack of mechanistic understanding for the change in 
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reactivity with the switch to the in-situ protocol further development of the reaction could 
benefit from a DOE (design of experiment) based optimisation of reaction conditions. 
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4 [2,3]-Sigmatropic Rearrangement of Allylic Selenimides: 
The Synthesis of Enantioenriched Vinyl Glycine Peptides 
and Peptidomimetics 
 
As previously discussed, the synthesis of C-N bonds is an important aspect of synthetic 
organic chemistry, particularly in both natural product synthesis and medicinal chemistry, 
and as such development of new methodologies and expansion of the substrate scope of 
existing methodologies is highly sought after. Whilst previous chapters have focused on 
the formation of C-N bonds, utilising O-(diphenylphosphinyl) hydroxylamines as nitrogen 
transfer agents in both the aziridination of electron-deficient alkenes and the amination of 
electron-deficient aromatics, this chapter will focus on the synthesis of enantioenriched 
vinyl glycine derivatives via the formation of C-N bonds through the [2,3]-sigmatropic 
rearrangement of enantioenriched allylic selenimides.  
 
Section 4.1 will firstly discuss current asymmetric methods available for synthesis of vinyl 
glycine derivatives and then go on to provide an overview of the use of organoselenium 
chemistry in the synthesis of allylic amines, with particular focus on the methodology 
available for the amidation of allylic selenides and their subsequent [2,3]-sigmatropic 
rearrangements.  
 
Sections 4.2 and 4.3 will then discuss our work into the expansion of the scope of the 
NCS-mediated amination/[2,3]-sigmatropic rearrangement of allylic selenides. Finally, 
Section 4.4 will discuss the application of this methodology in the formal synthesis of 
pharmaceutical ACE inhibitor Perindopril. 
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4.1 Introduction 
 
Vinyl glycine and its substituted congeners are known to be biologically important 
structures with roles in a large number of biological pathways. In nature D-vinylglycine is 
produced by the mushroom Rhodophyllis nidorosus,173 while the L-antipode is generated in 
a number of PLP (pyridoxal phosphate) enzyme active sites;174 one example of this is its 
role as an intermediate in the conversion of homoserine to threonine by threonine 
synthase.175 Studies have also shown α-vinyl amino acids to have promise as potential 
mechanism-based inhibitors of PLP enzymes.176 Examples of PLP enzymes include 
transamidases, racemases and β- and γ-eliminase which act through an initial α-
deprotonation177 (Figure 10) or in some cases α-decarboxylation.178  
 
 
Figure 10 PLP enzyme mechanisms and α-vinylic amino acid structure 
 
Vinyl glycine and its congeners, particularly those with substitution at the γ-position, are 
believed to function as PLP inhibitors by migration of the alkene to the conjugated (α,β-
unsaturated) position forming a new Michael acceptor that then reacts irreversibly with 
nucleophilic residues present in the active site. A more detailed overview of the biological 
activity and biological mechanisms of vinyl glycine and its congeners can be found in the 
following review and the references therein.174 
 
4.1.1 Asymmetric Methodology for the Synthesis of α-Vinylic Amino Acids 
 
Four general approaches for the synthesis of optically active α-vinylic amino acids will be 
discussed in this introduction, these are; the use of enzymatic and kinetic resolutions, the 
modification of amino acids, the use of chiral auxiliaries and finally the stereoselective 
reactions of prochiral starting materials. 
R
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4.1.1.1 Enzymatic and Kinetic Resolutions  
 
A number of resolutions, both enzymatic and kinetic, have been applied to vinyl glycine 
targets. An early example by Helboe utilised bakers yeast for the kinetic resolution of D/L-
vinylglycine, obtained through the use of a Strecker reaction, affording D-vinylglycine in 
39% yield with 82% ee.179 
 
Later, Pinhey utilised substilisin in the enzymatic ester hydrolysis of N-acetyl vinylglycine 
ethyl ester 102 affording both antipodes in high ee, 82% ee for the L-vinylglycine 103 and 
93% ee for the returned D-vinylglycine ethyl ester D-103.180 Crout reported a 
complementary approach via a bi-phasic papain-catalysed enzymatic esterification of N-
acetyl vinylglycine derivative 103 giving the corresponding L-ethyl ester 102 in 38% yield 
with high optical purity (as determined by optical rotation) and the returned D-vinyl glycine 
103 in 28% yield.181 Both of these enzymatic resolutions are detailed below in Scheme 64. 
 
 
Scheme 64 Enzymatic kinetic resolutions of vinyl glycine derivatives 
 
More recently, Deng182 has reported the synthesis of β,γ-unsaturated α-amino acids using 
a cinchona alkaloid-catalysed kinetic resolution of α-amino acid N-carboxyanhydrides 104, 
accessing α-vinylic amino acids of both antipodes as either the ethyl ester 105 or the 
carboxylic acid 106 in up to 99% ee. Relevant α-vinyl examples are shown in Table 26. 
Studies on similar urethane-protected α-amino acid N-carboxyanhydrides (where R1 is a 
benzyl group) have shown the rate of reaction to have a first-order dependence on the 
alcohol (in these studies MeOH was used in place of EtOH), the substrate and the 
(DHQD)2AQN, as well as a 1st order KIE (kMeOH/kMeOD = 1.3) under pseudo-first-order 
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reaction conditions.183 These results have led to the suggestion of a general base catalysis 
mechanism, where ring opening by alcoholysis is the rate-determining step. 
 
 
Table 26 Cinchona alkaloid-catalysed kinetic resolution of acid anhydride 104 
 
4.1.1.2 Chemical Manipulation of α-Amino Acids 
 
A second approach to the synthesis of vinyl glycine derivatives is the modification of other 
α-amino acids, where the use of chiral pool starting materials allows the synthesis of highly 
enantioenriched α-vinylic amino acids. The synthesis of vinyl glycine from L-methionine 
reported by Afzali-Ardakani and Rapoport184 is a good example of this and has been the 
basis of a number of more recent syntheses.185,186 Initial Cbz-protection of L-methionine 
ethyl ester is followed by selective oxidation to afford sulfoxide 107. Subsequent pyrolysis 
and deprotection afforded L-vinyl glycine with no loss of optical purity (Scheme 65). 
 
 
Scheme 65 Synthesis of L-vinyl glycine from L-methionine 
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Other examples of this general approach include the elimination of selenoxides 
incorporated into homo-L-serine motifs,187,188 a Cu/Pb mediated decarboxylation of L-
glutamate189 and Peterson olefination of L-serine derivatives.190 
4.1.1.3 Use of Chiral Auxiliaries 
 
The use of chiral auxiliaries is also widely reported in the synthesis of α-vinylic amino 
acids; examples include the first reported synthesis of a γ-substituted vinyl glycine 
derivative by Schöllkopf.191 Schöllkopf reported the use of bis-lactam ether 108 with 
Hudrlik’s vinyl cation equivalent 109192 to access, via silyl intermediate 110, γ-substituted 
vinyl glycine derivative 111 (Scheme 66). However, Schöllkopf’s methodology is let down 
by a lack of E:Z selectivity, presumably due to the mixture of hydroxysilane diastereomers 
prior to the elimination step. Kirihata has also utilised bis-lactam ether chiral auxiliary 108 
in the synthesis of E-APPA (D-(E)-2-amino-5-phosphono-3-pentenoic) acid, a constitutional 
phosphono-amino acid of plumbemycine, a threonine anti-metabolite.193 
 
  
Scheme 66 Schöllkopf’s synthesis of γ-substituted vinyl glycine derivative 111 
 
A wider range of γ-substituted vinyl glycine derivatives were synthesised via the initial 
bromination of derivative 112 followed by alkynylation to give intermediate 113. However, 
yields in the subsequent reduction of the cyclic intermediate 113 to the vinyl glycine 
products 114 were generally low and racemisation proved to be a problem with some 
substrates (Table 27).194 
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Table 27 Vinyl glycine synthesis via electrophilic glycine derivative 112  
 
Beaulieu reported the use of L-serine-derived aldehyde 115 in a Wittig reaction to access a 
range of Z-vinyl glycine derivatives 116 with good Z-selectivity and high stereoselectivity; 
however, the synthesis of E-vinyl glycines was not possible with this methodology (Table 
28).195 
 
  
Table 28 Asymmetric synthesis of α-vinylic amino acids via Wittig olefination  
 
Petasis reactions have been used to synthesise a wide range of racemic E-α-vinyl amino 
acids with generally good yields (54-96%) including both di- and tri-substituted examples 
and a single examples of a quaternary α-disubstituted amino acid, with a wide range of 
aryl, benzyl and alkyl N-substituents.196,197 A single enantioenriched example was 
accessed through the use of optically active benzyl amine 119 which allowed the 
asymmetric synthesis of vinyl glycine derivative 120 in good yield and stereoselectivity 
(>99% de) (Scheme 67). However, cleavage of the phenylalaminol chiral auxiliary without 
loss of the alkene functionality has not been achieved. 
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Scheme 67 The use of Petasis reactions in synthesis of N-protected vinyl glycine derivatives 
 
More recently, the use of an optically active amino sulfoximine 121, in place of the benzyl 
derived chiral auxiliary 119, allowed cleavage of the chiral auxiliary using thionyl chloride in 
methanol, in place of hydrogenation conditions used with the benzyl analogue, and thus 
access to high enantioenriched vinyl glycine methyl ester 122 (Scheme 68).198 Also 
reported was an extended range of boronic acids, with the reaction tolerating the use of 
both electron-rich and poor E-styrenyl boronic acids and linear E-alkenyl boronic acids, all 
with moderate-to-good yields and excellent stereoselectivity (93-99% ee), though cleavage 
of the auxiliary was only reported in the case of (γ-phenyl)vinyl glycine 122. 
 
 
Scheme 68 The use of sulfoxide chiral auxiliary 121 in synthesis of vinyl glycine 122 
 
An approach to the synthesis of optically enriched quaternary vinyl glycine derivatives has 
been described via the de-conjugative α-alkylation of dehydroamino acids. This approach 
builds upon reported syntheses of racemic (E)-vinyl glycine derivatives via the double 
deprotonation of dehydroamino acids followed by α-protonation with complete selectivity 
for the E-products.199–201 The use of a range of alkyl, benzylic and allylic halides, along 
with an 8-phenyl-menthol chiral auxiliary, allowed access to a wide range of α-substituted 
(E)-vinyl glycines in generally good yields (35-97%), the lower yields were observed with 
the use of benzyloxymethyl chloride, and high diastereoselectivity (>95:5 d.r.) (Scheme 
69).202 The free amino acid could then be accessed in a single step via cleavage of both 
the ester and carbamate functionality under basic conditions.203 
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Scheme 69 De-conjugative α-alkylation of dehydroamino acids 
 
The use of a trans-2-(β-naphthyl)menthol auxiliary has also been described;203 however, 
with the use of this chiral auxiliary the regioselectivity of the deconjugative addition (α vs. 
γ) was found to be highly dependent on the nature of the halide electrophiles used, with 
only harder electrophiles affording high selectivity for the desired α-deconjugative addition 
product. 
 
4.1.1.4 Use of Asymmetric Catalysis 
 
The synthesis of α-vinylic amino acids via the stereoselective addition of nucleophiles into 
prochiral starting materials, often imines, is a commonly employed approach allowing 
access to α-vinylic amino acids in often-excellent enantiomeric excess. The asymmetric 
Strecker reaction is widely utilised in the synthesis of vinyl glycine derivatives, though this 
methodology is often hampered by poor selectivity and the harsh conditions required. One 
approach utilising tripeptide ligand 123 in the Ti-mediated 1,2-conjugate addition of 
cyanide to imine 124 allowed access to amino nitrile derivatives 125 in good yields and 
stereoselectivity (Scheme 70).204 The subsequent hydrolysis of the conjugated aminonitrile 
125 (R1 = H, R2 = Me) over three steps allowed access to the corresponding vinyl glycine 
derivative in good yields and with no loss of ee. 
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Scheme 70 The use of Strecker reactions in the synthesis of β,γ-substituted vinyl glycine derivatives 
 
A similar approach using N-diphenylphosphinoyl ketoimines in a Gd-catalysed Strecker 
reaction accessed α-disubstituted amino nitriles using difluorocatechol ligand 126, 
including two γ-substituted-γ,β-unsubstituted amino nitriles 127 and 128 (Scheme 71).205 A 
three-step conversion of vinyl glycine derivative 128 to the corresponding quaternary 
amino acid 129 was reported, with no loss of enantioenrichment. 
 
 
Scheme 71 Gd-catalysed Strecker reaction in the synthesis of quaternary amino acids 
 
Finally, Leckta reports a highly enantioselective synthesis of a range α-amino acid 
derivatives (>99% ee) via a [4+2] cycloaddition/ring opening reaction between O-
benzoquinone imides and chiral ketene enolates.206 However, only a single vinyl glycine 
example (131) is reported, accessed from O-benzoquinone imide 132 and a chiral ketene 
enolate, produced in situ from the reaction of acid chloride 133 and a cinchona alkaloid 
catalyst 134, providing access to N-aryl vinyl glycine derivative 135 with excellent 
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stereocontrol (Scheme 72). Subsequent oxidative cleavage of the aryl group using cerium 
ammonium nitrate afforded vinyl glycine 131 in good yield and with no loss of optical 
purity. 
 
 
Scheme 72 [4+2] cycloaddition/ring opening as a route to vinyl glycine 131 
 
4.1.2 The Role of Selenium in the Synthesis of Allylic Amines. 
 
The [2,3]-sigmatropic rearrangement of allylic selenoxides and selenimides has long been 
used to gain access to allylic alcohols and allylic amines respectively. The first example of 
such was reported by Sharpless in 1972 where the in situ oxidation of allylic selenide 136 
affords selenoxide 137, which then undergoes a [2,3]-sigmatropic rearrangement to afford 
selenenate 138 which after hydrolysis affords the allylic alcohol 139 in quantitative yields 
(Scheme 73).207 
 
 
Scheme 73 Oxidation/[2,3]-sigmatropic rearrangement of allylic selenides 
 
Subsequently Reich has reported the use of low temperature NMR experiments to study 
the thermodynamics and kinetics of the selenoxide-selenoate versus the sulfoxide-
sulfenate equilibrium.208 The results of these studies, using the system shown in Scheme 
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74, demonstrated that the [2,3]-sigmatropic rearrangement of allylic selenoxides proceeds 
faster than the corresponding allylic sulfoxide, due to the lower activation energy for the 
transformation, and that the equilibrium favours the selenate in the selenium series, 
whereas in the sulfur series the sulfoxide is favoured. The two, proposed, principal 
contributors to these observations are the weaker C-Se bond strength (versus C-S) and 
the smaller degree of multiple bonding in the dipolar Se-O bond (versus S-O).  
 
 
Scheme 74 Substrates used in Reich’s studies into the selenoxide-selenoate exchange 
 
4.1.3 [2,3]-Sigmatropic Rearrangement of Allylic Selenimides 
 
Sharpless subsequently reported the first examples of the allylic amination of olefins and 
acetylenes using imido-selenium compound 140, synthesised in situ through the reaction 
of elemental selenium with Chloramine T.209 The reaction was proposed to proceed via an 
ene/[2,3]-sigmatropic rearrangement mechanism, as reported for the analogous oxo-
process, whereby amination occurs with the olefinic linkage retaining its original position 
(Scheme 75).207 
 
 
Scheme 75 First reported Se-mediated direct allylic amination of olefins and acetylenes 
 
Sharpless then further developed this chemistry for allylic amination via amination/[2,3]-
sigmatropic rearrangement of allylic selenides.210 In this first example Chloramine T 
(TsNClNa) was reacted with 10-(phenylseleno)-β-pinene 141 to access 3-(p-
toluenesulfonamido)-β-pinene 142 in 44% yield, via the corresponding selenimide 143 
(Scheme 76). The analogous rearrangement of  
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sulfimides was first reported in 1951.211 A comprehensive overview of the chemistry of 
sulfimides can be found in the following reviews.212,213 
 
 
Scheme 76 First example of the amination/[2,3]-sigmatropic rearrangement of allylic selenides  
 
Hopkins subsequently reported that the use of methanol, in place of dichloromethane, as 
the reaction solvent afforded a cleaner reaction with higher yields, though no direct 
comparison to the reaction reported by Sharpless was made.214 Hopkins suggests that the 
methanol plays an important role in the reaction, acting as an efficient nucleophile aiding 
the cleavage (methanolysis) of the Se-N bond of the selenamide 144 (Scheme 77). 
Hopkins also reported the need for anhydrous conditions in order to obtain optimum yields, 
with the use of Chloramine T hydrate, in place of the anhydrous Chloramine T, resulting in 
the yield of N-tosyl allylic amine 145 decreasing to 40%. 
 
 
Scheme 77 Amination/[2,3]-rearrangement of allylic selenides 
 
Despite its efficiency in the conversion of allylic selenides into N-tosyl allylic amines, the 
use of Chloramine T suffers from a number of drawbacks, the foremost being the hazards 
associated with handling of anhydrous Chloramine T and a second being the often 
problematic deprotection of N-tosyl amines. With this in mind Hopkins looked at 
alternatives to the use of Chloramine T. Initial studies with O-alkyl-N-chloro-N-
sodiocarbamates afforded the desired N-carbalkoxy allylic amines in good yield.215  
 
However, a second approach that negates the need for the use of potentially unstable 
sodiocarbamates proved more successful. This approach utilises NCS to access the 
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chloride intermediate 146, which can then react with the nucleophilic nitrogen source 
(Scheme 78).216 Previously Sharpless had employed similar methodology, in the absence 
of the nitrogen source, to access the corresponding allylic chloride products.210 In the 
presence of competing nitrogen nucleophiles (Hopkins used N-Boc or N-Cbz-protected 
amines), displacement of the chloride affords the selenimide intermediate 147 which can 
then undergo a [2,3]-sigmatropic rearrangement giving phenylselenohydroxylamine 148. 
Subsequent cleavage of the weak Se-N bond, via hydrolysis/methanolysis or displacement 
by attack of an appropriate nucleophile, affords the allylic amine products in good-to-
excellent yields. The ease of Se-N bond cleavage highlights one of the key advantages 
over the sulfur analogues, where additional steps/reagents are required for cleavage of the 
equivalent S-N bond.217 
 
 
Scheme 78 NCS-mediated synthesis of allylic amines from allylic selenides 
 
Hopkins and co-workers noted that the use of several equivalents of NCS was required in 
order to obtain the optimum yields; this observation was attributed to NCS reacting with the 
selenium by-products of the reaction and thus preventing competing side-reactions. 
Hopkins has since expanded this methodology towards the synthesis of a wide range of 
allylic amines218,219 and applied the methodology to the racemic synthesis of protected 
amino acids.220 
 
Hopkins also reported a study using optically active nitrogen source 149 in an attempt to 
obtain diastereoselectivity in the amination/[2,3]-sigmatropic rearrangement using achiral 
allylic selenides. However, the difference in the relative stabilities of the diastereomeric 
transition states was not sufficient and only relatively low diastereomeric excesses of 17-
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37% (Scheme 79) were observed in the rearrangement products and no further work, by 
Hopkins or others, has been reported using this approach. 
 
 
Scheme 79 Diastereoselective amination/[2,3]-rearrangement of allylic selenides  
 
Hopkins’ NCS-mediated amination/rearrangement methodology has been applied in a 
number of natural product and biological target syntheses, including the synthesis of sugar 
moiety 3'-amino-2,3,-dideoxy-2'-methylidenecytidine,221 synthesis of diethyl 3-alkylidene-2-
hydroxysuccinates222 and the synthesis of a N-Boc-α-cyclopropylallylic amine intermediate 
in the synthesis of conformationally restricted analogs of antidepressant Milnacipran.223 
 
Recently, Breder has reported the first examples of the use of catalytic selenium in the 
oxidative allylic amination of electron-neutral linear E-alkenes (Scheme 80), cyclic alkenes 
and styrene derivatives using NFSI (N-fluorodibenzenesulfonamide) as both the nitrogen 
source and terminal oxidant, accessing a range of allylic amines in moderate to good 
yields.224,225 Though the mechanism has yet to be studied, the authors propose it proceeds 
via initial reaction between the diphenyldiselenide and NFSI affording cationic adduct I, 
which can then react via addition across the alkene to afford adduct II with a subsequent 
elimination step affording the allylic amine products. One key question to be answered 
when considering the proposed mechanism below is the regiochemistry of the alkene 
addition step. Assuming an initial electrophilic addition of the nitrogen, followed by the 
nucleophilic addition of the resultant diphenyl diselenide, the opposite regiochemistry 
would be expected. However, the authors also suggest that an alternative pathway 
involving the formation of an aziridinium species instead of adduct II cannot be ruled out 
and may help account for the observed regioselectivity. 
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Scheme 80 Se-catalysed oxidative synthesis of allylic amines 
 
The presence of the electron-withdrawing substituent was found to be vital for the high 
levels of regioselectivity observed in the elimination step, with the use of linear alkenes 
without the allylic electron-withdrawing substituent affording complex product mixtures. 
Substitution at the allylic position of the alkene starting material was expansive with a wide 
range of electron-withdrawing substituents tolerated, including esters, sulfones, nitriles, 
phosphonates and ketones. The scope at the alkene terminus was less explored with 
examples of only simple alkyl and benzyl substitution reported. 
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4.1.4 Asymmetric Synthesis of Allylic Amines via [2,3]-Sigmatropic Rearrangement 
of Allylic Selenimides. 
 
Assuming that the synthesis of allylic amines via allylic selenimides proceeds via the 
proposed concerted [2,3]-sigmatropic rearrangement then chirality present at either the 
C1-carbon or the Se centre of the allylic selenide/selenimides should be transferred to the 
newly formed C-N bonds.208,226,227 As such, allylic selenides with substituents at the alkene 
terminus (C-3 position), which form stereocentres upon rearrangement, are precursors to 
optically active allylic amines. This transfer of chirality can be controlled at the selenium 
centre (Eq. 1), at the C-1 position (Eq. 2) or possibly at both stereocentres (Eq. 3) of the 
allylic selenimide intermediates formed (Scheme 81). Similar C-1 to C-3 chirality transfer in 
the [2,3]-sigmatropic rearrangement of optically active selenoxides has been used in 
synthesis of enantioenriched allylic alcohols,228–231 and has been utilised in a range of 
natural product syntheses.232,233 
 
  
Scheme 81 Asymmetric amination/[2,3]-sigmatropic rearrangement of allylic selenides 
 
4.1.4.1 Asymmetric Amination of Allylic Selenides 
 
Direct asymmetric amination (Eq. 1, Scheme 81) via an enantioselective imidation of 
achiral allylic selenides with the use of chiral catalysts would be an ideal method for the 
synthesis of allylic amines, as the use of simple achiral allylic selenides would be possible. 
However, to date most direct asymmetric imidations of selenides reported make use of 
chiral auxiliaries at the selenium centre, which often require lengthy syntheses. Key 
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examples of the synthesis of optically active selenimides and their use in the synthesis of 
allylic amines are discussed below. 
 
Early attempts at the synthesis of optically active selenimides suffered from poor yields 
and low optical purity234 and it was not until 1994 that Kamigata reported the first isolation 
of optically pure selenimides, via the optical resolution of diastereomeric selenimides.235 
Kamigata also reported studies into the susceptibility of selenimides to racemisation via 
pyramidal inversion and found them to be more stable, in this regard, than the 
corresponding sulfur analogs due to an increased activation energy for the inversion.236 
The increased stability of the selenimides was proposed to arise from the lower valance 
shell electron-pair repulsion in the selenium imides and/or the lower electronegativity of 
selenium causing the electrons in the C-Se to sit a greater distance from the selenium than 
the electrons in the corresponding sulfur imide. More recent examples of the synthesis of 
optically active selenides include conversion from chiral selenoxides,237,238 with retention of 
configuration and optical purity, and the use of chiral chromatography to separate optically 
pure selenimides from racemic mixtures.239 
 
The in-situ stereoselective amination followed by [2,3]-sigmatropic rearrangement of allylic 
selenides, affording the corresponding optically enriched allylic amines, was reported by 
Uemura in 1995.240 Diastereoselective imidation of allylic selenide 151, containing a 
cinnamyl 2-(1-dimethylaminoethyl)ferrocenyl chiral auxiliary, with N-(p-
tolylsulfonyl)imino(phenyl)iodinane afforded the desired allylic amine 152 with 87% ee (the 
absolute configuration of the products was never determined) (Scheme 82). However, only 
the single example was reported and further studies found the use of tellurium to be 
preferential to selenium, with the use of allylic tellurides affording allylic amine 152 with an 
increased 93% ee.241 
 
   
Scheme 82 Uemura’s use of a chiral ferrenyl auxiliary in the diastereoselective imidation of allylic selenides  
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Uemura also reported the first enantioselective imidation of racemic allylic selenides using 
copper(I) triflate and a chiral 4,4-disubstituted bis(oxazoline) ligand (Scheme 83).242 This 
methodology only achieved a moderate yield and poor ee (32%) in the synthesis of allylic 
amine 152 and again only a single example was reported. Uemura reports a similar 
approach using sulfimides accessing α-vinyl sulfenamides in generally poor-to-moderate 
yields (30-80%) and low-to-moderate ee (up to 58%); however, subsequent cleavage of 
the S-N bond required to access allylic amine 151 is not reported.243 
 
 
Scheme 83 Cu-catalysed enantioselective imidation/rearrangement of allylic selenides 
 
Uemura also reported the use of selenide-containing optically active oxazoline auxiliaries 
in the copper-catalysed imidation with N-(p-tolylsulfonyl)imino(phenyl)iodinane, affording 
selenimides with up to 76% de; however, this chemistry has yet to be applied to substrates 
capable of undergoing sigmatropic rearrangement.242 
 
Koizumi reported a different approach to optically enriched allylic selenimides via the 
nucleophilic substitution of chloride in chiral allylic chloroselenuranes 152, synthesised in 
five steps from 2-exo-hydroxy-10-bornyl bromide 153.244,245 Nucleophilic substitution at the 
selenium centre with lithiated carbamates and amides afforded the selenimides 154, that 
could then undergo the [2,3]-sigmatropic rearrangement to access allylic amines in 
moderate to good yields (57-86%) and high enantioselectivity (up to 93% ee), though the 
use of only two allylic selenides is reported (Scheme 84). 
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Scheme 84 Use of bornyl-chiral auxiliary in the synthesis of allylic amines 
 
Koizumi observed that increased steric bulk on the nitrogen source caused an increased 
enantioenrichment in the allylic amine products. It was proposed that this increased 
stereoselectivity arises due to the increased steric bulk causing an increased preference 
for an endo-transition state (where the lone pair sits in the endo position of the 5-
membered envelope transition state), minimising the interactions between the R1 and R2 
substituents (Scheme 85). Koizumi has subsequently utilised the same bornyl chiral 
auxiliaries in the synthesis of enantioenriched homoallylic selenides via [2,3]-sigmatropic 
rearrangement of selenonium ylides.246 
 
 
Scheme 85 Exo vs. endo transition states for [2,3]-sigmatropic rearrangement 
 
Currently the moderate yields, generally low optical purities and limited substrate scope 
reported for the synthesis of allylic amines via the asymmetric amination of allylic 
selenides limits the usefulness of this methodology. Furthermore, where higher ee were 
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observed the use of chiral auxiliaries was required, complicating the synthesis of the allylic 
selenide substrates. As such the use of optically active allylic selenides, with 
enantioenrichment at the C1 position, currently offers a more attractive route to optically 
active allylic amines. 
 
4.1.4.2 Synthesis of Optically Active Allylic Selenides and Their Use in the NCS Mediated 
Amination/[2,3]-Sigmatropic Rearrangement  
 
The synthesis of enantioenriched allylic selenides for the use in the 
amination/rearrangement reaction (Eq. 2, Scheme 81) has to date proved more successful 
than the direct asymmetric amination methodology in the synthesis of optically active allylic 
amines, both in terms of the reported enantioenrichment of the products and the reported 
substrate scope.  
 
Hopkins reported the first use of enantioenriched allylic selenides in the amination/[2,3]-
sigmatropic rearrangement, accessing N-protected optically active amino acid 155 in up to 
84% ee (Scheme 86).247 The limiting factor in this synthesis was the lack of methodology 
for accessing highly enantioenriched allylic selenides. Hopkins accessed allylic selenide 
156 from the corresponding enantioenriched α-selenoaldehyde 157 which in turn were 
synthesised from ethyl-(S)-lactate in three steps. Furthermore, the synthesis afforded 
variable results and inconsistent enantiopurity due to the configurational instability of 
selenoaldehyde 157. 
 
 
Scheme 86 Synthesis of N-Cbz amino acids via amination/[2,3]-sigmatropic rearrangement 
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More recently, Tunge has reported the use of a Pd-catalysed decarboxylative kinetic 
resolution of selenocarbonate 158 (Scheme 87), to access allylic selenide 159 in up to 
96% ee.248 Use of allylic selenide 159 in the amination/rearrangement reaction with 4-tert-
butyl aniline afforded allylic amine 160 with only minor loss of optical purity (92% ee). 
 
 
 
Scheme 87 Pd-catalysed decarboxylative kinetic resolution of selenocarbonate 158 
 
Two similar one-pot α-selenylation/olefination methodologies for the synthesis of allylic 
selenides were developed simultaneously by Armstrong249 and Posner229 (Scheme 88). 
Both methodologies make use of an initial prolinol ether-catalyzed α-selenylation of 
aldehydes, using N-(phenylseleno)phthalimide (NPSP), as described by Melchiorre,250 
followed by a subsequent olefination step. For the olefination step Armstrong utilised a 
Horner-Wadsworth-Emmons (HWE) olefination allowing access to a range of di- and tri-
substituted E-allylic selenides with up to 97% ee. Use of Ando-modified phosphonates, 
with phenyl ethers in place of the ethyl ethers ((PhO)2P(O)CH2CO2R), in the HWE reaction 
also allowed access to Z-allylic selenides with similar levels of stereocontrol. Posner’s 
methodology employed a Wittig olefination to access a range of di-substituted E-allylic 
selenides, which where then applied to the synthesis of enantioenriched allylic alcohols229 
and chlorides251 in up to 97% ee. 
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Scheme 88 One-pot selenylation/olefination protocols for the asymmetric synthesis of allylic selenides 
 
Armstrong then employed the enantioenriched tri-substituted allylic selenides in the 
synthesis of simple enantioenriched α-disubstituted vinyl glycine derivatives, via the NCS-
mediated amination/rearrangement with simple carbamates, in moderate-to-good yields 
(31-81%) and with high retention of optical purity (up to 97% ee) (Scheme 89). It was 
observed that both the E- and Z-allylic selenides under the amination/rearrangement 
conditions afforded E-allylic carbamates as the sole products, though with opposite 
stereochemistry at the newly formed C-N bond. This allows access to both enantiomers of 
the vinyl glycine products without the need for unnatural proline organocatalysts in the α-
selenenation step. Similar selectivity has also been observed in analogous 
amination/rearrangements of allylic sulfides.217  
 
 
 
Scheme 89 Asymmetric synthesis of vinyl glycine derivatives via NCS-mediated  
amination/rearrangement of enantioenriched allylic selenides  
 
The following transition state models can be used to explain this observed selectivity for 
the E-isomer. If, as commonly accepted, the reaction proceeds via a concerted [2,3]-
sigmatropic rearrangement then the observed selectivity for the E-isomer can be 
explained, at least partly, by a preference for the bulkier R1 group to adopt the pseudo-
equatorial position in the 5-membered transition state (Scheme 90). This transoid 
transition state TS1 avoids the destabilising 1,3-allylic interaction between the R1 and R2 
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substituents found in the cisoid transition state TS2. The same argument applies to the 
rearrangement with the Z-allylic selenide, though with the 1,3-allylic strain occurring 
between the R1 substituent and the ester group at the C-3 position, again giving rise to a 
preference for the transoid transition state TS3 and as a result the E-isomer as the major 
product. 
 
 
Scheme 90 Explanation of stereocontrol in [2,3]-sigmatropic rearrangment of allylic selenides 
 
When considering the mechanism of the reaction it is apparent that upon the electrophilic 
chlorination of the selenium, via reaction with the NCS, a second stereocentre is formed. 
Whilst the stereochemistry at the selenium of the allylic selenimide can play a role in the 
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stereochemistry of [2,3]-sigmatropic rearrangements have shown that the interactions 
between the substituents on the Y atom (at the C-1 position, in this case Se) and the C-
2/C-3 substituents are generally much weaker than those between the C-1 and C-2/C-3 
substituents.208,226 As such, where C-1 is a stereocentre the configuration at selenium can 
be assumed to have a relatively minor influence on the relative energies of the transition 
states of the [2,3]-sigmatropic rearrangement and as such the C-1 to C-3 chirality transfer. 
This lack of influence that the chirality at the Se-centre has on the configuration of the 
rearrangement products also means that any inversion of chirality at the Se-centre will 
have no significant role on the chirality transfer/stereo-outcome of the reaction 
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4.2 Project Aims: 
 
While there are numerous examples of the use of amination/[2,3]-sigmatropic 
rearrangement of allylic selenides as a route to allylic amines, there are limited examples 
featuring the use of more complex nitrogen sources, i.e. moving away from the use of 
simple amine or carbamate substrates. Previous work from the Armstrong group focused 
on the scope with respect to the allylic selenide, in particular substitution at the C1- and 
C3-positions. The aim of this project was to expand the scope to include more complex 
nitrogen sources. More specifically we wished to apply the NCS-mediated 
amination/rearrangement methodology to the synthesis of a wide range of novel unnatural 
amino acids, peptides, and peptidomimetic vinyl glycine derivatives. The three product 
classes chosen as targets were: 
 
• Vinyl glycine peptides, through the use of N-protected amino acid amides at nitrogen 
source; 
 
• N,N-dicarboxymethylamines, a peptidomimetic motif found in a number of 
pharmaceuticals, through the use of amino acid esters. This methodology was further 
tested in the formal synthesis of Perindopril, an on-market ACE inhibitor; 
 
• N-Aryl amino acids, through extension of the substrate scope to a range of N-
aromatic/heteroaromatic amines. 
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4.3 Results and Discussion: 
4.3.1 Synthesis of Enantioenriched Allylic Selenides: 
 
For the synthesis of the enantioenriched vinyl glycine products we first required a route to 
the enantioenriched allylic selenides required for the [2,3]-sigmatropic rearrangement. As 
described above (Scheme 88), recently both Armstrong and Posner have described one-
pot α-selenenation/olefination protocols for synthesising highly enantioenriched allylic 
selenides. For the purpose of the work described in this thesis the Posner protocol was the 
method of choice, though only for practical reasons. The methodology developed by 
Armstrong requires a filtration prior to the HWE step in order to prevent a low yielding 
olefination step, whereas the use of Wittig conditions developed by Posner circumvents 
this, allowing for a genuine one-pot protocol. 
 
The Posner conditions were applied to the synthesis of four novel allylic selenides 160-163 
with the high levels of enantioselectivity desired (94-96% ee) (Table 29). With the scope of 
the allylic selenides already explored in the work previously described by the Armstrong 
group,249 the simple alkyl and benzyl substrates were chosen based on the known stability 
of similar allylic selenides during the amination/rearrangement reactions and known high 
levels of enantioselectivity afforded in the α-selenation step. Corresponding racemic 
samples were synthesised though the use of pyrrolidine in place of the prolinol ether in the 
initial α-selenation step and were used for HPLC comparison to the enantioenriched 
products. 
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Entry Product R1 R2 E:Za Yield (%) b eec 
  1 ii 160 Bn Et 98:2 45 94 
  2 ii 161 iPr tBu >99:1 54 96 
3 162 Et tBu >99:1 67 96 
4 163 Me Et >99:1 53 94 
a Determined by 1H NMR analysis of crude mixture. b Yield of 
E-isomer after column chromatography. c Determined by chiral HPLC. 
Table 29 One-pot asymmetric synthesis of allylic selenides 
 
We also wished to test the tolerance of Posner’s methodology to the use of α,α-
disubstituted phosphoranes, providing a route to tri-substituted allylic selenides. However, 
attempts at the synthesis of tri-substituted allylic selenide 164 via Posner’s protocol were 
unsuccessful with significant loss of enantiopurity observed in the allylic selenide product, 
164. However, the use of Armstrong’s HWE protocol allowed access to the desired tri-
substituted allylic selenide 164 in 95% ee (Scheme 91). 
 
 
Scheme 91 Asymmetric synthesis of tri-substituted allylic selenide 164 
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With a route to the allylic selenides in place, attention was then turned to the expansion of 
the substrate scope for the [2,3]-sigmatropic rearrangement reaction. The use of amino 
acid amides, previously untested as nucleophiles in the NCS-mediated amination/[2,3]-
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sigmatropic rearrangement reaction, would allow the synthesis of vinyl glycine peptides 
(Scheme 92) in an approach complementary to more traditional amide coupling reactions. 
 
 
Scheme 92 Dipeptide synthesis via NCS-mediated amination/[2,3]-sigmatropic rearrangement of 
enantioenriched allylic selenides 
 
As discussed above (Section 4.1.4.2), the work of Armstrong made use of benzyl 
carbamate as the nitrogen source for the amination/rearrangement reaction with a range of 
tri-substituted allylic selenides to synthesise a number of vinyl glycine derivatives.249 In this 
protocol, the nitrogen source (3.0 eq.) and the allylic selenide (1.0 eq.) are first stirred for 
30 minutes with trimethyl orthoformate (5.9 eq.) and p-TSA (~1 mg) in dry methanol, 
removing any residual water from the reaction mixture.  
 
As observed in the work of Hopkins, it is important the reaction mixture is as dry as 
possible with yields decreasing with an increased water concentration in the reaction 
mixture.214 One explanation for this can be found in the ready formation of selenoxide from 
either the reversible reaction of water molecules with the selenimides, via a relatively 
stable hydrate intermediate (Scheme 93),252 or reaction of water with the intermediate-
chloro species. The resultant selenoxide can then undergo a [2,3]-sigmatropic 
rearrangement affording the unwanted allylic alcohol product resulting in a decreased yield 
of the desired allylic amines. Furthermore, the rapid racemisation of selenoxide, through 
pyramidal inversion via a proposed hydrate intermediate, is widely reported,228 leading to a 
loss of enantiopurity in the selenimide intermediate (Scheme 94). However, this 
racemisation was not expected to be problematic in our work as the transfer of chirality 
during the sigmatropic rearrangement is predominantly controlled by the stereochemistry 
at the C1 position and not the configuration of the Se centre. 
 
 
Scheme 93 Selenium imide-selenoxide equilibrium  
R1 CO2R2
SePh H
NH2N
O
R4
R3
+
R1 CO2R2
NHO
R3 HN
R4NCS
R1 R2
SePh
NR3 H2O
-H2O R1 R2
SePh
NHR3OH
R1 R2
SePh
O-H2NR3
H2NR3
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Scheme 94 Racemisation of selenoxides 
 
After the reaction mixture has been dried, the reaction mixture is then cooled to 0 °C and 
DIPEA added before addition of NCS (2 eq.). The reaction is allowed to stir for a further 5 
minutes before quenching with 1M HCl (aq.). These conditions required little optimisationiii 
for the use of amino acid amides, the only notable changes being the use of the nitrogen 
source, the amino acid amides, as the limiting reagent, and a required increased reaction 
time of 20 minutes (following the NCS addition). These optimised conditions were then 
applied to the synthesis of a range of di-peptide vinyl glycine derivatives (Table 30).  
  
                                            
iii Optimisation studies carried out by Dr D.P.G. Emmerson and will not be discussed in any further detail in this thesis. 
Ph
Se
R1
O
Ph
Se
R1 Ph
Se
R1
OOHHO -H2OH2O
H2O-H2O
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Entry 
Allylic  
Selenide 
Amino Acid Amide Product Yield (%)a E/Z b d.r.c 
1 iv 
  
171 60 n/d n/d 
2 iv 
  
172 60 n/d n/d 
3 iv 
  
173 55 6:1 >95:5d 
4 iv 
  
174 59 7:1 97.5:2.5 
5 iv 
  
175 69 7.5:1 88.5:11.5 
6 iv 
  
176 39 >20:1 >95:5d 
a Of E:Z mixture after column chromatography. b Determined by 1H NMR analysis of purified product mixture. c d.r. of E-
isomer. d Estimated through integration of peaks in partially overlapping multiplets. 
Table 30 Use of amino acid amides in the NCS-mediated amination/[2,3]-rearrangement reaction iv 
 
Initial results using both Cbz- and Boc-protected proline amino acid amides (Table 30, 
Entries 1 and 2) both gave a 60% yield of the desired vinyl glycine products. However, the 
presence of rotameric products prevented accurate determination of the E:Z and 
diastereomeric ratios by 1H NMR analysis.  
 
The use of non-cyclic valine derived amino acid amide 167 gave a yield of 55% and an E:Z 
ratio of 6:1. Examples of amination/rearrangement reactions with tri-substituted allylic 
selenides performed previously by the Armstrong group have all have shown either 
complete or a very strong preference for the formation of the E-product.249 The reasons for 
                                            
iv Reaction performed by Dr D.P.G. Emmerson, for experimental details and data see the following reference.323  
R1 CO2R2
SePh H
NH2N
O
R4
R3
i) HC(OMe)3, p-TSA, MeOH, 30 min, rt.
ii) DIPEA then NCS, 0 °C, 20 min
+
R1 CO2R2
NHO
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R4
Bn CO2Et
SePh
160 165
N
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CONH2
iPr CO2tBu
SePh
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N
Boc
CONH2
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Et CO2tBu
SePh
162
BocHN CONH2
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Et CO2tBu
SePh
162
BocHN CONH2
Ph
168
Et CO2tBu
SePh
162
BocHN CONH2
Ph
169
Et CO2tBu
SePh
162
BocHN CONH2
170
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this observed selectivity lies in the strong preference for a transoid transition state, as 
shown in Scheme 90 above. The lower E:Z selectivity observed with the use of di-
substituted allylic selenide 162, compared to the previously reported use tri-substituted 
allylic selenides, can be attributed, at least partially, to the reduced steric bulk at the C-3 
position of the allylic selenide. This reduced steric bulk reduces the influence of 1,3-allylic 
strain on the energy difference between the preferred transoid and the cisoid transition 
states (see Scheme 90 above) and decreases the selectivity for the E-product. 
 
Also visible in the 1H NMR spectra of the vinyl glycine products were minor peaks due to 
the presence of small amounts of the minor diastereomer of the E-product. An 
amination/rearrangement reaction carried out using racemic allylic selenide 162 confirmed 
that the extra peaks present in the product mixture were a result of the presence of the 
minor diastereomer of the E-product. (N.B. This approach was repeated for all examples 
reported in order to confirm that the presence of the additional minor product peaks was a 
result of the presence of the minor diastereomer of the E-product and not other reaction 
by/side products.) 
 
Assuming that the [2,3]-sigmatropic rearrangment of allylic selenides proceeds with 
complete transfer of chirality, as previously observed,199,249,251,253 the formation of the 
minor diastereomeric E-product would be expected to arise from the minor R-enantiomer 
of the allylic selenide starting material (Scheme 95).  
 
 
Scheme 95 Stereochemical outcome from the reaction of the two enantiomers of the allylic selenide 
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A second explanation for the formation of the minor diastereomer would be epimerisation 
at the α-position (R3 substitutent in Scheme 95) of the amino acid amide moiety either in 
the starting material or the product. A possible mechanism for this racemisation of N-
Boc/Cbz-protected amino acid is the deprotonation at the α-position and subsequent 
delocalisation of the negative charge formed (Scheme 96). However, racemisation by this 
pathway under the reaction conditions is thought to be unlikely with the majority of 
substrates tested, due to the low acidity of the α-protons of the amino acid amides and the 
low strength of base employed (DIPEA). A second reported mechanism for the 
racemisation of N-Boc/Cbz-protected amino acids is, where a suitable leaving group is 
present, via β-elimination folloiwng the inital α-deprotonation. However, due to the 
substrates testing lacking a suitable leaving group racemisation by this route was unlikley 
to cause any racemisation under the reaction conditions. 
 
 
Scheme 96 Possile pathways for the racemisation of carbamate protected amino acids 
 
Unfortunately, accurate determination of the diastereomeric ratio was not possible in most 
vinyl glycine products formed, due to a lack of baseline-resolved peaks in the 1H NMR 
spectrum and failure to separate all of the product peaks under a range of chiral HPLC 
conditions. This problem quantifying the exact d.r. of the vinyl glycine products was 
encountered with the majority of the examples reported (Tables 30, 32 & 33). However, an 
approximate estimate of the d.r. could be made, in examples where complete baseline 
resolution of the 1H NMR peaks was not possible, via partial integration of partially 
overlapping multiplet peaks of the two diastereomeric products. While this approach does 
not allow for accurate quantification of the d.r., it does indicate that no significant 
epimerisation of the vinyl glycine products was observed in any of the examples reported. 
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The use of phenylalanine amide 168 (Entry 4) gave a 59% yield with a 7:1 E:Z ratio and, 
pleasingly in this case, baseline resolution of the 1H NMR peaks allowed the d.r. to be 
accurately determined as 97.5:2.5. Assuming that no epimerisation of the optically pure 
amino acid amides occurred over the course of the reaction, the lack of significant 
decrease in enantiomeric purity from the starting material 162 (96% ee) during formation of 
the product 168 (97.5:2.5 d.r.) lends support to the hypothesis that the yield of the minor 
diastereomer is afforded due to the reaction of the minor enantiomer of the allylic selenide 
starting material (see Scheme 95 above). 
 
The use of phenyl glycine amide 169 (Entry 5, 69% yield, 7.5:1 E:Z) gave a d.r. of 
88.5:11.5. In this case the significant epimerisation observed is proposed to arise from 
epimerisation of the C-Ph bond (in the amino acid amide motif) under the reaction 
conditions. Literature studies have shown that arylglycine amino acids are readily 
racemised in the presence of tertiary amine bases through the reversible abstraction of the 
acidic proton on the α-carbon by tertiary amine bases with an observed 50% loss of optical 
purity of benzyloxycarbonyl-L-phenylglycine p-nitrobenzyl ester after 9 minutes in DMF in 
the presence of DIPEA (2 eq.).254–256 
 
Finally the use of a more sterically hindered gem-dimethyl amino acid amide 170 (Entry 5) 
afforded a poor yield of 39%. Interestingly the more hindered amino acid amide gave a 
much increased E:Z (>20:1), suggesting that the substitution on the amino acid amide also 
plays a significant role in the preference for the transoid versus the cisoid transitions state 
and the E:Z selectivity observed. This is supported by the observed increased E:Z 
selectivity observed with increased steric bulk in the α-substituent (R group) of the amino 
acid amides in Entries 3,5&6. 
 
Next the synthesis of longer peptide chains was studied, utilising di- and tri-peptide 
amides. The use of dipeptide 177 and tripeptide 178 were well-tolerated allowing access to 
the corresponding tripeptide 179 and tetrapeptide 120 in moderate yields and with no 
significant loss of enantioenrichment (Scheme 97). 
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Scheme 97vUse of di- and tri-peptide amides in amination/rearrangement reactions v 
 
Studies were then carried out to further expand the scope of amino acid amides to 
examples where the α-substituent of amino acid amides was not a simple alkyl or aryl 
substituent, allowing the functional group tolerance of the amination rearrangement to be 
tested. To test this, serine, tyrosine, tryptophan and azido-lysine amino acid amides, along 
with commercial available N-Boc-L-Asn-OH, were chosen. 
 
4.3.3 Synthesis of Amino Acid Amides 
 
Serine amino acid amide 181 was synthesised starting from N-Boc-L-Ser-OH, via 
cyclisation to serine lactone 182257 followed by ring opening with ammonia affording the 
desired amino acid 181 in an overall 40% yield (Scheme 98).258 
 
 
Scheme 98 Synthesis of N-Boc-Ser-OH 
 
The other amino acid amides selected were accessed via coupling reactions of the 
corresponding amino acid with aqueous ammonia using EDCI and HOBt in DMF (Table 
31).259 
                                            
v Reaction performed by Dr D.P.G. Emmerson, for experimental details and data see the following reference.323 
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Entry Amino Acid Amino Acid Amide Yield (%) 
1 N-Boc-L Tyr-OH 
 
72 
2 N-Cbz- L-Trp-OH 
 
88 
3 N-Fmoc- L-Lys(N3)-OH 
 
63 
Table 31 Synthesis of amino acid amide 
  
N
H
R2
R1
N
H
R2
O
OH
O
NH2R
1
NH3 (28%, aq)
EDCI, HOBt
DMF, rt, 24 h
BocNH CONH2
HO
183
CbzHN CONH2
HN
184
CONH2NH
N3
Fmoc
185
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4.3.4 Functional Group Tolerance of Amination/[2,3]-Sigmatropic Rearrangement 
Reaction with Amino Acid Amides 
 
The amino acid amides were then tested in the amination/rearrangement reaction with 
allylic selenide 162, the results of which are shown below in Table 32. 
 
 
Entry Amino Acid Amide Product Yield (%)a E:Z b d.r.c 
1 
 
186 42 8.5:1 >95:5d 
2 
 
187 32 7:1 >95:5d 
3 
 
188 48 7.5:1 >95:5d 
4 
 
189 77 4:1 >95:5d 
5 
 
- <1 - - 
a Of E:Z mixture after column chromatography. b Determined by 1H NMR analysis of 
purified product mixture. c d.r. of E-isomer. d Estimated through integration of peaks in 
partially overlapping multiplets. 
Table 32 Functional group tolerance of the amination/rearrangement reaction 
 
Hydroxyl functionality was tolerated, though only moderate yields were obtained with the 
use of serine-derived amino acid amide 181 affording vinyl glycine 186 in a 42% yield 
(Table 32, Entry 1) and a still lower yield was afforded with the use of tyrosine-derived 
CO2tBu
SePh
NHR1H2N
O
R2
i) HC(OMe)3, p-TSA, MeOH, 30 min, rt.
ii) DIPEA then NCS, 0 °C, 20 min
+
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R2 HN
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amino acid amide 183 (32% yield, Entry 2). The reason for the decrease in yield with the 
use of hydroxy functionality is unclear, though perhaps one explanation is the competitive 
displacement of the chloride from the chloride intermediate 146 (see Scheme 78) 
preventing full conversion to the selenimide and instead affording a selenium species 
unable to undergo the [2,3]-sigmatropic rearrangement. 
The use of tryptophan amino acid amide 184 was also tolerated giving the desired product 
in a 48% yield (Entry 3). Pleasingly, azido functionality was well tolerated with azido-lysine 
amide 185 affording the desired product in a good yield (77%, Entry 4).  
 
As with the examples discussed above, low levels of the minor diastereomer of the E-
product were observed in all examples. Again, lack of baseline separation of 
diastereomeric peaks in 1H NMR analysis and problems with separation of the product 
peaks via chiral HPLC prevented the accurate quantification of the d.r. However, in all 
cases partial integration of multiplets in the 1H NMR spectrum indicated that no significant 
epimerisation was observed. 
 
The use of Boc-N-L-Asn-OH (Entry 5) afforded only trace amounts of the desired products, 
highlighting the lack of tolerance for carboxylic acid functionality under the 
amination/rearrangement conditions. 
 
4.3.5 Amination/[2,3]-Sigmatropic Rearrangement using Amino Acid Esters 
 
The use of amino acids as the nitrogen source for the [2,3]-sigmatropic rearrangement of 
allylic selenides would allow access to a range of vinyl glycine derivatives containing the 
N,N-dicarboxymethylamine structural motif. This N,N-dicarboxymethylamine 
peptidomimetic motif, an analogue of the more readily hydrolysed peptide bond, is found in 
a number of pharmaceutical products including a family of angiotensin-converting enzyme 
(ACE) inhibitors (Figure 11).260 A range of amino acid esters were tested under the 
amination/rearrangement conditions to validate this methodology as a route to the desired 
N,N-dicarboxymethylamine products. 
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Figure 11 Examples of ACE inhibitors containing N,N-dicarboxymethylamine motif 
 
Initial attempts at the amination/rearrangement of allylic selenide 162 with NH2-L-Ala-OBn 
under the reaction conditions developed for the amino acid amide reactions afforded the 
desired product (190) in only 33% yield, with 35% of an undesired allylic alcohol side 
product (191) and a 17% return of allylic selenide 162 (Scheme 99). 
 
 
Scheme 99 Initial attempt at amination/rearrangement using amino acids 
 
It was thought that perhaps the amine was reacting with the NCS, thus preventing full 
conversion of the chloride intermediate to the selenimide and resulting in a decreased yield 
of the desired product with increased formation of the selenoxide, which underwent a [2,3]-
sigmatropic rearrangement affording the allylic alcohol product 191. This problem was 
overcome with a change in the addition order whereby the amino acid was added last, 
after the NCS addition. Reaction monitoring by TLC indicated complete conversion of the 
allylic starting material within 2 minutes of the NCS addition and no returned allylic 
selenide was recovered in the crude product mixture. The change in addition order, with 
the amino acid amide added 2 minutes after the NCS afforded an improved 72% yield of 
190 (Table 33, Entry 1) with less than 5% of allylic alcohol 191.  
 
These improved conditions were then applied to the synthesis of a small range of N,N-
dicarboxymethylamines (Table 33). 
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Entry Allylic Selenide R1 Amino Acid Ester Product Yield (%)a E:Z b d.r.c 
1 162 H 
 
190 72 8:1 >95:5d 
2 162 H 
 
192 60 >25:1 96:4 
3 162 H 
 
193 54e >25:1 >95:5d 
4 164 Me 
 
194 46 >25:1 >95:5d 
5 162 H 
 
- - - - 
a Of E:Z mixture after column chromatography. b Determined by 1H NMR analysis of purified product mixture. c d.r. of E-
isomer. d Estimated through integration of peaks in partially overlapping multiplets. 
e Cooled to -45 °C and held for 12 hours after amino acid ester addition. 
Table 33 Use of amino acid esters in amination/rearrangement reaction 
 
The E:Z ratio for the reaction with the amino acid esters are improved when compared to 
those of the amino acid amide examples discussed above with essentially complete 
selectivity for the E-product in almost all cases. This selectivity again highlights the 
influence of the nitrogen source in the E:Z selectivity. For the same reasons as with the 
use of amino acid amides (discussed above) the diastereomeric ratio could not be 
accurately determined for the majority of the examples. However, the use of NH2-L-Phg-
CO2Me (Entry 2, 60% yield) did allow the diastereomeric ratio to be determined as 96:4, 
although in this case a slight loss of enantioenrichment was observed, allylic selenide 162 
being of 96% ee. As discussed above, the proposed explanation for this is epimerization of 
the phenylglycine C-Ph bond, though to a lesser extent than in the examples with 
phenylglycine amino acid amide 169 due to the less acidic nature of the amino acid ester 
α-proton compared to that of the amino acid amide. 
 
Again hydroxyl functionality was tolerated with a serine example (Entry 3) giving a 54% 
yield, although for this example a lower reaction temperature, -45 °C, was required to 
CO2tBu
SePh
CO2tBu
i) HC(OMe)3, p-TSA, MeOH, 30 min, rt.
ii) DIPEA then NCS, 0 °C, 2 minR1
NHR1
CO2R3R2
iii) amino acid ester, 0 °C, 20 min
H2N CO2Bn
H2N CO2Me
Ph
H2N CO2Bn
OH
H2N CO2Bn
H2N CO2Bn
NH2
O
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prevent loss of enantiopurity, with reactions run at 0 °C and -20 °C giving similar yields 
(57% and 55% respectively) but with significant loss of enantioenrichment. 
 
A tri-substituted allylic selenide, R1 = Me, (Entry 4) was also employed in the reaction, 
albeit with a poorer yield of 46% (when compared to similar disubstituted examples). 
Attempts using NH2-L-Asn-CO2Bn (Entry 5) afforded none of the desired product with the 
major product isolated being allylic alcohol 191 in a 22% yield. 
 
4.3.6 Amination/[2,3]-Sigmatropic Rearrangement Using N-Aromatic and 
N-Heteroaromatic Amines 
 
The last nitrogen source to be tested in the NCS mediated amination/[2,3]-sigmatropic 
rearrangement was N-aryl amines, in particular N-heteroaromatic amines the use of which 
is previously unreported with this methodology. This expansion in substrate scope 
provides a new route for the synthesis of N-aryl amino acids, a motif found in a number of 
medicinally and biologically important compounds; examples are found in hepatitis C virus 
replicator inhibitors,261 ACE inhibitors,262 anticoagulant factor Xa inhibitors,263 the GPIIb/IIIa 
fibrinogen receptor antagonist Lotrafiban264 and compounds with antiulcer activity.265  
 
Typically N-aryl amino acids are accessed via Ullman-type chemistry,266–268 and while this 
method is convenient for the synthesis of enantioenriched products it relies upon the 
availability of the corresponding enantioenriched starting material. While this may be trivial 
in the case of chiral pool amino acids, the synthesis of unnatural amino acids can often be 
non-trivial. Furthermore, often harsh conditions are required and while couplings with 
benzene functionality are commonplace, couplings of amino acids with heteroaromatic 
substrate are not. A number of alternative methods for the synthesis of enantioenriched N-
aryl amino acids starting from pro-chiral starting materials have also been developed, 
examples include asymmetric Mannich reactions using chiral amino sulfonamide 
organocatalysis,269 enantioselective aza-Friedel-Crafts reactions270 and an asymmetric 
Petasis reaction,271 although none of these examples report the synthesis of N-
heteroaromatic products.  
 146 
As such, the use of N-aromatic and N-heteroaromatic amines in the 
amination/rearrangement methodology would allow access to a range of novel N-aryl vinyl 
glycine derivatives including a range of N-heteroaromatic amino acids for which, currently, 
there is a lack of examples. 
 
Initial investigations were undertaken using 2-aminothiazole and the results of this 
optimisation are shown below in Table 34. One key difference that was made to the 
examples above, using amino acid amides and esters, is that in the examples with N-
(hetero)aryl amines the conditions were optimised for the use of the commercially 
available amines in excess, in order to limit the amount of the synthetically more valuable 
enantioenriched allylic selenide required. 
 
 
Entry 
Eq. 
2-Aminothiazole 
Addition Order a 
T1 
(°C) 
t1 
(min) 
t2 
(min) 
Yield 195 
(%)b 
1 1.5 Reverse 0 2 10 60 
2 1.5 Normal 0 - 10 47 
3 1.1 Reverse 0 2 10 49 
4 2.0 Reverse 0 2 10 59 
5c 1.0 Reverse 0 2 10 50 
6 1.5 Reverse 0 0.5 10 55 
7 1.5 Reverse 0 5 10 34 
8 1.5 Reverse -20 2 10 73 
9 1.5 Reverse -40 2 60 40 
a Addition orders: Reverse = 2-aminothiazole added after NCS, Normal = 2-aminothiazole 
added at the start of the reaction with 162. b After flash column chromatography. c 1.5 
equivalent of 162 used. 
Table 34 Optimization of amination/rearrangement reaction using 2-aminothiazole 
 
Initial attempts using the conditions from the amino acid ester examples (Table 33) but 
with the 2-aminothiazole in excess gave a 60% isolated yield of the desired E-vinyl glycine 
product (Table 34, Entry 1) with complete conversion of the allylic selenide starting 
material. Use of the reaction conditions from the amino acid amide examples, where the 
Se
CO2tBu
Ph
i) HC(OMe)3, p-TSA, MeOH, rt, 30 min
ii) DIPEA, NCS, T1, t1
CO2tBu
HN N
S
162 195
iii) 2-aminothiazole, T1, t2
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nitrogen source is present in the reaction mixture prior to the addition of the NCS (Entry 2), 
resulted in a reduced yield of 47%, presumably again caused by the reaction of the amine 
with the NCS. Changing the equivalents of the thiazole was not beneficial, with a decrease 
in equivalents reducing the yield (Entry 3) and an increase having no positive effect on the 
yield (Entry 4). A test reaction with the allylic selenide used in excess gave a reduced yield 
of 50% (Entry 5), suggesting that despite the amine being added last some reaction with 
the NCS was still occurring. Changes to the time between the NCS addition, both an 
increase and decrease in time (Entries 6&7), resulted in a decrease in yield. Finally a 
decrease in the reaction temperature gave an increase in yield affording the desired allylic 
amine product 195 in a 73% yield (Entry 8). Further reduction in temperature gave no 
further improvement in the yield despite an increase in reaction time (Entry 9). 
 
The optimised conditions were then applied to the synthesis of a wide range of 
enantioenriched vinyl glycine derivatives (Table 35). All examples showed complete 
selectivity for the E-isomer and highlight the high levels of retention of optical purity 
afforded by [2,3]-sigmatropic rearrangements (94.5-100% cee).  
 
 
Entry Amine Product 
Yield 
(%)a 
ee 
(%)b 
cee 
(%)c 
1 
 
195 73 89 94.5 
2 
 
196 74 94 100 
3 
 
197 82 94 100 
4 
 
198 75 94d 100 
5 
 
199 61 93 99 
6 
 
200 49 93d 99 
Se
CO2tBu
Ph
i) HC(OMe)3, p-TSA, MeOH, rt, 30 min
ii) DIPEA, NCS, -20 °C, 2min
CO2tBu
HN
162
94% ee
iii) H2NAr, 10 min
Ar
H2N N
S
H2N N
S
H2N N
S
OMe
H2N
H2N
H2N
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7 
 
201 31 (54)e 93 99 
8 
 
202 85 93 99 
9 
 
203 62 93 99 
10 
 
204 71 89 94.5 
11 
 
205 70 93 99 
12 
 
206 78 93 99 
13 
 
207 63 93 99 
14 
 
208 26 94 100 
15 
 
209 43 94 100 
16 
 
210 70 93 99 
a After column chromatography. b Determined by chiral HPLC. c cee = conservation 
of enantiomeric excess. d ee determined after LiAlH4 reduction to alcohol. e Use of a 
1.1 eq. excess of NCS afforded a 54% yield. 
Table 35 Amination/rearrangement reaction using N-(hetero)aryl amines 
 
As discussed above the optimised conditions for the amination/rearrangement reaction 
using 2-aminothiazole gave a good yield of 73%; however, there was a slight loss of 
enantiopurity (Table 35, Entry 1, 89% ee, 94.5% cee). (N.B. Upon scale up (12 mmol) the 
synthesis of allylic selenide 162 afforded a slightly decreased ee, hence the allylic selenide 
starting material used for these reactions had a 94% ee.) The use of 2-
aminobenzothiazole was similarly high-yielding, affording the desired product in a 74% 
yield (Entry 2) with complete conservation of the enantiopurity of the starting allylic 
selenide (100% cee). A more electron-rich ring system, 2-amino-5-methoxybenzothiazole, 
was found to give an increased yield of 82% (Entry 3). 
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A number of aniline derivatives were also tested, with aniline itself (Entry 4) giving a yield 
of 75%. The use of the more electron-rich p-toluidine in this case gave a slightly decreased 
yield of 61% (Entry 5) and the use of sterically more hindered o-toluidine saw further 
decrease in the yield (49%, Entry 6). The use of electron-rich substrate p-methoxyaniline 
afforded a significantly lower 31% yield of the vinyl glycine product (Entry 7). Test 
reactions showed there to be a significant side reaction occurring between the 4-
methoxyaniline and the NCS, accounting for the observed decrease in yield. Decreasing 
the number of equivalents of the NCS was observed to have a beneficial effect on the 
observed yields, with the best results (54%) obtained when using 1.1 eq. of NCS, though 
this was with a 22% return of allylic selenide 162. Reactions run with subsequent addition 
of extra equivalents of NCS once the reaction had started afforded no improvement upon 
the 54% yield. The use of a more electron-deficient substrate, p-nitroaniline, gave an 
increased yield of 85% (Entry 8). Hydroxyl functionality was again tolerated as highlighted 
by the use of 3-aminobenzyl alcohol (Entry 9, 62% yield). 
 
The scope was then expanded to a range of pyridine examples, with 2-aminopyridine 
(Entry 10) affording the desired vinyl glycine derivative in a 71% yield. Iodo-, bromo- and 
nitrile-substitution were also well tolerated, as highlighted in Entries 11-13. The use of 
pyrazole and benzimidazole amine heterocycles was found to give poor yields with 3-
aminopyrazole only affording 26% (Entry 14) and 2-aminobenzimidazole affording 43% 
yield (Entry 15). Finally, oxazole functionality was well tolerated with ethyl 2-(4-
aminophenyl)oxazole-4-carboxylate affording the desired product in 70% yield. 
 
4.3.7 Other studies: Proof of Retention of Configuration in 
Amination/Rearrangement Reactions 
 
Whilst it is proposed that, by analogy to the corresponding sulfimide rearrangement,272 the 
amination/[2,3]-sigmatropic rearrangement of allylic selenides with amines and 
carbamates proceeds with complete retention of configuration,218,226 no studies have been 
undertaken to confirm this. We sought to test this hypothesis and provide more evidence 
for the proposed reaction mechanism. This was achieved through the synthesis of vinyl 
glycine derivative 211, followed by ozonolysis with a NaBH4 work up which afforded serine 
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derivative 212 in 82% ee ([α]D24 -11.7 (c = 1.02, EtOH)) (Scheme 100). Comparison of the 
observed optical rotation to reported literature values273 (>99% ee, [α]D22 -13.7 (c = 1.03, 
EtOH)), synthesised from chiral pool L-serine derivatives, show good agreement. This 
provides evidence for the retention of the configuration, and more support for the proposed 
amination/[2,3]-sigmatropic rearrangement mechanism. 
 
 
Scheme 100 Proof of retention of configuration in the [2,3]-sigmatropic rearrangement 
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 151 
4.4 The Use of the Amination/[2,3]-Sigmatropic Rearrangement in the 
Synthesis of ACE Inhibitor Perindopril 
 
Perindopril is an angiotensin converting enzyme (ACE) inhibitor, containing the N,N-
dicarboxymethylamine motif, currently marketed for the treatment of hypertension, 
congestive heart failure and coronary artery disease, as well as being taken to help 
prevent complications following heart attacks and procedures to increase the flow of blood 
through the heart.274 Perindopril 213 itself is an acid-ester prodrug whose active metabolite 
perindoprilate is accessed in vivo via hydrolysis of the ethyl ester. Perindopril was first 
synthesised in 1982 via the tert-butyl ester 214 as a single all S-diastereomer, though the 
yields were not reported (Scheme 101).275 The 3D structure was later confirmed in 2011, 
with the report of the first crystal structure.276 
 
 
Scheme 101 First reported synthesis of Perindopril 
 
Various syntheses of Perindopril have been reported, mainly in the patent literature, and a 
number of key examples can be found in Scheme 102 below. One approach taken is via a 
key amide bond forming step using perhydroindole esters with a pre-activated L-alanine 
amino acid as either the oxazolidinedione277 or its sulfur analogue278 (Scheme 102, route 
a). Similar routes using amide couplings via either the acid chloride279 or directly from the 
carboxylic acid280 are also reported (route b). An alternative approach is via a C(sp3)-N 
bond formation step installing the secondary amine motif; examples of this approach 
include SN2 displacement using enantiomerically pure α-halo281 or α-sulfonyloxy 
esters281,282 (route c). Syntheses are also reported making use of a SN2 displacement 
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+
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using enantiomerically pure α-propyl amino esters283 (route d) and the stereoselective 
reductive amination using ethyl 2-oxopentanoate (route e).275  
 
 
Scheme 102 Selected examples of literature syntheses of Perindopril 
 
4.4.1 Proposed Route for Perindopril Synthesis 
 
We envisaged that a new step-efficient and highly enantioselective synthesis of Perindopril 
could be achieved via utilisation of the amination/[2,3]-sigmatropic rearrangement 
methodology. The initial proposed synthetic route (Scheme 103) starts with protection of 
(2S,3aS,7aS)-octahydroindole-2-carboxylic acid as the benzyl ester 215. Here a protecting 
group that can be removed under the same reduction conditions needed to remove the 
alkene functionality is key to a step-efficient synthesis. Subsequent amide bond formation 
and deprotection will give amino acid 216. Amination/[2,3]-sigmatropic rearrangement with 
allylic selenide 163 will give Perindopril precursor 217 with a final 
hydrogenation/hydrogenolysis reaction allowing both reduction of the double bond and 
deprotection of the carboxylic acid affording Perindopril in five steps from the commerically 
available octahydroindole-2-carboxylic acid. 
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Scheme 103 Proposed synthetic route to Perindopril 
 
NH2-L-Ala-OBn was used as a test substrate for the key amination/[2,3]-sigmatropic 
rearrangement step with allylic selenide 163, as there are no examples to date of the 
amination/[2,3]-rearrangement of an allylic selenide with a methyl substituent in the C1. 
Pleasingly, under the reaction conditions described above (Table 33) the desired product 
218 was isolated in a 62% yield with a 10:1 E:Z ratio. Subsequent Pd-catalysed reduction 
of the double bond/hydrogenolysis of the benzyl ester afforded N-[(S)-1-carbethoxybutyl]-
(S)-alanine (97%, 219), a key intermediate in a number of Perindopril syntheses (Scheme 
104).280,282 
 
 
Scheme 104 Synthesis of N-[(S)-1-carbethoxybutyl]-(S)-alanine 219 
 
4.4.2 Initial Attempts and Undesired Diketopiperazine Formation during Perindopril 
Synthesis 
 
Initial benzyl protection of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid proceeded 
smoothly using p-TSA and benzyl alcohol in toluene under Dean-Stark conditions to afford 
the benzyl ester 215 as the p-TSA salt in a quantitative yield (Scheme 105). 
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Scheme 105 Protection of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid as benzyl ester 215 
 
A range of conditions were then tested for the amide coupling with N-Boc-Ala-OH, 
described below in Table 36, with the use of a DIPEA/EDCI/HOBt system giving the best 
results (Entry 4). 
 
 
Entry Reaction Conditions Yield (%) 
1 DIPEA (2.0 eq.), HBTU (1.2 eq.), DMF, rt, o/n 81 
2 DIPEA (2.0 eq.), HATU (1.2 eq.), DMF, rt, o/n 77 
3 DIPEA (2.5 eq.), HOBt (1.1 eq.), EDCI (1.1 eq.), DMF, rt, o/n 89 
4 NMM (2.5 eq.), HOBt (1.1 eq.), EDCI (1.1 eq.), DMF, rt, o/n 63 
5 Zr(Cp)2Cl2 (5 mol%), toluene, reflux284 0a 
a 0% conversion of the starting material 
Table 36 Optimization of amide coupling step in Perindopril synthesis 
 
Interestingly if the p-TSA salt 215 was first reacted with NaHCO3 and then with the 
zirconium(IV) catalyst, instead of the desired amide coupling product a 69% yield of a 
diketopiperazine 221 product was observed (Scheme 106), presumably formed via an 
initial amide bond formation followed by cyclisation aided by the zirconium Lewis acid. 
 
 
Scheme 106 Formation of diketopiperazine product under zirconium catalyzed amide-coupling conditions 
 
N
H
CO2H
H
H
benzyl alcohol
p-TSA
N
H2
CO2Bn
H
H
215
toluene, reflux
100% p-TSA
N
H2
CO2Bn
H
H
215
p-TSA
N-Boc-Ala-OH (1.0 eq)
N
CO2Bn
H
H
O NHBoc220
N
H2
CO2Bn
H
H
215
p-TSA
i) NaHCO3
ii) ZrCp2Cl2 (5 mol%), N-Boc-Ala-OH, toluene, reflux
N NBoc
O
O
H
H
221
69%
 155 
Deprotection of N-Boc amino acid 220 was achieved via stirring in an 1:4 mixture of 
TFA:CH2Cl2 affording the desired amination/rearrangement precursor 222 as the TFA salt 
(Scheme 107).  
 
Scheme 107 Deprotection of N-Boc protected amino acid 220 
 
However, when submitted to the amination/rearrangement conditions, TFA salt 222 with 
allylic selenide 163 failed to give the desired vinyl glycine product and instead afforded a 
63% yield of the diketopiperazine product 221 (Scheme 108).  
 
 
Scheme 108 Attempted NCS-mediated amination/rearrangement reaction with 222 
 
While formation of this diketopiperazine 221 has not been reported in any of the chemical 
literature, Perindopril itself is known to be relatively chemically unstable with clinical 
Perindopril administered as either the tert-butyl amine or L-arginine salt and the N-
substituted diketopiperazine 223 (Figure 12) is reported to be its major biological 
degradation product.285 
 
 
Figure 12 Major Perindopril diketopiperazine-degradation product 
 
Test reactions stirring the rearrangement precursor 222 with base (DIPEA) in MeOH 
afforded rapid, complete conversion (< 5 min) of the rearrangement precursor 222 to 
diketopiperazine 221. Attempts at changing the order of addition, with TFA salt 222 added 
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at the start of the reaction, DIPEA added after the NCS and changes to the reaction 
temperature both increase and decrease all failed to afford any of the desired products. At 
this point it seemed unlikely that changes to reaction conditions alone would prevent the 
rapid cyclisation and work instead focused on varying the ester-protecting group with the 
aim of decreasing the rate of the unwanted cyclisation relative to the rate of amination of 
the chloride intermediate, i.e. via the use of a more sterically hindered ester. 
 
It is worth noting that, while not explicitly mentioned in the literature references, it is 
perhaps the undesired formation of diketopiperazine 221 that leads to the use of the 
unsaturated analogues of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid in many of the 
literature examples discussed above (see Scheme 102 and references found in the text). 
Use of the unsaturated analogue was discounted as a viable approach for this synthesis 
due to the extra steps required for the syntheses of the unsaturated analogue of the 
octahydroindole-2-carboxylic acid280 and the increased cost of the starting materials 
required, preventing development of an efficient and economical synthesis. 
 
4.4.3 Use of Alternative Ester Protecting Groups 
 
In order to maintain the step-efficiency of the synthesis, a more sterically bulky ester-
protecting group that could still be removed under hydrogenolysis conditions was sought. 
With this in mind the bulkier diphenylmethyl ester 224 was prepared from the reaction of 
(2S,3aS,7aS)-octahydroindole-2-carboxylic acid with diphenyldiazomethane 225 in 62% 
yield. The diphenylmethyl ester was chosen over the more sterically hindered trityl ester, 
as it was thought that the acid-labile trityl ester might present a problem during the Boc-
deprotection following the amide coupling step.  
 
Reaction under the optimised amide coupling conditions used above afforded N-Boc 
amino acid 226 in a 92% yield. However, attempts to deprotect Boc-protected 226 in 1:4 
TFA:CH2Cl2 afforded the diketopiperazine product in 60% yield, with only 38% yield of the 
desired deprotected product (Scheme 109). Attempts using anhydrous 2M HCl in ether 
gave 27% yield of the desired deprotected product 227 and 51% of the diketopiperazine 
221. The use of lower concentrations of acid gave poor conversion of the protected 
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starting material 226 and still failed to selectively deprotect the amine without subsequent 
cyclisation. 
 
 
Scheme 109 Use of diphenyl methyl protecting group in the Perindopril Synthesis 
 
Whilst not as acid labile as a trityl ester, diphenylmethyl esters are still relatively acid labile 
and either the acid conditions were aiding the hydrolysis of the diphenylmethyl protecting 
group, and aiding the formation of the diketopiperazine product, or the diphenylmethyl 
ester is still not sterically hindered enough to prevent the cyclisation. In an attempt to by-
pass the need for acidic de-protection conditions, use of a N-(p-methoxybenzyl) protected 
aniline for the amide coupling was attempted whereby cleavage of the PMB protecting 
group, with CAN or DDQ, would by-pass the need for acidic conditions and as such limit 
the levels of diketopiperazine formation. However, attempts at the amide coupling with 
diphenylmethylester 224 and N-PMB-Ala-OH under the optimised conditions gave no 
conversion of the starting materials over 24 hours (Scheme 110). Poor solubility of the N-
PMB-Ala-OH was noted and in hindsight it is likely that double protection of the amine 
functionality would be necessary to facilitate this amide coupling. 
 
 
Scheme 110 Attempted synthesis of PMB-protected analogue  
 
At this point it was decided to test the stability of the tert-butyl analogue to the cyclisation. 
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Cbz-Ala-OH in the amide coupling step with tert-butyl ester 228 and therefore removed the 
need for an acidic deprotection step. Synthesis of tert-butyl ester 228 was achieved in 3 
steps with a 77% overall yield and subsequent amide coupling under the optimised 
conditions gave the N-Cbz product 229 in 89% yield. Facile deprotection of Cbz group 
under hydrogenation conditions afforded the amination/rearrangement precursor 230 in 5 
steps with a 72% overall yield without any formation of the unwanted diketopiperazine 
product (Scheme 111). 
 
 
Scheme 111 Synthesis of tert-butyl ester analogue 230 
 
The tert-butyl ester was then subjected to the optimised amination/rearrangement 
conditions using allylic selenide 163 (Scheme 112). Initial attempts at 0 °C afforded the 
desired amination/rearrangement product 164 in 26% yield with 52% of the undesired 
diketopiperazine product 221. A lower reaction temperature (-20 °C) afforded an increase 
in the yield of the desired product 231 (40%, E:Z 4:1), though still in a 1:1 ratio with the 
undesired diketopiperazine product 221. Further decrease in the reaction temperatures (-
40 °C) resulted in a significantly slower reaction with no significant improvement in the 
yield of the desired product.  
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Scheme 112 Synthesis of Perindopril tert-butyl ester 232 
 
Initial attempts at the reduction of the double bond using H2 10% Pd/C were unsuccessful 
with no conversion of the starting material. The use of Pd(OH)2 and PtO2 also failed to give 
any of the desired product and while Raney nickel did allow access to the desired product, 
yields were variable. Finally the use of a higher pressure of hydrogen, 4 bar, with 10% 
Pd/C allowed access to the reduced tert-butyl ester analogue of Perindopril 232, thus 
completing a 7 step formal synthesis of Perindopril with an overall 28% yield and a 96:4 
d.r. (determined by 1H NMR and comparison to the diastereomeric mixture prepared using 
racemic allylic selenide 163).275  
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4.5 Conclusions and Future Work 
 
To summarise, an increased scope of nitrogen sources for the NCS-mediated 
amination/[2,3]-sigmatropic rearrangement of enantioenriched allylic selenides is reported, 
accessing a wide range of novel, enantioenriched vinyl glycine derivatives (Scheme 113). 
The three classes of nitrogen sources utilised were; amino acid amides in the first reported 
synthesis of vinyl glycine dipeptides via this methodology; amino acid esters in the highly 
diastereoselective synthesis of N,N-dicarboxymethylamine peptidomimetic products; N-
heteroaromatic amines in the first reported synthesis of highly enantioenriched N-
heteroaryl amino acids via the amination/[2,3]-sigmatropic rearrangement methodology. 
Generally moderate-to-good yields were obtained with good retention of the optical purity 
observed throughout; however, some decrease in yield was observed with the use of more 
hindered substrates. 
 
 
Scheme 113 New substrate scope for the NCS-mediated amination/[2,3]-sigmatropic rearrangement of 
allylic selenidesvi 
 
This methodology was then tested in the synthesis of pharmaceutical ACE inhibitor 
Perindopril. However, the undesired cyclisation of the rearrangement precursors (230 and 
its analogues) to diketopiperazine 221 limited both the choice of acid protecting groups 
and the yield from the key [2,3]-rearrangement step (Scheme 114). Despite this difficulty, 
                                            
vi Another 8 examples with amino acid amides were performed by Dr D.P.G. Emmerson and can be found in discussion 
above and the following reference.323 
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the synthesis of Perindopril was accomplished in 7 steps with an overall 28% yield and 
96:4 d.r.  
 
 
Scheme 114 Summary of Perindopril synthesis via NCS-mediated amination/[2,3]-sigmatropic 
rearrangement 
 
Despite the difficulties with the diketopiperazine formation in the Perindopril synthesis the 
work covered in this chapter highlights the versatility of this methodology as a method for 
accessing highly enantioenriched allylic amines. As such, future work developing the NCS 
mediated amination/[2,3]-methodology would focus on new target syntheses to test this 
methodology.  
 
One other area that could be explored is the [2,3]-sigmatropic rearrangement of optically 
active selenonium ylides allowing access to optically enriched homoallylic selenides 
(Scheme 115). While Koizumi has reported their synthesis via the bornyl chiral axially 
methodology,246 there is, to the best of our knowledge, no reported synthesis of 
selenonium ylides directly from enantioenriched allylic selenides. 
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Scheme 115 Possible route to access optically enriched homoallylic selenides from allylic selenides 
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5 Experimental 
5.1 General Procedures 
 
Unless stated otherwise, all non-aqueous reactions were carried out under argon using 
anhydrous solvents in oven (160°C) or flame dried glassware. 
Solvents: Anhydrous solvents acetone, MeCN, CHCl3, 1,4-dioxane, DME, DMF, DMSO 
and IPA were used as commercially supplied. Anhydrous CH2Cl2, THF and toluene were 
purified using an Innovative Technology INC. PureSolvTM Solvent Purification System. 
MeOH was dried by refluxing over magnesium and iodine, then distillation and stored for at 
least 3 days over 3Å molecular sieves prior to use. H2O was distilled for use in reactions. 
Reagents: mCPBA was purified by dissolving in CH2Cl2 and washing with pH 7.5 
phosphate buffer, dried over MgSO4 and concentrated under reduce pressure.286 
Aldehydes and amine bases were distilled immediately prior to use. Anhydrous NMM was 
purchased for VNA reactions and used as supplied. NCS was purified by re-crystallisation 
from toluene prior to use. Commercial organometallic solutions were titrated against 
salicylhydrazine immediately prior to use.287 All other reagents were used as commerically 
supplied unless stated otherwise.  
Chromatography: Flash column chromatography, unless stated otherwise, was carried out 
using silica gel 40-63 µm (VWR Prolabo). Analytical thin layer chromatography (TLC) was 
carried out using glass back plates pre-coated with silica gel F254 and visualised by 
ultraviolet light and potassium permanganate, anisaldehyde, ceric ammonium nitrate or 
ninhydrin stains as appropriate. 
IR Spectroscopy: Infrared spectra were recorded on a Perkin Elmer Spectrum 100 FT-IR 
spectrometer by means of a Universal ATR Sampling Accessory. Selected peaks (νmax) 
are reported in wavenumbers (cm-1).  
NMR Spectroscopy: 1H NMR spectra were recorded at 400 MHz on Bruker AV400 
instruments and chemical shifts (δH) are reported in ppm with respect to the residual 
solvent peak (CDCl3 (δH = 7.26 ppm), d6-acetone (δH = 2.05 ppm), d6-DMSO (δH = 2.50 
ppm) and CD3OD (δH = 3.31 ppm)) and assigned the qualifiers: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet), br (broad). Coupling constants (J) are reported in Hz to 
the nearest 0.1 Hz. 13C NMR spectra were recorded at 100 MHz on Bruker AV400 
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instruments. Chemical shifts (δC) are reported in ppm referenced with respect to the 
residual solvent peak (CDCl3 (δC = 77.0 ppm), d6-acetone (δC = 29.84 ppm), d6-DMSO (δC 
= 39.5 ppm), CD3OD (49.00)). 31P spectra were recorded at 162 MHz on a Bruker AV400 
spectrometer. NMR yields are calculated by comparison to an internal standard, either 
1,3,5-trimethoxybenzene or dibenzylether. Calibrations were carried out with known 
quantities of standard and products to ensure accuracy. 
Mass Spectrometry: Was carried out using CI+ (NH3) or EI+ and were recorded using 
Micromass Platform II or AutoSpecQ instruments. Only molecular ions and fragments from 
molecular ions are reported. 
Melting Points: Melting points were obtained using a Reichert hot plate microscope and 
are uncorrected. 
Optical rotations were recorded on an Optical Activity Ltd. Polarimeter at 589 nm (Na D-
line) with a path length of 0.5 dm, concentrations (c) are quoted in g /100 ml and specific 
rotations, [α]TD, are quoted in units of 10-1degcm2g-1 . 
HPLC analysis was carried out on a modular, multi-wavelength JASCO instrument with 
250 mm columns from Daicel Chemical Industries Ltd 
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5.2 Experimental Details 
5.2.1 Experimental Details for Chapter 2: Use of O-(Diphenylphosphinyl) 
Hydroxylamines in the Aziridination of Enones and Phenyl Vinyl Sulfones 
 
N-Boc-O-(diphenylphosphinyl) hydroxylamine, 21 
 
According to the procedure of Whiting,65 to a stirred solution of tert-butyl N-
hydroxycarbamate (2.5 g, 18.8 mmol) in CH2Cl2 (67 mL) at 0 °C was added triethylamine 
(3.2 mL, 28.2 mmol) followed by a dropwise addition of a solution of diphenylphosphinic 
chloride (3.59 mL, 18.8 mmol) in CH2Cl2 (8.5 mL). The reaction was allowed to warm to 
room temperature and stirred for an additional 3 hours. H2O (80 mL) was added and the 
reaction mixture was extracted into CH2Cl2, dried over Na2SO4 and concentrated under 
reduced pressure to afford the title compound as a white solid (6.19 g, 99%); m.p. 173-176 
°C (lit.65 172-174 °C); νmax / cm-1 3077, 2975, 2895, 1750, 1482, 1443, 1366, 1275, 1217, 
1158, 1132, 1080; δH (400 MHz, CDCl3) 8.48 (1H, br s, NH), 8.00-7.90 (4H, m, 4 x ArH), 
7.59-7.52 (2H, m, 2 x ArH), 7.49-7.41 (4H, m, 4 x ArH), 1.39 (9H, s, C(CH3)3); δC (101 
MHz, CDCl3) 155.8, 132.8 (d, 4JCP 2.5), 132.4 (d, 3JCP 10.1), 128.7 (d, 1JCP 135.7), 128.4 
(d, 2JCP 13.5), 82.9, 27.9; δP (162 MHz, CDCl3) 40.0; m/z (ES+) 334 (100%, [MH]+); HRMS 
(ES+/TOF) found 334.1206, C17H21NO4P requires 334.1208. These data are consistent 
with literature values.65 
 
 (E)-6-Phenyl-3-hexen-2-one, 22 
 
According to the procedure of Yamazaki,288 to a stirred solution of 3-
phenylpropionaldehyde (395 μL, 3.0 mmol) in THF (10 mL) was added 1-
triphenylphosphoranylidene-2-propanone (1.05 g, 3.3 mmol). The reaction mixture was 
stirred at 60 °C for 6 hours, concentrated under reduced pressure and purified by flash 
column chromatography (15:1 nhexane:EtOAc) affording the title compound as a 
colourless oil (426.5 mg, 82%); δH (400 MHz, CDCl3) 7.35-7.26 (2H, m, 2 x ArH), 7.26-7.15 
(3H, m, 3 x ArH), 6.82 (1H, dt, J 16.0 and 6.8, CH2CH=CH), 6.10 (1H, dt, J 15.9 and 1.5, 
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CH2CH=CH), 2.85-2.75 (2H, m, PhCH2), 2.59-2.52 (2H, m, CH2CH=CH), 2.33 (3H, s, 
CH3); δC (101 MHz, CDCl3) 198.5, 147.0, 140.6, 131.7, 128.5, 128.3, 126.2, 34.4, 34.1, 
26.9. These data are consistent with literature values.288 
 
(E)-7-Phenylhept-4-en-3-one, 25 
 
Based on the procedure of Yamazaki,288 to a stirred solution of 1-
(triphenylphosphanylidene)butan-2-one (400 mg, 1.2 mmol) in THF (3.6 mL) was added 
hydrocinnamaldehyde (159 μL, 1.2 mmol). The reaction mixture was stirred overnight at 
60 °C, concentrated under reduced pressure and purified via flash column chromatography 
(20:1 nhexane:EtOAc) affording the title compound as a clear oil (105 mg, 46%); νmax /   
cm-1 3064, 3027, 2978, 2937, 1699, 1671, 1455, 1356, 1201, 1124; δH (400 MHz, CDCl3) 
7.33-7.27 (2H, m, 2 x ArH), 7.23-7.15 (3H, m, 3 x ArH), 6.85 (1H, dt, J 15.9 and 6.8, 
CH2CH=CH), 6.12 (1H, dt, J 15.9 and 1.5, CH2CH=CH), 2.79 (2H, dd, J 8.7 and 6.7, 
CH2CH=CH), 2.63-2.48 (4H, m, PhCH2 and CH2CH3), 1.09 (3H, t, J 7.8, CH3); δC (101 
MHz, CDCl3) 201.1, 145.7, 140.7, 130.5, 128.5, 128.3, 126.2, 34.5, 34.1, 33.3, 8.11; m/z 
(ES+) 230 (100%, [MH+MeCN]+), 189 (52%, [MH]+); HRMS found 189.1284, C13H17O 
requires 189.1279. 
 
 (4E)-2,2-Dimethyl-7-phenylhept-4-en-3-one, 26 
 
Based on the procedure of Yamazaki,288 to a stirred solution of 3-phenylpropionaldehyde 
(131 μL, 1. mmol) in THF (3 mL) was added (3,3-dimethyl-1-(triphenylphosphoranylidene)-
2-butanone (396 mg, 1.1 mmol). The reaction mixture was stirred overnight at 60 °C, 
concentrated under reduced pressure and purified via flash column chromatography (9:1 
nhexane:EtOAc) affording two isomeric products (the major E isomer and the minor Z-
isomer). 
 
(4E)-2,2-dimethyl-7-phenylhept-4-en-3-one was isolated as a white solid (85.3 mg, 39%); 
m.p. 31-33 °C; νmax / cm-1 3062, 3027, 2970, 2930, 2868, 1739, 1688, 1623, 1476, 1454, 
1366, 1229, 1217, 1077; δH (400 MHz, CDCl3) 7.13-7.05 (2H, m, 2 x ArH), 7.03-6.95 (3H, 
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m, 3 x ArH); 6.78 (1H, dt, J 15.2 and 6.8, CH2CH=CH), 6.28 (1H, dt, J 15.2 and 1.5, 
CH2CH=CH), 2.62-2.56 (2H, m, PhCH2), 2.39-2.31 (2H, m, CH2CH=CH), 0.93 (9H, s, 
C(CH3)3); δC (101 MHz, CDCl3) 204.4, 146.2, 141.0, 128.54, 128.52, 126.2, 125.0, 34.7, 
34.4, 26.3, 25.9; m/z (ES+) 217 (100% [MH]+); HRMS (ES+/TOF) found 217.1600; 
C15H21O requires 217.1592. 
 
(4Z)-2,2-dimethyl-7-phenylhept-4-en-3-one was isolated as a colourless oil (13,0 mg, 6%); 
νmax / cm-1 3064, 3027, 2966, 2930, 2868, 1684, 1612, 1479, 1454, 1365, 1074; δH (400 
MHz, CDCl3) 7.32-7.25 (2H, m, 2 x ArH), 7.23-7.15 (3H, m, 3 x ArH), 6.41 (1H, dt, J 11.7 
and 1.7, CH2CH=CH), 6.14 (1H, dt, J 11.6 and 7.3, CH2CH=CH), 2.94-2.87 (2H, m, 
CH2CH=CH), 2.76 (2H, t, J 7.6, PhCH2), 1.12 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 
206.9, 147.4, 141.5, 128.6, 128.5, 126.0, 123.7, 43.8, 35.3, 34.4, 26.4; m/z (ES+) 217 
(100% [MH]+); HRMS (ES+/TOF) found 217.1597; C15H21O requires 217.1592. 
 
(E)-Hept-3-en-2-one, 27 
 
Based on the procedure of Yamazaki,288 to a stirred solution of 1-(triphenyl-
phosphanylidene)propan-2-one (318 mg, 1.0 mmol) in THF (3 mL) was added 
butyraldehyde (90 μL, 1.0 mmol). The reaction mixture was stirred overnight at 60 °C, 
concentrated under reduced pressure and purified via flash column chromatography (20:1 
nhexane:EtOAc) affording the title compound as a clear oil (103 mg, 92%); δH (400 MHz, 
CDCl3) 6.78 (1H, dt, J 15.9 and 6.9, CH2CH=CH), 6.05 (1H, dt, J 16.0 and 1.6, 
CH2CH=CH), 2.25-212 (5H, m, CH2CH=CH and C(O)CH3), 1.42 (2H, app. hept., J 7.4, 
CH3CH2), 0.92 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 198.7, 148.3, 131.4, 34.4, 
26.8, 21.3 and 13.6. These data are consistent with literature values.289 
 
(3E,5E)-6-Phenylhexa-3,5-dien-2-one, 30 
 
Based on the procedure of Yamazaki,288 to a stirred solution of cinnamaldehyde (126 μL, 
1.0 mmol) in THF (3 mL) was added 1-triphenylphosphoranylidene-2-propanone (349 mg, 
1.1 mmol). The reaction mixture was stirred overnight at 60 °C, concentrated under 
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reduced pressure and purified via flash column chromatography (20:1 nhexane:EtOAc) 
affording the title compound as an off-white solid (81.7 mg, 48%); m.p. 67-68 °C (Lit.290 67-
68 °C); νmax / cm-1 3083, 3059, 3032, 3002, 2971, 1740, 1666, 1649, 1614, 1592, 1452, 
1360, 1256, 989; δH (400 MHz, CDCl3) 7.52-7.44 (2H, m, 2 x ArH), 7.41-7.27 (4H, m, 3 x 
Ar and 1 x CH), 7.04-.6.81 (2H, m, 2 x CH), 6.26 (1H, d, J 15.7, CH), 2.32 (3H, s, CH3); δC 
(101 MHz, CDCl3) 198.4, 143.4, 141.2, 135.9, 130.5, 129.2, 128.8, 127.2, 126.6, 27.4). 
These data are consistent with literature values.290 
 
General Procedure A: N-Boc-Aziridination of Enones: 
 
To a stirred solution of N-Boc-O-(diphenylphosphinyl) hydroxylamine (133 mg, 0.4 mmol) 
in CH2Cl2 (2.3 mL) was added Cs2CO3 (195 mg, 0.6 mmol) and then the enone substrate 
(0.2 mmol). The reaction mixture was allowed to stir for 40 hours at room temperature and 
then quenched with NH4.HCl (sat. aq., 1 mL), extracted into CH2Cl2, dried over Na2SO4 
and then concentrated under reduced pressure to afford the crude product mixture which 
was further purified via flash column chromatography. 
 
(±)tert-Butyl-2-acetyl-3-phenethyl-trans-aziridine-1-carboxylate, 23 
 
Following general procedure A, using (E)-6-Phenyl-3-hexen-2-one (26.11 mg, 0.15 mmol). 
Purification by flash column chromatography (9:1 nhexane:EtOAc) afforded the title 
compound as a colourless oil (37 mg, 75%); δH (400 MHz, CDCl3) 7.32-7.26 (2H, m, 2 x 
ArH), 7.23-7.16 (3H, m, 3 x ArH), 2.92-2.83 (2H, m, PhCHCH and CH2CHCH), 2.74 (1H, 
dt, J 14.0 and 8.1, PhCHCH), 2.67 (1H, dt, J 6.2 and 2.6, CH2CHCH), 2.12 (3H, s, CH3), 
1.96-2.04 (1H, m, PhCH2CHH), 1.67-1.76 (1H, m, PhCH2CHH), 1.46 (9H, s, C(CH3)3); δC 
(101 MHz, CDCl3) 202.2, 159.0, 140.6, 128.5, 128.4, 126.1, 81.8, 46.6, 44.9, 33.0, 29.3, 
27.9, 27.6. These data are consistent with literature values.291 
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(±)tert-Butyl 2-phenethyl-3-propionyl-trans-aziridine-1-carboxylate, 33 
 
Following the general procedure A, using (E)-7-phenylhept-4-en-3-one (33.0 mg, 0.17 
mmol). Purification by flash column chromatography (9:1 nhexane:EtOAc) afforded the title 
compound as a colourless oil (27.5 mg, 54%); νmax / cm-1 3088, 3065, 3026, 2978, 2936, 
1724, 1714, 1455, 1368, 1311, 1155; δH (400 MHz, CDCl3) 7.31-7.25 (2H, m, 2 x ArH), 
7.22-7.16 (3H, m, 3 x ArH), 2.91-2.81 (2H, m, CH2CHCH and PhCHH), 2.80-2.65 (2H, m, 
CH2CHCH and PhCHH), 2.54-2.31 (2H, m, CH2CH3), 1.98 (1H, ddt, J 14.0, 8.2 and 5.7, 
PhCH2CHH), 1.73 (1H, dtd, J 14.4, 8.2 and 5.7, PhCH2CHH), 1.45 (9H, s, C(CH3)3), 1.05 
(3H, t, J 7.3, CH3); δC (101 MHz, CDCl3) 204.7, 159.1, 140.7, 128.5, 128.4, 126.1, 81.6, 
46.0, 44.8, 35.9, 33.1, 33.0, 27.9, 7.3; m/z (ES+) 367 (33%, [M+MeCN+Na]+), 304 (24%, 
[MH]+), 289 (28%, [MH-CH3]+), 204 (100%, [MH-CO2tBu]+); HRMS (ES+/TOF) found 
367.2014, C20H28N2O3Na requires 367.1997. 
 
(±)tert-Butyl 2-phenethyl-3-pivaloyl-trans-aziridine-1-carboxylate, 34 
 
Following general procedure A, using (4E)-2,2-dimethyl-7-phenylhept-4-en-3-one (22.2 
mg, 0.10 mmol). Purification by flash column chromatography (30:1 nhexane:EtOAc) 
afforded the title compound as a colourless oil (8.3 mg, 24%); νmax / cm-1 2973, 2933, 
2870, 1726, 1477, 1455, 1367, 1314, 1257, 1225, 1158; δH (400 MHz, CDCl3) 7.31-7.24 
(2H, m, 2 x ArH), 7.22-1.26 (3H, m, 3 x ArH), 3.22 (1H, d, J 2.7, CH2CHCH), 2.88-2.73 
(2H, m, PhCH2), 2.70 (1H, dt, J 6.1 and 2.5, CH2CHCH), 1.99-1.75 (2H, m, PhCH2CH2), 
1.45 (9H, s, C(CH3)3), 1.17 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 207.7, 159.3, 140.9, 
128.5, 128.4, 126.1, 81.4, 45.3, 43.9, 42.4, 33.4, 32.9, 28.0, 25.4; m/z (ES+) 354 (100% 
[MNa+], 232 (63% [MH-CO2tBu+]; HRMS (ES+/TOF) found 354.2047; C20H29NO3Na 
requires 254.2045. 
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(±)tert-Butyl 2-acetyl-3-propyl-trans-aziridine-1-carboxylate, 35 
 
Following general procedure A, using (E)-hept-3-en-2-one (27.4 mg, 0.24 mmol). 
Purification by flash column chromatography (4:1 nhexane:EtOAc) afforded the title 
compound as a colourless oil (12.2 mg, 24%); νmax / cm-1 3006, 2976, 2934, 2875, 1725, 
1424, 1368, 1313, 1250, 1153; δH (400 MHz, CDCl3) 2.97 (1H, d, J 2.7, CHCHC(O)), 2.65 
(1H, dt, J 5.9 and 2.7, CHCHC(O)), 2.26 (3H, s, C(O)CH3), 1.61-1.37 (13H, m, includes 
1.45 (9H, s, C(CH3)3)) and 2x alkyl CH2), 0.96 (3H, t, J 7.1, CH2CH3); δC (101 MHz, CDCl3) 
202.6, 159.1, 81.7, 46.6, 45.3, 33.2, 29.0, 27.9, 20.1, 13.6; m/z (ES+) 291 (17%, 
[M+MeCN+Na]+), 213 (21%, [MH-CH3]+), 128 (100%, [MH-CO2tBu]+); HRMS (ES+/TOF) 
found 291.1693, C14H24N2O3Na requires 291.1685. 
 
(±)tert-Butyl 2-benzoyl-3-methyl-trans-aziridine-1-carboxylate, 36 
 
Following general procedure A, using (E)-1-phenylbut-2-en-1-one (29.2 mg, 0.2 mmol). 
Purification by flash column chromatography (9:1 nhexane:EtOAc) afforded the title 
compound as a pale yellow oil (46.3 mg, 89%); νmax / cm-1 2978, 2934, 1718, 1678, 1598, 
1450, 1367, 1304, 1222, 1150, 1015; δH (400 MHz, CDCl3) 8.07-7.98 (2H, m, 2 x ArH), 
7.65-7.55 (1H, m, ArH), 7.53-7.44 (2H, m, 2 x ArH), 3.69 (1H, d, J 2.7, C(O)CH), 2.96 (1H, 
qd, J 5.5 and 2.7, CH3CH), 1.43-140 (12H, m, contains 1.42 (9H, s, C(CH3)3) and alkyl 
CH3); δC (101 MHz, CDCl3) 193.6, 159.5, 136.8, 133.5, 128.7, 128.3, 81.6, 44.3, 41.3, 
27.9, 16.8; m/z (ES+) 325 (17%, [M+MeCN+Na]+), 162 (100%, [MH-CO2tBu]+); HRMS 
(ES+/TOF) found 325.1537 ([M+MeCN+Na]+), C17H22N2O3Na requires 325.1535. 
(±)tert-Butyl 2-oxo-7-azabicyclo[4.1.0]heptane-7-carboxylate, 37 
 
Following general procedure A, using cyclohexenone (14.1 μL, 0.15 mmol). Purification by 
flash column chromatography (4:1 nhexane:EtOAc) afforded the title compound as a 
colourless oil (3.4 mg, 11%); δH (400 MHz, CDCl3) 3.08 (1H, ddt, J 5.9, 2.4 and 1.2, 
C(O)CHCH), 2.89 (1H, d, J 2.4, C(O)CHCH), 2.54-2.47 (1H, m, alkyl CH), 2.27-2.21 (1H, 
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m, alkyl CH), 2.09-1.92 (2H, m, 2 x alkyl CH), 1.83-1.73 (1H, m alkyl CH), 1.69-1.59 (1H, 
m, alkyl CH), 1.45 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 204.2, 160.6, 82.2, 43.4, 40.4, 
36.8, 27.8, 22.6, 17.3. These data are consistent with literature values.54 
 
Bis(3,5-bis(trifluoromethyl)phenyl)phosphinic chloride, 42 
 
According to the procedure of Spencer,69 through a solution of bis(3,5-
bis(trifluoromethyl)phenyl)chlorophosphine (1 g, 2.0 mmol) in toluene (10 mL) was bubbled 
dry oxygen for 5 hours. After this time the reaction mixture was concentrated under 
reduced pressure to afford the title compound as an off-white solid, which was used 
without further purification. δH (400 MHz, CDCl3) 8.37 (2H, br s, 2 x ArH), 8.34 (2H, br s, 2 
x ArH), 8.17 (2H, br s, 2 x ArH); δP (162 MHz, CDCl3) 34.3. These data are consistent with 
literature values.69 
Bis(4-chlorophenyl)phosphine oxide, 47 
 
According to the procedure of Harger,70 to a stirred solution to diethyl phosphite (1.28 mL, 
10 mmol) in THF (15 mL) under nitrogen at 0 °C was added (4-chlorophenyl)magnesium 
bromide (1.0 M in THF, 30 mL, 30 mmol). The reaction mixture was stirred for 3 hours at 0 
°C then quenched with H2O (10 mL), diluted with toluene (40 mL) and 6M HCl (aq., 10 
mL). The crude mixture was then stirred for a further 30 minutes at room temperature. The 
organic layer was then separated and washed in sequence with H2O, NaHCO3 (sat. aq.) 
and brine then dried over MgSO4 and concentrated under reduced pressure. Titration in 
Et2O at -18 °C overnight afforded the title compound as a white solid (1.52 g, 56%); m.p. 
132-133 °C (Lit.292 131-133 °C); δH (400 MHz, CDCl3) 8.07 (1H, d, 1JH-P 484, PH), 7.66-
7.59 (4H, m, 4 x ArH), 7.53-7.47 (4H, m, 4 x ArH); δC (101 MHz, CDCl3) 139.5 (d, 4JCP 
2.9), 132.5 (d, 3JCP 12.6), 129.5 (d, 2JCP 13.5), 129.4 (d, 1JCP 103.1); δP (162 MHz, CDCl3) 
18.7. These data are consistent with literature values.293 
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Bis-(4-chlorophenyl)phosphinic acid, 46 
 
According to the procedure of Harger,70 to a solution of bis(4-chlorophenyl)phosphine 
oxide (1.5 g, 5.53 mmol) in CH2Cl2 (5 mL) was added hydrogen peroxide (30% v/v, 3.5 mL, 
5.53 mmol). The reaction mixture was allowed to stir at room temperature for 24 hours. 2M 
NaOH (aq.) was added until the aqueous layer was pH 14 and the organic layer was 
separated. The aqueous layer was then acidified using 2M HCl (aq.) and extracted into 
EtOAc. The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure afforded the title compound as a white crystalline solid (1.2 g, 76%); 
m.p. 133-135 °C (Lit.294 133-135 °C); δH (400 MHz, CDCl3) 9.38 (1H, br s, OH), 7.62-7.54 
(4H, m, 4 x ArH), 7.35-7.29 (4H, m, 4 x ArH); δC (101 MHz, CDCl3) 138.8 (d, 4JCP 3.6), 
132.5 (d, 3JCP 11.5), 130.4 (d, 1JCP 143.8), 128.8 (d, 2JCP 14.1); δP (162 MHz, CDCl3) 30.7. 
These data are consistent with literature values.295 
 
tert-Butyl bis(4-chlorophenyl)phosphoryl)oxycarbamate, 45 
 
Based on the procedure of Whiting,65 a stirred solution of bis(4-chloropehnyl)phosphinic 
acid (720 mg, 2.5 mmol) in thionyl chloride (6 mL) under nitrogen was heated to reflux for 2 
hours. The reaction mixture was cooled to room temperature and excess thionyl chloride 
removed under reduced pressure. The crude reaction mixture was then dissolved in 
CH2Cl2 (10 mL) and cooled to 0 °C, tert-butyl hydroxycarbamate (333 mg, 2.5 mmol) and 
triethylamine (0.52 mL, 3.75 mmol) were added and the reaction mixture allowed to warm 
to room temperature over 3 hours. H2O (90 mL) was then added and the crude reaction 
mixture extracted into CH2Cl2 (3x), dried over MgSO4 and concentrated under reduced 
pressure. Partial re-crystallisation from CH2Cl2 afforded the title compound as a white solid 
(414 mg, 41%); m.p. decomp. >165 °C; νmax / cm-1 3086, 2981, 2906, 1753, 1587, 1474, 
1392, 1368, 1252, 1222, 1162, 1086; δH (400 MHz, CDCl3) 8.24 (1H, br s, NH), 7.92-7.81 
(4H, m, 4 x ArH), 7.51-7.40 (4H, m, 4 x ArH), 1.41 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 
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155.6, 139.8 (d, 4JCP 3.8), 133.7 (d, 3JCP 11.1), 129.0 (d, 2JCP 14.1), 126.9 (d, 1JCP 139.1), 
83.4, 27.9; δP (162 MHz, CDCl3) 37.8. m/z (ES+) 439 (11%, [(M+MeCN+Na)+4]+), 467 
(53%, [(M+MeCN+Na)+2]+), 465 (100%, [M+MeCN+Na]+), 404 (25%, [MH+2]+), 402 (30%, 
[MH]+), 349 (7%, [(MH+4)-C4H9]+) , 347 ((50%, [(MH+2)-C4H9]+), 345 (80%, [MH-C4H9]+); 
HRMS (ES+/TOF) found 402.0444, C17H19NO435Cl2P requires 402.0429. 
 
tert-Butyl (bis(4-methoxyphenyl)phosphoryl)oxycarbamate, 48 
 
According to the procedure of Vedejs,71 a solution of bis(4-methoxyphenyl)phosphinic acid 
(1g, 3.59 mmol) in thionyl chloride (8 mL) under nitrogen was heated to reflux for 2 hours. 
The reaction mixture was cooled to room temperature and the excess thionyl chloride was 
removed under reduced pressure. The crude reaction mixture was then re-dissolved in 
CH2Cl2 (16 mL) and cooled to 0 °C, tert-butyl hydroxycarbamate (0.487g, 3.59 mmol) and 
triethylamine (0.751 mmol, 5.39 mmol) were added and the reaction mixture was allowed 
to warm to room temperature and stirred at room temperature for a further 3 hours. The 
reaction mixture was then diluted with H2O (10 mL), the aqueous layer was separated and 
extracted into CH2Cl2 (3x). The combined organic layers and dried over MgSO4 and 
concentrated under reduced pressure. Purification via flash column chromatography (1:1 
chexane:EtOAc) afforded the title compound as a white crystalline solid (866 mg, 61%); 
m.p. 60-62 °C; νmax / cm-1 3101, 2978, 2897, 2839, 1747, 1717, 1597, 1504, 1250, 1128; 
δH (400 MHz, CDCl3) 8.52 (1H, br s, NH), 7.90-7.81 (4H, m 4 x ArH), 6.98-6.91 (4H, m, 4 x 
ArH), 3.83 (6H, s, 2 x OCH3), 1.39 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 163.0, 155.9 (d, 
4JCP 5.2), 134.0 (d, 3JCP 12.0), 120.4 (d, 1JCP 143.3), 113.9 (d, 2JCP 14.4), 82.6, 55.3, 27.8; 
δP (162 MHz, CDCl3) 40.9; m/z (ES+) 457 (47%, [M+MeCN+Na]+), 394 (100%, [MH]+), 338 
(28%, [MH-C4H9]+); HRMS (ES+/TOF) found 394.1430; C19H25NO6P requires 394.1420. 
 
N-Hydroxy-4-methylbenzenesulfonamide, 51 
 
According to the procedure of Porcheddu,296 to a stirred solution of hydroxylamine 
hydrochloride (831 mg, 12.0 mmol) in MeOH:H2O (5 mL, 3:2) was added magnesium 
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oxide (628 mg, 15.6 mmol), then a solution of tosyl chloride (1 g, 5.2 mmol) in THF (34 
mL) was added. The reaction mixture was stirred vigorously for 2 hours then filtered 
through Celite followed by a short pad of silica. The filtrate was then concentrated under 
reduced pressure to afford the title compound as a white solid (424 mg, 44%); m.p. 152-
153 °C (Lit.297 153°C); δH (400 MHz, d6-DMSO) 9.55 (1H, d, J 3.2 heteroatom-H), 9.49 
(1H, d, J 3.2 heteroatom-H), 7.72 (2H, d, J 8.2, 2x ArH), 7.42 (2H, d, J 8.0, 2x ArH), 2.40 
(3H, s CH3). These data are consistent with literature values.298 
 
N-((Diphenylphosphoryl)oxy)-4-methylbenzenesulfonamide, 50 
 
To a stirred solution of N-hydroxy-4-methylbenzenesulfonamide (395 mg, 2.11 mmol) in 
CH2Cl2 (9 mL) at 0 °C was added triethylamine (324 μL, 2.32 mmol) followed by 
diphenylphosphinic chloride (690 mg, 2.11 mmol) as a solution in CH2Cl2 (1.4 mL). The 
reaction mixture was allowed to warm to room temperature and stirred for an additional 4 
hours. The reaction mixture was then diluted with H2O (10 mL) and stirred for an additional 
30 minutes during which time a thick white slurry was formed. The solid was collected via 
filtration to afford the title compound as a white solid (590 mg, 72%); m.p. gradual decomp. 
>200 °C; νmax / cm-1 2959, 2931, 2817, 2763, 1593, 1442, 1240, 1220, 1173, 1158, 1093; 
δH (400 MHz, d6-DMSO) 11.2 (1H, d, J 1.9, NH), 7.84-7.72 (6H, m, 6 x ArH), 7.68-7.61 
(2H, m, 2 x ArH), 7.58-7.51 (4H, m, 4 x ArH), 7.47-7.42 (2H, m, 2 x ArH), 2.41 (3H, s, 
CH3); δC (101 MHz, CDCl3) 144.9, 133.1, 132.9, 131.8 (d, 3JCP), 129.7, 129.2 (d, 1JCP), 
128.7 (d, 2JCP 13.0), 128.9, 21.1; δP (162 MHz, CDCl3) 36.9; m/z (ES+) 388 (100%, [MH]+), 
338 (84%); HRMS (ES+/TOF) 388.0764, C19H19NO4SP requires 388.0772. 
 
Diethyl [(phenylthio)methyl]phosphonate, 52 
 
Prepared according to the procedure of Enders,74 a solution of triethyl phosphite (20.5 mL, 
120 mmol) and chloromethyl phenyl sulfide (8.0 mL, 60 mmol) was stirred at reflux for 12 
hours. The reaction was cooled to room temperature. Excess triethyl phosphite was 
removed under reduced pressure (1.3 mbar) through short path distillation apparatus and 
the crude product further purified via fractional distillation at reduced pressure using a 19 
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cm Vigreux column to afford the title compound as a colourless oil (13.8 mg, 88%); b.p. 
178-180 °C at 0.97 mmHg (Lit.74 130-135 °C at 0.08 mmHg); νmax / cm-1 3459, 2980, 2905, 
1582, 1481, 1439, 1392, 1247, 1163, 1049, 1021, 965, 826, 741, 690; δH (400 MHz, 
CDCl3) 7.45-7.41 (2H, m, 2 x ArH), 7.31-7.27 (2H, m, 2 x ArH), 7.26-7.17 (1H, m, ArH), 
4.18-4.08 (4H, m, 2 x CH2CH3), 3.19 (2H, d, J 14.0, CH2SPh), 1.29 (6H, t, J 7.1, 2 x 
CH2CH3); δC (101 MHz, CDCl3) 135.5 (d, 2JCP 5.7), 129.6, 129.0, 126.8, 62.7 (d, 2JCP 6.5), 
28.5 (d, 1JCP 148.5), 16.3 (d, 2JCP 6.0). These data are consistent with literature values.74 
 
Diethyl [(phenylsulfonyl)methyl]phosphonate, 53 
 
Prepared according to the procedure of Enders,74 to a stirred solution of diethyl 
[(phenylthio)methyl]phosphonate (13.8 g, 53 mmol) in a 1:1 mixture of EtOH:EtOAc (70 
mL) at 0 °C was added dropwise a solution of oxone (97.7 g, 159 mmol) in H2O (400 mL). 
The reaction mixture was allowed to warm to room temperature and stirred for a further 4 
hours, then concentrated under reduced pressure and the crude reaction mixture extracted 
into CH2Cl2. The organic layers were combined and concentrated under reduced pressure. 
Purification via flash column chromatography (EtOAc) afforded the title compound as an 
off-white crystalline solid (14.7 g, 95%); m.p. 48-49 °C (Lit.74 51 °C); δH (400 MHz, CDCl3) 
8.02-7.96 (2H, m, 2 x ArH), 7.73-7.63 (1H, m, ArH), 7.62-7.52 (2H, m, 2 x ArH), 4.22-4.09 
(4H, m, 2 x CH2CH3), 3.76 (2H, d, J 16.8, CH2SO2Ph), 1.29 (6H, t, J 7.1, 2 x CH2CH3); δC 
(101 MHz, CDCl3) 140.0, 134.1, 129.1, 128.4, 63.4 (d, J 6.4), 53.8 (d, J 137.5), 16.2 (d, J 
6.4). These data are consistent with literature values.74 
 
(E)-Styryl phenyl sulfone, 54 
 
Prepared according on the procedure of Wnuk,75 to a stirred solution of diethyl 
[(phenylsulfonyl)methyl]phosphonate (292.0 mg, 1.0 mmol) in dry THF (5 mL) at – 78 °C 
was added dropwise a solution of LiHMDS (1.1 mL, 1.0 M in THF) and the reaction was 
stirred for a further 20 minutes at -78 °C. Benzaldehyde (112 μL, 1.1 mmol) and then 
allowed to warm to -40 °C over 2 hours. Glacial acetic acid (0.1 mL) was added and 
volatiles removed under reduced pressure. The crude reaction mixture was dissolved in 
EtO P
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EtOAc, washed with NaHCO3 (sat. aq.) then brine and dried over MgSO4. Further 
purification by flash column chromatography (20:1 nhexane:EtOAc) afforded the title 
compound as a colourless crystalline solid (212 mg, 86%); m.p. 75-76 °C (Lit299 76 °C); δH 
(400 MHz, CDCl3) 8.00-7.92 (2H, m, 2 x ArH), 7.69 (1H, d, J 15.4, PhCH=CH), 7.66-7.59 
(2H, m, 2x ArH), 7.59-7.53 (2H, m, 2 x ArH), 7.44-7.45 (3H, m, 3 x ArH), 6.86 (1H, d, J 
15.5, PhCH=CH); δC (101 MHz, CDCl3) 142.3, 140.6, 133.4, 132.4, 131.2, 129.3, 128.6, 
128.0 127.7, 127.3. These data are consistent with literature values.299 
 
Phenyl ((E)-prop-1-en-1-yl) sulfone, 55 
 
Based on the procedure of Wnuk,75 to a stirred solution of diethyl 
[(phenylsulfonyl)methyl]phosphonate (292.0 mg, 1.0 mmol) in dry THF (5 mL) under argon 
at -78 °C was added dropwise a solution of LiHMDS (1.1 mL, 1.0 M in THF) and the 
reaction was stirred for a further 20 minutes at -78 °C. Acetaldehyde (61.7 μL, 1.1 mmol) 
was added and the reaction mixture allowed to warm to -40 °C over 2 hours. Glacial acetic 
acid (0.1 mL) was added and volatiles removed under reduced pressure. The crude 
reaction mixture was dissolved in EtOAc, washed with NaHCO3 (sat. aq.) then brine and 
dried over MgSO4. Further purification via flash column chromatography (3:1 
nhexane:EtOAc) afforded the title compound as a 4.2:1 mix of the E:Z-isomers (136.5 mg, 
75%); m.p. 59-60 °C; δH (400 MHz, CDCl3) 7.90-7.86 (2H, m, 2 x ArH), 7.61-7.59 (1H, m, 
ArH), 7.56-7.51 (2H, m, 2 x ArH), 6.98 (1H, dq, J 15.0 and 6.9, CH3CH=CH), 6.35 (1H, dq, 
J 15.0 and 1.8, CH3CH=CH), 1.92 (3H, dd, J 7.0 and 1.7, CH3); δC (101 MHz, CDCl3) 
142.5, 140.7, 133.2, 131.8, 129.2, 127.6, 17.3. These data are consistent with literature 
values.300 The following distinct signals were observed for the Z-isomer; δH (400 MHz, 
CDCl3) 7.94-7.91 (2H, m, 2 x ArH), 2.17 (3H, dd, J 6.9 and 1.3, CH3); δC (101 MHz, 
CDCl3) 142.5, 133.3, 113.3, 127.2, 14.1. 
 
 (But-2-en-1-ylsulfonyl)benzene, 56 
 
According to the procedure of Funk,76 to a stirred solution of sodium benzenesulfinate 
(1.642 g, 10.00 mmol) in DMF (50.0 ml) was added (E)-1-bromobut-2-ene (1.029 ml, 10 
mmol). The reaction mixture was stirred at room temperature for 44 hours then quenched 
SO2Ph
SO2Ph
 177 
with H2O  (300 mL), extracted into EtOAc (3x), passed through a hydrophobic frit and 
concentrated under reduced pressure. Further purification via flash column 
chromatography (4:1 nhexane:EtOAc) afforded the title compound as a colourless oil (1.75 
g, E:Z 5:1, 89%); δH (400 MHz, CDCl3) for major E-isomer 7.90-7.83 (2H, m, 2 x ArH), 
7.67-7.62 (1H, m, ArH), 7.58-7.52 (2H, m, 2 x ArH), 5.60-5.52 (1H, m, CH3CH=CH), 5.47-
5.38 (1H, m, CH=CHCH2), 3.73 (2H, m, CH2), 1.68 (3H, d, J 6.5, CH3); δC (101 MHz, 
CDCl3) 138.6, 136.5, 133.8, 128.96, 128.46, 117.0, 60.1, 18.1. The following peaks were 
observed for the minor Z-isomer; δH (400 MHz, CDCl3) 3.86 (2H, m, CH2), 1.31 (3H, d, J 
7.1, CH3); δC (101 MHz, CDCl3) 129.02, 128.52, 116.2, 154.8, 12.7. These data are 
consistent with literature values.301 
 
(E)-(But-1-en-1-ylsulfonyl)benzene, 57 
 
According to the procedure of Funk,76 to a stirred solution of (but-2-en-1-
ylsulfonyl)benzene (440 mg, 2.25 mmol) in THF (11 ml) at -78 °C was added dropwise 
butyllithium (1.6 M in nhexane, 1.58 ml). The reaction mixture was stirred for at -78 °C for 
10 minutes before the dropwise addition of chlorotrimethylsilane (0.855 ml, 6.75 mmol). 
After an additional 30 minutes at -78 °C the reaction mixture was stirred 0 °C for 15 
minutes followed by the addition of H2O (10 mL). CH2Cl2 (15 mL) was added and the 
aqueous layer separated and extracted into CH2Cl2 (3x), the combined organic layers were 
passed through a hydrophobic frit and concentrated under reduced pressure. The crude 
reaction mixture was then used in the next step without further purification. 
The crude reaction mixture was dissolved in toluene (0.9 mL) and trifluoromethanesulfonic 
acid (198 μL, 2.243 mmol) was added dropwise. The reaction mixture was allowed to 
stir at room temperature overnight, cooled to 0 °C and quenched with H2O (10 mL) 
then NaHCO3 (10 mL, sat. aq.). The reaction mixture was extracted into EtOAc (3x), the 
combined organic layers were then passed through a hydrophobic frit and concentrated 
under reduced pressure. Purification via flash column chromatography (20:1 
nhexane:EtOAc) afforded the title compound as a single isomer, clear oil (291.1 mg, 60% 
over two steps); δH (400 MHz, CDCl3) 7.89-7.84 (2H, m, 2 x ArH), 7.63-7.57 (1H, m, ArH), 
7.55-7.49 (2H, m, 2 x ArH), 7.03 (1H, dt, J 15.1 and 6.2, CH2CH=CH), 6.30 (1H, dt, J 15.1 
and 1.7, CH2CH=CH), 2.26 (2H, qdd, J 7.4, 6.1 and 1.7, CH2), 1.05 (3H, t, J 7.4, CH3); δC 
SO2Ph
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(101 MHz, CDCl3) 148.4, 140.7, 133.2, 129.6, 129.2, 127.5, 24.7, 11.6. These data are 
consistent with literature values.302 
 
1-Methyl-4-(vinylsulfonyl)benzene, 58 
 
According to the procedure of Kumar,77 to a stirred solution of 2-(p-tolylsulfonyl)ethanol (1 
g, 5 mmol) in CH2Cl2 (15 mL) at 0 °C was added first triethylamine (1.74 mL, 12.5 mmol) 
then methanesulfonyl chloride (0.46 mL, 6.0 mmol). The reaction mixture was stirred for a 
further 20 minutes and then concentrated under reduced pressure, re-dissolved in CH2Cl2, 
washed twice with NH4.Cl (sat. aq.), dried over Na2SO4 and concentrated under reduced 
pressure. Further purification via flash column chromatography (1:1 nhexane:EtOAc) 
afforded the title compound as a crystalline white solid (700 mg, 77%); m.p. 65-66 °C 
(Lit.303 65-66 °C); δH (400 MHz, CDCl3) 7.78 (2H, d, J 8.2, 2 x ArH), 7.35 (2H, d, J 8.3, 2 x 
ArH), 6.65 (1H, dd, J 16.6 and 9.8, H2C=CH), 6.42 (1H, d, J 16.6, HHC=CH), 6.00 (1H, d, J 
9.8, HHC=CH), 2.44 (3H, s, CH3). These data are consistent with literature values.77 
 
1-Fluoro-4-(vinylsulfonyl)benzene, 59 
 
Based on the procedure of Stirling,78 to a stirred solution of 1-((2-chloroethyl)sulfonyl)-4-
fluorobenzene (1 g, 4.5 mmol) in dry THF (100 mL) was added dropwise triethylamine (0.7 
mL, 5.02 mmol). The reaction mixture was stirred at room temperature for a further 24 
hours after which the reaction mixture was filtered, washed with toluene (2x 10 mL). The 
filtrate was washed with 1M HCl (aq.), NaHCO3 (sat. aq.) then brine and the organic layer 
dried over Na2SO4 and concentrated under reduced pressure. Purification via flash column 
chromatography (4:1 nhexane:EtOAc) afforded the title compound as a clear oil (768 mg, 
93%); νmax / cm-1 3106, 3047, 1590, 1493, 1316, 1291, 1284, 1142, 1086, 976; δH (400 
MHz, CDCl3) 7.94-7.89 (2H, m, 2 x ArH), 7.26-7.20 (2H, m, 2 x ArH), 6.65 (1H, dd, J 16.5 
and 9.7, H2C=CH), 6.46 (1H, d, J 16.5, HHC=CH), 6.05 (1H, d, J 9.7, HHC=CH); δC (101 
MHz, CDCl3) 168.7 (d, 1JCF 256.3), 138.3, 135.6 (d, 4JCF 3.2), 130.7 (d, 3JCF 9.6), 127.9, 
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116.6 (d, 2JCF 22.6); δF (376.5 MHz, CDCl3) -100.5; m/z (CI+) 204 (100%, [M+NH4]+); 
HRMS (CI+) found 204.0502, C8H11NO2FS requires 204.0495. 
 
 (Ethylsulfonyl)ethene, 60 
 
To a stirred solution of mCPBA (380 mg, 2.2 mmol) in CH2Cl2 (20 mL) at 0 °C was added 
dropwise ethylvinyl sulfone (100 μL, 1.0 mmol). The reaction mixture was warmed to room 
temperature and allowed to stir overnight. The reaction mixture was then diluted with 
CH2Cl2 (20 mL), washed with NaHCO3 (sat. aq.), dried over Na2SO4 and concentrated 
under reduced pressure. Further purification via flash column chromatography (1:1 
nhexane:EtOAc) afforded the title compound as a clear oil (131 mg, 98%); νmax / cm-1 
3061, 2922, 2852, 1457, 1385, 1305, 1276, 1126, 978. δH (400 MHz, CDCl3) 6.62 (1H, dd, 
J 16.6 and 9.8, H2C=CH), 6.46 (1H, d, J 16.6, HHC=CH), 6.19 (1H, d, J 9.8, HHC=CH), 
3.01 (2H, q, J 7.4, CH2), 1.35 (3H, t, J 7.5, CH3); δC (101 MHz, CDCl3) 135.4, 130.8, 48.5, 
7.0. m/z (CI+) 138 (100%, [M+NH4]+); HRMS (CI+) found 138.0584, C4H12NO2S requires 
138.0589. 
 
General Procedure B: N-Boc-Aziridination of Vinyl Sulfones: 
 
To a stirred solution of the vinyl sulfone (0.2 mmol) in THF (2 mL) was added the N-Boc-O-
(diphenylphosphinyl) hydroxylamine (133 mg, 0.4 mmol) and Cs2CO3 (195 mg, 0.6 mmol). 
The reaction mixture was allowed to stir for 4 hours at room temperature before quenching 
with NH4.HCl (sat. aq., 1 mL), extracted into CH2Cl2, dried over Na2SO4 and then 
concentrated under reduced pressure to afford the crude product mixture which was 
further purified via flash column chromatography. 
 
(±)tert-Butyl 2- (phenylsulfonyl)aziridine-1- carboxylate, 38 
 
According to general procedure B, using phenyl vinyl sulfone (0.2 mmol). Purification via 
flash column chromatography (9:1 nhexane:EtOAc) afforded the title compound as a white 
crystalline solid (36 mg, 64%); m.p. 119-121 °C; νmax / cm-1 3096, 3003, 2981, 2935, 1729, 
1369, 1323, 1280, 1145, 1021, 845; δH (400 MHz, CDCl3) 8.00-7.95 (2H, m, 2 x ArH), 
SO2Et
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7.72-7.65 (1H, m, ArH), 7.61-7.55 (2H, m, 2 x ArH), 3.70 (1H, dd, J 5.7 and 3.0, 
CHSO2Ph), 2.87 (1H, d, J 2.9, CHHCHSO2Ph), 2.66 (1H, d, J 5.8, CHHCHSO2Ph), 1.25 
(9H, s, C(CH3)3); δC (101 MHz, CDCl3) 158.5, 137.5, 134.1, 129.1, 128.8, 82.9, 51.0, 30.0, 
27.5; m/z (ES+) 347 (100%, [M+MeCN+Na]+), 266 (47%, [MH-C4H9]+); HRMS (ES+/TOF) 
found 347.1049, for C15H20N2O3NaS requires 347.1041. 
 
tert-Butyl ((diphenylphosphoryl)oxy)(2-(phenylsulfonyl)ethyl)carbamate, 39 
 
Also, isolated from the crude product mixture of the reaction of phenyl vinyl sulfone and 
DppONHBoc affording tert-butyl 2-(phenylsulfonyl)aziridine-1-carboxylate (described 
above) was tert-butyl ((diphenylphosphoryl)oxy)(2-(phenylsulfonyl)ethyl)carbamate. The 
side product was unstable on SiO2, but could be isolated with a significant loss of material 
using preparative HPLC; Sunfire C18 column (150mm x 30mm i.d. 5µm packing 
diameter), gradient 50:50 to 99:1 of 0.1% v/v solution of formic acid in H2O: 0.1% v/v 
solution of formic acid in acetonitrile, flow rate 40 mLmin-1, retention time 13.5 min.  
 
When the reaction was carried out on a 0.5 mmol scale, the title compound was isolated 
via preparative HPLC as a white foam (45 mg, 18%); νmax / cm-1 3062, 2983, 2936, 1748, 
1717, 1441, 1307, 1289, 1233, 1148, 1131; δH (400 MHz, CDCl3) 7.92-7.90 (2H, m, 2 x 
ArH), 7.87-7.82 (4H, m, 4 x ArH), 7.64 (1H, m ArH), 7.57-7.51 (4H, m, 4 x ArH), 7.47-7.41 
(4H, m, 4 x ArH), 4.07 (2H, t, J 7.4, alkyl CH2), 3.59 (2H, t, J 7.4, alkyl CH2), 1.27 (9H, s, 
C(CH3)3); δC (101 MHz, CDCl3) 155.7 (d, 3JCP 3.1), 139.1, 134.0, 133.0 (d, 4JCP 2.8), 132.6 
(d, 3JCP 10.3), 129.4, 128.6 (d, 1JCP 134.5), 128.5 (d, 2JCP 13.4), 128.1, 83.9, 52.4, 48.2, 
27.8; m/z (ES+) 524 (45%, [MNa]+), 502 (100%, [MH]+), 446 (30%, [MH-C4H9]+); HRMS 
(ES+/TOF) found 502.1450, C25H29NO6SP requires 502.1453. 
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(±)tert-Butyl-2-(ethylsulfonyl)aziridine-1-carboxylate, 62 
 
According to the general procedure B, using ethyl vinyl sulfone (0.15 mmol). Purification 
via flash column chromatography (1:1 nhexane:EtOAc) afforded the title compound as a 
clear oil (8.3 mg, 24%); νmax / cm-1 2980, 2937, 2886, 1729, 1370, 1320, 1280, 1258, 
1139, 1115; δH (400 MHz, CDCl3) 3.74 (1H, dd, J 5.9 and 2.9, HHCCH), 3.34-3.12 (2H, m, 
CH2), 2.87 (1H, d, J 2.9, HHCCH), 2.67 (1H, d, J 5.9, HHCCH), 1.53 (3H, t, J 7.5, CH3), 
1.50 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 158.7, 83.6, 47.5, 46.7, 21.0, 27.8, 6.5; m/z 
(CI+) 253 (33%, [M+NH4]+), 197 (47%, [M+NH4-C4H9]+), 153 (65%, [M+NH4-CO2tBu]+], 136 
(100%, [M-CO2tBu]+); HRMS (CI+) found 253.1223, C9H21N2O4S requires 253.1222. 
 
(±)tert-Butyl 2-tosylaziridine-1-carboxylate, 63 
 
According to general procedure B, using 1-methyl-4-(vinylsulfonyl)benzene (0.15 mmol). 
Purification via flash column chromatography (4:1 nhexane:EtOAc) afforded the title 
compound as a clear oil (21.9 mg, 49%); νmax / cm-1 2980, 2943, 2852, 1734, 1326, 1285, 
1152, 1086; δH (400 MHz, CDCl3) 7.87-7.82 (2H, m, 2 x ArH), 7.39-7.35 (2H, m, 2 x ArH), 
3.68 (1H, dd, J 5.8 and 2.9 HHCCH), 2.85 (1H, d, J 2.9, HHCCH), 2.64 (1H, d, J 5.8, 
HHCCH), 2.45 (3H, s, CH3), 1.28 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 158.6, 145.2, 
134.5, 129.7, 128.8, 82.9, 51.1, 30.1, 27.6, 21.7; m/z (ES+) 361 (100%, [M+MeCN+Na]+), 
336 (27%, [M+K]+), 315 (47%, [M+NH4]+), 239 (54%, [MH-C4H9]+); HRMS (ES+/TOF) 
found 361.1197, C16H22N2O4Na requires 361.1198. 
 
(±)tert-Butyl 2-((4-fluorophenyl)sulfonyl)aziridine-1-carboxylate, 64 
 
According to general procedure B, using 1-fluoro-4-(vinylsulfonyl)benzene (0.15 mmol), 
Purification via flash column chromatography (4:1 nhexane:EtOAc) afforded the title 
compound as a clear oil (27.1 mg, 46%); νmax / cm-1 3107, 2981, 2929, 1733, 1592, 1493, 
1330, 1291, 1152, 1086; δH (400 MHz, CDCl3) 8.03-7.92 (2H, m, 2 x ArH), 7.30-7.21 (2H, 
m, 2 x ArH), 3.69 (1H, dd, J 5.7 and 2.9, HHCCH), 2.88 (1H, d, J 2.9, HHCCH), 2.68 (1H, 
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d, J 5.8, HHCCH), 1.28 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 166.2 (d, 1JCF 256.9), 
158.5, 133.5 (d, 4JCF 3.3), 131.8 (d, 3JCF 9.7), 116.5 (d, 2JCF 22.7), 83.1 and 51.1, 30.3, 
27.6; δF (376.5 MHz, CDCl3) -102.7; m/z (CI+) 319 (40%, [M+NH4]+), 263 (40%, [M+NH4-
C4H9]+), 219 (98%, [M+NH4-CO2tBu]+), 202 (100%, [M-CO2tBu]+); HRMS (CI+) found 
319.1132, C13H20N2O4SF requires 319.1128. 
 
tert-Butyl hydroxy(2-(phenylsulfonyl)ethyl)carbamate, 40 
 
To a stirred solution of tert-butyl ((diphenylphosphoryl)oxy)(2-
(fluorosulfonyl)ethyl)carbamate (15 mg, 0.030 mmol) in THF (0.5 mL) at room temperature 
was added sodium hydroxide (2.392 mg, 0.060 mmol). The reaction mixture was stirred at 
room temperature for 20 minutes then quenched with NH4.Cl (sat. aq., 0.5 mL). The 
reaction mixture was extracted into CH2Cl2 (3x), passed through a hydrophobic frit and 
concentrated under reduced pressure to afford the title compound as a clear oil (8 mg, 
94%); νmax / cm-1 3360, 3244, 2979, 2930, 1694, 1448, 1368, 1308, 1288, 1149, 1086; δH 
(400 MHz, CDCl3) 7.96-7.89 (2H, m, 2 x ArH), 7.74-7.65 (1H, m, ArH), 7.61-7.55 (2H, m, 2 
x ArH), 3.88 (2H, t, J 7.6, alkyl CH2), 3.42 (2H, t, J 7.6, alkyl CH2), 1.46 (9H, s, C(CH3)3); 
δC (101 MHz, CDCl3) 156.1, 138.9, 134.0, 129.4, 128.0, 82.8, 53.1, 44.4, 28.2; m/z (ES+) 
365 (97%, [M+MeCN+Na]+), 243 (100%); HRMS (ES+/TOF) found 365.1141, 
C15H22N2O5Na requires 365.1142. 
 
2-Chloroethane-1-sulfonyl fluoride, 66 
 
According to the procedure of Sharpless,80 to a stirred solution of KHF2 (890 mg, 11.4 
mmol) in H2O (2.3 mL) at 0 °C was added in one portion 2-chloroethan-1-sulfonyl chloride 
(810 mg, 5.0 mmol). The reaction mixture was stirred at room temperature for 3 hours, 
then diluted with CH2Cl2 (5 mL) and the aqueous layer was separated and extracted into 
CH2Cl2 (3x). The combined organic layers were dried over Na2SO4 and concentrated 
under reduced pressure to afford the title compound as a pale yellow oil (721 mg, 99%); δH 
(400 MHz, CDCl3) 3.96-3.88 (2H, m, ClCH2CH2), 3.87-3.78 (2H, m, ClCH2CH2); δC (101 
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MHz, CDCl3) 52.6 (d, 2JCF 17.6), 35.0); δF (376.5 MHz, CDCl3) +57.2. These data are 
consistent with literature values.80 
 
Ethenesulfonyl fluoride (ESF), 65 
 
According to the procedure of Sharpless,80 to a stirred solution of 2-chloroethane-1-
sulfonyl fluoride (387 mg, 2.65 mmol), in H2O (0.7 mL) was added in portions magnesium 
oxide (59 mg, 1.45 mmol). The reaction mixture was stirred at room temperature for 2.5 
hours, then diluted with CH2Cl2 (5 mL). The aqueous layer was separated and extracted 
into CH2Cl2, the combined organic layer was then dried over Na2SO4 and concentrated 
under reduced pressure (N.B. Care should be taken as the product is a volatile, highly 
toxic lachrymator.) to afford the title compound as a clear oil (184 mg, 64%); νmax / cm-1 
3124, 3083, 1404, 1388, 1197, 991, 952; δH (400 MHz, CDCl3) 6.77-6.63 (2H, m, 
H2C=CH), 6.39 (1H, dd, J 8.3 and 5.2, H2C=CH); δC (101 MHz, CDCl3) 134.2 (d, 3JCF 2.6), 
130.2 (d, 2JCF 28.3); δF (376.5 MHz, CDCl3) +57.9; m/z (CI+) 128 (80%, [M+NH4]+), 99 
(100%, [M+NH4-C4H9]+); HRMS (CI+) found 128.0176, C2H7NO2SF requires 128.0182. 
 
tert-Butyl ((diphenylphosphoryl)oxy)(2-(fluorosulfonyl)ethyl)carbamate, 69 
 
To a stirred solution of tert-butyl (bis(aryl)phosphoryl)oxycarbamates (166 mg, 0.4 mmol) 
and triethylamine (56 μL, 0.4 mmol) in DMF was added ethenesulfonyl fluoride (16.6 μL, 
0.2 mmol). The reaction mixture was stirred for 10 minutes, diluted with EtOAc (5 mL) and 
washed with H2O (10 x 1 mL), dried over Na2SO4 and concentrated under reduced 
pressure. Purification via flash column chromatography (2:1 nhexane:EtOAc) afforded the 
title compound as a white foam (87 mg, 98%); νmax / cm-1 3477, 3063, 2984, 2935, 1751, 
1723, 1440, 1409, 1370, 1232, 1207, 1150, 1130, 1073; δH (400 MHz, CDCl3) 7.99-7.86 
(4H, m, 4 x ArH), 7.64-7.55 (2H, m, 2 x ArH), 7.52-7.47 (4H, m, 4 x ArH), 433-4.23 (2H, m, 
NCH2CH2), 4.00-3.90 (2H, m, NCH2CH2), 1.31 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 
155.1 (d, 3JCP 3.3), 133.0 (d, 4JCP 2.7), 132.5 (d, 3JCP 10.3), 128.4 (d, 2JCP 13.5), 128.1 (d, 
1JCP 134,3), 84.4, 48.3, 47.5 (d, 2JCF 17.2), 27.6; δF (376.5 MHz, CDCl3) 56.3; δP (162 
MHz, CDCl3) 40.5. No molecular ion could be observed under the ionisation conditions 
tested, however CI+ showed a peak at 220 which agrees with [Ph2P(O)+NH4]+. 
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(±)tert-Butyl 2-(fluorosulfonyl)aziridine-1-carboxylate, 67 
 
To a stirred solution of tert-butyl ((diphenylphosphoryl)oxy)(2-
(fluorosulfonyl)ethyl)carbamate (87 mg, 0.2 mmol) in DMF (0.5 mL) at 0 °C was added 
sodium hydride (60% dispersion in mineral oil, 5.4 mg, 0.136 mmol). The reaction mixture 
was stirred at 0 °C for 30 minutes then the reaction was quenched with H2O (5 mL), 
extracted into EtOAc and dried over Na2SO4. Further purification via flash column 
chromatography (9:1 to 4:1 nhexane:EtOAc) afforded the title compound as a white foam 
(8.5 mg, 19%); νmax / cm-1 2992, 2976, 2934, 1740, 1418, 1372, 1292, 1260, 1206, 1153; 
δH (400 MHz, CDCl3) 4.07-4.04 (1H, m, HC2CH), 2.83 (1H, dd, J 2.9 and 1.2 HHC=CH), 
2.77 (1H, dd, J 5.6 and 1.2, HHC=CH), 1.49 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 157.3, 
84.5, 47.0 (d, 2JCF 33.4), 30.8, 27.7; m/z (ES+) 226 (36%, [MH]+), 208 (100%, [MH-19F]+); 
δF (376.5 MHz, CDCl3) 53.2; HRMS (ES+/TOF) found 226.0540, C7H13NO4FS requires 
226.0549. 
 
Also isolated was: 
Diphenylphosphinic fluoride, 68 
 
νmax / cm-1 3065, 2979, 2932, 1720, 1593, 1441, 1256, 1137, 833; δH (400 MHz, CDCl3) 
7.86-7.80 (4H, m, 4 x ArH), 7.63-7.60 (2H, m, 2 x ArH), 7.54-7.49 (4H, 4 x ArH); δC (101 
MHz, CDCl3) 133.4 (d, 4JCP 2.9), 131.4 (d, 3JCP 11.1), 128.8 (d, 2JCP 14.1), 128.7 (d, 1JCP 
141.4); δF (376.5 MHz, CDCl3) -75.2 (d, 1JFP 1017.1); δP (162 MHz, CDCl3) -75.2 (d, 1JFP 
1022.0); m/z (CI+) 238 (9%, [M+NH4]+), 221 (10%, [MH]+), 168 (100%); HRMS found 
221.0527, C12H11POF requires 221.0532. 
 
tert-Butyl 1,2,5-oxathiazolidine-5-carboxylate 2,2-dioxide, 70 
 
m.p. 78-79 °C; νmax / cm-1 3036, 3006, 2982, 2939, 1728, 1373, 1363, 1321, 1244, 1170; 
δH (400 MHz, CDCl3) 4.53-4.45 (2H, m, CH2N), 3.46-3.40 (2H, m, CH2S), 1.53 (9H, s, 
N
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C(CH3)3); δC (101 MHz, CDCl3)  155.9, 85.1, 48.7, 44.4, 27.9; m/z (CI+) 241 (87%, 
[M+NH4]+), 185 (100%); HRMS (CI+) 241.0851, C7H17N2O5S requires 241.0858. 
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5.2.2 Experimental Details for Chapter 3: O-(Diphenylphosphinyl) Hydroxylamine 
(DppONH2) as a Nitrogen Source in the Vicarious Nucleophilic  Amination 
(VNA) of Electron-Deficient Aromatics 
 
4-Amino-4-methylmorpholinium Iodide, 16a 
 
According to the procedure of Armstrong,57 to a solution of N-aminomorpholine (1.44 mL, 
15 mmol) in THF (10 mL) at 0 °C was added MeI (0.98 mL, 15.7 mmol) dropwise over 5 
min. The reaction mixture was warmed to room temperature and allow to stir for an 
additional for 30 min. Et2O (20 mL) was added and the white solid was isolated by filtration 
and subsequently washed with Et2O (4 × 10 mL) affording the title compound as a white 
powder which was recrystallised from hot EtOH:MeOH (3:1) to give clear plates (2.56 g, 
70%); m.p. 181-183°C (softening at 176°C); δH (400 MHz, d6-DMSO) 5.95 (2H, s, NH2), 
4.01-3.95 (2H, m, HHCOCHH), 3.86 (2H, dt, J 13.5 and 3.5, HHCOCHH), 3.61-3.55 (2H, 
m, HHCNCHH), 3.40 (2H, br d, J 12.5 HHCNCHH), 3.33 (3H, s, NCH3); δC (101 MHz, d6-
DMSO); 62.6, 60.4, 56.6. These data are consistent with literature values.57 
 
General Procedure C: Amination of Electron-Deficient Aromatics using 4-Amino-4-
methylmorpholinium Iodide 
 
To a stirred solution of 4-amino-4-methylmorpholinium iodide (40 mg, 0.165 mmol) in 
DMSO (0.8 mL) was added substrate (0.15 mmol), followed by NaOH (14 mg, 0.36 mmol). 
The reaction mixture was allowed to stir at room temperature for an additional 20 hours, 
after which the reaction was quenched with NH4.Cl (sat. aq., 10 mL). The acidified solution 
was stirred at room temperature for 30 minutes and extracted with EtOAc (3x). The 
combined organic layers were washed with H2O, dried over MgSO4, filtered and 
concentrated under reduced pressure. Further purification was achieved via flash column 
chromatography. 
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Nitroaniline, 92 
 
According to general procedure C, using nitrobenzene (1.5 mmol). Purification by flash 
column chromatography (4:1 to 2:1 nhexane:EtOAc) afforded the title compound as two 
separate isomers;  
 
2-nitroaniline as an orange crystalline solid (40 mg, 19%); m.p. 68-69 °C (Lit.304 67-69 °C); 
δH (400 MHz, CDCl3) 8.11 (1H, dd, J 8.6 and 1.5, ArH), 7.35 (1H, ddd, J 8.4, 7.0 and 1.5, 
ArH), 6.81 (1H, dd, J 8.5 and 1.2, ArH), 6.70 (1H, ddd, J 8.5, 7.1 and 1.4, ArH), 6.07 (2H br 
s, NH2). These data are consistent with literature values.153 
 
4-nitroaniline as an orange solid (112 mg, 54%) m.p. 146-148 °C (Lit.304 147-148 °C); δH 
(400 MHz, CDCl3) 8.07 (2H, d, J 9.1, 2 x ArH), 6.62 (2H, d, J 9.1, 2 x ArH), 4.40 (2H, br s, 
NH2). These data are consistent with literature values.153 
 
2,4-Dinitroaniline, 93 
 
According to general procedure C, using 1,3-dinitrobenzne (0.15 mmol). Purification by 
flash column chromatography (1:1 nhexane:EtOAc) afforded the title compound as a yellow 
solid (21.5 mg, 79%); m.p. 169-177 °C (Lit.305 177 °C); δH (400 MHz, d6-acetone); 8.94 (1 
H, d, J 2.7, ArH), 8.21 (1 H, dd, J 9.4 and 2.7, ArH), 7.85-8.05 (2 H, br s, NH2), 7.25 (1 H, 
d, J 9.4, ArH). These data are consistent with literature values.153 
 
2-Amino-1-nitronaphthalene, 94 
 
According to general procedure C, using 1-nitronaphthalene (0.15 mmol). Purification by 
flash column chromatography (4:1 to 2:1 nhexane:EtOAc) afforded the title compound as a 
yellow crystalline solid (24.5 mg, 88%); m.p. 124-126 °C (Lit.306 125-129 °C); δH (400 MHz, 
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d6-acetone) 8.57 (1 H, dd, J 8.7 and 0.8 ArH), 7.85 (1H, d, J 9.1, ArH), 7.77 (1H, dd, J 8.0 
and 1.4, ArH), 7.59 (1H, ddd, J 8.7, 7.1 and 1.5, ArH), 7.42 (2H, br s, NH2), 7.34 (1H, ddd, 
J 8.0, 7.0 and 1.0, ArH), 7.22 (1H, d, J 9.1, ArH). These data are consistent with literature 
values.306 
 
2-Aminobenzoxazole, 95 
 
According to general procedure C, using benzoxazole (0.15 mmol). Purification via flash 
column chromatography (1:1 nhexane:EtOAc) afforded the title compound as an off-white 
solid (8.5 mg, 41%); m.p. 129-131 °C (Lit.307 129 °C); δH (400 MHz, CDCl3) 7.36-7.33 (1H, 
m, ArH), 7.29-7.26 (1H, m, ArH), 7.18 (1H, td, J 7.7 and 1.2, ArH), 7.07 (1H, td, J 7.7 and 
1.2, ArH), 5.59 (2H, br s, NH2). These data are consistent with literature values.308 
 
2-Aminobenzothiazole, 96 
 
According to general procedure C, using benzothiazole (0.15 mmol). Purification via flash 
column chromatography (1:1 nhexane:EtOAc) afforded the title compound as an off-white 
solid (4.5 mg, 20%); m.p. 130-131 °C (Lit.309 129-130 °C); δH (400 MHz, CDCl3) 7.60 (1H, 
dd, J 8.1 and 1.2, ArH), 7.57-7.53 (1H, m, ArH), 7.32 (1H, ddd, J 8.1, 7.3 and 1.3, ArH), 
7.13 (1H, dt, J 7.6 and 1.2, ArH), 5.36 (2H, br s, NH2). These data are consistent with 
literature values.310 
 
2-Amino-6-nitrobenzothiazole, 97 
 
According to general procedure C, using 6-ntirobenzothiazole (0.15 mmol). Purification via 
flash column chromatography (1:1 nhexane:EtOAc) afforded the title compound as a yellow 
solid (9 mg, 31%); m.p. 247-248 °C (Lit.311 249 °C); δH (400 MHz, d6-DMSO) 8.53 (1 H, d, 
J 2.4, ArH), 8.23 (1 H, dd, J 8.9, 2.4, ArH), 7.57 (1 H, d, J 8.9, ArH), 5.58 (2 H, s, NH2). 
These data are consistent with literature values.312 
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1,2-Bis(phenylsulfinyl)ethane, 98 
 
According to the procedure of White,167 to a stirred solution of 1,2-bis(phenylthio)ethane 
(1.25 g, 5.08 mmol) in glacial acetic acid (7.5 mL) was added dropwise a solution of 
hydrogen peroxide (30 wt.%, 10.1 mmol, 0.58 mL) in acetic acid (2.1 mL) and the reaction 
mixture allowed to stir overnight. The acetic acid was removed under reduced pressure 
and the white solid obtained was washed with cold EtOH (3 x 40 mL). The product was 
dried overnight under reduce pressure to afford the title compound as a white solid (1.01 g, 
72%, 5:1 meso:rac); m.p. 116-120 °C; δH (400 MHz, CDCl3); 7.56-7.53 (10H, m, 10 x ArH 
meso), 7.50 (10H, m, 10 x ArH rac), 3.46-3.33 (2H, m, alkyl CH2 rac), 3.08-3.02 (4H, m, 2x 
alkyl CH2 meso), 2.81-2.68 (2H, m, alkyl CH2 rac). δC (101 MHz, CDCl3) 142.4, 142.2, 
131.4, 131.3, 129.5, 123.93, 123.86, 47.72, 46.94. These data are consistent with 
literature values.167 
 
O-(Diphenylphosphinyl) hydroxylamine, 20 
 
According to the procedure of Nantz,313 to a stirred solution of hydroxylamine 
hydrochloride (6.46 g, 93 mmol) in H2O (20 mL) at -20 °C was added a solution of sodium 
hydroxide (3.58 g, ) in H2O (20 mL). Et2O (130 mL) was added and the biphasic mixture 
was cooled to -15 °C. Diphenylphosphinic chloride (10 g, 42 mmol) was added rapidly via 
a syringe and the reaction mixture was stirred vigorously for a further 10 minutes. The 
reaction mixture was then warmed to 0 °C and stirred for an additional 15 minutes. The 
resulting slurry was filtered and washed with cold H2O and then cold Et2O. The solid was 
dried under reduced pressure to afford the title compound as a white solid. The solid was 
then slurried in a 0.25 M solution of NaOH (120 mL) at 0 °C for 30 minutes, filtered and the 
solid washed with cold H2O. The solid was then again dried under reduced pressure 
affording the title compound as a white solid (5.92 g, 60%); m.p. > 130 °C (gradual 
decomp.); δH (400 MHz, CDCl3) 7.88-7.82 (4H, m, 4 x ArH), 7.58-7.53 (2H, m, 2 x ArH), 
7.50-7.45 (4H, m, 4 x ArH), 5.93 (2H, br s, NH2); δP (162 MHz, CDCl3) 37.5. These data 
are consistent with literature values.313 
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General Procedure D: Amination of Electron-Deficient Aromatics with In Situ 4-
Amino-4-methylmorpholinium Formation 
 
To a stirred solution of O-(diphenylphosphinyl) hydroxylamine (96 mg, 0.39 mmol) in 
CH2Cl2 (2 mL) was added dropwise N-methylmorpholine (43 µL, 0.39 mmol). The solution 
was stirred for 30 minutes at room temperature, after which substrate (0.36 mmol) and 
NaOH (47 mg, 1.17 mmol) were added. The reaction mixture was stirred for a further 24 
hours at room temperature, after which the reaction was quenched with NH4.Cl (sat. aq., 2 
mL). The acidified mixture was stirred at room temperature for 30 minutes, extracted into 
EtOAc, washed with H2O, dried over MgSO4 and concentrated under reduced pressure. 
Further purification was achieved via flash column chromatography. 
 
Nitroaniline, 92 
 
According to general procedure D, using nitrobenzene (0.36 mmol) and using anhydrous 
DMSO in place of CH2Cl2 and quenched 18 hours after the NaOH was added. Purification 
via flash column chromatography (4:1 to 2:1 nhexane:EtOAc) afforded the title compound 
as two separate isomers; 2-nitroaniline as an orange crystalline solid (1 mg, 1%) and 4-
nitroaniline as an orange solid (8.5 mg, 17%). All data was in agreement with that reported 
above. 
 
2,4-Dinitroaniline, 93 
 
According to general procedure D, using 1,3-dinitrobenzene (0.36 mmol) and using 
anhydrous DMSO in place of CH2Cl2 and quenched 18 hours after the NaOH was added. 
Purification by flash column chromatography (1:1 nhexane:EtOAc) afforded the title 
compound as a yellow solid (14.0 mg, 21%). All data was in agreement with that reported 
above. 
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Amino-1-nitroaniline, 94 
 
According to general procedure D, using1-nitronaphthalene (0.36 mmol). Purification by 
flash column chromatography (4:1 to 2:1 nhexane:EtOAc) afforded the title compound as 
two separate isomers; 
 
 2-Amino-1-nitronaphthalene as a yellow crystalline solid (42 mg, 62%); all data was in 
agreement with that reported above. 
 
4-Amino-1-nitronaphthalene as yellow solid (4 mg, 6%); m.p. 190-193 °C (Lit.306 190-191 
°C); δH (400 MHz, d6-acetone); 8.96-8.93 (1H, m, ArH), 8.38 (1H, d, J 8.8, ArH), 8.28 (1H, 
dt, J 8.6 and 0.6, ArH), 7.75 (1H, ddd, J 8.8, 6.8 and 1.3, ArH), 7.57 (1H, ddd, J 8.4, 7.0 
and 1.3, ArH), 6.82 (1H, d, J 8.8, ArH and 2H, br s, NH2). These data are consistent with 
literature values.306 
 
2-Amino-3-nitropyridine, 99 
 
According to the procedure D, using 3-nitropyridine (0.36 mmol). Purification by flash 
column chromatography (1:1 nhexane:EtOAc) afforded the title compound as an orange 
solid (7 mg, 14%); m.p. 186-190 °C (Lit.314 188 °C); δH (400 MHz, DMSO); 8.84 (1H, d, 
2.7, ArH), 8.11 (1H, dd, J 9.3 and 2.8, ArH), 7.54 (2H, br s, NH2), 6.49 (1H, d, J 9.3, ArH). 
These data are consistent with literature values.145 
 
Also isolated was: 
5,5’-Dinitrobis(2-pyridyl)amine, 101 
 
Yellow solid (33 mg, 35%); m.p. 230-231 °C (Lit.315 223-226 °C); δH (400 MHz, DMSO) 
11.46 (1H, br s, NH), 9.19 (2H, dd, J 2.8 and 0.5, 2 x ArH), 8.57 (2H, dd, J 9.3 and 2.8, 2 x 
ArH), 7.99 (2H, dd, J 9.3 and 0.4, 2 x ArH); δC (100 MHz, DMSO) 156.8, 150.0, 138.6, 
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133.7, 112.3; m/z (electrospray) 262 (MH+, 100%). These data are consistent with 
literature values.316 
 
2-Amino-3-nitrothiophene, 100 
 
According to general procedure D, using 2-nitrothiophene (0.4 mmol). Purification by flash 
column chromatography (4:1 chexane:EtOAc) afforded the title compound as an orange 
solid (10 mg, 17%); m.p. 157-159 °C (lit.149 159-160 °C); δH (400 MHz, CDCl3) 7.32 (1H, d, 
J 5.9, SCH), 6.54 (1H, d, J 5.9, SCHCH), 6.33 (2H, br s, NH2). These data are consistent 
with literature values.149 
 
2-Aminobenzoxazole, 95 
 
According to general procedure D, using benzoxazole (0.36 mmol). Purification by flash 
column chromatography (1:1 nhexane:EtOAc) afforded the title compound as an off-white 
solid (15 mg, 31%). All data was in agreement with that reported above. 
 
2-Amino-6-nitrobenzothiazole, 97 
 
According to general procedure D, using 6-nitrobenzothiazole (0.36 mmol). Purification by 
flash column chromatography (1:1 nhexane:EtOAc) afforded the title compound as a 
yellow solid (3.5 mg, 5%). All data was in agreement with that reported above. 
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5.2.3 Experimental Details for Chapter 4: [2,3]-Sigmatropic Rearrangement of 
Allylic Selenimides: The Synthesis of Enantioenriched Vinyl Glycine Peptides 
and Peptidomimetics 
 
(S)-tert-Butyl 4-phenylselanyl-hex-2-(E)-enoate, 162 
 
To a solution of butyraldehyde (576 μL, 6.4 mmol) in toluene (4.8 mL) at 0 °C was added 
(S)-2-[bis-(3,5-bistrifluoromethyl-phenyl)-trimethylsilanyloxy-methyl]-pyrrolidine (384 mg, 
0.64 mmol) and p-nitrobenzoic acid (106 mg. 0.64 mmol). The reaction mixture was stirred 
for 10 minutes after which N-(phenylselenyl)phthalimide (96%, 2.42 g, 7.68 mmol) added 
and stirred at 0 °C for an additional 20 hours. The reaction mixture was diluted with THF 
(32 mL) and cooled to -40 °C. To the reaction mixture was added a solution (tert-
butoxycarbonylmethylene)triphenylphosphorane (3.13 g, 8.32 mmol) in THF (32 mL) at -40 
°C via cannula. The reaction was stirred at -40 °C for an additional 2 hours before slowly 
warming to 0 °C and stirring for an additional 20 hours. NH4Cl (sat. aq., 8 mL) was added 
and the reaction extracted into Et2O, washed with brine, dried over MgSO4 and 
concentrated under reduced pressure. Crude NMR indicated a >99:1 E:Z ratio. Purification 
via flash column chromatography (20:1 nhexane:Et2O) afforded the title compound as the 
pure E-isomer as a colourless oil (1.39 g, 67%); [α]D19 -128.7 (c = 0.886, CHCl3); νmax / cm-
1 3072, 2972, 2931, 2873, 1702, 1641, 1579, 1476, 1140; δH (400 MHz, CDCl3) 7.50-7.40 
(2H, m, 2 x ArH), 7.32-7.25 (3H, s, 3 x ArH), 6.77 (1H, dd, J 15.4 and 9.6, CH=CHCO2tBu), 
5.25 (1H, dd, J 15.5 and 0.9, CH=CHCO2tBu), 3.62 (1H, dddd, J 9.5, 7.6, 6.4 and 0.9, 
CHSePh), 1.86-1.66 (2H, m, CH2), 1.44 (9H, s, C(CH3)3), 1.01 (3H, t, J 7.4, CH3); δC (101 
MHz, CDCl3) 165.7, 146.5, 136.5, 129.0, 128.4, 128.2, 121.9, 80.3, 47.8, 28.3, 27.1, 13.0; 
m/z (CI+) 344 (80%, [M+NH4]+), 327 (20% [MH]+), 288 (100%, [M+NH4-C4H9]+), 270 (5%, 
[M-(C4H9)]+); HRMS (CI+) found 344.1134, C16H26NO2Se80 requires 344.1134; 
enantiomeric ratio was determined as 98:2 using HPLC; Chiralcel OD-H column, 100% 
hexane, flow 1.0 mLmin-1, UV detection at 236 nm, 14.9 min (minor), 16.7 min (major). 
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(S)-Ethyl 4-phenylselanylbut-2-(E)-enoate, 163 
 
To a stirred solution of propanal (200 μL, 2.79 mmol) in toluene (1.5 mL) at 0 °C was 
added (S)-2-[bis-(3-5-bistrifluoromethyl-phenyl)-trimethyl-silanyloxy-methyl]-pyrrolidine (87 
μL, 0.279 mmol) and 4-nitrobenzoic acid (46.5 mg, 0.279 mmol). The reaction mixture was 
stirred for 10 minutes after which N-(phenylselenyl)phthalimide (1.01 g, 3.24 mmol) was 
added and stirred at 0 °C for an additional 17 hours. The reaction was diluted with THF (11 
mL) and the temperature lowered to -40 °C. To the reaction mixture was added a solution 
of (carbethoxymethylene)triphenylphosphorane (1.26 g, 3.62 mmol) in THF (11 mL) at -40 
°C via cannula. The reaction was stirred at -40 °C for 2 hours before slowly warming to 0 
°C and stirring for an additional 20 hours. NH4Cl (sat., aq., 5 mL) was added and the 
reaction was extracted into Et2O, washed with brine, dried over MgSO4 and concentrated 
under reduced pressure. Purification via flash column chromatography (40:1 to 20:1 
nhexane:Et2O) afforded the title compound as a pale yellow oil (415 mg, 53%); [α]D21 -93.1 
(c = 1.313, CH2Cl2); νmax / cm-1 3072, 3056, 2978, 2924, 2866, 1712, 1643, 1438, 1259; δH 
(400 MHz, CDCl3) 7.52-7.50 (2H, m, 2 x ArH), 7.34-7.25 (3H, m, 3 x ArH), 6.98 (1H, dd, J 
15.5 and 8.6, CHCH=CH), 5.38 (1H, dd, J 15.5 and 1.1, CHCH=CH), 4.15 (2H, q, J 7.13, 
CH2CH3), 3.92-3.84 (1H, m, CH), 1.51 (3H, d, J 6.88, CH3CH), 1.26 (3H, t, J 7.13, 
CH2CH3); δC (101 MHz, CDCl3) 167.9, 148.9, 136.3, 129.1, 128.6, 128.1, 119.1, 60.4, 
39.4, 19.7, 14.4; m/z (EI+) 284 (99%, [M]+!), 157 (57%), 127 (79%), 99 (100%); HRMS 
(EI+) found 284.0314, C13H16O2Se80 requires 284.0310; enantiomeric ratio was determined 
as 97:3 using HPLC; Chiralcel OD-H column, 100% hexane, flow 0.5 mLmin-1, UV 
detection at 236 nm, 65.6 min (minor), 76.6 min (major). 
 
(S)-Ethyl-2-methyl-4-(phenylselanyl)hex-2-(E)-enoate, 164 
 
According to the procedure of Armstrong,249 to a solution of butyraldehyde (178 μL, 2.0 
mmol) in toluene (1.5 mL) at 0 °C was added (S)-2-[bis-(3,5-bistrifluoromethyl-phenyl)-
trimethylsilanyloxy-methyl]-pyrrolidine (119 mg, 0.2 mmol) and p-nitrobenzoic acid (33 mg. 
0.2 mmol). The reaction mixture was stirred for 10 minutes after which N-phenylselenyl-
phthalimide (95%, 763 g, 2.4 mmol) added and the reaction stirred for a further 20 hours. 
CO2Et
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The reaction was then filtered through a plug of cotton wool, washed with toluene (6 mL) 
and the filtrate was cooled to -78 °C. In a separate flask, to a solution of triethyl-2-
phosphonopropionate (1.07 mL, 5.0 mmol) in CH2Cl2 (14.5 mL) at -78 °C was added nBuLi 
(3.05 mL, 1.57 M in hexanes, 4.8 mmol) and stirred for 30 minutes before being added via 
a cannula to the reaction vessel at -78 °C. The reaction was held at -78 °C for a further 1.5 
hours before the reaction was warmed to -45 °C for 1 hours, then warmed to 0 °C and 
stirred for a further 30 minutes. The reaction was quenched with NH4.Cl (sat. aq., 15 mL), 
extracted into Et2O (3x), washed brine (2x) and dried over MgSO4. Purification via flash 
column chromatography (1:1 nhexane:Et2O) gave a colourless oil (270 mg, 43%); [α]D21 -
66.0 (c = 0.66, CH2Cl2); νmax / cm-1 3056, 2964, 2931, 2873, 1706, 1639, 1579, 1275, 
1231, 1172; δH (400 MHz, CDCl3) 7.57-7.53 (2H, m, ArH), 7.34-7.27 (1H, m, ArH), 7.26-
7.20 (2H, m, ArH), 6.67 (1H, dq, J 11.3 and 1.5, CHCH=C), 4.18 (2H, m, OCH2CH3), 3.95 
(1H, ddd, J 11.3, 8.7 and 5.6, CHSePh) 1.84 (1H, dqd, J 13.0, 7.4 and  5.5, CH3CHHCH), 
1.76-1.65 (1H, m, CH3CHHCH), 1.41 (3H, d, J 1.5, HC=C(CH3)), 1.29 (3H, t, J 7.1, 
OCH2CH3), 0.98 (3H, t, J 7.4, CH3CH2CH); δC (101 MHz, CDCl3) 168.0, 141.8, 137.0, 
128.9, 128.5, 128.0, 127.7, 60.7, 44.5, 28.2, 14.4, 13.1, 12.2; m/z (ES+) 313 (71% [MH]+), 
282 (100%), 267 (74%), 155 (96%); HRMS (ES+/TOF) found 313.0711, C15H21O2Se80 
requires 313.0707; enantiomeric ratio was determined as 97.5:2.5 using HPLC; Chiralcel 
OD-H column, 100% hexane, flow 0.5 mLmin-1, UV detection at 254 nm, 44 min (minor), 
67 min (major). 
 
tert-Butyl (S)-(2-oxooxetan-3-yl)carbamate, 182  
 
According to the procedure of Vederas,257 to a stirred solution of triphenylphosphine (2.62 
g, 10 mmol) in THF (70 mL) at -78 °C was added diethyl azodicarboxylate (DEAD) (1.6 
mL, 10.2 mmol). The reaction mixture was stirred for 20 minutes at -78 °C, then N-Boc-L-
Ser-OH (2.05 g, 10 mmol) in THF (15 mL) was added dropwise over 20 minutes. The 
reaction mixture was allowed to warm to room temperature over 4 hours then concentrated 
under reduced pressure. Purification via flash column chromatography (1:1 
nhexane:EtOAc) afforded the title compound as a white solid (760 mg, 41%), m.p. 117-119 
°C (Lit.257 119.5-120.5 °C); δH (400 MHz, CDCl3) 5.24-5.37 (1H, br s, NH), 5.15-5.06 (1H, 
O
O
NHBoc
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m, NHCH), 4.40-4.48 (2H, m, CH2), 1.45 (9H, s, C(CH3)3). These data are consistent with 
literature values.257 
 
N-Boc-L-Ser-NH2, 181 
 
According to the procedure of Le Goffic,258 to tert-butyl (S)-(2-oxooxetan-3-yl)carbamate 
(465 mg, 2.16 mmol) in a 100 mL round bottom flask at -78 °C was condensed NH3(g) 
giving approximately 20 mL NH3(l). The reaction mixture was held at -78 °C for 20 minutes 
before being slowly warmed to room temperature, allowing the ammonia to evaporate 
affording the title compound as a off-white solid (427 mg, 97%); m.p. 100-102 °C (Lit.258 
101 °C); νmax / cm-1 3384, 3340, 3199, 2970m 1683, 1644, 1523, 1297, 1249, 1158, 1005; 
δH (400 MHz, d6-acetone) 7.04 (1H, br s, NH), 6.59 (1H, br s, NH), 5.98 (1H, br s, NH), 
4.16-4.06 (2H, m, CH and OH), 3.81 (1H, dd, J 10.9 and 5.0, CHHOH), 3.71 (1H, dd, J 
10.9 and 5.5, CHHOH), 1.41 (9H, s, C(CH3)3); δC (101 MHz, d6-acetone) 173.8, 156.4, 
79.4, 63.3, 56.9, 28.5; m/z (CI+) 205 (100%, [MH]+); HRMS (CI+) found 205.1187, 
C8H17N2O4 requires 205.1188. 
 
N-Boc-L-Tyr-NH2, 183 
 
Based on the procedure of Ley,259 to a stirred solution of N-Boc-L-Tyr-OH (0.5 g, 1.77 
mmol) in DMF (2.8 mL) was added EDCI (355 mg, 1.86 mmol) and HOBt (251 mg, 1.86 
mmol) followed by aqueous ammonia (28%, 142 μL, 2.12 mmol). Stirred for 24 hours at 
room temperature, diluted with H2O (30 mL), extracted into EtOAc (10 mL), washed with, 
alternately, 1M HCl (aq.), brine, sat. NaHCO3 (sat. aq.), brine and dried over Na2SO4. The 
crude reaction mixture was concentrated under reduced pressure and purified via flash 
column chromatography (1:0 to 10:1 Et2O:EtOAc) affording the title compound as a white 
solid (357 mg, 72%); m.p. 198-199 °C; [α]D22 +20.0 (c = 0.886, EtOH); νmax / cm-1 3410, 
3331, 3212, 2977, 1688, 1659, 1515, 1250, 1163; δH (400 MHz, d6-DMSO ) 9.14 (1H, s, 
OH), 7.30 (1H, s, CONHH), 7.02 (2H, d, J 8.1, ArH), 6.96 (1H, s, CONHH), 6.68 (1H, d, J 
8.6, CHNH), 6.64 (2H, d, J 8.1, ArH), 4.06-3.91 (1H, m, CH), 2.82 (1H, dd, J 13.9 and 4.5, 
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CHCHH), 2.61 (1H, dd, J 13.8 and 9.8, CHCHH), 1.31 (9H, s, C(CH3)3); δC (101 MHz, d6-
DMSO) 173.8, 155.7, 155.2, 130.0, 128.3, 114.8, 77.9, 55.9, 36.8, 28.2; m/z (ES+) 303 
(20%, [MNa]+), 242 (100%); HRMS (ES+/TOF) found 303.1326, C14H20N2O4Na requires 
303.1321. 
 
N-Cbz-L-Trp-NH2, 184 
 
Based on the procedure of Ley,259 to a stirred solution of N-Cbz-L-Trp-OH (0.5 g, 1.47 
mmol) in DMF (3 mL) was added EDCI (296 mg, 1.55 mmol) and HOBt (210 mg, 1.55 
mmol) followed by aqueous ammonia (28%, 118 μL). The reaction mixture was stirred 
overnight, diluted with H2O (30 mL), extracted into EtOAc, washed with, alternately, with 
1M HCl (aq.), brine, NaHCO3 (sat. aq.), brine and dried over Na2SO4. The crude reaction 
mixture was concentrated under reduced pressure and recrystallized from EtOAc:nhexane 
to afford the title compound as a white solid ( 436 mg, 88%); m.p. 190-192 °C (Lit.317 185-
187 °C); [α]D21 -12 (c 1.0, MeOH) [lit.317 [α]D21 -11.5 (c = 0.866, EtOH)]; νmax / cm-1 3427, 
3400, 3296, 3196, 3055, 2913, 1661, 1608, 1538, 1461, 2415, 1296, 1256, 1235, 1047, 
993; δH (400 MHz, d6-DMSO ) 10.81 (1H, s, NH-indole), 7.64 (1H, d, J 7.8, ArH indole), 
7.48 (1H, s, CONHH), 7.39-7.22 (7H, m, 5 x ArH-Ph and ArH-indole and CONHH), 7.15 
(1H, d, J 2.4, ArH-indole), 7.13-7.02 (2H, m, ArH-indole and NHCbz), 6.97 (1H, t, J 7.4, 
ArH-indole), 5.00-4.84 (2H, m, CH2Ph), 4.24 (1H, td, J 9.2 and 4.6, CHCONH2), 3.12 (1H, 
dd, J 14.7 and 4.6, CHHCHCONH2), 2.92 (1H, dd, J 14.6 and 9.7, CHHCHCONH2); δC 
(101 MHz, d6-DMSO) 173.8, 155.8, 137.0, 136.1, 128.2, 127.6, 127.5, 127.3, 123.7, 120.8, 
118.5, 118.2, 111.3, 110.3, 65.2, 55.4, 27.8; m/z (ES+) 360 (61%, [MNa]+), 259 (58%), 242 
(100%); HRMS (ES+/TOF) found 360,1341, C19H19N3O3Na requires 230.1324. 
 
N-FMOC-L-Lys (N3)-NH2, 185 
 
Based on the procedure of Ley,259 to a stirred solution of N-Fmoc-L-Lys(N3)-OH (238 mg, 
0.6 mmol) in DMF (0.9 mL) was added EDCI (121 mg, 0.63 mmol) and HOBt (85 mg, 0.63 
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mmol) followed by aqueous ammonia (28%, 48 μL, 0.72 mmol). Stirred for 24 hours at 
room temperature, diluted with H2O (10 mL), extracted into EtOAc, washed with, 
alternately, 1M HCl (aq.), brine, NaHCO3 (sat. aq.), brine then dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash column chromatography (1:1 to 
1:0 nhexane:EtOAc) afforded the title compound as a white solid (144 mg, 63%); m.p. 111-
114 °C, [α]D28 -3.8 (c = 1.06, CHCl3); νmax / cm-1 3395, 3317, 3201, 2947, 2096, 1674, 
1532, 1450, 1253; δH (400 MHz, CDCl3) 7.76 (2H, dt, J 7.6 and 1.0, ArH), 7.57 (2H, d, J 
7.4, ArH), 7.40 (2H, t, J 7.4 ArH), 7.31 (2H, td, J 7.5 and 1.2, ArH), 6.11 (1H, s, CONHH), 
5.71 (1H, s, CONHH), 5.47 (1H, d, J 7.9, NH), 4.44 (2H, d, J 6.8, OCH2CH), 4.20 (2H, t, J 
6.7, 2 x CH), 3.26 (2H, t, J 6.7, CH2N3), 2.02-1.80 (2H, m, CHCH2), 1.70-1.52 (2H, m, 
CH2CH2N3), 1.49-1.36 (2H, m, CHCH2CH2); δC (101 MHz, CDCl3) 174.1, 156.4, 143.8, 
141.5, 127.9, 127.2, 125.1, 120.2, 77.2, 67.1, 54.3, 51.2, 47.3, 32.0, 28.6, 22.7; m/z (ES+) 
416 (100% [MNa]+), 394 (83%, [MH]+), 338 (26%); HRMS (ES+/TOF) found 416.1695, 
C21H23N5O3Na requires 416.1699. 
 
General Procedure E: Amination/Rearrangement of Allylic Selenides with Amino 
Acid Amides 
To a solution of allylic selenide (0.30 mmol) in dry methanol (1 mL) was added amino acid 
amide (0.20 mmol), trimethylorthoformate (129 μL, 1.18 mmol) and para-toluene sulfonic 
acid (1 mg). The solution was stirred for 30 minutes at room temperature before cooling to 
0 °C, diisopropylethylamine (209 μL, 1.20 mmol) then N-chlorosuccinimide (80 mg, 0.6 
mmol) were added. The reaction was stirred at 0 °C for 20 minutes, then 1M HCl (aq., 
1mL) was added, followed by saturated NaHCO3 (1 mL). The reaction was extracted into 
EtOAc (3x), washed with brine (3x), dried over Na2SO4, concentrated under reduced 
pressure and further purified by flash column chromatography.  
  
 199 
tert-Butyl (2S,3E)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-hydroxypropanamido)hex-
3-enoate, 186 
 
Following general procedure E, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.3 
mmol) and Boc-L-Ser-NH2 (0.2 mmol). Purification via flash column chromatography (3:1 to 
1:2 nhexane:EtOAc) afforded the title compound as alight yellow foam (31 mg, 42%); [α]D21 
−13.5 (c = 0.74, CHCl3); νmax / cm-1 3311, 2977, 2936, 1720, 1659, 1507, 1457; δH 
(400 MHz, CDCl3) 7.08 (1H, br d, J 6.3, NHCO2tBu), 5.78 (1H, dtd, J 15.5, 6.4 and 1.5, 
CH2CH=CH), 5.57 (1H, d, J 6.7, CHNH), 5.45 (1H, ddt, J 15.5, 6.0 and 1.6, CH2CH=CH), 
4.92–4.87 (1H, m, CHNH), 4.22 (1H, br s, OH), 4.04 (1H d, J 10.7, CHCH2OH), 3.68–3.62 
(1H, m, CHHOH), 3.36 (1H, m, CHHOH), 2.09–2.01 (2 H, m, CH2), 1.45 (9H, s, C(CH3)3), 
1.44 (9H, s, C(CH3)3), 0.97 (3H, t, J 7.4, CH3); the following distinct signals for the Z-
isomer were observed: 5.68 (1H, dt, J 10.1 and 7.5), 5.21 (1H, ddt, J 10.1, 9.1 and 1.6), 
5.15–5.10 (1H, m), 2.26–2.19 (2H, m), 1.02 (3H, d, J 7.5) and the E:Z ratio was 
determined to be 8.5:1 by integration of the signals at 2.09–2.01 and 2.26–2.19 
respectively; δC (100 MHz, CDCl3) 170.9, 170.0, 156.0, 136.1, 122.7, 82.5, 80.3, 63.0, 
54.8, 54.7, 28.3, 27.8, 25.2, 13.1; m/z (ES+) 395 (100%, [MNa]+), 373 (10%, [MH]+); 
HRMS (ES+/TOF) found 373.2346, C18H33N2O6 requires 373.2339. The diastereomeric 
mixture was prepared by the same method from racemic tert-butyl 4-phenylselanyl-hex-2-
(E)-enoate. Spectroscopic data agreed with the material prepared above; the following 
additional NMR signals were observed for the other diastereomer: δH (400 MHz, CDCl3) 
4.09 (1H, d, J 11.0) 3.20 (1H, br s), 1.45 (9H, s), 1.44 (9H, s); δC (100 MHz, CDCl3) 136.2, 
63.0, 25.2, 13.1. 
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tert-Butyl (2S,3E)-2-((S)-2-tert-butoxycarbonylamino-3-(4-hydroxyphenyl)propionyl-
amido)-hex-3-enoate, 187 
 
Following general procedure E, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.3 
mmol) and N-Boc-L-Tyr-OH (0.2 mmol). Purification via flash column chromatography (4:1 
to 2:3 nhexane:EtOAc) afforded the title compound as a pale orange oil (28.6mg, 32%); 
[α]D20 +29.04 (c = 0.619, CHCl3); νmax / cm-1 3312, 2979, 1656, 1517, 1368, 1251; δH (400 
MHz, CDCl3) 7.01 (2H, t, J 7.5, 2 x ArH), 6.76-6.66 (2H, m, 2 x ArH), 6.60 (1H, d, J 7.6, 
NHCHCO2tBu), 6.53-6.37 (1H, br s, OH), 5.71 (1H, dtd, J 15.5, 6.1 and 1.3, 
CH3CH2CH=CH) 5.36 (1H, ddt, J 15.5, 6.1 and 1.6 Hz, CH3CH2CH=CH), 5.16-4.99 (1H, m, 
NHCO2tBu), 4.90-4.79 (1H, m, NHCHCO2tBu), 4.48-4.20 (1H, m, CHCH2(C6H4)OH), 2.98 
(2H, m, CHCH2(C6H4)OH), 2.06-1.98 (2H, m, CH2CH3), 1.43 (9H, s, C(CH3)3), 1.41 (9H, s, 
C(CH3)3), 0.95 (3H, t, J 7.4, CH2CH3); the following distinct signals for the Z-isomer were 
observed 6.89 (2H, d, J 7.6), 6.68 (2H, d, J 7.6), 5.66-5.61 (2H, m), 2.25-2.18 (2H, m), 
1.01 (3H, t, J 7.4) and the E:Z ratio was determined to be 7:1 by integration of the signals 
at 0.95 and 1.01 respectively; δC (101 MHz, CDCl3) 170.7, 169.7, 155.4, 155.1, 136.0, 
130.5, 127.8, 123.0, 115.5, 82.4, 60.4, 54.6, 37.5, 28.2, 27.9, 25.2, 14.7, 13.1; m/z (ES+) 
512 (23%, [M+MeCN+Na]+), 471 (100%, [MNa]+), 449 (21%, [MH]+), 369 (9%); HRMS 
(ES+/TOF) found 471.2457, C24H36N2O6Na requires 471.2471. The diastereomeric mixture 
was prepared by the same method using racemic tert-butyl 4-phenylselanyl-hex-2-(E)-
enoate. Spectroscopic data agreed with the material above; the following additional signals 
were observed for the other diastereomer; δH (400 MHz, CDCl3) 1.45 (s, 9H, C(CH3)3), 
1.42 (s, 9H, C(CH3)3); δC (101 MHz, CDCl3) 170.8, 115.6, 82.7, 54.7, 13.3. 
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tert-Butyl (2S,3E)-2-((S)-2-(benzyloxy)carbonylamino3-(1H-indol-3-yl)propionyl-
amino)hex-3-enoate, 188 
 
Following general procedure E, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.3 
mmol) and N-Cbz-L-Trp-NH2 (0.2 mmol). Purification via flash column chromatography (4:1 
to 1:1.5 nhexane:EtOAc) afforded the title compound as a pale yellow oil (48.4 mg, 48%); 
[α]D20 + 11.9 (c = 1.844, CHCl3); νmax / cm-1 3408, 3319, 2976, 1710, 1659, 1510, 1249, 
1230; δH (400 MHz, CDCl3) 8.19 (1H, br s, indole NH), 7.68 (1H, d, J 7.7, indole ArH), 
7.38-7.28 (6H, m, 5 x phenyl ArH and 1 x indole NH), 7.19 (1H, t, J 7.7, indole ArH), 7.10 
(1H, t, J 7.7, indole ArH) and 7.06 (1H, m, indole ArH), 6.40 (1H, d, J 6.9, NHCHCO2tBu), 
5.65-5.49 (2H, m, CH3CH2CH=CH and NHCO2Bn), 5.29 (1H, app. dd, J 15.6 and 6.0, 
CH3CH2CH=CH), 5.11 (2H, s, OCH2Ph), 4.80 (1H, t, J 6.7, CHNHCO2Bn), 4.62-4.50 (1H, 
m, CHH(C8H6N)), 3.42-3.21 (1H, dd, J 14.6 and 7.2 CHH(C8H6N)), 1.97 (2H, app. p, J 7.2, 
CH3CH2CH=CH), 1.42 (9H, s, C(CH3)3), 0.92 (3H, t, J 7.4, CH3CH2CH=CH); the following 
distinct signals for the Z-isomer were observed 4.89 (1H, t, J 6.9), 2.20 (2H, app. p, J 7.3), 
1.01 (3H, t, 7.4) and the E:Z ratio was determined to be 7.5:1 by integration of the signals 
at 0.92 and 1.01 respectively; δC (101 MHz, CDCl3) 170.5, 169.5, 155.9, 136.2, 135.9, 
128.5, 128.1, 128.0, 127.4, 123.4, 122.9, 122.2, 119.7, 118.8, 111.2, 82.1, 69.9, 60.3, 
55.4, 54.7, 27.9, 25.1, 13.3, 14.2, 13.0; m/z (ES+) 512 (23%, [M+MeCN+Na]+) 528 (100%, 
[MNa]+), 506 (56%, [MH]+), 450 (35%), 406 (12%); HRMS (ES+/TOF) found 528.2480, 
C29H35N3O5Na requires 528.2474; The diastereomeric mixture was prepared by the same 
method using racemic tert-Butyl 4-phenylselanyl-hex-2-(E)-enoate. Spectroscopic data 
agreed with the material above; the following additional signals were observed for the 
other diastereomer; δH (400 MHz, CDCl3) 5.19 (1H, ddt, J 15.4, 6.1 and 1.5, 
CH3CH2CH=CH) 1.40 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 170.5, 169.8, 136.4, 122.9, 
122.5, 54.7. 
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tert-Butyl (2S,3E)-2-((S)-6-azido-2-(9H-fluoren-9-ylmethoxy)carbonylaminohexanyl-
amino)hex-3-enoate, 189 
 
Following general procedure E, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.3 
mmol) and N-Fmoc-L-Lys(N3)-NH2 (0.2 mmol). Purification via flash column 
chromatography (4:1 to 2:1 nhexane:EtOAc) afforded the title compound as a pale yellow 
oil (43 mg, 77%); [α]D20 +2.67 (c = 2.24, CHCl3); νmax / cm-1 3304, 2968, 2095, 1729, 1655, 
1530, 1247, 1151; δH (400 MHz, CDCl3) 7.76 (2H, d, J 7.5, 2 x ArH), 7.59 (2H, d, J 7.4, 2 x 
ArH), 7.44-7.35 (2H, m, 2 x ArH), 7.35-7.26 (2H, m, 2 x ArH), 6.58 (1H, d, J 7.7, 
NHCHCO2tBu), 5.83-5.71 (1H, m, CH3CH2CH=CH), 5.55-5.36 (2H, m, CH3CH2CH=CH and 
NHBoc), 4.90 (1H, t, J 7.1, NHCHCO2tBu), 4.48-4.31 (2H, m, fluorene-CH2), 4.28-4.18 (2H, 
m, fluorene-CH and CHNHFmoc), 3.27 (2H, t, J 6.7, CH2CH2CH2CH2N3), 2.11-1.97 (2H, 
m, CH3CH2CH=CH), 1.96-1.82 (1H, m, CHHCH2CH2CH2N3), 1.75-1.53 (3H, m, 
CHHCH2CH2CH2N3 and CH2CH2CH2CH2N3), 1.44 (11H, m, CH2CH2CH2CH2N3 and 
C(CH3)3), 0.95 (3H, t, J 7.4, CH3CH2CH=CH); the following distinct signals for the Z-isomer 
were observed 6.70 (2H, m), 5.71-5.64 (2H, m), 2.26 (2H, m), 1.03 (3H, t, J 7.4) and the 
E:Z ratio was determined to be 4:1 by integration of the signals at 5.83-5.71 and 5.71-5.64 
respectively; δC (101 MHz, CDCl3) 170.7, 169.8, 156.1, 143.8, 143.7, 141.2, 136.3, 127.7, 
127.0, 125.0, 122.8, 119.9, 82.4, 67.1, 54.6, 51.1, 47.1, 32.5, 28.4, 27.9, 25.2, 22.5, 13.1; 
m/z (ES+) 584 (100%, [MNa]+), 562 (90%, [MH]+), 506 (53%), 242 (41%), 208 (34%); 
HRMS (ES+/TOF) found 584.2858, C31H39N5O5Na requires 584.2849; The diastereomeric 
mixture was prepared by the same method using racemic tert-butyl 4-phenylselanyl-hex-2-
(E)-enoate. Spectroscopic data agreed with the material above; the following additional 
signals were observed for the other diastereomer; δC (101 MHz, CDCl3) 170.0, 136.4, 
82.7, 54.6, 32.5, 13.3. 
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General Procedure F: Amination/Rearrangement of allylic selenides With Amino 
Acid Esters 
To a solution of allylic selenide (0.30 mmol) in dry methanol (1 mL) was added 
trimethylorthoformate (129 μL, 1.18 mmol) and para-toluene sulfonic acid (1 mg). The 
solution was stirred for 30 minutes at room temperature before cooling to 0 °C, 
diisopropylethylamine (209 μL, 1.20 mmol) then N-Chlorosuccinimide were added. The 
solution was stirred for 2 minutes and then the amino acid ester was added. The reaction 
mixture was held at 0 °C for 20 min, then 1M HCl (aq., 1mL) was added, followed by 
saturated NaHCO3 (1 mL). The reaction was extracted into EtOAc, washed with brine, 
dried over Na2SO4, concentrated under reduced pressure and purified by flash column 
chromatography 
 
(2S,3E)-tert-Butyl 2-((S)-1-Benzyloxycarbonylethylamino)hex-3-enoate, 190 
 
Following general procedure F, using (S)-tert-butyl 4-phenylselenylhex-2-(E)-enoate (0.3 
mmol) and H2N-L-Ala-CO2Bn (0.3 mmol). Purification via flash column chromatography 
(7:1 to 5:1 nhexane:EtOAc) afforded the title compound as a light yellow oil (50 mg, 72%); 
[α]D21 +3.1° (c = 2.58, CHCl3);  νmax / cm-1  2975, 2934, 1730, 1498, 1456; δH (400 MHz, 
CDCl3) 7.38-7.30 (5 H, m, 5 x ArH), 5.74 (1H, dtd, J 15.4, 6.3 and 1.0, CH2CH=CH), 5.35 
(1H, ddt, J 15.4, 7.7 and 1.6,  CH2CH=CH), 5.18 (1H, d, J 12.4, CHCHPh), 5.11 (1H, d, J 
12.4, CHCHPh), 3.72−3.70 (1H, m, C=CHCHNH), 3.40 (1H, q, J 7.0, CHCH3), 2.06−1.98 
(2H, m, CH2CH3), 1.44 (9H, s, C(CH3)3), 1.32 (3H, d, J 7.0, CHCH3), 0.96 (3H, t, J 7.4, 
CH2CH3); the following distinct signals for the Z-isomer were observed, 5.63 (1H, dtd, J 
10.8, 7.4, 0.9, CH2CH=CH), 0.92 (3H, d, J 7.5, CH2CH3) and the E:Z ratio was determined 
to be 8:1 by integration of the signals at 5.74 and 5.63 ppm, respectively; δC (101 MHz, 
CDCl3) 175.0, 171.1, 136.7, 135.8, 128.5, 128.2, 128.1, 125.6, 81.3, 66.5, 62.8, 64.4, 28.0, 
25.3, 19.1, 13.2; m/z (ES+) 370 (20%, [MNa]+), 348 (100%, [MH]+), 292 (40%); HRMS 
(ES+/TOF) found 348.2167, C20H30NO4 requires 348.2175. The diastereomeric mixture 
was prepared by the same method from racemic (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-
enoate. The mixture was partially separable by careful column chromatography. Data for 
the minor diastereomer; δH (400 MHz, CDCl3) 7.39-7.30 (5H, m, 5 x ArH), 5.67 (1H, dtd, J 
CO2tBu
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15.4, 6.4 and 1.0, CH2CH=CH), 5.32 (1H, ddt, J 15.3, 7.7 and 1.5, CH2CH=CH), 5.18-5.12 
(2H, m, CH2Ph), 3.70-3.68 (1H, m, C=CHCHNH), 3.43 (1H, q, J 7.0, CHCH3), 2.04 (2H, m, 
CH2CH3), 1.43 (9H, s, C(CH3)3), 1.33 (3H, d, J 7.0, CHCH3), 0.97 (3H, t, J  7.4, CH2CH3); 
δC (100 MHz, CDCl3) 174.9, 171.7, 137.1, 135.8, 128.5, 128.2, 128.1, 125.3, 81.4, 62.4, 
62.0, 53.6, 28.0, 25.3, 19.0, 13.4; m/z (ES+) 370 (20%, [MNa]+), 348 (100%, [MH]+), 292 
(40%); HRMS (ES+/TOF) found 348.2176, C20H30NO4 requires 348.2175,.  
 
(2S,3E)-tert-Butyl 2-((S)-1-benzyloxycarbonylethylamino)hex-3-enoate, 192 
 
Following general procedure F, using (S)-tert-butyl 4-phenylselenylhex-2-(E)-enoate (0.3 
mmol) and H2N-L-Phg-CO2Me (0.3 mmol). Purification via flash column chromatography 
(15:1 to 5:1 nhexane:EtOAc) afforded the title compound as a light yellow oil (40 mg, 60%); 
[α]D21+107 (c = 2.13, CHCl3); νmax / cm-1  2970, 1730s, 1456, 1435, 1393, 1368; δH (400 
MHz, CDCl3) 7.37-7.28 (5 H, m, 5 x ArH), 5.66 (1H, dtd, J 15.4, 6.3 and 0.9, CH2CH=CH), 
5.34 (1H, ddt, J 15.4, 8.0 and 1.6, CH2CH=CH ), 4.40 (1H, s, CHPh), 3.66 (3H, s, OMe), 
3.56 (1H, d, J 8.0, C=CHCHNH), 2.66 (1H, br s, NH), 2.21-1.94 (2H, m, CH2), 1.41 (9H, s, 
C(CH3)3), 0.99 (3H, t, J 7.5, CH2CH3); δC (101 MHz, CDCl3) 172.9, 171.7, 137.7, 137.4, 
128.7, 128.1, 127.8, 125.3, 81.3, 62.6, 61.7, 52.2, 27.9, 25.3, 13.3; m/z (ES+) 334 (100%, 
[MH]+), 278 (40%, [MH-C(CH3)3]+); HRMS (ES+/TOF) found 334.2013, C19H28NO4 requires 
334.2018. The diastereomeric mixture was prepared by the same method from racemic 
tert-butyl 4-phenylselenylhex-2-(E)-enoate. The mixture was partially separable by careful 
column chromatography. Data for minor diastereomer: δH (400 MHz, CDCl3) 7.39-7.30 
(5H, m, 5 x ArH), 5.75 (1H, dtd, J 15.5, 6.4 and 1.2, CH2CH=CH), 5.39 (1H, ddt, J 15.4, 7.1 
and 1.6, CH2CH=CH), 4.43 (1H, s, CHPh), 3.68 (3H, s, OMe), 3.58 (1H, d, J 7.1, 
C=CHCHNH), 2.72 (1H, br s, NH), 2.09-2.01 (2H, m, CH2), 1.5 (9H, s, C(CH3)3), 0.98 (3H, 
t, J 7.4, CH2CH3); δC (101 MHz, CDCl3) 172.9, 172.0, 137.8, 136.3, 128.6, 128.1, 127.9, 
125.4, 81.4, 62.8, 61.2, 52.3, 28.0, 25.4, 13.3. The diastereomeric ratio of the material 
derived from the enantiomerically enriched allylic selenide was determined to be 96:4 by 
integration of the 1H NMR signals at 5.67 (major) and 5.75 (minor) ppm. 
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(2S,3E)-tert-Butyl ((2S)-1-(benzyloxy)-3-hydroxy-1-oxopropan-2-yl)amino)hex-3-
enoate, 193 
 
Following general procedure F, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.3 
mmol) and H2N-L-Ser-CO2Bn (0.2 mmol) with cooling to -40 °C prior to the 
diisopropylethylamine addition. The reaction was then held at -40 °C and allowed to stir for 
12 hours after the NCS addition, purification via flash column chromatography (9:1 to 1:1 
nhexane:EtOAc) afforded the title compound as a pale yellow oil (39.5 mg, 54%); [α]D18 
+25.3 (c = 0.71, CH2Cl2); νmax / cm-1 3034, 2968, 2934, 2873, 1729, 1456, 1368, 1259, 
1152, 1060; δH (400 MHz, CDCl3) 7.37-7.32 (5H, m, 5 x ArH), 5.78 (1H, dtd, J 15.6, 6.3 
and 0.8, CH2CH=CH), 5.36 (1H, ddt, J 15.5, 8.1 and 1.7, CH2CH=CH), 5.18 (2H, d, J 1.9, 
CH2Ph), 3.79-3.70 (2H, m, CH=CHCHNH and CHHOH), 3.64 (1H, dd, J 10.9 and 6.2, 
CHHOH), 3.43 (1H, dd, J 6.2 and 4.1, CHCH2OH), 2.21 (2H, br s, OH and NH), 2.02 (2H, 
ddd, J 7.6, 6.3 and 1.6, CH3CH2CH=CH), 1.45 (9H, s, C(CH3)3), 0.96 (3H, t, J 7.4, 
CH2CH3); δC (101 MHz, CDCl3) 172.5, 171.9, 137.7, 135.3, 128.6, 128.4, 128.1, 125.1, 
81.7, 67.0, 63.1, 62.5, 60.5, 27.9, 25.3, 13.2; m/z (ES+) 386 (51%, [MNa]+), 364 (100%, 
[MH]+), 308 (33%); HRMS (ES+/TOF) found 364.2136, for C20H30NO5 364.2124; The 
diastereomeric mixture was prepared by the same method from racemic (S)-tert-butyl 4-
phenylselanyl-hex-2-(E)-enoate. Spectroscopic data agreed with the material above; the 
following additional signals were observed for the other diastereomer; δC (101 MHz, 
CDCl3) 128.7, 128.6, 128.5, 128.4, 81.8, 67.1, 62.8, 60.2, 28.2, 25.5 13.5. 
 
Ethyl (2S,3E)-2-(((2S)-1-(benzyloxy)-1-oxopropan-2-yl)amino)-2-methylhex-3-enoate, 
194 
 
Following general procedure F, using (S)-ethyl-2-methyl-4-(phenylselanyl)hex-2-(E)-enoate 
(0.3 mmol) and H2N-L-Ala-CO2Bn (0.2 mmol). Purification via flash column 
chromatography (19:1 to 1:1 nhexane:EtOAc) afforded the title compound as a colourless 
oil (15.4 mg, 46%); [α]D21 -8.9 (c = 0.89, CH2Cl2); νmax / cm-1 3068, 3036, 2979, 2964, 
2935, 1731, 1455, 1375, 1292, 1146, 974; δH (400 MHz, CDCl3) 7.42-7.31 (5H, m, 5 x 
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ArH), 5.71 (1H, dt, J 15.8 and 6.3, CH3CH2CH=CH), 5.49 (1H, dt, J 15.9 and 1.6, 
CH3CH2CH=CH), 5.23-5.19 (1H, d, J 12.1, CHHPh), 5.13 (1H, d, J 12.1, CHHPh), 4.16 
(2H, q, J 7.1, OCH2CH3), 3.41 (1H, q, J 7.1, CHCH3), 2.52 (1H, br s, NH), 2.01 (2H, m, 
CH3CH2CH=CH), 1.38 (3H, s, CCH3), 1.34 (3H, d, J 7.1, CHCH3), 1.28 (3H, t, J 7.2, 
OCH2CH3), 0.98 (3H, t, J 7.4, (CH3CH2CH=CH); δC (101 MHz, CDCl3) 176.4, 174.8, 135.7, 
133.3, 130.8, 128.5, 128.3, 128.2, 66.4, 63.0, 61.1, 52.2, 25.4, 22.8, 21.3, 14.1, 13.3; m/z 
(ES+) 334 (100%, [MH]+), 208 (87%); HRMS (ES+/TOF) found 334.2030, C19H28NO4 
requires 334.2018. The diastereomeric mixture was prepared by the same method from 
racemic (S)-ethyl-2-methyl-4-(phenylselanyl)hex-2-(E)-enoate. Spectroscopic data agreed 
with the material above; the following additional signals were observed for the other 
diastereomer; δC (101 MHz, CDCl3) 133.6, 130.7, 63.0, 61.2, 52.2, 23.8, 14.2. 
 
General Procedure G: Amination/Rearrangement of allylic selenides using aromatic 
amines 
To a solution of allylic selenide (0.20 mmol) in dry methanol (1 mL) was added trimethyl 
orthoformate (129 μL, 1.18 mmol) and para-toluenesulfonic acid (1 mg). The solution was 
stirred for 30 minutes at room temperature before cooling to -20 °C, diisopropylethylamine 
(209 μL, 1.20 mmol) then N-chlorosuccinimide (80 mg, 0.6 mmol) were added. The 
solution was stirred for 2 minutes and then the aromatic amine (0.30 mmol) was added. 
The reaction was stirred at -20 °C for 20 minutes, then 1M HCl (aq., 1mL) was added, 
followed by saturated NaHCO3 (1 mL). The reaction was extracted into EtOAc, washed 
with brine, dried over Na2SO4, concentrated under reduced pressure and further purified 
by flash column chromatography. 
 
tert-Butyl (2S,3E)-2-[(1,3-thiazol-2-yl)amino]hex-3-enoate, 195 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-aminothiazole (0.3 mmol). Purification via flash column chromatography (8:1 
to 4:1 nhexane:EtOAc) afforded the title compound as a colourless oil (39.4 mg, 73%); 
[α]D24 +93.2 (c = 1,11, CHCl3); νmax / cm-1 3326, 3198, 2969, 2933, 1726, 1619, 1523, 
1368, 1255, 1148; δH (400 MHz, CDCl3) 7.12 (1H, d, J 3.6, ArH), 6.50 (1H, d, J 3.6 ArH), 
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5.91 (1H, dtd, J 15.6, 6.4 and 1.4, CH3CH2CH=CH), 5.72 (1H, br s, NH), 5.48 (1H, ddt, J 
15.4, 6.1 and 1.6, CH3CH2CH=CH), 4.67 (1H, ddd, J 7.3, 5.9 and 1.2, NHCHCO2tBu), 2.10 
(2H, ddt, J 7.6, 6.3 and 1.4, CH3CH2), 1.47 (9H, s, C(CH3)3), 0.99 (3H, t, J 7.4, CH3CH2); 
the following distinct signals for the Z-isomer were observed δH (400 MHz, CDCl3) 5.86 
(1H, dtd, J 10.4, 6.5 and 1.4, CH3CH2CH=CH), 5.23 (1H, ddt, J 10.4, 8.9 and 1.4, 
CH3CH2CH=CH), 2.31 (2H, qd, J 7.4 and 1.6, CH3CH2), 1.06 (3H, t, J 7.5, CH3CH2) and 
the E/Z ratio was determined to be 28:1 by integration of the signals at 5.48 and 5.23 
respectively; δC (101 MHz, CDCl3) 170.1, 168.2, 138.9, 136.7, 123.2, 107.3, 82.4, 60.1, 
27.9, 25.3, 13.2; m/z (ES+) 269 (100%, [MH]+), 224 (45%), 214 (61%); HRMS (ES+/TOF) 
found 269.1334, C13H21N2O2S requires 269.1324; enantiomeric ratio was determined as 
94.5:5.5 using HPLC; Chiralpak IA-3 column, 98:2 nhexane:IPA, flow 1 mLmin-1, UV 
detection at 254 nm, 30.3 min (minor), 70.8 min (major). 
 
tert-Butyl (2S,3E)-2-[(1,3-benzothiazol-2-yl)amino]hex-3-enoate, 196 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-aminobenzthiazole (0.3 mmol). Purification via flash column chromatography 
(14:1 nhexane:EtOAc) afforded the title compound as an orange oil (46.8 mg, 74%); [α]D23 
+54.8 (c = 0.99, CHCl3); νmax / cm-1 3314, 2973, 2932, 2875, 1725, 1599, 1540, 1456, 
1445, 1368, 1153; δH (400 MHz, CDCl3) 7.59-7.54 (2H, m, 2 x ArH), 7.31 (1H, ddd, J 7.7, 
7.4 and 1.3, ArH), 7.12 (1H, td, J 7.6 and 1.2, ArH), 6.14-5.93 (2H, includes (1H br s, NH) 
and (1H, dtd, J 15.5, 6.4 and 1.5, CH3CH2CH=CH)), 5.56 (1H, ddt, J 15.5, 5.9 and 1.6, 
CH3CH2CH=CH), 4.91 (1H, d, J 5.9, NHCHCO2tBu), 2.18-2.05 (2H, m, CH3CH2), 1.51 (9H, 
s, C(CH3)3); 1.01 (3H, t, J 7.4, CH3H2) the following distinct signals for the Z-isomer were 
observed δH (400 MHz, CDCl3) 5.27 (1H, ddt, J 10.6, 90 and 1.5, CH3CH2CH=CH), 2.42-
2.32 (2H, m, CH3CH3) and the E/Z ratio was determined to be 27:1 by integration of the 
signals at 5.56 and 5.27 respectively; δC (101 MHz, CDCl3) 169.9, 165.4, 152.1, 136.7, 
130.8, 125.8, 123.1, 121.8, 120.8, 119.2, 82.6, 59.5, 28.0, 25.3, 13.2; m/z (ES+) 319 
(100%, [MH]+), 263 (54%), 224 (59%), 208 (49%); HRMS (ES+/TOF) found 319.1495, 
C17H23N2O2S requires 319.1480; enantiomeric ratio was determined as 97:3 using HPLC; 
CO2tBu
HN S
N
 208 
Chiralcel OD-H column, 99:1 nhexane:IPA, flow 1 mLmin-1, UV detection at 254 nm, 22.6 
min (minor), 35.0 min (major). 
 
tert-Butyl (2S,3E)-2-[(4-methoxy-1,3-benzothiazol-2-yl)amino]hex-3-enoate, 197 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-aminobenzthiazole (0.3 mmol). Purification via flash column chromatography 
(9:1 nhexane:EtOAc) afforded the title compound as a pale yellow foam (57.1 mg, 82%); 
[α]D17 +37.7 (c = 1.06, CHCl3); νmax / cm-1 3396, 2971, 2937, 2906, 1729, 1589, 1546, 
1479, 1369, 1327, 1254, 1154, 1048; δH (400 MHz, CDCl3) 7.19 (1H, dd, J 7.9 and 1.0, 
ArH), 7.03 (1H, t, J 8.0, ArH), 6.79 (1H, dd, J 8.0 and 1.0, ArH), 6.13 (1H, br s, NH), 5.94 
(1H, dtd, J 15.4, 6.4 and 1.5, CH3CH2CH=CH), 5.49 (1H, ddt, J 15.5, 6.0 and 1.6, 
CH3CH2CH=CH), 4.75 (1H, m, NHCHCO2tBu), 3.20 (3H, s, OCH3), 2.10-2.03 (2H, m, 
CH3CH2), 1.47 (9H, s, C(CH3)3), 0.97 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 169.5, 
164.9, 150.7, 141.5, 136.8, 131.8, 123.1, 122.2, 113.1, 107.2, 82.6, 59.9, 55.8, 27.9, 25.2, 
13.1; m/z (ES+) 349 (100%, [MH]+), 293 (47%); HRMS (ES+/TOF) found 349.1592, 
C18H25N2O3S requires 349.1586; enantiomeric ratio was determined as 97:3 using HPLC; 
Chiralcel AD column, 95:1 nhexane:IPA, flow 1 mLmin-1, UV detection at 254 nm, 19.7 min 
(minor), 23.9 min (major). 
tert-Butyl (2S,3E)-2-(phenylamino)hex-3-enoate, 198 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and aniline (0.3 mmol). Purification via flash column chromatography (80:1 
nhexane:Et2O) afforded the title compound as a clear oil (38.8 mg, 75%); [α]D21 +50.2 (c = 
1.39, CHCl3); νmax / cm-1 3405, 2970, 2933, 2872, 1730, 1604, 1505, 1369, 1316, 1256, 
1152; δH (400 MHz, CDCl3) 7.22-7.11 (2H, m, 2 x ArH), 6.72 (1H, tt, J 7.4 and 1.1, ArH), 
6.65-6.57 (2H, m, 2 x ArH), 5.91 (1H, dtd, J 15.5, 6.4 and 1.3, CH3CH2CH=CH), 5.51 (1H, 
ddt, J 15.5, 5.7 and 1.6, CH3CH2CH=CH), 4.46 (1H, br d, J 6.4, NH), 4.41 (1H, br t, J 5.9, 
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NHCHCO2tBu), 2.14-2.02 (2H, m, CH3CH2), 1.46 (9H, s, C(CH3)3), 0.99 (3H, t, J 7.4, 
CH3CH2); δC (101 MHz, CDCl3) 171.4, 146.6, 135.9, 129.1, 124.7, 117.9, 113.5, 81.9, 
59.1, 28.0, 25.3, 13.4; m/z 262 (100%, [MH]+), 214 (13%), 206 (37%); HRMS (ES+/TOF) 
found 262.1801 for C16H24NO2 requires 262.1807; the enantiomeric ratio could not be 
determined using HPLC analysis of the above compound, reduction to the primary alcohol 
allowed the enantiomeric ratio to be determined as 97:3 see below. 
 
(2S,3E)-2-(Phenylamino)hex-3-en-1-ol 
 
To a stirred solution to tert-butyl (2S,3E)-2-(phenylamino)hex-3-enoate (0.11 mmol) in THF 
(0.8 mL) at 0 °C under argon was added dropwise a solution of LiAlH4 in THF (1.0M, 0.33 
mmol). The solution was stirred at 0 °C for a further 1.5 hours and then quenched with H2O 
(6 mL). The reaction was extracted into CH2Cl2, dried with Na2SO4 and concentrated under 
reduced pressure. Further purification by flash column chromatography afforded the 
product as a clear oil (17.8 mg, 79%); [α]D22 +39.0 (c = 0.81, CH3OH); νmax / cm-1 3369, 
3052, 3024, 2962, 2929, 2873, 1601, 1501, 1317, 1261, 1027, 967; δH (400 MHz, CDCl3) 
7.17 (2H, td, J 7.5 and 2.1, 2 x ArH), 6.76-6.71 (1H, m, ArH), 6.70-6.66 (2H, m, ArH), 5.79 
(1H, dtd, J 15.5, 6.3 and 1.3, CH3CH2CH=CH), 5.37 (1H, ddt, J 15.5, 6.1 and 1.5, 
CH3CH2CH=CH), 4.01-3.95 (1H, m, NHCHCH2OH), 3.74 (1H, dd, J 10.8 and 4.6, 
CHHOH), 3.61 (1H, dd, J 10.9 and 6.5, CHHOH), 2.05 (2H, ddt, J 7.6, 6.3 and 1.3, 
CH3CH2), 0.97 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 147.2, 135.7, 129.2, 126.9, 
118.1, 114.1, 65.3, 57.4, 25.4, 13.5; m/z (ES+) 192 (100%, [MH]+), 135 (21%), 94 (12%); 
HRMS (ES+/TOF) found 192.1391, C12H18NO requires 192.1388; enantiomeric ratio was 
determined as 97:3 using HPLC; Chiralpak IA-3 column, 95:5 nhexane:IPA, flow 1 mLmin-
1, UV detection at 254 nm, 13.1 min (major), 14.0 min (minor). 
 
tert-Butyl (2S,3E)-2-[(4-methylphenyl)amino]hex-3-enoate, 199 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and p-toluidine (0.3 mmol). Purification via flash column chromatography (50:1 
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nhexane:Et2O) afforded the title compound at an off white solid (33.3 mg, 61%); m.p. 44-46 
°C; [α]D23 +63.2 (c = 1.24, CHCl3); νmax / cm-1 3399, 2976, 2969, 2932, 2873, 1728, 1619, 
1520, 1368, 1253, 1147; δH (400 MHz, CDCl3) 6.98 (2H, d, J 8.1, 2 x ArH), 6.54 (2H, d, J 
8.2, 2 x ArH), 5.90 (1H, dtd, J 15.4, 6.4 and 1.2, CH3CH2CH=CH), 5.50 (1H, ddt, J 15.4, 
5.8 and 1.6, CH3CH2CH=CH), 4.39 (1H, br d, J 5.0, NHCHCO2tBu), 4.32 (1H, br s, NH), 
2.24 (3H, s, ArCH3), 2.14-2.01 (2H, m, CH3CH2), 1.46 (9H, s, C(CH3)3), 0.99 (3H, t, J 7.4, 
CH3CH2); δC (101 MHz, CDCl3) 171.6, 144.3, 135.8, 129.6, 127.0, 124.9, 113.6, 81.8, 
59.4, 28.0, 25.3, 20.4, 13.4; m/z (ES+) 276 (100%, [MH]+), 220 (19%); HRMS (ES+/TOF) 
found 276.1969, C17H26NO2 requires 276.1964; enantiomeric ratio was determined as 
96.5:3.5 using HPLC; Chiralpak IA-3 column, 95-5 nhexane:IPA, flow 1 mLmin-1, UV 
detection at 254 nm, 4.9 min (major), 5.7 min (minor). 
 
tert-Butyl (2S,3E)-2-[(2-methylphenyl)amino]hex-3-enoate, 200 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and o-toluidine (0.3 mmol). Purification via flash column chromatography (50:1 
nhexane:Et2O) afforded the title compound as a pale yellow oil (26.9 mg, 49%); [α]D23 
+48.1 (c = 1.08, CHCl3); νmax / cm-1 3420, 2967, 2932, 2874, 1728, 1606, 1510, 1368, 
1256, 1149; δH (400 MHz, CDCl3) 7.12-7.03 (2H, m, 2 x ArH), 6.67 (1H, td, J 7.4 and 1.0, 
ArH), 6.49 (1H, dd, J 8.5 and 1.0), 5.91 (1H, dtd, J 15.4, 6.3 and 0.9, CH3CH2CH=CH), 
5.54 (1H, ddt, J 15.3, 5.4 and 1.5, CH3CH2CH=CH), 4.48-4.38 (2H, m, NH and 
NHCHCO2tBu), 2.24 (3H, s, ArCH3), 2.15-206 (2H, m, CH3CH2), 1.47 (9H, s, C(CH3)3), 
1.00 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 171.6, 144.7, 135.7, 130.1, 126.9, 124.8, 
122.4, 117.3, 110.6, 81.9, 59.0, 28.0, 25.3, 17.5, 13.4; m/z (ES+) 276 (100%, [MH]+), 220 
(15%); HRMS (ES+/TOF) found 276.1964, C17H26NO2 requires 276.1964; the enantiomeric 
ratio could not be determined using HPLC analysis of the above compound, reduction to 
the primary alcohol allowed the enantiomeric ratio to be determined as 96.5:3.5 see below. 
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 (2S,3E)-2-[(2-Methylphenyl)amino]hex-3-en-1-ol 
 
To a stirred solution of tert-butyl (2S,3E)-2-[(2-methylphenyl)amino]hex-3-enoate (34 mg, 
0.12 mmol) in THF (0.8 mL) under argon at 0 °C was added dropwise a solution of LiAlH4 
in THF (1.0 M, 036 mmol). The solution was stirred at 0 °C for a further 1.5 hours and then 
quenched with H2O (6 mL). The reaction was extracted into CH2Cl2, dried with Na2SO4 and 
concentrated under reduced pressure. Further purification by flash column 
chromatography provided the product as a clear oil (21.0 mg, 85%); [α]D23 +65.3 (c = 0.76, 
CHCl3); νmax / cm-1 3346, 2968, 2934, 2874, 1712, 1501, 1456, 1326, 1222, 1153, 1045 ; 
δH (400 MHz, CDCl3) 7.15-7.04 (2H, m, 2 x ArH), 6.71-6.66 (2H, m, 2 x ArH), 5.78 (1H, 
dtd, J 15.4, 6.2 and 1.2, CH3CH2CH=CH), 5.40 (1H, ddt, J 15.5, 6.1 and 1.6, 
CH3CH2CH=CH), 4.03 (1H, tdd, J 6.1, 4.8 and 1.2, CHCH2OH), 3.77 (1H, dd, J 10.9 and 
4.5, CHCHHOH), 3.65 (1H, dd, J 10.9 and 6.4, CHCHHOH), 2.19 (3H, s, CH3C6H4), 2.06 
(2H, ddt, J 6.3 and 1.3, CH3CH2CH=CH), 0.98 (3H, t, J 7.4, CH3CH2CH=CH); δC (101 
MHz, CDCl3) 145.1, 135.6, 130.2, 127.0, 126.8, 122.7, 117.6, 111.6, 65.3, 57.2, 25.4, 
17.6, 13.4; m/z (EI+) 205 (32%, [M]+!) 174 (100%, [M-CH2OH]+); HRMS (EI+) found 
205.1463, C13H19NO requires 205.1467; enantiomeric ratio was determined as 96.5:3.5 
using HPLC; Chiralpak IB-3 column, 90:10 nhexane:IPA, flow 1 mLmin-1, UV detection at 
254 nm, 7.6 min (minor), 10.1 min (major). 
 
tert-Butyl (2S,3E)-2-[(4-methoxy)amino]hex-3-enoate, 201 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and p-anisidine (0.3 mmol) with 1.1 equivalents of NCS. Purification via flash 
column chromatography (20:1 nhexane:EtOAc) afforded the title compound as an orange 
oil (31.8 mg, 54%); [α]D18 +41.3 (c = 0.93, CHCl3); νmax / cm-1 3384, 2966, 2932, 1728, 
1513, 1459, 1369, 1239, 1150; δH (400 MHz, CDCl3) 6.76 (2H, d, J 8.9, 2 x ArH), 6.58 (2H, 
d, J 8.9, 2 x ArH), 5.89 (1H, dtd, J 15.5, 6.5 and 1.4, CH3CH2CH=CH), 5.49 (1H, ddt, J 
15.4, 6.0 and 1.6, CH3CH2CH=CH), 4.34 (1H, br t, J 5.9, NHCHCO2tBu), 4.15 (1H, br d, J 
OH
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6.3, NH), 3.73 (3H, s, OCH3) 2.13-2.01 (2H, m, CH3CH2), 1.44 (9H, s, C(CH3)3), 0.98 (3H, 
t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 171.9, 152.6, 141.0, 136.1, 125.2, 115.1, 114.9, 
81.9, 60.3, 55.9, 28.1, 25.2, 13.5; m/z (ES+) 292 (100% [MH]+); HRMS (ES+/TOF) found 
292.1925, C17H26NO3 requires 292.1913; enantiomeric ratio determined as 96.5:3.5 using 
HPLC; Chiralpak IA-3 column, 90:10 nhexane:IPA, flow 1 mLmin-1, UV detection at 254 
nm, 5.9 min (minor), 7.6 min (major). 
 
tert-Butyl (2S,3E)-2-[(4-nitrophenyl)amino]hex-3-enoate, 202 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 4-nitroaniline (0.3 mmol). Purification via flash column chromatography (19:1 
nhexane:EtOAc) afforded the title compound a yellow oil (52.2 mg, 85%); [α]D15 +119.7 (c = 
1.38, CHCl3); νmax / cm-1 3377, 2972, 2933, 1726, 1597, 1504, 1475, 1313, 1148, 1110; δH 
(400 MHz, CDCl3) 8.07 (2H, d, J 9.2, 2 x ArH), 6.53 (2H, d, J 9.2, 2 x ArH), 5.86 (1H, dtd, J 
15.6, 6.5 and 1.4, CH3CH2CH=CH), 5.48 (1H, ddt, J 15.5, 5.9 and 1.6, CH3CH2CH=CH), 
5.36 (1H, br s, NH), 4.47 (1H, dd, J 5.9 and 1.4, NHCHCO2tBu), 2.15-2.04 (2H, m, 
CH3CH2), 1.48 (9H, s, C(CH3)3), 0.98 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 170.0, 
151.5, 138.5, 137.0, 126.2, 123.0 111.9, 83.0, 58.0, 27.9, 25.2, 13.3; m/z (ES+) 307 
(100%, [MH]+), 251 (49%, [M-CH3CH2CH=CH]+); HRMS (ES+/TOF) found 307.1665, 
C16H23N2O4 requires 307.1658; enantiomeric ratio determined as 96.5:3.5 using HPLC; 
Chiralpak IB-3 column, 95:5 nhexane:IPA, flow 1 mLmin-1, UV detection at 224 nm, 6.3 min 
(minor), 6.8 min (major). 
 
tert-Butyl (2S,3E)-2-{[3-(hydroxymethyl)phenyl]amino}hex-enoate, 203 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 3-aminobenxylalcohol (0.3 mmol). Purification via flash column 
chromatography (4:1 nhexane:EtOAc) afforded the title compound as a pale yellow oil 
(27.3 mg, 62%); [α]D23 +20.7 (c = 0.868, CH3OH); νmax / cm-1 3391, 2968, 2932, 2874, 
1726, 1608, 1488, 1369, 1323, 1256, 1148; δH (400 MHz, CDCl3) 7.14 (1H, t, J 7.9, ArH), 
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6.70 (1H, ddd, J 7.6, 1.6 and 0.8, ArH), 6.61 (1H, t, J 2.0, ArH), 6.53 (1H, ddd, J 8.1, 2.4 
and 0.9, ArH), 5.89 (1H, dtd, J 15.4, 6.4 and 1.4, CH3CH2CH=CH), 5.49 (1H, ddt, J 15.4, 
5.7 and 1.6, CH3CH2CH=CH), 4.58 (2H, s, CH2OH), 4.51 (1H, br s, NH), 4.42 (1H, app. br 
s, NHCHCO2tBu), 2.14-2.01 (2H, m, CH3CH2), 1.73 (1H, br s, OH), 1.46 (9H, s, C(CH3)3), 
0.98 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 171.4, 146.9, 142.0, 136.0, 129.4, 124.5, 
116.3, 112.7, 111.9, 82.0, 65.5, 58.9, 28.0, 25.3, 13.4; m/z (ES+) 292 (100%, [MH]+), 236 
(16%); HRMS (ES+/TOF) found 292.1920, C17H26NO3 requires 292.1913; enantiomeric 
ratio determined as 96.5:3.5 using HPLC; Chiralpak IA-3 column, 90:10 nhexane:IPA, flow 
1 mLmin-1, UV detection at 212 nm, 10.6 min (minor), 13.4 min (major). 
 
tert-Butyl (2S,3E)-2-[(pyridin-2-yl)amino]hex-3-enoate, 204 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-aminopyridine (0.3 mmol). Purification via flash column chromatography 
(19:1 nhexane:EtOAc) afforded the title compound as a pale yellow oil (38.4 mg, 71%); 
[α]D21 +23.6 (c = 1.27, CHCl3); νmax / cm-1 3363, 2967, 2933, 2874, 1724, 1600, 1482, 
1368, 1328, 1254, 1146, 967; δH (400 MHz, CDCl3) 8.07 (1H, ddd, J 5.2, 2.0 and 0.9, 
ArH), 7.38 (1H, ddd, J 8.2, 7.2 and 1.9, ArH), 6.57 (1H, ddd, J 7.2, 5.1 and 1.0, ArH), 6.40 
(1H, dt, J 8.4 and 1.0, ArH), 5.87 (1H, dtd, J 15.6, 6.4 and 1.5, CH3CH2CH=CH), 5.55 (1H, 
ddt, J 15.5, 6.4 and 1.5, CH3CH2CH=CH), 5.07 (1H, br d, J 7.5, NH), 4.85 (1H, ddd, J 7.5, 
5.8 and 1.4, NHCHCO2tBu), 2.12-2.00 (2H, m, CH3CH2), 1.45 (9H, s, C(CH3)3), 0.97 (3H, t, 
J 7.4, CH3CH2); δH (400 MHz, CDCl3) 171.3, 157.4, 147.9, 137.2, 135.5, 124.3, 113.4, 
108.1, 81.7, 56.9, 28.0, 25.3, 13.3; m/z (ES+) 263 (19%, [MH]+), 207 (100%, [MH-
C(CH3)3]+, 189 (9%), 161 (18%); HRMS (ES+/TOF) found 262.1765, C15H23N2O2 requires 
263.1760; enantiomeric ratio was determined 94.5:5.5 using HPLC; Chiralpak IA-3 column, 
94.:5.5 nhexane:IPA, flow 1 mLmin-1, UV detection at 268 nm, 10.9 min (minor), 22.1 min 
(major). 
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tert-Butyl (2S,3E)-2-[(6-bromopyridin-2-yl)amino]hex-3-enoate, 205 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-amino-6-bromopyridine (0.3 mmol). Purification via flash column 
chromatography (20:1 nhexane:EtOAc) afforded the title compound as a pale yellow oil 
(52.0 mg, 70%); [α]D19 +23.6 (c = 1.19, CHCl3); νmax / cm-1 3353, 2971, 2934, 2876, 1722, 
1594, 1557, 1491, 1150; δH (400 MHz, CDCl3) 7.20 (1H, t, J 7.8, ArH), 6.73 (1H, d, J 7.5, 
ArH), 6.28 (1H, d, J 8.1, ArH), 5.86 (1H, dtd, J 15.4, 6.4 and 1.5, CH3CH2CH=CH), 5.48 
(1H, ddt, J 15.4, 6.1 and 1.6, CH3CH2CH=CH), 5.26 (1H, br d, J 7.4, NH), 4.74 (1H, ddd, J 
7.3, 6.1 and 1.2, NHCHCO2tBu), 2.12-2.09 (2H, m, CH3CH2), 1.46 (9H, s, C(CH3)3), 0.97 
(3H, t, J 7.5, CH3CH2); δC (101 MHz, CDCl3) 170.7, 157.3, 140.1, 139.2, 136.2, 123.7, 
116.4, 105.9, 82.0, 57.0, 27.9, 25.3, 13.3; m/z (ES+) 343 (88%, [MH+2]+). 341 (82% 
[MH]+), 287 (100%), 285 (91%) 224 (89%), 208 (91%); HRMS (ES+/TOF) found 341.0850, 
C15H22N2O279Br requires 341.0865; enantiomeric ratio was determined as 96.5:3.5 using 
HPLC; Chiralcel OD-H column, 95:1 nhexane:IPA, flow 1 mLmin-1, UV detection at 236 nm, 
8.6 min (minor), 12.3 min (major). 
 
tert-Butyl (2S,3E)-2-[(5-iodopyridin-2-yl)amino]hex-3-enoate, 206 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-amino-5-iodopyridine (0.3 mmol). Purification via flash column 
chromatography (9:1 nhexane:EtOAc) afforded the title compound as a clear oil (60.2 mg, 
78%); [α]D27 +34.9 (c = 0.97, CHCl3); νmax / cm-1 3359, 2967, 2933, 2873, 1722, 1586, 
1476, 1368, 1256, 1149, 966; δH (400 MHz, CDCl3) 8.22 (1H, dd, J 2.3 and 0.7, ArH), 7.58 
(1H, dd, J 8.7 and 2.3, ArH), 6.27 (1H, dd, J 8.7 and 0.8, ArH), 5.84 (1H, dtd, J 15.5, 6.4 
and 1.5, CH2CH=CH), 5.51 (1H, ddt, J 15.5, 5.8 and 1.5, CH2CH=CH), 5.16 (1H, br d, J 
7.4, NH), 4.78 (1H, ddd, J 7.4, 6.0 and 1.3, CHNH), 2.12-2.30 (2H, m, CH2CH3), 1.45 (9H, 
s, C(CH3)3), 0.97 (3H, t, J 7.4, CH3); δC (101 MHz, CDCl3) 171.0, 156.1, 153.6, 144.7, 
135.9, 123.9, 110.4, 81.9, 77.4, 56.8., 28.0, 25.3, 13.3; m/z (ES+) 389 (100%, [MH]+); 
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HRMS (ES+/TOF) found 389.0717, C15H22N2O2127I requires 389.0726; enantiomeric ratio 
was determined as 96.5:3.5 using HPLC; Chiralcel OD-H column, 95:5 nhexane:IPA, flow 1 
mLmin-1, UV detection at 236 nm, 8.6 min (minor), 12.3 min (major). 
 
tert-Butyl (2S,3E)-2-[(5-cyanopyridin-2-yl)amino]hex-3-enoate, 207 
 
Following general procedure G using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-amino-5-cyanopyridine (0.3 mmol). Purification via flash column 
chromatography (9:1 nhexane:EtOAc) afforded the title compound as an off-white 
crystalline solid (36.6 mg, 63%); m.p. 94-97 °C; [α]D22 +74.0 (c = 1.01, CHCl3); νmax / cm-1 
3356, 2979, 2935, 2216, 1721, 1603, 1575, 1512, 1392, 1365, 1230, 1150; δH (400 MHz, 
CDCl3) 8.38 (1H, dd, J 2.1 and 0.8, 2 x ArH), 7.55 (1H, dd, J 8.8 and 2.2, 2 x ArH), 6.42 
(1H, dd, J 8.8 and 0.8, ArH), 5.84 (1H, dtd, J 15.4, 6.4 and 1.5, CH3CH2CH=CH), 5.67 (1H, 
br d J 6.3, NH), 5.51 (1H, ddt, J 15.5, 6.0 and 1.6, CH3CH2CH=CH), 4.90 (1H, br t, J 6.1, 
NHCHCO2tBu), 2.07 (1H, ddt, J 7.6, 6.4 and 1.4, CH3CH2), 1.47 (9H, s, C(CH3)3), 0.98 
(3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 170.3, 158.4, 153.0, 139.4, 136.4, 123.2, 
118.4, 107.9, 97.7, 82.5, 56.5, 27.9, 25.3, 13.2; m/z (ES+) 288 (36%, [MH]+), 232 (100%), 
224 (17%); HRMS (ES+/TOF) found 288.1726, C16H22N3O2 requires 288.1712; 
enantiomeric ratio was determined as 96.5:3.5 using HPLC; Chiralpak IA-3 column, 90:10 
nhexane:IPA, flow 1 mLmin-1, UV detection at 236 nm, 7.6 min (minor), 33.4 min (major). 
 
tert-Butyl (2S,3E)-2-[(1H-pyrazol-3-yl)amino]hex-3-enoate, 208 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 3-aminopyrazole (0.3 mmol). Purification with flash column chromatography 
(4:1 nhexane:EtOAc) afforded the title compound as a pale orange oil (13.0 mg, 26%); 
[α]D23 +16.2 (c = 0.617, CHCl3); νmax / cm-1 3298, 2965, 2934, 1729, 1555, 1368, 1255, 
1154; δH (400 MHz, CDCl3) 7.31 (1H, d, J 2.4, ArH), 5.89 (1H, dtd, J 15.6, 6.4 and 1.3, 
CH3CH2CH=CH), 5.63 (1H, d, J 2.4, ArH), 5.53 (1H, ddt, J 15.4, 6.0 and 1.5, 
CH3CH2CH=CH), 4.51 (1H, d, J 6.0, NHCHCO2tBu), 4.40 (1H, br s, NH), 2.13-2.01 (2H, m, 
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CH3CH2), 1.44 (9H, s, C(CH3)3), 0.98 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 171.9, 
155.3, 135.6, 130.2, 125.0, 91.9, 81.5, 59.9, 28.0, 25.3, 13.3; m/z (ES+) 252 (92%, [MH]+), 
196 (100%); HRMS (ES+/TOF) found 252.1716, C13H22N3O2 requires 252.1707; 
enantiomeric ratio determined as 97:3 using HPLC; Chiralpak IA-3 column, 90:10 
nhexane:IPA, flow 1 mLmin-1, UV detection at 236 nm, 15.5 min (minor), 19.7 min (major). 
 
tert-Butyl (2S,3E)-2-[(1H-1,3-benzodiazol-2-yl)amino]hex-3-enoate, 209 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and 2-aminobenzimidazole (0.3 mmol). Purification via flash column 
chromatography (3:1 nhexane:EtOAc) afforded the title compound as an off-white solid 
(52.0 mg, 43%); m.p. gradual decomp. at >155 °C; [α]D17 +32.9 (c = 1.03, CHCl3); νmax / 
cm-1 3303, 3060, 2970, 2934, 2877, 1707, 1602, 1463, 1369, 1259, 1041; δH (400 MHz, 
CDCl3) 7.24-7.15 (2H, m, 2 x ArH), 7.02-6.96 (2H, m, 2 x ArH), 5.96 (1H, br s, NH), 5.88 
(1H, dtd, J 15.5, 6.4 and 1.5, CH3CH2CH=CH), 5.55 (1H, ddt, J 15.5, 5.9 and 1.5, 
CH3CH2CH=CH), 5.06 (1H, dd, J 5.9 and 1.5, NHCHCO2tBu), 2.05-1.96 (2H, m, CH3CH2), 
1.44 (9H, s, C(CH3)3), 0.92 (3H, t, J 7.4, CH3CH2); δC (101 MHz, CDCl3) 171.7, 154.0, 
137.8, 136.0, 123.8, 120.5, 112.4, 82.6, 58.1, 27.9, 25.2, 13.1; m/z (ES+) 302 (100%, 
[MH]+), 146 (69%), 219 (24%); HRMS (ES+/TOF) found 302.1876, C17H24N3O2 requires 
302.1863; enantiomeric ratio determined as 97:3 using HPLC; Chiralpak IA-3 column, 
90:10 nhexane:IPA, flow 1 mLmin-1, UV detection at 254 nm, 11.2 min (minor), 26.0 min 
(major). 
 
Ethyl (S,E)-2-(4-((1-(tert-butoxy)-1-oxohex-3-en-2-yl)amino)phenyl)oxazole-4-
carboxylate, 210 
 
Following general procedure G, using (S)-tert-butyl 4-phenylselanyl-hex-2-(E)-enoate (0.2 
mmol) and ethyl 2-(4-aminophenyl)oxazole-4-carboxylate (0.3 mmol). Purification via flash 
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column chromatography (4:1 nhexane:EtOAc) afforded the title compound as a white solid 
(56.2 mg, 70%); m.p. 98-102 °C; [α]D26 +57.7 (c = 0.84, CHCl3); νmax / cm-1 3373, 3155, 
3138, 2976, 2935, 2874, 1727, 1612, 1507, 1370m 1320, 1251, 1144, 1113; δH (400 MHz, 
CDCl3) 8.17 (1H, s, ArH(oxazole)), 7.89 (2H, d, J 8.7, 2 x ArH(phenyl)), 6.60 (2H, d, J 8.7, 
2 x ArH(phenyl)), 5.88 (1H, dtd, J 15.1, 6.4 and 1.3, CH3CH2CH=CH), 4.89 (1H, ddt, J 
15.2, 5.8 and 1.4, CH3CH2CH=CH), 4.89 (1H, br d, J 6.6, NH), 4.45 (1H, br t, J 5.9, 
NHCHCO2tBu), 4.20 (2H, q, J 7.1, C(O)OCH2CH3), 2.13-1.99 (2H, m, CH3CH2), 1.46 (9H, 
s, C(CH3)3), 1.38 (3H, t, J 7.2, C(O)OCH2CH3), 0.97 (3H, t, J 7.4, CH3CH2); δC (101 MHz, 
CDCl3) 170.7, 163.2, 161.7, 148.8, 142.6, 136.4, 134.2, 128.4, 123.8, 115.7, 112.9, 82.4, 
61.1, 58.3, 27.9, 25.4, 14.3, 13.3; m/z (ES+) 464 (28%), 401 (100% [MH]+); HRMS 
(ES+/TOF) found 401.2079, C22H29N2O5 requires 401.2076; enantiomeric ratio determined 
as 96.5:3.5 using HPLC; Chiralpak IA-3 column, 90:10 nhexane:IPA, flow 1 mLmin-1, UV 
detection at 236 nm, 15.5 min (minor), 30.8 min (major). 
 
tert-Butyl (2S, 3E)-2-{[(benzyloxy)carbonyl]amino}hex-3-enoate, 211 
 
According to the procedure of Armstrong,249 to a solution of (S)-tert-butyl 4-phenylselanyl-
hex-2-(E)-enoate (110 mg, 0.33 mmol) and benzyl carbamate (151 mg, 1 mmol) in dry 
methanol (1.5 mL) was added trimethylorthoformate (255 μL, 1.95 mmol) and para-toluene 
sulfonic acid (1 mg). The solution was stirred at room temperature for 30 minutes before 
cooling to 0 °C, diisopropylethylamine (350 μL, 1,98 mmol) was added followed by N-
chlorosuccinimide (135 mg, 1.0 mmol). The reaction was stirred for a further 5 minutes 
then quenched with 1M HCl (aq., 2 mL) then NaHCO3 (sat. aq., 1 mL). The reaction was 
extracted into EtOAc, washed with brine, dried over Na2SO4, concentrated under reduced 
pressure and purified by flash column chromatography (19:1 nhexane:EtOAc) to afford the 
title compound as a clear oil (74.5 mg, 71%); [α]D24 +93.2 (c = 1.11, CHCl3); νmax / cm-1 
3342, 2968, 2930, 2958 1726, 1526, 1437, 1369, 1228, 1156; δH (400 MHz, CDCl3) 7.40 
(5H, m, 5 x ArH), 5.80 (1H, dtd, J 5.15, 6.2 and 1.0, CH3CH2CH=CH), 5.49-5.33 (2H, m, 
CH3CH2CH=CH and NH), 5.11 (2H, s, CH2Ph), 4.72 (1H, t, J 6.8, NHCHCO2tBu), 2.06 (2H, 
app. p, J 7.3, CH3CH2), 1.46 (9H, s, C(CH3)3), 0.98 (3H, t, J 7.4, CH3CH2); δC (101 MHz, 
CDCl3) 170.3, 155.7, 155.6, 136.5, 135.9, 128.6, 128.3, 82.3, 67.1, 56.3, 28.1, 24.5, 13.4; 
m/z (ES+) 358 (100%, [MK]+), 342 (85%, [MN]a+), 220 (53%, [MH]+); HRMS (ES+/TOF) 
CO2tBu
HN Cbz
 218 
found 342.1678, C18H25NO4Na requires 342.1681; enantiomeric ratio was determined as 
97:3 using HPLC; Chiralcel OD-H columns, 99:1 nhexane:IPA, flow 1 mLmin-1, UV 
detection at 215 nm, 24.1 min (minor), 27.2 min (major). 
 
tert-Butyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-hydroxypropanoate, 212 
 
Through a stirred solution of tert-butyl (3E)-2-{[(benzyloxy)carbonyl]amino}hex-3-enoate 
(60 mg, 0.189 mmol) in CH2Cl2 (2 mL) at -78 °C was bubbled O2 for 15 minutes. Then 
ozone was bubbled through the reaction until the colourless solution turns to a blue 
solution (~10 min). Oxygen was then bubbled through the solution until the solution turns 
colourless. The reaction mixture was then diluted with MeOH (5 mL) and NaBH4 (71.5 mg, 
1.89 mmol) and allowed to warm to room temperature over 2 hours. The reaction mixture 
was concentrated under reduced pressure and the crude reaction mixture dissolved in 
CH2Cl2, washed twice with H2O and then dried over Na2SO4. Purification by flash column 
chromatography (2:1 nhexane :EtOAc) provided the title compound as an off-white solid 
(42.3 mg, 76%); m.p. 86-88 °C (lit.273 89-90); [α]D24 -11.7 (c = 1.02, EtOH), [lit.273 [α]D22 -
13.7 (c = 1.03, EtOH)]; νmax / cm-1 3401, 3263, 3063, 2952, 2892, 1710, 1550, 1455, 1366, 
1274, 1236, 1154, 1087, 1050; δH (400 MHz, CDCl3) 7.42-7.27 (5H, m, 5 x ArH), 5.72 (1H, 
br d, J 7.1, NH), 5.11 (2H, s, CH2Ph), 4.36-4.27 (1H, m, CHCO2tBu), 2.39 (1H, br t, J 5.6, 
OH), 1.47 (9H, s, C(CH3)3); δC (101 MHz, CDCl3) 169.6, 156.4, 136.3, 128.7, 128.34, 
128.26, 83.0, 67.2, 63.9, 56.8, 28.1; m/z (ES+) 334 (100%, [MK]+), 318 (72% [MNa]+), 196 
(43%); HRMS (ES+/TOF) found 318.1335, C15H21NO5Na requires 318.1317; enantiomeric 
ratio was determined as 91:9 using HPLC; Chiralcel OD column, 91:9 nhexane:IPA, flow 1 
mLmin-1, UV detection at 214 nm, 11.1 min (major), 13.5 min (minor). 
(S)-Ethyl-2-((2)-1-benzyloxy)-1-oxopropan-2-yl)amino)pent-3-enoate, 218 
 
Following general procedure F, using (S)-ethyl 4-phenylselanylbut-2-(E)-enoate (0.3 mmol) 
and H2N-L-Ala-CO2Bn (0.2 mmol). Purification via flash column chromatography (20:1 to 
4:1 nhexane:EtOAc) afforded the title compound as pale yellow oil (37.7 mg, 62%); [α]D21 
CO2tBu
HN Cbz
HO
CO2Et
HN CO2Bn
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+12.4 (c = 1.13, CHCl3); νmax / cm-1 3036, 2981, 2939, 1733, 1456, 1370, 1240, 1154, 
1028; δH (400 MHz, CDCl3) 7.39-7.31 (5H, m, 5 x ArH), 5.73 (1H, dqd, J 15.5, 6.3 and 
0.89, CH3CH=CH). 5.39 (1H, ddq, J 15.5, 8.0 and 1.6, CH3CH=CH), 5.14 (2H, app. q, J 
12.3, OCH2Ph), 4.17 (2H, qd, J 7.1, 1.8, OCH2CH3), 3.81 (1H, d, J 8.0, NHCHCO2Et), 3.39 
(1H, q, J 7.0, CHCH3), 1.94 (1H, br s, NH), 1.66 (3H, dd, J 7.0 and 1.6 CH3CH=CH), 1.32 
(3H, d, J 6.9, NHCHCH3), 1.25 (3H, t, J 7.1, OCH2CH3); the following distinct signals for 
the Z-isomer were observed 5.26 (1H, ddd, J 11.0, 9.3 and 1.8, CH3CH=CH), 1.59 (3H, dd, 
J 7.0 and 1.8) and the E:Z ratio was determined to be 10:1 by integration of the signals at 
5.29 and 5.26 respectively; δC (101 MHz, CDCl3) 175.0, 172.7, 135.7, 130.7, 128.6, 128.3, 
128.1, 127.3, 66.6, 62.4, 61.1, 54.4, 19.1, 17.8, 14.1; m/z (ES+) 328 (100%, [MNa]+), 306 
(95%, MH+), 232 (38%), 132 (12%); HRMS (ES+/TOF) found 306.17052, C17H24NO4 
requires 306.17080. The diastereomeric mixture was prepared by the same method from 
racemic phenylselanylbut-2-enoic acid ethylester. Spectroscopic data agreed with the 
material above; the following additional signals were observed for the other diastereomer; 
δC (101 MHz, CDCl3) 174.9. 172.3, 135.9, 131.0, 127.3, 66.8, 61.8, 61.4, 53.7, 19.1. 
 
(2S)-2-{[(2S,3E)-1-Ethoxy-1-oxopent-3-en-2-yl]amino}propanoic acid, 219 
 
A suspension of (S)-ethyl-2-((2)-1-benzyloxy)-1-oxopropan-2-yl)amino)pent-3-enoate (65 
mg, 0.24) and 10% Pd/C (6.5 mg) in dry methanol (0.4 mL) was stirred for 5.5 hours under 
hydrogen. Filtration through Celite and concentration under reduced pressure afforded the 
title compound as a white solid (44.1 mg, 97%); m.p. 158-160 °C; [α]D18 +7.98 (c = 1.00, 
EtOH) ; νmax / cm-1 2694, 2937, 2735, 1750, 1568, 1397, 1351; δH (400 MHz, d6-DMSO ) 
4.08 (2H, q, J 7.0, OCH2CH3), 3.26 (1H, t, J 6.7, CHCO2Et), 3.15 (1H, q, J 6.9, CHCH3), 
1.57-1.46 (2H, m, CH3CH2CH2), 1.34-1.24 (2H, m, CH3CH2CH2), 1.19-1.14 (6H, m, CHCH3 
and OCH2CH3), 0.85 (3H, t, J 7.8, CH3CH2CH2); δC (101 MHz, d6-DMSO) 175.6, 174.2, 
60.1, 58.8, 54.5, 34.9, 18.8, 18.5, 14.2, 13.7; m/z (ES+) 218 (100%, [MH]+), 172 (53%), 
116 (28%); HRMS (ES+/TOF) found 218.1398, C10H20NO4 requires 218.1392. 
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(2S,3aS,7aS)-Octahydroindole-2-carboxylic acid benzyl ester, 215 
 
According to the procedure of Pascard,318 a solution of (2S,3aS,7aS)-octahydroindole-2-
carboxylic acid (5 mmol), para-toluenesulfonic acid (1.5 g, 8.5 mmol) in BnOH (2g, 18.5 
mmol) and toluene (15mL) was stirred at refluxed for 4 hours with H2O collected in a Dean-
Stark trap. The solution was then concentrated under reduced pressure and triturated with 
MeOtBu overnight, filtered and concentrated under reduced pressure to afford the title 
compound as a white solid (2.17 g, 100%); m.p. 113-116 °C; νmax / cm-1 2949, 2873, 2724, 
1745, 1519, 1454, 1388, 1202, 1152, 1030, 1008; δH (400 MHz, CDCl3) 10.19 (1H, br s, 
NH), 7.77 (2H, d, J 8.1, 2 x ArH), 7.40-7.25 (5H, m, 5 x ArH), 7.15 (2H, d, J 8.0, 2 x ArH), 
5.22 (1H, d, J 12.5 CHHPh), 5.15 (1H, d, J 12.5, CHHPh), 4.68 (1H, app. dq, J 8.3 and 
3.3, NCHCH), 4.14 (1H, br s, NH), 3.86 (1H, app. br s, CHCO2Ph), 2.54 (1H, dq, J 11.4 
and 5.8, CHHCHCO2Ph), 2.39-2.30 (4H, m, includes 2.34 (3H, s, CH3) and 
CHHCHCO2Ph), 2.03-1.88 (2H, m, 2 x alkyl CHH), 1.67-1.11 (7H, m, 7 x alkyl CHH); δC 
(101 MHz, CDCl3) 169.9, 141.7, 140.2, 134.4, 128.8, 128.7, 128.6, 128.5, 68.4, 59.6, 57.9, 
36.4, 31.5, 24.8, 22.4, 21.3, 20.3; m/z (ES+) 260 (15% [MH-C7H7O3S]+), 211 (60%), 170 
(100%, [MH-C7H7]+); HMRS (ES+/TOF) found 260.1678, C16H22NO2 requires 260.1645. 
 
Benzyl (2S,3aS,7aS)-1- (2S)-2-[(tert-butyloxycarbonyl)-amino]-propionyl}-octahydro-
1H-indole-2-carboxylate, 220 
 
Based on the procedure of Fox,319 to a stirred solution of benzyl (2S,3aS,7aS)-
octahydroindole-2-carboxylic acid benzyl ester (900 mg, 2.08 mmol) in DMF (8.6 mL, 0.55 
M) was added diisopropylethylamine (1.68 mL), N-Boc-L-Ala-OH (393 mg, 2.08 mmol), 
HOBT (365 mg, 2.70 mmol) and EDCI (517 mg, 2.70 mmol). The reaction was stirred at 
room temperature for 25 hours, concentrated under reduced pressure. The crude reaction 
mixture was then diluted with EtOAc (40 mL), washed with, alternately H2O (20 mL), 1M 
HCl (aq.), brine, NaHCO3 (sat. aq.), brine then dried over Na2SO4 and concentrated under 
reduced pressure to afford the title compound as a colorless oil (803 mg, 89%); νmax / cm-1 
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3300, 1747, 1703, 1639, 1455, 1245, 1166; δH (400 MHz, CDCl3) 7.36-7.28 (5H, m, 5 x 
ArH), 5.23-5.09 (3H, m, OCH2Ph and NHBoc), 4.53-4.45 (2H, m, CH(CH3) and 
NCHCO2Bn), 4.08 (1H, dt, J 11.62 and 5.92, NCH(CH)) 2.40 (2H, dq, J 12.6 and 6.2, alkyl 
CHH), 2.14 (1H, dt, J 12.3 and 7.2, alkyl CHCHH 2.03-2.86 (1H, m, alkyl CHH), 1.75-1.63 
(3H, m, alkyl CHH), 1.61-1.47 (2H, m, alkyl CHH), 1.41 (9H, s, C(CH3)3), 1.29 (3H, d, J 6.8, 
CH3), 1.26-1.13 (2H, m, alkyl CHH); δC (101 MHz, CDCl3) 172.1 (2 x C=O), 155.3, 135.8, 
128.6, 128.26, 128.14, 79.7, 66.9, 58.9, 58.1, 47.1, 37.7, 30.5, 28.7, 28.5, 25.7, 23.8, 20.1, 
20.0; m/z (ES+) 453 (100%, [MNa]+), 431 (23%, [MH]+); HRMS (ES+/TOF) 431.2547, 
C24H35N2O3 requires 431.2546. 
 
(2S)-1-[(2S,3aS,7aS)-2-[(Benzyloxy)carbonyl]-octahydro-1H-indol-1-yl]-1-oxopropyl-
2-ammonium trifluoroacetate, 221 
 
To a stirred solution of 4-phenylselanylbut-2-enoic acid ethyl ester (25.4 mg, 0.093 mmol) 
in methanol (1 mL) was added trimethylorthoformate (39.8 μL, 0.35 mmol) and para-
toluenesulfonic acid (1 mg). The reaction mixture was stirred for 30 minutes at room 
temperature before cooling to 0 °C, diisopropylethylamine (61.6 μL, 0.36 mmol) then N-
chlorosuccinimide (24.2mg, 0.18 mmol) were added and after an additional 2 minutes 
(2S)-1-[(2S,3aS,7aS)-2-[(benzyloxy)carbonyl]-octahydro-1H-indol-1-yl]-1-oxopropyl-2-
ammonium trifluoroacetate (20 mg, 0.6 mmol) was added. The reaction was stirred at 0 °C 
for 1 hour, then 1M HCl (aq., 1mL) was added, followed by NaHCO3 (sat. aq., 1 mL). The 
reaction was extracted into EtOAc, washed with brine, dried over Na2SO4 and 
concentrated under reduced pressure. Purification via flash column chromatography (99:1 
to 95:5 EtOAc:MeOH) to afford (3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-
a]indole-1,4-dione (9.1 mg, 63%); m.p.168-169 °C; νmax / cm-1 3493, 3225, 2926, 2864, 
1686, 1637, 1426, 1299, 1163, 1116; δH (400 MHz, CDCl3) 6.08 (1H, br s, NH), 4.14 (1H, 
dd, J 10.0 and 7.0, NCHC(O)), 4.03-3.98 (2H, m, CHCH3 and NCHCH), 2.41-2.19 (2H, m, 
NCHCH2), 2.04 (1H, ddd, J 12.3, 7.0 and 5.2, NCHCH), 1.82-1.75 (2H, m, alkyl CH2), 1.75-
1.56 (2H, m, alkyl CH2), 1.54-1.47 (1H, alkyl CHH), 1.43 (3H, d, J 6.9, CH3), 1.36-1.25 (1H, 
m, alkyl CHH), 1.17 (1H, qt, J 12.6 and 2.8, alkyl CHH), 1.02 (1H, tdd, J 13.2, 10.6 and 
N NH
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3.4, alkyl CHH); δC (101 MHz, CDCl3) 171.6, 166.9, 59.5, 56.4, 51.2, 35.9, 29.0, 27.6, 
25.9, 23.5, 20.9, 15.4; m/z (ES+), 264 (55%, [M+MeCN]+), 223 (100% [MH]+); HRMS 
(ES+/TOF) found 223.1450, C12H19N2O5 requires 233.1447. 
 
(2S)-1-[(2S,3aS,7aS)-2-[(Benzyloxy)carbonyl]-octahydro-1H-indol-1-yl]-1-oxopropyl-
2-ammonium trifluoroacetate, 222 
 
Benzyl (2S,3aS,7aS)-1-((2S)-2-[amino]-propionyl)-octahydro-1H-indole-2-carboxylate (753 
mg, 1.75 mmol) was added to a 1:4 mixture of TFA:CH2Cl2 (20 mL). The reaction mixture 
was stirred at room temperature for 45 minutes, then concentrated under reduced 
pressure, azeotroped (3x) with toluene to remove H2O affording the title compound as a 
light brown oil (740 mg, 99%); νmax / cm-1 2934, 2862, 1743, 1651m 1444, 1169, 1023; δH 
(400 MHz, CDCl3) 7.84 (3H, br s, NH3), 7.37-7.28 (5H, m, 5 x ArH), 5.21 (1H, d, J 11.8, 
CHHPh), 5.07 (1H, d, J 11.8, CHHPh), 4.48 (1H, dd, J 10.2, 8.2, NCHCO2Bn), 4.31 (1H, 
m, CHCH3), 3.92 (1H, dt, J 12.2 and 6.2, NCHCH), 2.37 (1H, m, NCHCHH), 2.18 (1H, ddd, 
J 12.4, 7.9 and 6.3, NCHCHH), 1.98 (1H, m, NCHCH), 1.83-1.59 (4H, m, 4 x alkyl CHH), 
1.52-1.47 (2H, m, 2 x alkyl CHH), 1.44 (3H, d, J 6.7, CH3), 1.25-1.18 (2H, m, 2 x alkyl 
CHH), δC (101 MHz, CDCl3) 171.3, 168.9, 161.3 (q), 135.4, 128.8, 128.7, 128.3, 67.4, 
59.6, 59.1, 48.0, 37.4, 30.1, 28.3, 26.9, 25.3, 23.6, 19.7, 18.0; m/z (ES+) 353 (45%, 
[MNa+]), 331 (100%, [MH]+); HRMS (ES+/TOF) found 331.2020, C19H27N2O3 requires 
331.2022. 
 
Diphenyldiazomethane, 225 
 
According to the procedure of Murray,320 to a stirred mixture of benzophenone hydrazone 
(981mg, 5 mmol), anhydrous MgSO4 (2.4 g, 20 mmol) in CH2Cl2 (3.75 mL) at 0 °C was 
added activated MnO2 (1.74 g, 20 mmol). The reaction mixture was stirred for 2 hours at 0 
°C, then 1 hour at room temperature. Solid material filtered off and washed with CH2Cl2. 
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Volatiles were removed under reduced pressure as a dark red oil that upon cooling at -18 
°C afforded the title compound as a red crystalline solid (920 mg, 95%); m.p. 31 °C (Lit320 
30°C). The diazo compound was used immediately.  
 
(2S,3aS,7aS)-Octahydroindole-2-carboxylic acid diphenylmethyl ester, 224 
 
Based on the procedure of Li,321 to a stirred solution (2S,3aS,7aS)-octahydroindole-2-
carboxylic acid (380 mg, 2.25 mmol) and para-toluenesulfonic acid (428 mg, 2.25 mmol) in 
1:1 MeCN:H2O (20 mL) was added diphenyldiazomethane (875 mg, 4.5 mmol). The 
reaction mixture was stirred for two minutes and then the pH was adjusted to 9 through the 
dropwise addition of 1M NaOH. The reaction mixture was extracted into Et2O, washed with 
H2O then brine, dried over Na2SO4 and concentrated under reduced pressure. Purification 
via flash column chromatography (EtOAc) afforded the title compound as a white solid 
(473 mg, 62%); m.p. 99 °C; [α]D321 -29.0 (c = 0.966, CHCl3); νmax / cm-1 3422, 3328, 3067, 
3033, 2973, 2948, 2926, 2885, 2856, 1717, 1496, 1451, 1343, 1250, 1195, 1184, 1152, 
1118, 1097, 966; δH (400 MHz, CDCl3) 7.36-7.27 (10H, m, 10 x ArH), 6.92 (1H, s, CHPh2), 
3.94 (1H, dd, J 10.1 and 5.8, NCHCO2CHPh2), 3.11 (1H, q, J 5.2, NCH(CH)CH2), 2.51 
(1H, s, NH), 2.24 (1H, ddd, J 12.8, 10.1 and 6.8, CHHCHCO2CHPh2), 2.07-1.99 (1H, m, 
NCH(CH)CH2), 1.76 (1H, dt, J 12.8 and 5.4, CHHCHCO2CHPh2), 1.69-1.58 (2H, m, 
NCH(CH)CH2), 1.48-1.31 (4H, m, 4 x alkyl CHH), 1.26-1.15 (2H, m, 2 x alkyl CHH); δC 
(101 MHz, CDCl3) 175.1, 140.0/140.0, 128.6/128.5, 128.1/128.0, 127.3/127.0, 77.4/77.2, 
58.9, 58.3, 38.1, 35.9, 28.1, 27.0, 23.6, 21.6; m/z (ES+) 376 (52%, [M-MeCN]+), 336 
(100%, [MH]+); HRMS (ES+/TOF) found 336.1966, C22H26NO2 requires 336.1964. 
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(2S,3aS,7aS)-Benzhydryl 1-((S)-2-((tert-butoxycarbonyl)amino)propanoyl)octahydro-
1H-indole-2-carboxylate, 226 
 
To a stirred solution of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid diphenylmethyl 
ester (400 mg, 1.19 mmol) and N-Boc-L-Ala-OH (225 mg, 1.19 mmol) in DMF (2.5 mL) 
was added diisopropylethylamine (876 μL, 5.36 mmol), followed by EDCI (255 mg, 1.34 
mmol) and HOBt (180 mg, 1.34 mmol). The reaction mixture was stirred overnight at room 
temperature, diluted with H2O (25 mL), extracted into EtOAc, washed, in sequence, with 
1M HCl (aq.), brine, NaHCO3 (sat. aq.), brine then dried over Na2SO4 and concentrated 
under reduced pressure to afford the title compound as a white foam (564 mg, 92%); [α]D21 
-47.4 (c = 1.012, CHCl3); νmax / cm-1 3343, 3298, 2979, 2933, 2859, 1749, 1705, 1639, 
1455, 1366, 1253, 1169; δH (400 MHz, CDCl3) 7.36-7.26 (10H, m, 10 x ArH), 6.89 (1H, s, 
CHPh2), 5.21 (1H, d, J 8.8, NH), 4.59 (1H, dd, J 10.3 and 8.0, NCHCO2CHPh2),  4.49 (1H, 
J 13.4 and  6.6, CHCH3), 4.10 (1H, dt, J 12.1 and 5.5, NCHCH), 2.42 (1H, dq, J 12.1, 5.9 
and 5.5, NCHCHH), 2.15 (1H, m, NCHCHH), 1.94-1.81 (2H, m, NCHCH and 
NCHCHHCH2), 1.74-1.58 (3H, m, NCHCHHCH2 and 2 x alkyl CHH), 1.55-1.36 (11H, m, 
C(CH3)3 and 2 x alkyl CHH), 1.28 (3H, d, J 6.8, CH3), 1.21-1.15 (2H, m, 2 x alkyl CHH); δC 
(101 MHz, CDCl3) 172.3, 171.3, 155.3, 140.9/139.9, 128.6/128.5, 128.1/128.0, 
127.3/127.2, 79.9, 77.7, 59.0, 58.2, 41.2, 37.6, 30.4, 28.8, 28.5, 25.7, 23.8, 20.1, 20.0; m/z 
(ES+) 529 (100% [MNa]+), 507 (53%, [MH]+); HRMS (ES+/TOF) found 529.2678, 
C30H38N2O5Na requires 529.2678. 
 
(2S,3aS,7aS)-1-((Benzyloxy)carbonyl)octahydro-1H-indole-2-carboxylic acid 
 
To a solution of (2S,3aS,7aS)-octrahydroindole-2-carboxylic acid (1.0 g, 5.97 mmol) in 1M 
NaOH (7.5 mL) at 0 °C was added dropwise benzyl chloroformate (0.92 mL, 6.56 mmol). 
Solution was stirred overnight and the temperature allowed to increase to room 
temperature. The reaction was then diluted with H2O (20 mL), washed with Et2O, the 
aqueous layer acidified to pH 4 with 1M HCl (aq.), extracted with EtOAc. The combined 
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organic layers were dried over Na2SO4 and concentrated under reduced pressure to afford 
the title compound as a white foam/colourless oil (1.49 g, 84%); [α]D21 -29.3 (c = 1.025, 
CHCl3); δH (400 MHz, CDCl3) peaks appear as rotamers, 9.13 (1H, br s, COOH), 7.40-7.20 
(5H, m, 5 x ArH). 5.20-5.04 (2H, m, CH2Ph2), 4.14-4.28 (1H, m, NCHCOOH), 3.99-3.80 
(1H, m, NCHCH), 2.40-2.26 (1H, m, NCHCH), 2.23-2.06 (2H, m, NCH(COOH)CH2), 2.05-
1.93 (1H, m, 1 x alkyl CHH), 1.80-1.55 (3H, m, 3 x alkyl CHH), 1.55-1.36 (2H, m, 2 x alkyl 
CHH), 1.35-1.05 (2H, m, alkyl CHH); δC (101 MHz, CDCl3) 178.6/177.2, 155.4/154.1, 
136.6, 128.5/128.4, 128.1/127.9, 127.7/127.6, 67.3/67.0, 59.3/58.9, 58.0/57.7, 37.0/36.6, 
32.6/31.2, 27.9/27.3, 25.8, 23.8, 20.5/20.4. These data are consistent with literature 
values.322 
 
(2S,3aS,7aS)-1-Benzyl 2-tert-butyl octahydro-1H-indole-1,2-dicarboxylate 
 
To a stirred solution of (2S,3aS,7aS)-1-((benzyloxy)carbonyl)octahydro-1H-indole-2-
carboxylic acid (1.42 g, 4.7 mmol) in THF (25 mL) was added di-tert-butyl dicarbonate 
(2.05 g, 9.4 mmol) and DMAP (172.2 mg, 1.41 mmol). The reaction was stirred at room 
temperature for 6 hours and then the reaction mixture was then concentrated under 
reduced pressure. Purification via flash column chromatography (9:1 nhexane:EtOAc) to 
afford the title compound as a pale yellow oil (1.55 g, 92%); [α]D21 -38.5 (c = 0.986, CHCl3); 
νmax / cm-1 2976, 2928, 2857, 1741, 1702, 1412, 1356, 1153, 1010; δH (400 MHz, CDCl3) 
peaks appear as rotamers, 7.36-7.27 (5H, m, 5 x ArH), 5.14-5.04 (2H, m, CH2Ph), 4.22-
4.14 (1H, m, NCHCO2tBu), 3.92 (0.5H, dt, J 12.0 and 6.4, NCHCH), 3.81 (0.5H, dt, J 12.0 
and 6.4, NCHCH), 2.35-2.23 (1H, m, NC(CO2tBu)CHH), 2.18-1.90 (2H, m, 
NC(CO2tBu)CHH and NCHCH), 1.75-1.57 (4H, m, 4 x alkyl CHH), 1.53-1.21 (11H, m, 
C(CH3)3 and 2 x alkyl CH), CHH 1.20-1.07 (2H, m, 2 x alkyl CHH); δC (101 MHz, CDCl3) 
172.5/172.3, 154.7/154.2, 137.1/136.8, 128.6, 128.4, 127.9, 81.2/81.1, 66.9/66.8, 
58.0/57.4, 36.9/36.5, 32.9/31.7, 28.2/28.0, 28.02, 27.3, 26.0/25.9, 23.9/23.8, 20.7/20.6; 
m/z (ES+) 382 (100%, [MNa]+), 304 (42%), 208 (68%); HRMS (ES+/TOF) found 382.1988, 
C21H29NO4Na requires 382.1994. 
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(2S,3aS,7aS)-tert-Butyl octahydro-1H-indole-2-carboxylate, 228 
 
To a stirred solution of (2S,3aS,7aS)-1-benzyl 2-tert-butyl octahydro-1H-indole-1,2-
dicarboxylate (1.07 g, 2.99 mmol) in MeOH (15 mL) was added 10% Pd on carbon (107 
mg). The reaction was stirred for 24 hours under hydrogen, then the reaction mixture was 
filtered through Celite and concentrated under reduced pressure to afford the title 
compound as a white solid (672.2 mg, 99%); m.p. 150-151 °C; [α]D18 -28.7 (c = 0.766, 
CHCl3); νmax / cm-1 2976, 2928, 2857, 1741, 1702, 1412, 1356, 1153, 1010; δH (400 MHz, 
CDCl3) 7.38 (1H, br d, J 9.1, NH), 4.33-4.24 (1H, m, NCHCO2tBu), 3.79-3.69 (1H, m, 
NCHCH), 2.50-2.40 (1H, m, NCHCH), 2.30-2.16 (1H, m, NCH(CO2tBu)CHH), 2.07-1.98 
(1H, m, NCH(CH)CHH), 1.92-1.84 (1H, m, NCH(CO2tBu)CHH), 1.60-1.12 (16H, m, 
C(CH3)3 and 7 x alkyl CHH); δC (101 MHz, CDCl3) 168.8, 84.6, 59.1, 57.6, 36.4, 31.4, 27.7, 
24.6 (2 x CH2), 22.4, 20.2; m/z (ES+) 226 (100%, [MH]+), 211 (17%), 170 (90%); HRMS 
(ES+/TOF) found 226.1790, C13H24NO2 requires 266.1807. 
 
(2S,3aS,7aS)-tert-Butyl 1-((S)-2-(((benzyloxy)carbonyl)amino)propanoyl)octahydro-
1H-indole-2-carboxylate, 229 
 
To a stirred solution of (2S,3aS,7aS)-tert-butyl octahydro-1H-indole-2-carboxylate (650 
mg, 2.89 mmol) and N-Boc-L-Ala-OH (644.4 mg, 2.89 mmol) in DMF (3 mL) was added 
diisopropylethylamine (2.34 mL, 14.3 mmol), followed by EDCI (608 mg, 3.18 mmol) and 
HOBt (430 mg, 3.18 mmol). The reaction mixture was stirred overnight at room 
temperature, diluted with H2O (30 mL), extracted into EtOAc, washed sequentially with 1M 
HCl (aq.) brine, NaHCO3 (sat. aq.), brine, then dried over Na2SO4 and concentrated under 
reduced pressure. Purification via flash column chromatography (4:1 to 1:1 
nhexane:EtOAc) afforded the title compound as a white foam (1.0831 g, 95%); [α]D22 -37.0 
(c = 1.29, CHCl3); νmax / cm-1 3297, 2977, 2933, 2860, 1717, 1636, 1529, 1459, 1367, 
1244, 1157, 1067; δH (400 MHz, CDCl3) 7.39-7.27 (5H, m, 5 x ArH), 5.51 (1H, d, J 8.6, 
NH), 5.16-5.0 (2H, m, CH2Ph), 4.54 (1H, dq, J 8.7 and 6.8, CHCH3), 4.29 (1H, dd, J 10.4 
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and 7.9, NCHCO2tBu), 4.05 (1H, dt, J 12.1 and 6.4, NCHCH), 2.37 (1H, dq, J 11.9 and 6.3, 
NCHCH), 2.10 (1H, dt, J 12.4 and 7.2, NCH(CO2tBu)CHH), 1.98-1.84 (2H, m, 
NCH(CO2tBu)CHH and alkyl CHH), 1.79-1.55 (3H, m, 3 x alkyl CHH), 1.54-1.40 (11H, m, 
C(CH3)3 and 2 x alkyl CHH), 1.39-1.12 (5H, CH3 and 2 x alkyl CHH); δC (101 MHz, CDCl3) 
171.5, 171.3, 155.8, 136.5, 128.6, 128.1, 128.0, 81.2, 66.8, 59.9, 58.1, 47.7, 36.6, 30.5, 
28.7, 28.04, 25.72 (2 x CH2), 23.25, 20.0; m/z (ES+) 453 (100% [MNa]+), 431 (45%, 
[MH]+), 375 (14%); HRMS (ES+/TOF) found 453.2374, C24H34N2O5Na requires 453.2365. 
 
(2S,3aS,7aS)-tert-Butyl 1-(2-aminopropanoyl)octahydro-1H-indole-2-carboxylate, 230 
 
To a stirred solution of (2S,3aS,7aS)-tert-butyl 1-((S)-2-
(((benzyloxy)carbonyl)amino)propanoyl)octahydro-1H-indole-2-carboxylate (951 mg, 2.36 
mmol) in MeOH (9.5 mL) was added 10% Pd on carbon (95.1 mg). The reaction was 
stirred for 15 hours under hydrogen, the reaction mixture was then filtered through Celite 
and concentrated under reduced pressure to afford the title compound as a white solid 
(697 mg, 99%); m.p. 207-209 °C; [α]D20 -72.3 (c = 0.933, CHCl3); νmax / cm-1 3149, 2974, 
2924, 2861, 2787, 2687, 2586, 1743, 1656, 1603, 1366, 1156; δH (400 MHz, CDCl3) 6.01 
(2H, br s, NH2), 4.40 (1H, dd, J 10.3 and 7.8, NCHCO2tBu), 4.21 (1H, q, J 6.6, CHCH3), 
4.11 (1H, dt, J 12.2 and 6.3, NCHCH), 2.58-2.44 (1H, m, NCHCH), 2.15 (1H, dt, J 12.5 and 
7.3, NCH(CO2tBu)CHH), 1.98-1.78 (2H, m, NCH(CO2tBu)CHH and 1 x alkyl CHH), 1.77-
1.62 (3H, m, 3 x alkyl CHH), 1.61-1.35 (14H, m, CH3 and C(CH3)3 and 2 x alkyl CHH), 
1.35-1.17 (2H, m, 2 x alkyl CHH); δC (101 MHz, CDCl3) 171.1, 169.3, 81.3, 60.3, 58.7, 
47.8, 37.2, 30.5, 28.6, 28.1, 25.6, 23.9, 20.1, 18.6; m/z (ES+) 360 (43%, [M+MeCN+Na]+), 
297 (100%, [MH]+), 241 (48%); HRMS (ES+/TOF) found 297.2177, C16H29N2O3 requires 
297.2178. 
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(2S,3aS,7aS)-tert-Butyl 1-((S)-2-(((S,E)-1-ethoxy-1-oxopent-3-en-2-yl)amino) 
propanoyl)octahydro-1H-indole-2-carboxylate, 231 
 
To a stirred solution of (2S,3aS,7aS)-tert-butyl 1-(2-aminopropanoyl)octahydro-1H-indole-
2-carboxylate (220 mg, 0.74 mmol) and (S)-ethyl 4-phenylselanylbut-2-(E)-enoate (325 
mg, 1.11 mmol) in dry methanol (3.7 mL) was added trimethylorthoformate (479 μL, 4.38 
mmol) and para-toluene sulfonic acid (1 mg). The solution was stirred at room temperature 
for 30 minutes and then cooled to -20 °C. Diisopropylethyl amine (776 μL, 4.45 mmol) then 
N-chlorosuccinimide (293 mg, 2.23 mmol) were added. The solution was stirred at     -20 
°C for 2 hours, then 1M HCl (aq., 5 mL) was added, followed by NaHCO3 (sat. aq., 5 mL). 
The reaction was extracted into EtOAc, washed brine, dried over Na2SO4 and 
concentrated under reduced pressure. Purification via flash column chromatography (2:1 
to 1:1 nhexane:EtOAc) afforded the title compound as an clear oil (123 mg, 40%); [α]D18       
-35.9 (c = 1.17, CHCl3); νmax / cm-1 2977, 2931, 1738, 1642, 1423, 1367, 1286, 1257, 
1158; δH (400 MHz, CDCl3) 5.77-56.7 (1H, m, CH3CH=CH), 5.43 (1H, ddd, J 15.3, 8.1 and 
1.7, CH3CH=CH), 4.30 (1H, dd, J 10.3 and 7.8, NCHCO2tBu), 4.21-4.04 (3H, m, NH and 
CO2CH2CH3), 3.79-3.63 (2H, m, NCHCH(CH2)), 3.45 (1H, q, J 6.6, CHCH3), 2.3-2.27 (1H, 
m, NCHC=C), 2.14-2.06 (1H, m, NCH(CO2tBu)CHH), 1.97-1.87 (1H, m, 
NCH(CO2tBu)CHH), 1.85-1.39 (18H, m, includes C(CH3)3, CH=CHCH3 and 6 x alkyl CHH), 
1.33-1.07 (8H, m, includes CO2CH2CH3, CHCH3 and 2 x alkyl CHH); the following distinct 
signals for the Z-isomer were observed 5.36 (1H, ddd, J 10.9, 9.3 and 1.8), 3.50 (1H, q, J 
6.7) and the E:Z ratio was determined to be 4:1 by integration of the signals at 5.43 and 
5.36 respectively; δC (101 MHz, CDCl3) 173.8, 172.6, 171.4, 130.6, 127.9, 81.1, 63.1, 
61.1, 60.0, 58.0, 56.1, 52.4, 37.8, 30.5, 28.0, 26.0, 23.9, 20.4, 20.1, 17.9, 14.3; the 
following distinct signals were observed for the Z-isomer δC (101 MHz, CDCl3) 130.0, 81.2, 
61.3, 56.3, 51.3, 37.9, 30.3, 28.7, 20.5; m/z (ES+) 423 (100%, [MH]+), 367 (15%); HRMS 
(ES+/TOF) found 423.2842, C23H39N2O5 requires 423.2359. 
Also isolated was: 
  
N
CO2tBu
H
H
O
H
N CO2Et
 229 
(2S)-1-[(2S,3aS,7aS)-2-[(Benzyloxy)carbonyl]-octahydro-1H-indol-1-yl]-1-oxopropyl-
2-ammonium trifluoroacetate, 221 
 
White solid (66 mg, 40%), m.p. 167-169 °C. All data was in agreement with that reported 
above. 
 
(2S,3aS,7aS)-tert-Butyl 1-((S)-2-(((S)-1-ethoxy-1-oxopentan-2-yl)amino)propanoyl) 
octahydro-1H-indole-2-carboxylate, 232 
 
Preparation of (2S,3aS,7aS)-tert-butyl 1-((S)-2-(((S,E)-1-ethoxy-1-oxopent-3-en-2-
yl)amino)propanoyl)octahydro-1H-indole-2-carboxylate (125 mg, 0.29 mmol) was 
dissolved in MeOH (2 mL) and was reduced using a H-Cube (10% Pd/C, 4 bar, 1 
mLmin-1). After one pass through the column, the reaction mixture was concentrated under 
reduced pressure to afford the title compound as a clear oil (121 mg, 96%); νmax / cm-1 
3460, 3329, 2973, 2935, 2874, 1734, 1644, 1468, 1449, 1422, 1366, 1156; δH (400 MHz, 
CDCl3) 4.34 (1H, dd, J 10.3 and 7.9, NCHCO2tBu), 4.20 (2H, q, J 7.1, CO2CH2CH3), 3.77 
(1H, dt, J 12.1 and 6.3, NCHCH(CH2)), 3.52 (1H, q, J 6.6, CHCH3), 3.11 (1H, t, J 6.8, 
NCHCO2Et), 2.62 (1H, dt, J 12.2 and 6.0, NCHCH(CH2)), 2.12 (1H, ddd, J 12.4, 7.9 and 
6.6, NCH(CO2tBu)CHH) 1.98-1.68 (3H, m, includes NCH(CO2tBu)CHH and 2 x alkyl CHH), 
1.84-1.49 (8H, m, 8 x alkyl CHH), 1.45 (9H, s, C(CH3)3), 1.37-1.20 (8H, m, includes 
O2CH2CH3, CHCH3  and 2 x alkyl CHH), 0.88 (3H, t, J 7.3, CHCH2CH3); δC (101 MHz, 
CDCl3) 174.6, 173.5, 171.3, 81.0, 60.6, 60.0, 59.7, 58.0, 52.7, 27.6, 25.6, 30.3, 28.6, 27.0, 
25.8, 23.9, 20.2, 20.0, 19.0, 14.3, 13.0; m/z (ES+) 425 (100%, [MH]+); HRMS (ES+/TOF) 
found 425.3016, C23H41N2O5 requires 425.3015. 
 
The diastereomeric mixture was prepared over two steps from racemic (S)-ethyl 4-
phenylselanylbut-2-(E)-enoate. Spectroscopic data agreed with the material above; the 
following additional signals were observed for the other diastereomer; δH (400 MHz, 
N NH
O
O
H
H
N
CO2tBu
H
H
O
H
N CO2Et
 230 
CDCl3) 3.25 (1H, t, J 3.25); δC (101 MHz, CDCl3) 172.0, 82.2, 60.4, 59.5, 58.5, 54.1, 33.1, 
26.5, 25.5, 23.7, 20.3, 14.2. The diastereomeric ratio of the material derived from the 
enantiomerically enriched allylic selenide was determined to be 96:4 by integration of the 
1H NMR signals at 3.25 (minor) and 3.11 (major) ppm. 
  
 231 
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